data_2met_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2met _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.2 t . . . . . 0 N--CA 1.449 -0.507 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.519 ' HA ' HG13 ' A' ' 7' ' ' ILE . 1.5 t-20 -42.92 -51.12 5.68 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 14.0 mt -42.99 -48.52 5.97 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.578 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 0.8 OUTLIER -64.66 -31.36 72.55 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.916 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.538 ' HA ' HD22 ' B' ' 110' ' ' LEU . 4.0 mt -65.23 -30.23 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 23.7 mt -76.73 -42.11 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.421 ' O ' ' HB ' ' A' ' 13' ' ' THR . 53.7 mt -76.87 -24.29 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.532 HD13 ' CD1' ' B' ' 110' ' ' LEU . 15.4 mt -85.59 -46.77 10.49 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.517 ' HB3' ' HE2' ' A' ' 11' ' ' GLU . 57.1 mm-40 -59.37 -42.71 92.25 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.436 ' O ' ' CG1' ' A' ' 16' ' ' ILE . . . -72.56 -56.12 6.28 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.441 HG21 ' CD ' ' C' ' 211' ' ' GLU . 39.4 m -57.83 -25.88 61.25 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.421 ' CB ' ' O ' ' A' ' 10' ' ' LEU . . . -68.38 -63.05 1.14 Allowed 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.526 HG22 ' CG ' ' B' ' 118' ' ' MET . 2.7 t -68.56 -21.36 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.436 ' CG1' ' O ' ' A' ' 12' ' ' GLY . 29.2 mt -76.11 -64.7 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.89 -32.95 22.16 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.592 ' CE ' ' HE3' ' B' ' 118' ' ' MET . 6.4 mtp . . . . . 0 N--CA 1.449 -0.497 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 7.0 t . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . 0.523 ' HA ' HG13 ' B' ' 107' ' ' ILE . 1.5 t-20 -42.92 -51.15 5.67 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 14.1 mt -42.99 -48.57 5.97 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 106' ' ' GLU . . . . . 0.59 ' CD ' ' N ' ' B' ' 106' ' ' GLU . 0.8 OUTLIER -64.51 -31.41 72.61 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 107' ' ' ILE . . . . . 0.544 ' CG2' HD22 ' C' ' 210' ' ' LEU . 4.0 mt -65.2 -30.27 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 23.8 mt -76.72 -42.08 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 109' ' ' ILE . . . . . 0.417 ' O ' ' HB ' ' B' ' 113' ' ' THR . 54.1 mt -76.87 -24.29 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . 0.538 HD22 ' HA ' ' A' ' 7' ' ' ILE . 15.4 mt -85.53 -46.95 10.36 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 111' ' ' GLU . . . . . 0.491 ' HB3' ' HE2' ' B' ' 111' ' ' GLU . 57.8 mm-40 -59.37 -42.65 92.12 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 112' ' ' GLY . . . . . 0.433 ' O ' ' CG1' ' B' ' 116' ' ' ILE . . . -72.54 -56.16 6.27 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.281 -1.127 . . . . 0.0 110.281 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 113' ' ' THR . . . . . 0.437 HG21 ' CD ' ' A' ' 11' ' ' GLU . 38.5 m -57.96 -25.72 61.35 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 114' ' ' ALA . . . . . 0.423 ' CB ' ' O ' ' B' ' 110' ' ' LEU . . . -68.42 -62.99 1.15 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . 0.516 HG22 ' CG ' ' C' ' 218' ' ' MET . 2.7 t -68.73 -21.22 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 116' ' ' ILE . . . . . 0.433 ' CG1' ' O ' ' B' ' 112' ' ' GLY . 28.7 mt -76.18 -64.58 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -51.15 -33.0 24.92 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 118' ' ' MET . . . . . 0.592 ' HE3' ' CE ' ' A' ' 18' ' ' MET . 6.4 mtp . . . . . 0 N--CA 1.45 -0.474 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 203' ' ' THR . . . . . . . . . . . . . 7.0 t . . . . . 0 N--CA 1.449 -0.496 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 204' ' ' ASN . . . . . 0.507 ' HA ' HG13 ' C' ' 207' ' ' ILE . 1.5 t-20 -43.01 -51.21 5.76 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 205' ' ' LEU . . . . . . . . . . . . . 14.1 mt -43.02 -48.44 6.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 206' ' ' GLU . . . . . 0.575 ' N ' ' CD ' ' C' ' 206' ' ' GLU . 0.8 OUTLIER -64.58 -31.43 72.64 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 207' ' ' ILE . . . . . 0.531 ' CG2' HD22 ' A' ' 10' ' ' LEU . 4.0 mt -65.18 -30.24 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 208' ' ' ILE . . . . . . . . . . . . . 23.7 mt -76.72 -42.17 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 209' ' ' ILE . . . . . 0.412 ' O ' ' HB ' ' C' ' 213' ' ' THR . 54.1 mt -76.8 -24.27 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 210' ' ' LEU . . . . . 0.544 HD22 ' CG2' ' B' ' 107' ' ' ILE . 15.4 mt -85.61 -46.62 10.62 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 211' ' ' GLU . . . . . 0.459 ' HE2' ' HB3' ' C' ' 211' ' ' GLU . 57.2 mm-40 -59.42 -42.75 92.58 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 212' ' ' GLY . . . . . 0.434 ' O ' ' CG1' ' C' ' 216' ' ' ILE . . . -72.58 -56.05 6.3 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 213' ' ' THR . . . . . 0.435 HG21 ' CD ' ' B' ' 111' ' ' GLU . 38.2 m -57.93 -25.94 61.56 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 214' ' ' ALA . . . . . 0.422 ' CB ' ' O ' ' C' ' 210' ' ' LEU . . . -68.28 -63.07 1.13 Allowed 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 215' ' ' VAL . . . . . 0.514 HG22 ' CG ' ' A' ' 18' ' ' MET . 2.7 t -68.52 -21.42 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 216' ' ' ILE . . . . . 0.434 ' CG1' ' O ' ' C' ' 212' ' ' GLY . 28.5 mt -76.03 -64.66 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -51.0 -32.77 22.3 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 218' ' ' MET . . . . . 0.584 ' HE3' ' CE ' ' B' ' 118' ' ' MET . 6.2 mtp . . . . . 0 N--CA 1.449 -0.523 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.43 HG23 ' HG3' ' B' ' 106' ' ' GLU . 98.1 m . . . . . 0 N--CA 1.448 -0.545 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.499 ' HA ' HG13 ' A' ' 7' ' ' ILE . 5.9 p-10 -42.91 -50.65 5.76 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.471 ' N ' ' CG ' ' A' ' 4' ' ' ASN . 13.0 mt -43.51 -47.32 7.22 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.584 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 1.0 OUTLIER -66.04 -31.09 71.77 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.538 ' CG2' ' CD2' ' B' ' 110' ' ' LEU . 5.3 mt -64.69 -31.92 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 31.0 mt -75.75 -42.89 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.428 ' O ' ' HB ' ' A' ' 13' ' ' THR . 62.5 mt -74.34 -27.56 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.536 ' CD2' ' CG2' ' C' ' 207' ' ' ILE . 15.1 mt -83.16 -41.69 18.2 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.448 ' CD ' HG23 ' B' ' 113' ' ' THR . 34.5 mm-40 -58.54 -49.23 78.16 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.438 ' C ' HD13 ' A' ' 16' ' ' ILE . . . -69.91 -59.69 5.38 Favored Glycine 0 C--N 1.335 0.515 0 N-CA-C 110.294 -1.123 . . . . 0.0 110.294 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.491 ' HA ' HD11 ' A' ' 16' ' ' ILE . 23.6 m -49.05 -37.06 19.75 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.443 ' N ' ' OE1' ' C' ' 211' ' ' GLU . . . -60.08 -62.89 1.54 Allowed 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.504 HG23 ' CG ' ' B' ' 118' ' ' MET . 3.0 t -63.75 -21.16 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.491 HD11 ' HA ' ' A' ' 13' ' ' THR . 27.8 mt -70.73 -64.63 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.48 -35.63 30.0 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.622 ' HE1' ' CE ' ' C' ' 218' ' ' MET . 4.8 mtp . . . . . 0 N--CA 1.448 -0.533 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 103' ' ' THR . . . . . 0.416 HG23 ' HG3' ' C' ' 206' ' ' GLU . 98.6 m . . . . . 0 N--CA 1.449 -0.512 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . 0.507 ' HA ' HG13 ' B' ' 107' ' ' ILE . 5.9 p-10 -42.93 -50.47 5.8 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . 0.471 ' N ' ' CG ' ' B' ' 104' ' ' ASN . 13.1 mt -43.62 -47.3 7.54 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 106' ' ' GLU . . . . . 0.581 ' CD ' ' N ' ' B' ' 106' ' ' GLU . 1.0 OUTLIER -66.09 -30.98 71.59 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 107' ' ' ILE . . . . . 0.524 ' CG2' HD23 ' C' ' 210' ' ' LEU . 5.3 mt -64.75 -31.89 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 31.1 mt -75.72 -42.88 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 109' ' ' ILE . . . . . 0.41 ' O ' ' HB ' ' B' ' 113' ' ' THR . 62.4 mt -74.35 -27.61 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . 0.538 ' CD2' ' CG2' ' A' ' 7' ' ' ILE . 15.1 mt -83.19 -41.7 18.14 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 111' ' ' GLU . . . . . 0.431 ' OE1' ' N ' ' C' ' 214' ' ' ALA . 34.9 mm-40 -58.54 -49.19 78.32 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 112' ' ' GLY . . . . . 0.444 ' C ' HD13 ' B' ' 116' ' ' ILE . . . -70.01 -59.71 5.32 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 113' ' ' THR . . . . . 0.495 ' HA ' HD11 ' B' ' 116' ' ' ILE . 23.6 m -48.96 -37.07 19.04 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 114' ' ' ALA . . . . . 0.441 ' N ' ' OE1' ' A' ' 11' ' ' GLU . . . -60.11 -62.9 1.53 Allowed 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . 0.504 ' CG1' ' HG2' ' C' ' 218' ' ' MET . 3.0 t -63.72 -21.17 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 116' ' ' ILE . . . . . 0.495 HD11 ' HA ' ' B' ' 113' ' ' THR . 27.8 mt -70.67 -64.71 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -50.45 -35.53 29.25 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 118' ' ' MET . . . . . 0.603 ' HE1' ' CE ' ' A' ' 18' ' ' MET . 4.7 mtp . . . . . 0 N--CA 1.449 -0.482 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 203' ' ' THR . . . . . 0.426 HG23 ' HG3' ' A' ' 6' ' ' GLU . 97.9 m . . . . . 0 N--CA 1.449 -0.482 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 204' ' ' ASN . . . . . 0.496 ' HA ' HG13 ' C' ' 207' ' ' ILE . 5.8 p-10 -42.98 -50.4 5.88 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 205' ' ' LEU . . . . . 0.458 ' N ' ' CG ' ' C' ' 204' ' ' ASN . 13.1 mt -43.54 -47.35 7.31 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 206' ' ' GLU . . . . . 0.577 ' N ' ' CD ' ' C' ' 206' ' ' GLU . 1.0 OUTLIER -66.05 -31.14 71.85 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 207' ' ' ILE . . . . . 0.536 ' CG2' ' CD2' ' A' ' 10' ' ' LEU . 5.3 mt -64.67 -31.8 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 208' ' ' ILE . . . . . . . . . . . . . 30.9 mt -75.83 -42.97 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 209' ' ' ILE . . . . . 0.423 ' O ' ' HB ' ' C' ' 213' ' ' THR . 62.3 mt -74.32 -27.49 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 210' ' ' LEU . . . . . 0.524 HD11 ' CD1' ' A' ' 10' ' ' LEU . 15.1 mt -83.21 -41.64 18.18 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 211' ' ' GLU . . . . . 0.456 ' CD ' HG23 ' A' ' 13' ' ' THR . 34.5 mm-40 -58.58 -49.13 78.58 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 212' ' ' GLY . . . . . 0.434 ' C ' HD13 ' C' ' 216' ' ' ILE . . . -70.1 -59.68 5.3 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 213' ' ' THR . . . . . 0.492 ' HA ' HD11 ' C' ' 216' ' ' ILE . 23.7 m -48.92 -37.14 18.99 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 214' ' ' ALA . . . . . 0.431 ' N ' ' OE1' ' B' ' 111' ' ' GLU . . . -60.08 -62.9 1.53 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 215' ' ' VAL . . . . . 0.519 ' CG1' ' HG2' ' A' ' 18' ' ' MET . 3.0 t -63.73 -21.09 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 216' ' ' ILE . . . . . 0.492 HD11 ' HA ' ' C' ' 213' ' ' THR . 27.8 mt -70.73 -64.63 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -50.49 -35.47 29.34 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 218' ' ' MET . . . . . 0.622 ' CE ' ' HE1' ' A' ' 18' ' ' MET . 4.7 mtp . . . . . 0 N--CA 1.449 -0.49 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.753 ' HG1' ' CG ' ' B' ' 106' ' ' GLU . 5.4 t . . . . . 0 N--CA 1.449 -0.523 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.518 ' HA ' HG13 ' A' ' 7' ' ' ILE . 1.4 t-20 -42.87 -50.35 5.74 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.419 ' HA ' HD23 ' A' ' 5' ' ' LEU . 12.3 mt -43.07 -47.7 6.03 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.734 ' CG ' ' HG1' ' C' ' 203' ' ' THR . 2.2 mp0 -66.47 -30.89 71.33 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.551 ' CG2' ' CD2' ' B' ' 110' ' ' LEU . 5.2 mt -64.19 -32.1 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 24.3 mt -75.84 -44.02 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.413 ' O ' ' HB ' ' A' ' 13' ' ' THR . 98.3 mt -73.59 -25.51 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.546 HD21 ' CG2' ' C' ' 207' ' ' ILE . 15.5 mt -85.44 -41.3 15.52 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.446 ' CD ' HG22 ' B' ' 113' ' ' THR . 37.4 mm-40 -58.88 -45.9 89.12 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.445 ' C ' HD13 ' A' ' 16' ' ' ILE . . . -73.42 -55.06 6.33 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.454 HG22 ' CD ' ' C' ' 211' ' ' GLU . 22.9 m -55.08 -31.05 60.88 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.444 ' CB ' ' O ' ' A' ' 10' ' ' LEU . . . -66.43 -63.2 1.13 Allowed 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.821 -0.436 . . . . 0.0 109.821 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.512 HG23 ' CG ' ' B' ' 118' ' ' MET . 2.8 t -64.31 -21.37 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.445 HD13 ' C ' ' A' ' 12' ' ' GLY . 22.3 mt -73.59 -64.69 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.55 -26.18 20.2 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.577 ' HE1' ' HE1' ' C' ' 218' ' ' MET . 11.6 mtp . . . . . 0 N--CA 1.449 -0.503 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 103' ' ' THR . . . . . 0.749 ' HG1' ' CG ' ' C' ' 206' ' ' GLU . 5.3 t . . . . . 0 N--CA 1.449 -0.499 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . 0.525 ' HA ' HG13 ' B' ' 107' ' ' ILE . 1.4 t-20 -42.91 -50.35 5.8 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . 0.429 ' HA ' HD23 ' B' ' 105' ' ' LEU . 12.3 mt -43.22 -47.58 6.43 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 106' ' ' GLU . . . . . 0.753 ' CG ' ' HG1' ' A' ' 3' ' ' THR . 2.2 mp0 -66.42 -31.02 71.52 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 107' ' ' ILE . . . . . 0.547 ' CG2' HD21 ' C' ' 210' ' ' LEU . 5.2 mt -64.08 -32.02 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 24.1 mt -75.93 -44.19 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 109' ' ' ILE . . . . . 0.414 ' O ' ' HB ' ' B' ' 113' ' ' THR . 98.2 mt -73.43 -25.54 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . 0.551 ' CD2' ' CG2' ' A' ' 7' ' ' ILE . 15.5 mt -85.38 -41.45 15.45 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 111' ' ' GLU . . . . . 0.455 ' CD ' HG22 ' C' ' 213' ' ' THR . 37.2 mm-40 -58.57 -45.91 88.04 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 112' ' ' GLY . . . . . 0.436 ' C ' HD13 ' B' ' 116' ' ' ILE . . . -73.57 -55.39 6.07 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 113' ' ' THR . . . . . 0.446 HG22 ' CD ' ' A' ' 11' ' ' GLU . 23.2 m -54.69 -30.94 57.03 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 114' ' ' ALA . . . . . 0.452 ' CB ' ' O ' ' B' ' 110' ' ' LEU . . . -66.66 -63.32 1.09 Allowed 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . 0.517 HG12 ' HG2' ' C' ' 218' ' ' MET . 2.7 t -64.07 -21.35 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 116' ' ' ILE . . . . . 0.436 HD13 ' C ' ' B' ' 112' ' ' GLY . 23.0 mt -73.55 -64.67 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -53.59 -25.99 19.76 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 118' ' ' MET . . . . . 0.582 ' HE1' ' HE1' ' C' ' 218' ' ' MET . 11.5 mtp . . . . . 0 N--CA 1.45 -0.473 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 203' ' ' THR . . . . . 0.734 ' HG1' ' CG ' ' A' ' 6' ' ' GLU . 5.3 t . . . . . 0 N--CA 1.449 -0.513 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 204' ' ' ASN . . . . . 0.536 ' HA ' HG13 ' C' ' 207' ' ' ILE . 1.4 t-20 -42.86 -50.61 5.7 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 205' ' ' LEU . . . . . . . . . . . . . 12.4 mt -43.13 -47.48 6.15 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 206' ' ' GLU . . . . . 0.749 ' CG ' ' HG1' ' B' ' 103' ' ' THR . 2.2 mp0 -66.43 -30.92 71.38 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 207' ' ' ILE . . . . . 0.546 ' CG2' HD21 ' A' ' 10' ' ' LEU . 5.3 mt -64.26 -32.0 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 208' ' ' ILE . . . . . . . . . . . . . 24.1 mt -75.94 -43.92 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 209' ' ' ILE . . . . . 0.42 ' O ' ' HB ' ' C' ' 213' ' ' THR . 98.3 mt -73.6 -25.63 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.722 -0.474 . . . . 0.0 109.722 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 210' ' ' LEU . . . . . 0.547 HD21 ' CG2' ' B' ' 107' ' ' ILE . 15.5 mt -85.38 -41.26 15.62 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 211' ' ' GLU . . . . . 0.454 ' CD ' HG22 ' A' ' 13' ' ' THR . 37.3 mm-40 -58.9 -45.88 89.2 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 212' ' ' GLY . . . . . 0.442 ' C ' HD13 ' C' ' 216' ' ' ILE . . . -73.48 -55.09 6.28 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.291 -1.123 . . . . 0.0 110.291 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 213' ' ' THR . . . . . 0.455 HG22 ' CD ' ' B' ' 111' ' ' GLU . 22.8 m -55.04 -31.14 60.87 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 214' ' ' ALA . . . . . 0.451 ' CB ' ' O ' ' C' ' 210' ' ' LEU . . . -66.39 -63.36 1.09 Allowed 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 215' ' ' VAL . . . . . 0.508 HG23 ' CG ' ' A' ' 18' ' ' MET . 2.8 t -64.07 -21.55 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 216' ' ' ILE . . . . . 0.442 HD13 ' C ' ' C' ' 212' ' ' GLY . 22.2 mt -73.44 -64.67 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -53.57 -26.05 19.84 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 218' ' ' MET . . . . . 0.582 ' HE1' ' HE1' ' B' ' 118' ' ' MET . 11.6 mtp . . . . . 0 N--CA 1.45 -0.457 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.45 -0.468 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.525 ' HA ' HG13 ' A' ' 7' ' ' ILE . 1.1 t-20 -42.74 -51.05 5.48 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 13.1 mt -43.01 -48.9 6.07 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.587 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 2.6 mp0 -64.13 -31.63 72.9 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.525 HG13 ' HA ' ' A' ' 4' ' ' ASN . 3.8 mt -65.25 -29.89 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.8 mt -76.77 -42.13 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.427 ' O ' ' HB ' ' A' ' 13' ' ' THR . 83.4 mt -77.3 -23.82 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.533 HD23 ' CG2' ' C' ' 207' ' ' ILE . 15.5 mt -85.7 -49.75 7.72 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.441 ' CD ' HG21 ' B' ' 113' ' ' THR . 58.7 mm-40 -59.01 -40.42 84.87 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.429 ' O ' ' CG1' ' A' ' 16' ' ' ILE . . . -73.27 -57.52 5.11 Favored Glycine 0 C--N 1.335 0.509 0 N-CA-C 110.276 -1.129 . . . . 0.0 110.276 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.433 HG21 ' CD ' ' C' ' 211' ' ' GLU . 49.5 m -57.78 -25.18 60.17 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.416 ' CB ' ' O ' ' A' ' 10' ' ' LEU . . . -68.79 -62.92 1.18 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.6 t -69.04 -21.08 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.429 ' CG1' ' O ' ' A' ' 12' ' ' GLY . 22.4 mt -77.31 -64.85 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.15 -32.07 21.84 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.589 ' CE ' ' HE2' ' B' ' 118' ' ' MET . 6.7 mtp . . . . . 0 N--CA 1.449 -0.506 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.449 -0.51 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . 0.52 ' HA ' HG13 ' B' ' 107' ' ' ILE . 1.1 t-20 -42.72 -51.09 5.44 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 13.1 mt -42.81 -48.92 5.79 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 106' ' ' GLU . . . . . 0.589 ' CD ' ' N ' ' B' ' 106' ' ' GLU . 2.6 mp0 -64.27 -31.65 72.94 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 107' ' ' ILE . . . . . 0.525 ' CG2' HD23 ' C' ' 210' ' ' LEU . 3.8 mt -65.34 -29.75 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 39.4 mt -76.82 -42.17 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 109' ' ' ILE . . . . . 0.418 ' O ' ' HB ' ' B' ' 113' ' ' THR . 84.1 mt -77.3 -23.81 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . 0.523 HD23 ' HA ' ' A' ' 7' ' ' ILE . 15.5 mt -85.67 -50.23 7.36 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 111' ' ' GLU . . . . . 0.447 ' CD ' HG21 ' C' ' 213' ' ' THR . 59.3 mm-40 -58.88 -40.19 83.67 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 112' ' ' GLY . . . . . 0.427 ' O ' ' CG1' ' B' ' 116' ' ' ILE . . . -73.32 -57.58 5.05 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 113' ' ' THR . . . . . 0.441 HG21 ' CD ' ' A' ' 11' ' ' GLU . 49.5 m -57.81 -25.17 60.23 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 114' ' ' ALA . . . . . 0.41 ' CB ' ' O ' ' B' ' 110' ' ' LEU . . . -68.78 -63.11 1.12 Allowed 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . 0.423 HG21 ' CG ' ' C' ' 218' ' ' MET . 2.5 t -68.9 -21.09 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 116' ' ' ILE . . . . . 0.427 ' CG1' ' O ' ' B' ' 112' ' ' GLY . 22.6 mt -77.28 -64.81 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -51.01 -32.24 20.72 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 118' ' ' MET . . . . . 0.601 ' CE ' ' HE2' ' C' ' 218' ' ' MET . 6.6 mtp . . . . . 0 N--CA 1.449 -0.482 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 203' ' ' THR . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.448 -0.529 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 204' ' ' ASN . . . . . 0.504 ' HA ' HG13 ' C' ' 207' ' ' ILE . 1.1 t-20 -42.75 -51.23 5.43 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 205' ' ' LEU . . . . . . . . . . . . . 13.1 mt -42.89 -48.91 5.9 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 206' ' ' GLU . . . . . 0.58 ' N ' ' CD ' ' C' ' 206' ' ' GLU . 2.6 mp0 -64.03 -31.67 72.94 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 207' ' ' ILE . . . . . 0.533 ' CG2' HD23 ' A' ' 10' ' ' LEU . 3.8 mt -65.24 -29.93 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 208' ' ' ILE . . . . . . . . . . . . . 40.4 mt -76.67 -42.11 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 209' ' ' ILE . . . . . 0.414 ' O ' ' HB ' ' C' ' 213' ' ' THR . 84.0 mt -77.36 -23.87 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 210' ' ' LEU . . . . . 0.525 HD23 ' CG2' ' B' ' 107' ' ' ILE . 15.5 mt -85.66 -50.2 7.39 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 211' ' ' GLU . . . . . 0.442 ' CG ' ' O ' ' C' ' 207' ' ' ILE . 59.2 mm-40 -58.8 -40.39 83.93 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 212' ' ' GLY . . . . . 0.428 ' O ' ' CG1' ' C' ' 216' ' ' ILE . . . -73.28 -57.55 5.09 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 213' ' ' THR . . . . . 0.447 HG21 ' CD ' ' B' ' 111' ' ' GLU . 48.6 m -57.76 -25.2 60.14 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 214' ' ' ALA . . . . . 0.416 ' CB ' ' O ' ' C' ' 210' ' ' LEU . . . -68.69 -63.13 1.12 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 215' ' ' VAL . . . . . 0.462 HG21 ' CG ' ' A' ' 18' ' ' MET . 2.5 t -68.97 -21.11 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 216' ' ' ILE . . . . . 0.428 ' CG1' ' O ' ' C' ' 212' ' ' GLY . 22.0 mt -77.02 -64.8 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -51.07 -32.42 22.08 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 218' ' ' MET . . . . . 0.601 ' HE2' ' CE ' ' B' ' 118' ' ' MET . 6.5 mtp . . . . . 0 N--CA 1.449 -0.507 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.45 HG21 ' HG3' ' B' ' 106' ' ' GLU . 96.0 m . . . . . 0 N--CA 1.449 -0.484 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.705 ' ND2' ' H ' ' A' ' 5' ' ' LEU . 0.3 OUTLIER -42.6 -50.71 5.35 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.94 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.705 ' H ' ' ND2' ' A' ' 4' ' ' ASN . 16.1 mt -43.46 -48.33 7.21 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.596 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 2.7 mp0 -64.67 -31.56 72.84 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.545 ' CG2' HD22 ' B' ' 110' ' ' LEU . 4.9 mt -65.2 -30.38 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 60.7 mt -76.48 -42.17 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.419 ' O ' ' HB ' ' A' ' 13' ' ' THR . 32.0 mt -76.54 -25.22 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.545 HD22 ' HA ' ' C' ' 207' ' ' ILE . 15.1 mt -84.6 -46.46 11.52 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.448 ' CD ' HG21 ' B' ' 113' ' ' THR . 52.1 mm-40 -58.67 -45.14 90.04 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.58 -57.92 6.25 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.446 HG21 ' CD ' ' C' ' 211' ' ' GLU . 44.9 m -55.69 -27.02 47.93 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.43 ' CB ' ' O ' ' A' ' 10' ' ' LEU . . . -66.45 -63.14 1.14 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.587 ' CG1' ' HG2' ' B' ' 118' ' ' MET . 2.9 t -67.49 -22.04 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.431 ' HB ' ' HA ' ' A' ' 13' ' ' THR . 34.8 mt -73.09 -64.54 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.78 -34.89 29.19 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.587 ' HG2' ' CG1' ' C' ' 215' ' ' VAL . 6.0 mtp . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 103' ' ' THR . . . . . 0.433 HG21 ' HG3' ' C' ' 206' ' ' GLU . 96.2 m . . . . . 0 N--CA 1.449 -0.493 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . 0.702 ' ND2' ' H ' ' B' ' 105' ' ' LEU . 0.3 OUTLIER -42.66 -50.8 5.43 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.934 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . 0.702 ' H ' ' ND2' ' B' ' 104' ' ' ASN . 16.2 mt -43.57 -48.24 7.52 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 106' ' ' GLU . . . . . 0.599 ' CD ' ' N ' ' B' ' 106' ' ' GLU . 2.7 mp0 -64.58 -31.42 72.63 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 107' ' ' ILE . . . . . 0.546 ' CG2' HD22 ' C' ' 210' ' ' LEU . 4.8 mt -65.31 -30.36 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 61.0 mt -76.53 -42.07 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 109' ' ' ILE . . . . . 0.428 ' O ' ' HB ' ' B' ' 113' ' ' THR . 32.0 mt -76.64 -25.2 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . 0.545 HD22 ' CG2' ' A' ' 7' ' ' ILE . 15.1 mt -84.58 -46.53 11.46 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 111' ' ' GLU . . . . . 0.439 ' CG ' ' O ' ' B' ' 107' ' ' ILE . 52.4 mm-40 -58.72 -45.14 90.27 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 112' ' ' GLY . . . . . . . . . . . . . . . -70.56 -57.76 6.38 Favored Glycine 0 C--N 1.335 0.521 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 113' ' ' THR . . . . . 0.448 HG21 ' CD ' ' A' ' 11' ' ' GLU . 45.1 m -55.82 -26.95 48.96 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 114' ' ' ALA . . . . . 0.436 ' CB ' ' O ' ' B' ' 110' ' ' LEU . . . -66.47 -63.12 1.14 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . 0.598 ' CG1' ' HG2' ' C' ' 218' ' ' MET . 2.9 t -67.58 -22.1 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 116' ' ' ILE . . . . . 0.434 ' HB ' ' HA ' ' B' ' 113' ' ' THR . 35.3 mt -73.09 -64.53 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -50.65 -35.05 28.78 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 118' ' ' MET . . . . . 0.587 ' HG2' ' CG1' ' A' ' 15' ' ' VAL . 6.0 mtp . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 203' ' ' THR . . . . . 0.45 HG23 ' HG2' ' A' ' 6' ' ' GLU . 96.3 m . . . . . 0 N--CA 1.449 -0.489 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 204' ' ' ASN . . . . . 0.69 ' ND2' ' H ' ' C' ' 205' ' ' LEU . 0.3 OUTLIER -42.56 -50.72 5.3 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 205' ' ' LEU . . . . . 0.69 ' H ' ' ND2' ' C' ' 204' ' ' ASN . 16.2 mt -43.6 -48.24 7.61 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 206' ' ' GLU . . . . . 0.595 ' N ' ' CD ' ' C' ' 206' ' ' GLU . 2.7 mp0 -64.66 -31.47 72.71 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 207' ' ' ILE . . . . . 0.545 ' HA ' HD22 ' A' ' 10' ' ' LEU . 4.8 mt -65.24 -30.35 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 208' ' ' ILE . . . . . . . . . . . . . 60.5 mt -76.59 -42.12 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 209' ' ' ILE . . . . . 0.415 ' O ' ' HB ' ' C' ' 213' ' ' THR . 31.8 mt -76.59 -25.21 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 210' ' ' LEU . . . . . 0.546 HD22 ' CG2' ' B' ' 107' ' ' ILE . 15.1 mt -84.62 -46.5 11.46 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 211' ' ' GLU . . . . . 0.446 ' CD ' HG21 ' A' ' 13' ' ' THR . 52.3 mm-40 -58.71 -45.04 90.45 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -70.66 -57.85 6.25 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 213' ' ' THR . . . . . 0.452 ' HA ' ' HB ' ' C' ' 216' ' ' ILE . 45.4 m -55.68 -27.11 48.4 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 214' ' ' ALA . . . . . 0.435 ' CB ' ' O ' ' C' ' 210' ' ' LEU . . . -66.51 -63.05 1.16 Allowed 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 215' ' ' VAL . . . . . 0.587 ' CG1' ' HG2' ' A' ' 18' ' ' MET . 3.0 t -67.6 -22.02 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 216' ' ' ILE . . . . . 0.452 ' HB ' ' HA ' ' C' ' 213' ' ' THR . 34.6 mt -73.19 -64.42 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -50.92 -34.78 29.97 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 218' ' ' MET . . . . . 0.598 ' HG2' ' CG1' ' B' ' 115' ' ' VAL . 6.0 mtp . . . . . 0 N--CA 1.449 -0.523 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.1 t . . . . . 0 N--CA 1.449 -0.481 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.502 ' HA ' HG13 ' A' ' 7' ' ' ILE . 1.6 t30 -42.84 -51.23 5.54 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 12.8 mt -42.99 -48.57 5.97 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.571 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 3.8 mp0 -64.54 -31.36 72.54 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.567 ' CG2' HD21 ' B' ' 110' ' ' LEU . 4.0 mt -65.17 -30.2 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 73.6 mt -76.75 -42.24 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.415 ' O ' ' HB ' ' A' ' 13' ' ' THR . 95.7 mt -76.75 -24.21 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.569 HD21 ' HA ' ' C' ' 207' ' ' ILE . 15.4 mt -85.6 -47.59 9.71 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.448 ' CG ' ' O ' ' A' ' 7' ' ' ILE . 57.5 mm-40 -58.95 -42.34 89.57 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.431 ' O ' ' CG1' ' A' ' 16' ' ' ILE . . . -72.65 -56.38 6.05 Favored Glycine 0 C--N 1.335 0.521 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.458 HG23 ' CD ' ' C' ' 211' ' ' GLU . 37.1 m -57.77 -25.4 60.45 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.413 ' CB ' ' O ' ' A' ' 10' ' ' LEU . . . -68.83 -63.14 1.12 Allowed 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.537 HG22 ' CG ' ' B' ' 118' ' ' MET . 2.7 t -68.56 -21.17 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.431 ' CG1' ' O ' ' A' ' 12' ' ' GLY . 34.9 mt -76.84 -64.65 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.02 -32.32 21.13 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.589 ' HE3' ' CE ' ' C' ' 218' ' ' MET . 6.4 mtp . . . . . 0 N--CA 1.449 -0.482 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 7.0 t . . . . . 0 N--CA 1.449 -0.493 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . 0.513 ' HA ' HG13 ' B' ' 107' ' ' ILE . 1.5 t30 -42.93 -51.24 5.65 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 12.8 mt -43.01 -48.49 6.0 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 106' ' ' GLU . . . . . 0.583 ' CD ' ' N ' ' B' ' 106' ' ' GLU . 3.8 mp0 -64.54 -31.46 72.69 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 107' ' ' ILE . . . . . 0.542 ' HA ' HD21 ' C' ' 210' ' ' LEU . 4.0 mt -65.14 -30.14 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 73.5 mt -76.77 -42.24 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 109' ' ' ILE . . . . . 0.427 ' O ' ' HB ' ' B' ' 113' ' ' THR . 95.6 mt -76.84 -24.12 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . 0.567 HD21 ' CG2' ' A' ' 7' ' ' ILE . 15.5 mt -85.62 -47.48 9.8 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 111' ' ' GLU . . . . . 0.452 ' CD ' HG23 ' C' ' 213' ' ' THR . 57.5 mm-40 -58.98 -42.45 89.98 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 112' ' ' GLY . . . . . 0.428 ' O ' ' CG1' ' B' ' 116' ' ' ILE . . . -72.67 -56.25 6.12 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.319 -1.113 . . . . 0.0 110.319 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 113' ' ' THR . . . . . 0.435 HG23 ' CD ' ' A' ' 11' ' ' GLU . 36.9 m -57.89 -25.32 60.66 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 114' ' ' ALA . . . . . 0.421 ' CB ' ' O ' ' B' ' 110' ' ' LEU . . . -68.85 -63.15 1.11 Allowed 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . 0.52 HG22 ' CG ' ' C' ' 218' ' ' MET . 2.7 t -68.54 -21.29 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 116' ' ' ILE . . . . . 0.428 ' CG1' ' O ' ' B' ' 112' ' ' GLY . 34.5 mt -76.66 -64.66 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -51.11 -32.11 21.51 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 118' ' ' MET . . . . . 0.602 ' CE ' ' HE3' ' C' ' 218' ' ' MET . 6.3 mtp . . . . . 0 N--CA 1.449 -0.482 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 203' ' ' THR . . . . . . . . . . . . . 7.1 t . . . . . 0 N--CA 1.449 -0.476 0 N-CA-C 109.946 -0.391 . . . . 0.0 109.946 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 204' ' ' ASN . . . . . 0.526 ' HA ' HG13 ' C' ' 207' ' ' ILE . 1.5 t30 -42.88 -51.14 5.63 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 205' ' ' LEU . . . . . . . . . . . . . 12.8 mt -43.04 -48.53 6.08 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 206' ' ' GLU . . . . . 0.574 ' N ' ' CD ' ' C' ' 206' ' ' GLU . 3.8 mp0 -64.58 -31.43 72.64 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 207' ' ' ILE . . . . . 0.569 ' HA ' HD21 ' A' ' 10' ' ' LEU . 4.0 mt -65.14 -30.19 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 208' ' ' ILE . . . . . . . . . . . . . 73.3 mt -76.77 -42.26 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 209' ' ' ILE . . . . . 0.409 ' O ' ' HB ' ' C' ' 213' ' ' THR . 95.6 mt -76.74 -24.24 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 210' ' ' LEU . . . . . 0.542 HD21 ' HA ' ' B' ' 107' ' ' ILE . 15.4 mt -85.58 -47.28 10.01 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 211' ' ' GLU . . . . . 0.458 ' CD ' HG23 ' A' ' 13' ' ' THR . 57.1 mm-40 -59.03 -42.52 90.38 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 212' ' ' GLY . . . . . 0.425 ' O ' ' CG1' ' C' ' 216' ' ' ILE . . . -72.64 -56.27 6.13 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 213' ' ' THR . . . . . 0.452 HG23 ' CD ' ' B' ' 111' ' ' GLU . 38.3 m -57.82 -25.47 60.67 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 214' ' ' ALA . . . . . 0.415 ' CB ' ' O ' ' C' ' 210' ' ' LEU . . . -68.76 -63.19 1.11 Allowed 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 215' ' ' VAL . . . . . 0.536 HG22 ' CG ' ' A' ' 18' ' ' MET . 2.7 t -68.5 -21.33 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 216' ' ' ILE . . . . . 0.425 ' CG1' ' O ' ' C' ' 212' ' ' GLY . 34.3 mt -76.61 -64.62 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -51.11 -32.11 21.48 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 218' ' ' MET . . . . . 0.602 ' HE3' ' CE ' ' B' ' 118' ' ' MET . 6.3 mtp . . . . . 0 N--CA 1.448 -0.534 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.4 t . . . . . 0 N--CA 1.449 -0.523 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.53 ' HA ' HG13 ' A' ' 7' ' ' ILE . 1.6 t-20 -42.78 -50.85 5.57 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 11.5 mt -42.9 -48.61 5.86 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.585 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 2.1 mp0 -64.8 -31.58 72.88 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.546 ' CG2' HD21 ' B' ' 110' ' ' LEU . 4.2 mt -64.81 -30.26 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 66.1 mt -76.8 -42.74 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.416 ' O ' ' HB ' ' A' ' 13' ' ' THR . 18.9 mt -76.19 -24.0 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.546 HD21 ' HA ' ' C' ' 207' ' ' ILE . 15.8 mt -85.7 -52.78 5.56 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.445 ' CG ' ' O ' ' A' ' 7' ' ' ILE . 66.5 mm-40 -55.8 -40.96 73.45 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.434 ' O ' ' CG1' ' A' ' 16' ' ' ILE . . . -72.65 -54.99 6.93 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.458 HG22 ' CD ' ' C' ' 211' ' ' GLU . 17.2 m -57.7 -25.88 60.95 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.19 -63.38 1.08 Allowed 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.519 HG22 ' CG ' ' B' ' 118' ' ' MET . 2.6 t -67.57 -21.14 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.434 ' CG1' ' O ' ' A' ' 12' ' ' GLY . 32.6 mt -76.55 -64.6 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.42 -32.04 16.65 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.596 ' CE ' ' HE1' ' B' ' 118' ' ' MET . 6.5 mtp . . . . . 0 N--CA 1.449 -0.497 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 6.3 t . . . . . 0 N--CA 1.449 -0.489 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . 0.507 ' HA ' HG13 ' B' ' 107' ' ' ILE . 1.6 t-20 -42.97 -51.16 5.73 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 11.5 mt -42.97 -48.42 5.92 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 106' ' ' GLU . . . . . 0.58 ' CD ' ' N ' ' B' ' 106' ' ' GLU . 2.2 mp0 -64.55 -31.89 73.3 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 107' ' ' ILE . . . . . 0.521 ' HA ' HD21 ' C' ' 210' ' ' LEU . 4.0 mt -64.85 -29.73 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 66.3 mt -77.01 -42.91 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 109' ' ' ILE . . . . . 0.424 ' O ' ' HB ' ' B' ' 113' ' ' THR . 18.9 mt -76.33 -23.9 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . 0.546 HD21 ' CG2' ' A' ' 7' ' ' ILE . 15.4 mt -85.67 -50.78 6.92 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 111' ' ' GLU . . . . . 0.449 ' CG ' ' O ' ' B' ' 107' ' ' ILE . 63.9 mm-40 -57.23 -40.64 77.96 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 112' ' ' GLY . . . . . 0.43 ' O ' ' CG1' ' B' ' 116' ' ' ILE . . . -73.49 -55.77 5.91 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 113' ' ' THR . . . . . 0.424 ' HB ' ' O ' ' B' ' 109' ' ' ILE . 22.2 m -57.86 -24.93 59.83 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.12 -62.69 1.29 Allowed 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 3.1 t -68.27 -21.1 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 116' ' ' ILE . . . . . 0.43 ' CG1' ' O ' ' B' ' 112' ' ' GLY . 45.6 mt -79.61 -65.2 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -53.81 -27.98 32.62 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.786 -0.449 . . . . 0.0 109.786 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 118' ' ' MET . . . . . 0.596 ' HE1' ' CE ' ' A' ' 18' ' ' MET . 11.9 mtp . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 203' ' ' THR . . . . . . . . . . . . . 6.3 t . . . . . 0 N--CA 1.449 -0.482 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 204' ' ' ASN . . . . . 0.515 ' HA ' HG13 ' C' ' 207' ' ' ILE . 1.6 t-20 -42.82 -51.12 5.56 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 205' ' ' LEU . . . . . . . . . . . . . 11.6 mt -42.95 -48.52 5.91 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 206' ' ' GLU . . . . . 0.574 ' N ' ' CD ' ' C' ' 206' ' ' GLU . 2.2 mp0 -64.66 -31.45 72.68 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 207' ' ' ILE . . . . . 0.546 ' HA ' HD21 ' A' ' 10' ' ' LEU . 4.2 mt -64.98 -30.28 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 208' ' ' ILE . . . . . . . . . . . . . 64.9 mt -76.74 -42.49 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 209' ' ' ILE . . . . . 0.424 ' O ' ' HB ' ' C' ' 213' ' ' THR . 18.7 mt -76.51 -24.09 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 210' ' ' LEU . . . . . 0.541 HD13 ' CD1' ' A' ' 10' ' ' LEU . 15.6 mt -85.71 -52.47 5.76 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 211' ' ' GLU . . . . . 0.458 ' CD ' HG22 ' A' ' 13' ' ' THR . 67.1 mm-40 -56.49 -40.69 75.38 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 212' ' ' GLY . . . . . 0.436 ' O ' ' CG1' ' C' ' 216' ' ' ILE . . . -72.7 -55.95 6.28 Favored Glycine 0 C--N 1.335 0.513 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 213' ' ' THR . . . . . 0.428 HG22 ' CD ' ' B' ' 111' ' ' GLU . 20.4 m -57.65 -25.3 60.0 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 214' ' ' ALA . . . . . . . . . . . . . . . -69.37 -63.26 1.1 Allowed 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 215' ' ' VAL . . . . . . . . . . . . . 2.8 t -68.15 -21.09 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 216' ' ' ILE . . . . . 0.436 ' CG1' ' O ' ' C' ' 212' ' ' GLY . 37.8 mt -77.53 -64.67 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -50.99 -30.93 16.42 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 218' ' ' MET . . . . . 0.594 ' HE1' ' HE1' ' B' ' 118' ' ' MET . 6.9 mtp . . . . . 0 N--CA 1.449 -0.499 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.505 HG22 ' CG ' ' B' ' 106' ' ' GLU . 1.6 m . . . . . 0 N--CA 1.449 -0.499 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.513 ' HA ' HG13 ' A' ' 7' ' ' ILE . 1.6 t30 -42.12 -47.22 4.54 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 12.3 mt -42.84 -50.34 5.7 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.587 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 0.1 OUTLIER -66.08 -32.17 73.48 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.912 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.526 ' CG2' HD21 ' B' ' 110' ' ' LEU . 3.6 mt -65.01 -29.76 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.404 HD12 HD22 ' A' ' 4' ' ' ASN . 44.6 mt -76.93 -42.52 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.421 ' O ' ' HB ' ' A' ' 13' ' ' THR . 29.4 mt -76.74 -24.04 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.534 HD21 ' CG2' ' C' ' 207' ' ' ILE . 15.3 mt -85.73 -48.14 9.11 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.45 ' CG ' ' O ' ' A' ' 7' ' ' ILE . 60.6 mm-40 -58.81 -41.79 87.62 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.434 ' O ' ' CG1' ' A' ' 16' ' ' ILE . . . -72.96 -56.24 5.93 Favored Glycine 0 C--N 1.336 0.555 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.436 HG23 ' CD ' ' C' ' 211' ' ' GLU . 31.8 m -57.88 -25.72 61.15 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.7 -63.09 1.13 Allowed 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.522 HG22 ' CG ' ' B' ' 118' ' ' MET . 2.7 t -68.31 -21.24 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.434 ' CG1' ' O ' ' A' ' 12' ' ' GLY . 30.5 mt -76.57 -64.68 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.93 -32.28 20.28 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.594 ' HE1' ' CE ' ' C' ' 218' ' ' MET . 6.5 mtp . . . . . 0 N--CA 1.448 -0.526 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 103' ' ' THR . . . . . 0.517 HG22 ' CG ' ' C' ' 206' ' ' GLU . 1.6 m . . . . . 0 N--CA 1.449 -0.482 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . 0.521 ' HA ' HG13 ' B' ' 107' ' ' ILE . 1.6 t30 -42.13 -47.33 4.57 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 12.3 mt -42.75 -50.32 5.59 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 106' ' ' GLU . . . . . 0.576 ' CD ' ' N ' ' B' ' 106' ' ' GLU . 0.1 OUTLIER -66.14 -32.2 73.5 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.928 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 107' ' ' ILE . . . . . 0.537 ' CG2' HD21 ' C' ' 210' ' ' LEU . 3.5 mt -65.0 -29.79 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 108' ' ' ILE . . . . . 0.414 HD12 HD22 ' B' ' 104' ' ' ASN . 44.7 mt -76.9 -42.53 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 109' ' ' ILE . . . . . 0.421 ' O ' ' HB ' ' B' ' 113' ' ' THR . 29.3 mt -76.71 -24.03 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . 0.526 HD21 ' CG2' ' A' ' 7' ' ' ILE . 15.3 mt -85.72 -47.63 9.58 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 111' ' ' GLU . . . . . 0.449 ' CG ' ' O ' ' B' ' 107' ' ' ILE . 59.7 mm-40 -59.07 -41.99 89.28 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 112' ' ' GLY . . . . . 0.425 ' O ' ' CG1' ' B' ' 116' ' ' ILE . . . -72.91 -56.15 6.01 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 113' ' ' THR . . . . . 0.427 HG23 ' CD ' ' A' ' 11' ' ' GLU . 32.8 m -57.88 -25.83 61.3 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 114' ' ' ALA . . . . . 0.41 ' CB ' ' O ' ' B' ' 110' ' ' LEU . . . -68.65 -63.07 1.13 Allowed 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . 0.498 HG22 ' CG ' ' C' ' 218' ' ' MET . 2.7 t -68.32 -21.27 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 116' ' ' ILE . . . . . 0.425 ' CG1' ' O ' ' B' ' 112' ' ' GLY . 30.1 mt -76.33 -64.62 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -51.16 -32.14 22.28 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 118' ' ' MET . . . . . 0.592 ' CE ' ' HE1' ' C' ' 218' ' ' MET . 6.3 mtp . . . . . 0 N--CA 1.449 -0.513 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 203' ' ' THR . . . . . 0.494 HG22 ' CG ' ' A' ' 6' ' ' GLU . 1.6 m . . . . . 0 N--CA 1.449 -0.483 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 204' ' ' ASN . . . . . 0.524 ' HA ' HG13 ' C' ' 207' ' ' ILE . 1.6 t30 -42.1 -47.28 4.52 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 205' ' ' LEU . . . . . . . . . . . . . 12.3 mt -42.82 -50.24 5.68 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 206' ' ' GLU . . . . . 0.588 ' N ' ' CD ' ' C' ' 206' ' ' GLU . 0.1 OUTLIER -66.17 -32.27 73.61 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.938 -0.394 . . . . 0.0 109.938 179.938 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 207' ' ' ILE . . . . . 0.534 ' CG2' HD21 ' A' ' 10' ' ' LEU . 3.5 mt -64.95 -29.81 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 208' ' ' ILE . . . . . 0.422 HD12 HD22 ' C' ' 204' ' ' ASN . 44.9 mt -76.84 -42.56 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 209' ' ' ILE . . . . . 0.408 ' O ' ' HB ' ' C' ' 213' ' ' THR . 29.4 mt -76.67 -24.01 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 210' ' ' LEU . . . . . 0.537 HD21 ' CG2' ' B' ' 107' ' ' ILE . 15.4 mt -85.73 -47.64 9.57 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 211' ' ' GLU . . . . . 0.442 ' CG ' ' O ' ' C' ' 207' ' ' ILE . 59.3 mm-40 -59.09 -41.91 89.2 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 212' ' ' GLY . . . . . 0.434 ' O ' ' CG1' ' C' ' 216' ' ' ILE . . . -73.02 -56.08 5.98 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 213' ' ' THR . . . . . 0.439 HG23 ' CD ' ' B' ' 111' ' ' GLU . 34.0 m -57.93 -25.78 61.35 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 214' ' ' ALA . . . . . 0.402 ' CB ' ' O ' ' C' ' 210' ' ' LEU . . . -68.71 -63.03 1.14 Allowed 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 215' ' ' VAL . . . . . 0.503 HG22 ' CG ' ' A' ' 18' ' ' MET . 2.7 t -68.3 -21.41 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 216' ' ' ILE . . . . . 0.434 ' CG1' ' O ' ' C' ' 212' ' ' GLY . 30.4 mt -76.2 -64.64 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -51.05 -32.26 21.27 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 218' ' ' MET . . . . . 0.594 ' CE ' ' HE1' ' A' ' 18' ' ' MET . 6.4 mtp . . . . . 0 N--CA 1.449 -0.482 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.453 ' HG1' ' HG2' ' B' ' 106' ' ' GLU . 9.7 t . . . . . 0 N--CA 1.449 -0.523 0 N-CA-C 109.911 -0.404 . . . . 0.0 109.911 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.529 ' HA ' HG13 ' A' ' 7' ' ' ILE . 0.9 OUTLIER -42.77 -50.13 5.64 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 17.3 mt -42.88 -49.09 5.9 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.588 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 0.3 OUTLIER -64.57 -32.24 73.81 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.917 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.53 ' HA ' HD22 ' B' ' 110' ' ' LEU . 3.6 mt -65.19 -29.42 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 19.7 mt -76.92 -42.44 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.429 ' O ' ' HB ' ' A' ' 13' ' ' THR . 85.2 mt -77.29 -23.61 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.543 HD22 ' CG2' ' C' ' 207' ' ' ILE . 15.4 mt -85.77 -51.03 6.69 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.449 ' CG ' ' O ' ' A' ' 7' ' ' ILE . 66.7 mm-40 -58.63 -39.78 81.47 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.431 ' O ' ' CG1' ' A' ' 16' ' ' ILE . . . -73.42 -57.58 5.01 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.429 ' HB ' ' O ' ' A' ' 9' ' ' ILE . 46.2 m -57.88 -25.08 60.3 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.81 -63.03 1.14 Allowed 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.455 HG22 ' CG ' ' B' ' 118' ' ' MET . 2.5 t -69.0 -21.08 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.431 ' CG1' ' O ' ' A' ' 12' ' ' GLY . 38.0 mt -77.45 -64.85 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.13 -32.03 21.52 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.601 ' CE ' ' HE1' ' B' ' 118' ' ' MET . 6.9 mtp . . . . . 0 N--CA 1.449 -0.485 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 103' ' ' THR . . . . . 0.536 ' HG1' ' HG2' ' C' ' 206' ' ' GLU . 9.0 t . . . . . 0 N--CA 1.449 -0.506 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . 0.515 ' HA ' HG13 ' B' ' 107' ' ' ILE . 1.0 OUTLIER -42.96 -51.2 5.7 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' B' ' 105' ' ' LEU . 17.7 mt -43.05 -48.55 6.13 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 106' ' ' GLU . . . . . 0.583 ' CD ' ' N ' ' B' ' 106' ' ' GLU . 0.3 OUTLIER -64.27 -31.74 73.07 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 107' ' ' ILE . . . . . 0.534 ' CG2' HD22 ' C' ' 210' ' ' LEU . 3.8 mt -65.23 -29.86 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 20.3 mt -76.68 -42.19 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 109' ' ' ILE . . . . . 0.416 ' O ' ' HB ' ' B' ' 113' ' ' THR . 84.0 mt -77.39 -23.78 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . 0.541 ' CD1' HD12 ' C' ' 210' ' ' LEU . 15.6 mt -85.68 -50.95 6.79 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 111' ' ' GLU . . . . . 0.447 ' CG ' ' O ' ' B' ' 107' ' ' ILE . 67.3 mm-40 -58.63 -39.8 81.54 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 112' ' ' GLY . . . . . 0.433 ' O ' ' CG1' ' B' ' 116' ' ' ILE . . . -73.42 -57.59 5.0 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 113' ' ' THR . . . . . 0.446 HG21 ' CD ' ' A' ' 11' ' ' GLU . 45.0 m -57.83 -25.17 60.27 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.938 -0.394 . . . . 0.0 109.938 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.8 -63.04 1.14 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . 0.489 HG22 ' CG ' ' C' ' 218' ' ' MET . 2.5 t -68.97 -21.12 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 116' ' ' ILE . . . . . 0.433 ' CG1' ' O ' ' B' ' 112' ' ' GLY . 37.2 mt -77.24 -64.82 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -50.98 -32.26 20.56 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 118' ' ' MET . . . . . 0.601 ' HE1' ' CE ' ' A' ' 18' ' ' MET . 6.7 mtp . . . . . 0 N--CA 1.449 -0.481 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 203' ' ' THR . . . . . 0.531 ' HG1' ' HG2' ' A' ' 6' ' ' GLU . 8.9 t . . . . . 0 N--CA 1.448 -0.527 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 204' ' ' ASN . . . . . 0.515 ' HA ' HG13 ' C' ' 207' ' ' ILE . 1.0 OUTLIER -43.06 -51.4 5.79 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.937 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 205' ' ' LEU . . . . . . . . . . . . . 17.8 mt -43.06 -48.33 6.11 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 206' ' ' GLU . . . . . 0.581 ' N ' ' CD ' ' C' ' 206' ' ' GLU . 0.3 OUTLIER -64.24 -31.92 73.31 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 207' ' ' ILE . . . . . 0.543 ' CG2' HD22 ' A' ' 10' ' ' LEU . 3.8 mt -65.21 -29.7 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 208' ' ' ILE . . . . . . . . . . . . . 19.9 mt -76.79 -42.18 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 209' ' ' ILE . . . . . 0.42 ' O ' ' HB ' ' C' ' 213' ' ' THR . 83.8 mt -77.36 -23.86 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 210' ' ' LEU . . . . . 0.541 HD12 ' CD1' ' B' ' 110' ' ' LEU . 15.3 mt -85.58 -50.75 6.98 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 211' ' ' GLU . . . . . 0.447 ' CG ' ' O ' ' C' ' 207' ' ' ILE . 66.6 mm-40 -58.59 -40.18 82.49 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 212' ' ' GLY . . . . . 0.427 ' O ' ' CG1' ' C' ' 216' ' ' ILE . . . -73.2 -57.53 5.13 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 213' ' ' THR . . . . . 0.438 HG21 ' CD ' ' B' ' 111' ' ' GLU . 46.0 m -57.73 -25.22 60.09 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 214' ' ' ALA . . . . . . . . . . . . . . . -68.7 -63.04 1.14 Allowed 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 215' ' ' VAL . . . . . 0.492 HG22 ' CG ' ' A' ' 18' ' ' MET . 2.6 t -69.02 -21.11 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 216' ' ' ILE . . . . . 0.427 ' CG1' ' O ' ' C' ' 212' ' ' GLY . 37.1 mt -77.17 -64.72 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -51.22 -32.25 23.35 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 218' ' ' MET . . . . . 0.593 ' HE1' ' CE ' ' B' ' 118' ' ' MET . 6.6 mtp . . . . . 0 N--CA 1.449 -0.478 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.2 t . . . . . 0 N--CA 1.45 -0.471 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.53 ' HA ' HG13 ' A' ' 7' ' ' ILE . 1.0 OUTLIER -42.79 -51.28 5.45 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 12.1 mt -43.03 -48.43 6.03 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.587 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 1.8 mp0 -64.59 -31.3 72.45 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.548 ' HA ' HD21 ' B' ' 110' ' ' LEU . 4.1 mt -65.34 -30.07 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 73.9 mt -76.89 -42.05 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.419 ' O ' ' HB ' ' A' ' 13' ' ' THR . 15.9 mt -76.95 -24.29 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.545 HD12 ' CD1' ' C' ' 210' ' ' LEU . 15.4 mt -85.39 -49.85 7.78 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.491 ' HB3' ' HE2' ' A' ' 11' ' ' GLU . 61.7 mm-40 -57.87 -42.04 83.73 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.432 ' O ' ' CG1' ' A' ' 16' ' ' ILE . . . -72.02 -55.95 6.79 Favored Glycine 0 C--N 1.335 0.475 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.467 HG23 ' CD ' ' C' ' 211' ' ' GLU . 23.7 m -57.95 -25.38 60.88 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.52 -63.09 1.13 Allowed 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.505 HG23 ' CG ' ' B' ' 118' ' ' MET . 2.7 t -68.95 -21.13 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.432 ' CG1' ' O ' ' A' ' 12' ' ' GLY . 23.3 mt -76.54 -64.68 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.88 -33.44 24.02 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.599 ' HE3' ' CE ' ' C' ' 218' ' ' MET . 6.7 mtp . . . . . 0 N--CA 1.449 -0.522 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 5.2 t . . . . . 0 N--CA 1.449 -0.486 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . 0.521 ' HA ' HG13 ' B' ' 107' ' ' ILE . 1.0 OUTLIER -42.81 -51.23 5.5 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 12.0 mt -43.05 -48.45 6.1 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 106' ' ' GLU . . . . . 0.588 ' CD ' ' N ' ' B' ' 106' ' ' GLU . 1.8 mp0 -64.62 -31.33 72.5 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 107' ' ' ILE . . . . . 0.521 HG13 ' HA ' ' B' ' 104' ' ' ASN . 4.1 mt -65.28 -30.18 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 74.6 mt -76.84 -42.03 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 109' ' ' ILE . . . . . 0.424 ' O ' ' HB ' ' B' ' 113' ' ' THR . 16.1 mt -76.99 -24.32 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . 0.548 HD21 ' HA ' ' A' ' 7' ' ' ILE . 15.4 mt -85.44 -49.59 7.97 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 111' ' ' GLU . . . . . 0.482 ' HB3' ' HE2' ' B' ' 111' ' ' GLU . 61.5 mm-40 -57.99 -42.21 84.66 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 112' ' ' GLY . . . . . 0.434 ' O ' ' CG1' ' B' ' 116' ' ' ILE . . . -71.95 -55.94 6.84 Favored Glycine 0 C--N 1.336 0.547 0 N-CA-C 110.279 -1.129 . . . . 0.0 110.279 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 113' ' ' THR . . . . . 0.431 HG23 ' CD ' ' A' ' 11' ' ' GLU . 24.1 m -57.91 -25.58 61.05 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.34 -63.04 1.14 Allowed 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 115' ' ' VAL . . . . . 0.509 HG23 ' CG ' ' C' ' 218' ' ' MET . 2.7 t -68.98 -21.07 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 116' ' ' ILE . . . . . 0.434 ' CG1' ' O ' ' B' ' 112' ' ' GLY . 22.0 mt -76.2 -64.66 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -50.78 -34.02 25.69 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 118' ' ' MET . . . . . 0.592 ' HE3' ' CE ' ' A' ' 18' ' ' MET . 6.5 mtp . . . . . 0 N--CA 1.45 -0.466 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 203' ' ' THR . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.449 -0.522 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 204' ' ' ASN . . . . . 0.515 ' HA ' HG13 ' C' ' 207' ' ' ILE . 1.0 OUTLIER -42.85 -51.09 5.6 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.972 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 205' ' ' LEU . . . . . . . . . . . . . 12.0 mt -43.04 -48.46 6.08 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 206' ' ' GLU . . . . . 0.582 ' N ' ' CD ' ' C' ' 206' ' ' GLU . 1.8 mp0 -64.62 -31.34 72.51 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 207' ' ' ILE . . . . . 0.536 ' HA ' HD21 ' A' ' 10' ' ' LEU . 4.1 mt -65.23 -30.16 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 208' ' ' ILE . . . . . . . . . . . . . 74.3 mt -76.83 -42.2 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 209' ' ' ILE . . . . . 0.424 ' O ' ' HB ' ' C' ' 213' ' ' THR . 16.1 mt -76.8 -24.32 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 210' ' ' LEU . . . . . 0.545 ' CD1' HD12 ' A' ' 10' ' ' LEU . 15.4 mt -85.44 -49.5 8.05 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 211' ' ' GLU . . . . . 0.467 ' CD ' HG23 ' A' ' 13' ' ' THR . 60.8 mm-40 -57.92 -42.29 84.51 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 212' ' ' GLY . . . . . 0.434 ' O ' ' CG1' ' C' ' 216' ' ' ILE . . . -72.08 -55.83 6.82 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 213' ' ' THR . . . . . 0.437 HG23 ' CD ' ' B' ' 111' ' ' GLU . 23.9 m -57.85 -25.49 60.78 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 214' ' ' ALA . . . . . . . . . . . . . . . -68.48 -63.09 1.13 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 215' ' ' VAL . . . . . 0.523 HG23 ' CG ' ' A' ' 18' ' ' MET . 2.8 t -68.89 -21.09 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 216' ' ' ILE . . . . . 0.434 ' CG1' ' O ' ' C' ' 212' ' ' GLY . 23.1 mt -76.51 -64.8 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -50.78 -33.37 23.03 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 218' ' ' MET . . . . . 0.599 ' CE ' ' HE3' ' A' ' 18' ' ' MET . 6.5 mtp . . . . . 0 N--CA 1.45 -0.451 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.411 ' HE2' ' HB2' ' A' ' 2' ' ' LYS . 15.6 tppt? -78.01 -45.78 22.82 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.2 t -45.51 -36.79 4.77 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.519 ' HA ' HG13 ' A' ' 7' ' ' ILE . 1.5 t-20 -42.92 -51.12 5.68 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 14.0 mt -42.99 -48.52 5.97 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.578 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 0.8 OUTLIER -64.66 -31.36 72.55 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.916 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.538 ' HA ' HD22 ' B' ' 110' ' ' LEU . 4.0 mt -65.23 -30.23 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 23.7 mt -76.73 -42.11 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.421 ' O ' ' HB ' ' A' ' 13' ' ' THR . 53.7 mt -76.87 -24.29 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.532 HD13 ' CD1' ' B' ' 110' ' ' LEU . 15.4 mt -85.59 -46.77 10.49 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.517 ' HB3' ' HE2' ' A' ' 11' ' ' GLU . 57.1 mm-40 -59.37 -42.71 92.25 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.436 ' O ' ' CG1' ' A' ' 16' ' ' ILE . . . -72.56 -56.12 6.28 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.441 HG21 ' CD ' ' C' ' 211' ' ' GLU . 39.4 m -57.83 -25.88 61.25 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.421 ' CB ' ' O ' ' A' ' 10' ' ' LEU . . . -68.38 -63.05 1.14 Allowed 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.526 HG22 ' CG ' ' B' ' 118' ' ' MET . 2.7 t -68.56 -21.36 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.436 ' CG1' ' O ' ' A' ' 12' ' ' GLY . 29.2 mt -76.11 -64.7 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.89 -32.95 22.16 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.592 ' CE ' ' HE3' ' B' ' 118' ' ' MET . 6.4 mtp -64.45 -60.25 3.37 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -53.14 -44.23 67.58 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 12.7 m-30 -53.93 -42.91 69.34 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 38.3 m0 -68.58 -62.26 1.47 Allowed 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.3 tp -52.45 -20.53 2.93 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.3 mt -74.99 -61.75 1.78 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.2 pp -62.48 -17.72 60.21 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 37.5 t -77.36 -45.14 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 97.5 mt -70.48 -33.08 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 56.1 mt -68.99 -47.4 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 41.6 mt -61.76 -35.68 78.81 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.642 ' HA ' ' HE3' ' A' ' 32' ' ' LYS . 10.9 mtp-105 -76.63 -36.77 57.21 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.6 m -68.0 -32.15 72.34 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 71.2 t -75.97 -57.66 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.642 ' HE3' ' HA ' ' A' ' 29' ' ' ARG . 14.3 ptpt -52.12 -29.52 22.19 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.457 ' HA ' ' HD2' ' A' ' 33' ' ' ARG . 7.5 mmm180 -93.99 30.1 1.95 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -139.31 -0.02 1.85 Allowed 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -81.27 -7.45 59.57 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.9 -174.15 49.05 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.523 0 N-CA-C 110.301 -1.119 . . . . 0.0 110.301 -179.964 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 . . . . . 0 N--CA 1.449 -0.509 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . 0.414 ' HD3' ' HA ' ' B' ' 102' ' ' LYS . 15.7 tppt? -78.13 -45.8 22.35 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 7.0 t -45.58 -36.9 5.02 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . 0.523 ' HA ' HG13 ' B' ' 107' ' ' ILE . 1.5 t-20 -42.92 -51.15 5.67 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 14.1 mt -42.99 -48.57 5.97 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' GLU . . . . . 0.59 ' CD ' ' N ' ' B' ' 106' ' ' GLU . 0.8 OUTLIER -64.51 -31.41 72.61 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' ILE . . . . . 0.544 ' CG2' HD22 ' C' ' 210' ' ' LEU . 4.0 mt -65.2 -30.27 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 23.8 mt -76.72 -42.08 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' ILE . . . . . 0.417 ' O ' ' HB ' ' B' ' 113' ' ' THR . 54.1 mt -76.87 -24.29 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . 0.538 HD22 ' HA ' ' A' ' 7' ' ' ILE . 15.4 mt -85.53 -46.95 10.36 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 111' ' ' GLU . . . . . 0.491 ' HB3' ' HE2' ' B' ' 111' ' ' GLU . 57.8 mm-40 -59.37 -42.65 92.12 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 112' ' ' GLY . . . . . 0.433 ' O ' ' CG1' ' B' ' 116' ' ' ILE . . . -72.54 -56.16 6.27 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.281 -1.127 . . . . 0.0 110.281 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 113' ' ' THR . . . . . 0.437 HG21 ' CD ' ' A' ' 11' ' ' GLU . 38.5 m -57.96 -25.72 61.35 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 114' ' ' ALA . . . . . 0.423 ' CB ' ' O ' ' B' ' 110' ' ' LEU . . . -68.42 -62.99 1.15 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . 0.516 HG22 ' CG ' ' C' ' 218' ' ' MET . 2.7 t -68.73 -21.22 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 116' ' ' ILE . . . . . 0.433 ' CG1' ' O ' ' B' ' 112' ' ' GLY . 28.7 mt -76.18 -64.58 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -51.15 -33.0 24.92 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 118' ' ' MET . . . . . 0.592 ' HE3' ' CE ' ' A' ' 18' ' ' MET . 6.4 mtp -64.33 -60.11 3.57 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -51.93 -43.8 63.61 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 12.8 m-30 -53.27 -43.78 67.71 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 121' ' ' TRP . . . . . . . . . . . . . 38.4 m0 -69.3 -62.38 1.4 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 5.2 tp -52.1 -20.27 2.4 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 10.6 mt -73.24 -61.81 1.69 Allowed 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 pp -62.04 -17.51 57.59 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 37.3 t -78.2 -45.04 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 97.9 mt -70.53 -32.53 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 56.4 mt -68.2 -47.54 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 40.4 mt -61.92 -35.71 79.2 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . 0.644 ' HA ' ' HE3' ' B' ' 132' ' ' LYS . 10.9 mtp-105 -76.84 -36.66 56.69 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 4.5 m -67.84 -31.87 72.02 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 77.1 t -76.03 -57.95 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 132' ' ' LYS . . . . . 0.644 ' HE3' ' HA ' ' B' ' 129' ' ' ARG . 14.3 ptpt -51.87 -29.52 20.06 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 133' ' ' ARG . . . . . 0.473 ' HD2' ' HA ' ' B' ' 133' ' ' ARG . 7.4 mmm180 -94.24 30.24 1.98 Allowed 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 134' ' ' ALA . . . . . . . . . . . . . . . -139.03 -0.1 1.9 Allowed 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -81.26 -7.38 59.56 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -86.76 -174.7 49.3 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.51 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 -179.957 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 201' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 202' ' ' LYS . . . . . 0.405 ' HE2' ' HB2' ' C' ' 202' ' ' LYS . 15.7 tppt? -78.12 -45.9 22.12 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 203' ' ' THR . . . . . . . . . . . . . 7.0 t -45.59 -36.95 5.07 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 204' ' ' ASN . . . . . 0.507 ' HA ' HG13 ' C' ' 207' ' ' ILE . 1.5 t-20 -43.01 -51.21 5.76 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 205' ' ' LEU . . . . . . . . . . . . . 14.1 mt -43.02 -48.44 6.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 206' ' ' GLU . . . . . 0.575 ' N ' ' CD ' ' C' ' 206' ' ' GLU . 0.8 OUTLIER -64.58 -31.43 72.64 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 207' ' ' ILE . . . . . 0.531 ' CG2' HD22 ' A' ' 10' ' ' LEU . 4.0 mt -65.18 -30.24 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 208' ' ' ILE . . . . . . . . . . . . . 23.7 mt -76.72 -42.17 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 209' ' ' ILE . . . . . 0.412 ' O ' ' HB ' ' C' ' 213' ' ' THR . 54.1 mt -76.8 -24.27 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 210' ' ' LEU . . . . . 0.544 HD22 ' CG2' ' B' ' 107' ' ' ILE . 15.4 mt -85.61 -46.62 10.62 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 211' ' ' GLU . . . . . 0.459 ' HE2' ' HB3' ' C' ' 211' ' ' GLU . 57.2 mm-40 -59.42 -42.75 92.58 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 212' ' ' GLY . . . . . 0.434 ' O ' ' CG1' ' C' ' 216' ' ' ILE . . . -72.58 -56.05 6.3 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 213' ' ' THR . . . . . 0.435 HG21 ' CD ' ' B' ' 111' ' ' GLU . 38.2 m -57.93 -25.94 61.56 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 214' ' ' ALA . . . . . 0.422 ' CB ' ' O ' ' C' ' 210' ' ' LEU . . . -68.28 -63.07 1.13 Allowed 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 215' ' ' VAL . . . . . 0.514 HG22 ' CG ' ' A' ' 18' ' ' MET . 2.7 t -68.52 -21.42 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 216' ' ' ILE . . . . . 0.434 ' CG1' ' O ' ' C' ' 212' ' ' GLY . 28.5 mt -76.03 -64.66 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -51.0 -32.77 22.3 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 218' ' ' MET . . . . . 0.584 ' HE3' ' CE ' ' B' ' 118' ' ' MET . 6.2 mtp -64.51 -59.2 4.6 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -50.09 -44.95 52.2 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -55.39 -43.27 75.02 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 221' ' ' TRP . . . . . . . . . . . . . 38.6 m0 -69.51 -61.38 1.81 Allowed 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 5.3 tp -51.02 -20.71 1.48 Allowed 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.786 -0.449 . . . . 0.0 109.786 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 223' ' ' LEU . . . . . . . . . . . . . 11.1 mt -74.34 -61.83 1.73 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 1.3 pp -63.48 -17.4 62.69 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 225' ' ' VAL . . . . . . . . . . . . . 37.3 t -76.92 -44.46 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 92.7 mt -69.08 -33.25 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 227' ' ' ILE . . . . . . . . . . . . . 56.2 mt -69.19 -48.34 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 43.7 mt -62.65 -35.92 81.18 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 229' ' ' ARG . . . . . 0.645 ' HA ' ' HE3' ' C' ' 232' ' ' LYS . 11.0 mtp-105 -76.27 -36.25 58.53 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 230' ' ' THR . . . . . . . . . . . . . 4.5 m -67.89 -32.09 72.33 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 74.6 t -76.24 -57.49 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 232' ' ' LYS . . . . . 0.645 ' HE3' ' HA ' ' C' ' 229' ' ' ARG . 14.3 ptpt -52.29 -29.22 22.24 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 233' ' ' ARG . . . . . 0.475 ' HD2' ' HA ' ' C' ' 233' ' ' ARG . 7.5 mmm180 -94.13 30.2 1.96 Allowed 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 234' ' ' ALA . . . . . . . . . . . . . . . -139.38 -0.29 1.81 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 235' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -81.3 -7.37 59.56 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 236' ' ' GLY . . . . . . . . . . . . . . . -86.82 -174.22 49.12 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.506 0 N-CA-C 110.271 -1.131 . . . . 0.0 110.271 -179.978 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 . . . . . 0 N--CA 1.449 -0.476 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.1 tttt -70.35 -39.27 74.78 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.43 HG23 ' HG3' ' B' ' 106' ' ' GLU . 98.1 m -44.38 -30.91 0.92 Allowed 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.499 ' HA ' HG13 ' A' ' 7' ' ' ILE . 5.9 p-10 -42.91 -50.65 5.76 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.471 ' N ' ' CG ' ' A' ' 4' ' ' ASN . 13.0 mt -43.51 -47.32 7.22 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.584 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 1.0 OUTLIER -66.04 -31.09 71.77 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.538 ' CG2' ' CD2' ' B' ' 110' ' ' LEU . 5.3 mt -64.69 -31.92 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 31.0 mt -75.75 -42.89 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.428 ' O ' ' HB ' ' A' ' 13' ' ' THR . 62.5 mt -74.34 -27.56 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.536 ' CD2' ' CG2' ' C' ' 207' ' ' ILE . 15.1 mt -83.16 -41.69 18.2 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.448 ' CD ' HG23 ' B' ' 113' ' ' THR . 34.5 mm-40 -58.54 -49.23 78.16 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.438 ' C ' HD13 ' A' ' 16' ' ' ILE . . . -69.91 -59.69 5.38 Favored Glycine 0 C--N 1.335 0.515 0 N-CA-C 110.294 -1.123 . . . . 0.0 110.294 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.491 ' HA ' HD11 ' A' ' 16' ' ' ILE . 23.6 m -49.05 -37.06 19.75 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.443 ' N ' ' OE1' ' C' ' 211' ' ' GLU . . . -60.08 -62.89 1.54 Allowed 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.504 HG23 ' CG ' ' B' ' 118' ' ' MET . 3.0 t -63.75 -21.16 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.491 HD11 ' HA ' ' A' ' 13' ' ' THR . 27.8 mt -70.73 -64.63 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.48 -35.63 30.0 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.622 ' HE1' ' CE ' ' C' ' 218' ' ' MET . 4.8 mtp -61.57 -60.29 3.92 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.9 m-30 -63.68 -23.67 67.47 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -67.31 -47.04 71.74 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.548 ' CD1' ' C ' ' A' ' 21' ' ' TRP . 0.2 OUTLIER -67.54 -37.71 83.13 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.923 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.4 mt -63.57 -46.86 83.96 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.3 mt -61.46 -46.96 87.85 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.4 tp -60.25 -35.16 74.86 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.8 t -67.38 -38.26 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 56.6 mt -70.42 -42.35 78.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 55.4 mt -69.49 -36.98 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.2 mt -68.93 -45.93 69.56 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 64.4 mtt180 -66.48 -48.9 68.4 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.8 m -54.87 -46.55 74.73 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.1 t -66.54 -45.19 89.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 46.2 tttm -49.92 -33.5 17.61 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.8 mmt85 -94.01 34.67 1.22 Allowed 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.04 -5.25 1.3 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.566 ' CG ' ' N ' ' A' ' 36' ' ' GLY . 2.1 t-20 -94.92 173.25 7.68 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.566 ' N ' ' CG ' ' A' ' 35' ' ' ASN . . . 99.16 -125.43 8.57 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.573 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -179.968 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 . . . . . 0 N--CA 1.449 -0.506 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 63.9 tttt -70.37 -39.28 74.68 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 103' ' ' THR . . . . . 0.416 HG23 ' HG3' ' C' ' 206' ' ' GLU . 98.6 m -44.32 -31.04 0.92 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . 0.507 ' HA ' HG13 ' B' ' 107' ' ' ILE . 5.9 p-10 -42.93 -50.47 5.8 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . 0.471 ' N ' ' CG ' ' B' ' 104' ' ' ASN . 13.1 mt -43.62 -47.3 7.54 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 106' ' ' GLU . . . . . 0.581 ' CD ' ' N ' ' B' ' 106' ' ' GLU . 1.0 OUTLIER -66.09 -30.98 71.59 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 107' ' ' ILE . . . . . 0.524 ' CG2' HD23 ' C' ' 210' ' ' LEU . 5.3 mt -64.75 -31.89 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 31.1 mt -75.72 -42.88 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 109' ' ' ILE . . . . . 0.41 ' O ' ' HB ' ' B' ' 113' ' ' THR . 62.4 mt -74.35 -27.61 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . 0.538 ' CD2' ' CG2' ' A' ' 7' ' ' ILE . 15.1 mt -83.19 -41.7 18.14 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 111' ' ' GLU . . . . . 0.431 ' OE1' ' N ' ' C' ' 214' ' ' ALA . 34.9 mm-40 -58.54 -49.19 78.32 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 112' ' ' GLY . . . . . 0.444 ' C ' HD13 ' B' ' 116' ' ' ILE . . . -70.01 -59.71 5.32 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 113' ' ' THR . . . . . 0.495 ' HA ' HD11 ' B' ' 116' ' ' ILE . 23.6 m -48.96 -37.07 19.04 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 114' ' ' ALA . . . . . 0.441 ' N ' ' OE1' ' A' ' 11' ' ' GLU . . . -60.11 -62.9 1.53 Allowed 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . 0.504 ' CG1' ' HG2' ' C' ' 218' ' ' MET . 3.0 t -63.72 -21.17 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 116' ' ' ILE . . . . . 0.495 HD11 ' HA ' ' B' ' 113' ' ' THR . 27.8 mt -70.67 -64.71 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -50.45 -35.53 29.25 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 118' ' ' MET . . . . . 0.603 ' HE1' ' CE ' ' A' ' 18' ' ' MET . 4.7 mtp -61.85 -60.23 3.95 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 1.9 m-30 -63.4 -23.72 67.53 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -66.23 -47.78 72.7 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.838 -0.431 . . . . 0.0 109.838 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 121' ' ' TRP . . . . . 0.557 ' C ' ' CD1' ' B' ' 121' ' ' TRP . 0.2 OUTLIER -68.51 -37.26 79.9 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.952 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 80.6 mt -63.08 -45.19 93.3 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 11.3 mt -59.77 -46.72 88.3 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 12.4 tp -60.3 -35.61 75.98 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 28.1 t -67.36 -37.47 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 56.1 mt -69.54 -41.38 80.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 56.1 mt -68.86 -37.17 77.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 25.9 mt -69.32 -45.79 68.67 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 64.5 mtt180 -66.26 -48.6 69.96 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 4.1 m -54.26 -46.31 72.61 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 53.3 t -66.83 -45.25 88.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 46.3 tttm -49.72 -33.48 16.15 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 133' ' ' ARG . . . . . 0.459 HH11 ' HD2' ' B' ' 133' ' ' ARG . 11.8 mmt85 -93.77 34.4 1.21 Allowed 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 134' ' ' ALA . . . . . . . . . . . . . . . -139.61 -5.22 1.38 Allowed 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 135' ' ' ASN . . . . . 0.565 ' CG ' ' N ' ' B' ' 136' ' ' GLY . 2.0 t-20 -95.12 173.2 7.69 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 136' ' ' GLY . . . . . 0.565 ' N ' ' CG ' ' B' ' 135' ' ' ASN . . . 99.11 -125.32 8.52 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.525 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.939 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 201' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 . . . . . 0 N--CA 1.449 -0.516 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 63.9 tttt -70.41 -39.37 74.49 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 203' ' ' THR . . . . . 0.426 HG23 ' HG3' ' A' ' 6' ' ' GLU . 97.9 m -44.18 -31.07 0.88 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 204' ' ' ASN . . . . . 0.496 ' HA ' HG13 ' C' ' 207' ' ' ILE . 5.8 p-10 -42.98 -50.4 5.88 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 205' ' ' LEU . . . . . 0.458 ' N ' ' CG ' ' C' ' 204' ' ' ASN . 13.1 mt -43.54 -47.35 7.31 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 206' ' ' GLU . . . . . 0.577 ' N ' ' CD ' ' C' ' 206' ' ' GLU . 1.0 OUTLIER -66.05 -31.14 71.85 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 207' ' ' ILE . . . . . 0.536 ' CG2' ' CD2' ' A' ' 10' ' ' LEU . 5.3 mt -64.67 -31.8 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 208' ' ' ILE . . . . . . . . . . . . . 30.9 mt -75.83 -42.97 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 209' ' ' ILE . . . . . 0.423 ' O ' ' HB ' ' C' ' 213' ' ' THR . 62.3 mt -74.32 -27.49 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 210' ' ' LEU . . . . . 0.524 HD11 ' CD1' ' A' ' 10' ' ' LEU . 15.1 mt -83.21 -41.64 18.18 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 211' ' ' GLU . . . . . 0.456 ' CD ' HG23 ' A' ' 13' ' ' THR . 34.5 mm-40 -58.58 -49.13 78.58 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 212' ' ' GLY . . . . . 0.434 ' C ' HD13 ' C' ' 216' ' ' ILE . . . -70.1 -59.68 5.3 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 213' ' ' THR . . . . . 0.492 ' HA ' HD11 ' C' ' 216' ' ' ILE . 23.7 m -48.92 -37.14 18.99 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 214' ' ' ALA . . . . . 0.431 ' N ' ' OE1' ' B' ' 111' ' ' GLU . . . -60.08 -62.9 1.53 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 215' ' ' VAL . . . . . 0.519 ' CG1' ' HG2' ' A' ' 18' ' ' MET . 3.0 t -63.73 -21.09 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 216' ' ' ILE . . . . . 0.492 HD11 ' HA ' ' C' ' 213' ' ' THR . 27.8 mt -70.73 -64.63 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -50.49 -35.47 29.34 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 218' ' ' MET . . . . . 0.622 ' CE ' ' HE1' ' A' ' 18' ' ' MET . 4.7 mtp -61.76 -60.31 3.86 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 1.9 m-30 -63.39 -23.86 67.59 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -67.71 -47.54 69.09 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 221' ' ' TRP . . . . . 0.547 ' CD1' ' C ' ' C' ' 221' ' ' TRP . 0.2 OUTLIER -68.36 -36.33 79.04 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.908 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 80.0 mt -62.1 -45.35 93.86 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 223' ' ' LEU . . . . . . . . . . . . . 11.5 mt -60.14 -47.3 86.5 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.83 -0.434 . . . . 0.0 109.83 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 12.4 tp -60.59 -35.28 75.71 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 225' ' ' VAL . . . . . 0.404 HG22 ' CD1' ' C' ' 221' ' ' TRP . 28.7 t -67.07 -37.03 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 55.8 mt -69.2 -41.49 81.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 227' ' ' ILE . . . . . . . . . . . . . 55.9 mt -69.15 -37.19 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 26.6 mt -69.56 -46.04 67.33 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 229' ' ' ARG . . . . . . . . . . . . . 64.8 mtt180 -66.01 -48.63 70.54 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 230' ' ' THR . . . . . . . . . . . . . 4.1 m -53.82 -46.21 71.05 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 52.8 t -66.94 -45.31 87.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 232' ' ' LYS . . . . . . . . . . . . . 46.3 tttm -49.58 -33.57 15.44 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 233' ' ' ARG . . . . . 0.451 HH11 ' HD2' ' C' ' 233' ' ' ARG . 11.8 mmt85 -93.65 34.36 1.2 Allowed 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 234' ' ' ALA . . . . . . . . . . . . . . . -139.6 -4.75 1.41 Allowed 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 235' ' ' ASN . . . . . 0.57 ' CG ' ' N ' ' C' ' 236' ' ' GLY . 2.0 t-20 -94.84 173.36 7.63 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 236' ' ' GLY . . . . . 0.57 ' N ' ' CG ' ' C' ' 235' ' ' ASN . . . 99.42 -125.39 8.55 Favored Glycine 0 C--N 1.336 0.562 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.537 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 -179.943 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 . . . . . 0 N--CA 1.449 -0.496 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.529 ' HE2' HD11 ' A' ' 5' ' ' LEU . 23.3 tptm -77.29 -40.49 44.29 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.753 ' HG1' ' CG ' ' B' ' 106' ' ' GLU . 5.4 t -47.0 -35.51 6.7 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.518 ' HA ' HG13 ' A' ' 7' ' ' ILE . 1.4 t-20 -42.87 -50.35 5.74 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.529 HD11 ' HE2' ' A' ' 2' ' ' LYS . 12.3 mt -43.07 -47.7 6.03 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.734 ' CG ' ' HG1' ' C' ' 203' ' ' THR . 2.2 mp0 -66.47 -30.89 71.33 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.551 ' CG2' ' CD2' ' B' ' 110' ' ' LEU . 5.2 mt -64.19 -32.1 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 24.3 mt -75.84 -44.02 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.413 ' O ' ' HB ' ' A' ' 13' ' ' THR . 98.3 mt -73.59 -25.51 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.546 HD21 ' CG2' ' C' ' 207' ' ' ILE . 15.5 mt -85.44 -41.3 15.52 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.446 ' CD ' HG22 ' B' ' 113' ' ' THR . 37.4 mm-40 -58.88 -45.9 89.12 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.445 ' C ' HD13 ' A' ' 16' ' ' ILE . . . -73.42 -55.06 6.33 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.454 HG22 ' CD ' ' C' ' 211' ' ' GLU . 22.9 m -55.08 -31.05 60.88 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.444 ' CB ' ' O ' ' A' ' 10' ' ' LEU . . . -66.43 -63.2 1.13 Allowed 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.821 -0.436 . . . . 0.0 109.821 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.512 HG23 ' CG ' ' B' ' 118' ' ' MET . 2.8 t -64.31 -21.37 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.445 HD13 ' C ' ' A' ' 12' ' ' GLY . 22.3 mt -73.59 -64.69 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.55 -26.18 20.2 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.577 ' HE1' ' HE1' ' C' ' 218' ' ' MET . 11.6 mtp -66.99 -60.2 2.83 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -51.76 -35.93 45.46 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -61.14 -49.6 76.6 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -62.95 -37.65 87.92 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 88.3 mt -72.9 -27.15 61.71 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 14.0 mt -69.55 -61.52 1.75 Allowed 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.554 ' HG ' ' N ' ' A' ' 25' ' ' VAL . 2.0 pp -54.12 -39.89 66.84 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.554 ' N ' ' HG ' ' A' ' 24' ' ' LEU . 25.6 t -64.79 -38.29 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 40.3 mt -73.04 -29.58 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 34.4 mt -70.73 -46.25 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.441 ' HA ' HD23 ' A' ' 28' ' ' LEU . 81.8 mt -68.95 -35.74 77.13 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 42.1 ttt85 -71.23 -46.37 61.25 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.5 m -60.01 -44.99 94.2 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 53.5 t -60.9 -51.81 68.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 34.4 tttt -50.98 -34.21 28.03 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.66 ' HA ' ' HE ' ' A' ' 33' ' ' ARG . 1.5 mmp_? -95.49 35.58 1.33 Allowed 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -139.81 -1.08 1.65 Allowed 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -91.0 132.76 35.79 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.71 38.63 0.04 OUTLIER Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.492 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -179.977 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 . . . . . 0 N--CA 1.449 -0.476 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . 0.51 ' HE2' HD11 ' B' ' 105' ' ' LEU . 23.2 tptm -77.4 -40.54 43.28 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 103' ' ' THR . . . . . 0.749 ' HG1' ' CG ' ' C' ' 206' ' ' GLU . 5.3 t -46.98 -35.88 7.1 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . 0.525 ' HA ' HG13 ' B' ' 107' ' ' ILE . 1.4 t-20 -42.91 -50.35 5.8 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . 0.51 HD11 ' HE2' ' B' ' 102' ' ' LYS . 12.3 mt -43.22 -47.58 6.43 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 106' ' ' GLU . . . . . 0.753 ' CG ' ' HG1' ' A' ' 3' ' ' THR . 2.2 mp0 -66.42 -31.02 71.52 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 107' ' ' ILE . . . . . 0.547 ' CG2' HD21 ' C' ' 210' ' ' LEU . 5.2 mt -64.08 -32.02 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 24.1 mt -75.93 -44.19 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 109' ' ' ILE . . . . . 0.414 ' O ' ' HB ' ' B' ' 113' ' ' THR . 98.2 mt -73.43 -25.54 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . 0.551 ' CD2' ' CG2' ' A' ' 7' ' ' ILE . 15.5 mt -85.38 -41.45 15.45 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 111' ' ' GLU . . . . . 0.455 ' CD ' HG22 ' C' ' 213' ' ' THR . 37.2 mm-40 -58.57 -45.91 88.04 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 112' ' ' GLY . . . . . 0.436 ' C ' HD13 ' B' ' 116' ' ' ILE . . . -73.57 -55.39 6.07 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 113' ' ' THR . . . . . 0.446 HG22 ' CD ' ' A' ' 11' ' ' GLU . 23.2 m -54.69 -30.94 57.03 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 114' ' ' ALA . . . . . 0.452 ' CB ' ' O ' ' B' ' 110' ' ' LEU . . . -66.66 -63.32 1.09 Allowed 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . 0.517 HG12 ' HG2' ' C' ' 218' ' ' MET . 2.7 t -64.07 -21.35 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 116' ' ' ILE . . . . . 0.436 HD13 ' C ' ' B' ' 112' ' ' GLY . 23.0 mt -73.55 -64.67 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -53.59 -25.99 19.76 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 118' ' ' MET . . . . . 0.582 ' HE1' ' HE1' ' C' ' 218' ' ' MET . 11.5 mtp -67.2 -60.22 2.79 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -50.91 -37.14 42.17 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -62.59 -49.58 74.67 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 121' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -63.74 -35.72 81.49 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 82.6 mt -71.32 -28.4 64.07 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 14.3 mt -71.02 -61.65 1.69 Allowed 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . 0.535 ' HG ' ' N ' ' B' ' 125' ' ' VAL . 2.1 pp -54.92 -39.11 68.47 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . 0.535 ' N ' ' HG ' ' B' ' 124' ' ' LEU . 27.2 t -63.86 -37.97 81.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 41.5 mt -73.09 -29.86 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 35.9 mt -71.38 -46.98 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.428 ' HA ' HD23 ' B' ' 128' ' ' LEU . 82.4 mt -69.7 -35.27 74.93 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 42.1 ttt85 -71.17 -46.55 61.18 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 5.6 m -59.44 -44.93 92.84 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 55.1 t -61.34 -51.54 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 34.8 tttt -51.15 -33.59 27.51 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 133' ' ' ARG . . . . . 0.657 ' HA ' ' HE ' ' B' ' 133' ' ' ARG . 1.4 mmp_? -95.39 35.04 1.36 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 134' ' ' ALA . . . . . . . . . . . . . . . -139.24 -0.89 1.78 Allowed 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -91.21 132.69 35.94 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . 174.54 38.61 0.04 OUTLIER Glycine 0 CA--C 1.523 0.531 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.526 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 -179.947 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 201' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 . . . . . 0 N--CA 1.449 -0.48 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 202' ' ' LYS . . . . . 0.485 ' HE2' HD11 ' C' ' 205' ' ' LEU . 23.3 tptm -77.4 -40.55 43.25 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 203' ' ' THR . . . . . 0.734 ' HG1' ' CG ' ' A' ' 6' ' ' GLU . 5.3 t -47.1 -36.06 7.81 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 204' ' ' ASN . . . . . 0.536 ' HA ' HG13 ' C' ' 207' ' ' ILE . 1.4 t-20 -42.86 -50.61 5.7 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 205' ' ' LEU . . . . . 0.485 HD11 ' HE2' ' C' ' 202' ' ' LYS . 12.4 mt -43.13 -47.48 6.15 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 206' ' ' GLU . . . . . 0.749 ' CG ' ' HG1' ' B' ' 103' ' ' THR . 2.2 mp0 -66.43 -30.92 71.38 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 207' ' ' ILE . . . . . 0.546 ' CG2' HD21 ' A' ' 10' ' ' LEU . 5.3 mt -64.26 -32.0 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 208' ' ' ILE . . . . . . . . . . . . . 24.1 mt -75.94 -43.92 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 209' ' ' ILE . . . . . 0.42 ' O ' ' HB ' ' C' ' 213' ' ' THR . 98.3 mt -73.6 -25.63 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.722 -0.474 . . . . 0.0 109.722 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 210' ' ' LEU . . . . . 0.547 HD21 ' CG2' ' B' ' 107' ' ' ILE . 15.5 mt -85.38 -41.26 15.62 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 211' ' ' GLU . . . . . 0.454 ' CD ' HG22 ' A' ' 13' ' ' THR . 37.3 mm-40 -58.9 -45.88 89.2 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 212' ' ' GLY . . . . . 0.442 ' C ' HD13 ' C' ' 216' ' ' ILE . . . -73.48 -55.09 6.28 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.291 -1.123 . . . . 0.0 110.291 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 213' ' ' THR . . . . . 0.455 HG22 ' CD ' ' B' ' 111' ' ' GLU . 22.8 m -55.04 -31.14 60.87 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 214' ' ' ALA . . . . . 0.451 ' CB ' ' O ' ' C' ' 210' ' ' LEU . . . -66.39 -63.36 1.09 Allowed 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 215' ' ' VAL . . . . . 0.508 HG23 ' CG ' ' A' ' 18' ' ' MET . 2.8 t -64.07 -21.55 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 216' ' ' ILE . . . . . 0.442 HD13 ' C ' ' C' ' 212' ' ' GLY . 22.2 mt -73.44 -64.67 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -53.57 -26.05 19.84 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 218' ' ' MET . . . . . 0.582 ' HE1' ' HE1' ' B' ' 118' ' ' MET . 11.6 mtp -67.13 -60.11 2.89 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -51.41 -36.32 43.11 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -61.68 -48.2 81.87 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 221' ' ' TRP . . . . . 0.491 ' HA ' ' CD2' ' C' ' 224' ' ' LEU . 0.1 OUTLIER -61.9 -37.13 83.45 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.855 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 83.5 mt -72.6 -29.59 63.63 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 223' ' ' LEU . . . . . . . . . . . . . 14.4 mt -71.75 -60.87 2.01 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 224' ' ' LEU . . . . . 0.526 ' HG ' ' N ' ' C' ' 225' ' ' VAL . 2.1 pp -53.96 -38.88 65.46 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 225' ' ' VAL . . . . . 0.526 ' N ' ' HG ' ' C' ' 224' ' ' LEU . 25.7 t -63.87 -38.51 82.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 41.3 mt -73.8 -30.23 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 227' ' ' ILE . . . . . . . . . . . . . 34.7 mt -71.25 -46.23 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 228' ' ' LEU . . . . . 0.44 ' HA ' HD23 ' C' ' 228' ' ' LEU . 81.7 mt -68.93 -35.63 77.02 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 229' ' ' ARG . . . . . . . . . . . . . 42.3 ttt85 -71.31 -46.3 61.02 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 230' ' ' THR . . . . . . . . . . . . . 4.9 m -60.06 -45.21 93.63 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 53.3 t -61.32 -51.48 72.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 232' ' ' LYS . . . . . . . . . . . . . 34.6 tttt -50.91 -34.03 26.7 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 233' ' ' ARG . . . . . 0.667 ' HE ' ' HA ' ' C' ' 233' ' ' ARG . 1.5 mmp_? -95.46 35.44 1.34 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 234' ' ' ALA . . . . . . . . . . . . . . . -140.05 -0.72 1.64 Allowed 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 235' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -90.83 132.95 35.58 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 236' ' ' GLY . . . . . . . . . . . . . . . 174.84 38.87 0.05 OUTLIER Glycine 0 C--N 1.335 0.506 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.53 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -179.971 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 . . . . . 0 N--CA 1.45 -0.452 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -77.67 -44.75 27.01 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.1 t -43.76 -33.53 1.3 Allowed 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.525 ' HA ' HG13 ' A' ' 7' ' ' ILE . 1.1 t-20 -42.74 -51.05 5.48 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 13.1 mt -43.01 -48.9 6.07 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.587 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 2.6 mp0 -64.13 -31.63 72.9 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.525 HG13 ' HA ' ' A' ' 4' ' ' ASN . 3.8 mt -65.25 -29.89 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.8 mt -76.77 -42.13 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.427 ' O ' ' HB ' ' A' ' 13' ' ' THR . 83.4 mt -77.3 -23.82 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.533 HD23 ' CG2' ' C' ' 207' ' ' ILE . 15.5 mt -85.7 -49.75 7.72 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.441 ' CD ' HG21 ' B' ' 113' ' ' THR . 58.7 mm-40 -59.01 -40.42 84.87 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.429 ' O ' ' CG1' ' A' ' 16' ' ' ILE . . . -73.27 -57.52 5.11 Favored Glycine 0 C--N 1.335 0.509 0 N-CA-C 110.276 -1.129 . . . . 0.0 110.276 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.433 HG21 ' CD ' ' C' ' 211' ' ' GLU . 49.5 m -57.78 -25.18 60.17 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.416 ' CB ' ' O ' ' A' ' 10' ' ' LEU . . . -68.79 -62.92 1.18 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.6 t -69.04 -21.08 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.429 ' CG1' ' O ' ' A' ' 12' ' ' GLY . 22.4 mt -77.31 -64.85 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.15 -32.07 21.84 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.589 ' CE ' ' HE2' ' B' ' 118' ' ' MET . 6.7 mtp -66.1 -60.18 3.06 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.51 -25.34 67.21 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -71.29 -46.4 60.91 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -40.6 97.32 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.8 tp -61.39 -48.21 82.27 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 26.0 mt -57.22 -38.67 74.1 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.3 tp -65.66 -36.75 84.57 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.0 t -62.79 -41.22 91.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 79.6 mt -67.22 -43.1 88.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 93.4 mt -66.23 -35.69 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 25.8 mt -66.15 -49.99 65.52 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 39.4 mtt180 -64.32 -47.1 80.71 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.0 m -54.35 -43.13 71.03 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 53.8 t -69.18 -45.04 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.6 tttt -51.02 -32.91 22.98 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -97.19 36.8 1.4 Allowed 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.61 -3.87 0.89 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 23.5 m-20 -136.32 116.43 13.39 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.73 -8.61 37.08 Favored Glycine 0 C--N 1.335 0.505 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.525 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 -179.941 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 . . . . . 0 N--CA 1.448 -0.535 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -77.75 -44.87 26.34 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 5.1 t -43.64 -33.39 1.19 Allowed 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . 0.52 ' HA ' HG13 ' B' ' 107' ' ' ILE . 1.1 t-20 -42.72 -51.09 5.44 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 13.1 mt -42.81 -48.92 5.79 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 106' ' ' GLU . . . . . 0.589 ' CD ' ' N ' ' B' ' 106' ' ' GLU . 2.6 mp0 -64.27 -31.65 72.94 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 107' ' ' ILE . . . . . 0.525 ' CG2' HD23 ' C' ' 210' ' ' LEU . 3.8 mt -65.34 -29.75 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 39.4 mt -76.82 -42.17 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 109' ' ' ILE . . . . . 0.418 ' O ' ' HB ' ' B' ' 113' ' ' THR . 84.1 mt -77.3 -23.81 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . 0.523 HD23 ' HA ' ' A' ' 7' ' ' ILE . 15.5 mt -85.67 -50.23 7.36 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 111' ' ' GLU . . . . . 0.447 ' CD ' HG21 ' C' ' 213' ' ' THR . 59.3 mm-40 -58.88 -40.19 83.67 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 112' ' ' GLY . . . . . 0.427 ' O ' ' CG1' ' B' ' 116' ' ' ILE . . . -73.32 -57.58 5.05 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 113' ' ' THR . . . . . 0.441 HG21 ' CD ' ' A' ' 11' ' ' GLU . 49.5 m -57.81 -25.17 60.23 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 114' ' ' ALA . . . . . 0.41 ' CB ' ' O ' ' B' ' 110' ' ' LEU . . . -68.78 -63.11 1.12 Allowed 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . 0.423 HG21 ' CG ' ' C' ' 218' ' ' MET . 2.5 t -68.9 -21.09 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 116' ' ' ILE . . . . . 0.427 ' CG1' ' O ' ' B' ' 112' ' ' GLY . 22.6 mt -77.28 -64.81 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -51.01 -32.24 20.72 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 118' ' ' MET . . . . . 0.601 ' CE ' ' HE2' ' C' ' 218' ' ' MET . 6.6 mtp -66.29 -59.9 3.28 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.51 -25.58 66.2 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -71.38 -48.91 47.08 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 121' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -65.73 -40.62 92.34 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 10.7 tp -61.07 -47.97 83.87 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 26.1 mt -56.58 -40.52 75.39 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 12.3 tp -66.69 -36.96 83.74 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 25.0 t -63.78 -40.44 89.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 79.8 mt -66.44 -43.08 91.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 93.0 mt -67.03 -36.45 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' B' ' 128' ' ' LEU . 25.5 mt -67.06 -49.88 63.67 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 39.3 mtt180 -63.97 -46.99 82.15 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 4.0 m -54.14 -43.31 70.42 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 54.0 t -69.18 -45.11 80.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 29.0 tttt -51.03 -33.0 23.41 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -97.11 36.6 1.41 Allowed 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 134' ' ' ALA . . . . . . . . . . . . . . . -143.53 -4.05 0.89 Allowed 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 23.7 m-20 -136.29 116.4 13.39 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . 107.44 -8.85 38.08 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.534 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 -179.983 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 201' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -77.7 -44.85 26.57 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 203' ' ' THR . . . . . . . . . . . . . 5.1 t -43.69 -33.53 1.25 Allowed 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 204' ' ' ASN . . . . . 0.504 ' HA ' HG13 ' C' ' 207' ' ' ILE . 1.1 t-20 -42.75 -51.23 5.43 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 205' ' ' LEU . . . . . . . . . . . . . 13.1 mt -42.89 -48.91 5.9 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 206' ' ' GLU . . . . . 0.58 ' N ' ' CD ' ' C' ' 206' ' ' GLU . 2.6 mp0 -64.03 -31.67 72.94 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 207' ' ' ILE . . . . . 0.533 ' CG2' HD23 ' A' ' 10' ' ' LEU . 3.8 mt -65.24 -29.93 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 208' ' ' ILE . . . . . . . . . . . . . 40.4 mt -76.67 -42.11 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 209' ' ' ILE . . . . . 0.414 ' O ' ' HB ' ' C' ' 213' ' ' THR . 84.0 mt -77.36 -23.87 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 210' ' ' LEU . . . . . 0.525 HD23 ' CG2' ' B' ' 107' ' ' ILE . 15.5 mt -85.66 -50.2 7.39 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 211' ' ' GLU . . . . . 0.442 ' CG ' ' O ' ' C' ' 207' ' ' ILE . 59.2 mm-40 -58.8 -40.39 83.93 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 212' ' ' GLY . . . . . 0.428 ' O ' ' CG1' ' C' ' 216' ' ' ILE . . . -73.28 -57.55 5.09 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 213' ' ' THR . . . . . 0.447 HG21 ' CD ' ' B' ' 111' ' ' GLU . 48.6 m -57.76 -25.2 60.14 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 214' ' ' ALA . . . . . 0.416 ' CB ' ' O ' ' C' ' 210' ' ' LEU . . . -68.69 -63.13 1.12 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 215' ' ' VAL . . . . . 0.462 HG21 ' CG ' ' A' ' 18' ' ' MET . 2.5 t -68.97 -21.11 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 216' ' ' ILE . . . . . 0.428 ' CG1' ' O ' ' C' ' 212' ' ' GLY . 22.0 mt -77.02 -64.8 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -51.07 -32.42 22.08 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 218' ' ' MET . . . . . 0.601 ' HE2' ' CE ' ' B' ' 118' ' ' MET . 6.5 mtp -65.99 -59.86 3.4 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.31 -26.36 66.47 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -72.9 -47.52 45.1 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 221' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.89 -39.82 94.12 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 10.8 tp -59.96 -48.74 80.48 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 223' ' ' LEU . . . . . . . . . . . . . 25.7 mt -57.63 -40.23 78.73 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 12.1 tp -66.46 -36.05 81.82 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 225' ' ' VAL . . . . . . . . . . . . . 25.4 t -62.47 -39.99 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 78.1 mt -65.74 -43.73 93.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 227' ' ' ILE . . . . . . . . . . . . . 92.9 mt -67.59 -36.95 77.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 27.4 mt -67.17 -49.72 63.71 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 229' ' ' ARG . . . . . . . . . . . . . 39.3 mtt180 -63.91 -47.26 81.29 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 230' ' ' THR . . . . . . . . . . . . . 4.1 m -54.29 -42.8 70.47 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.911 -0.404 . . . . 0.0 109.911 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 53.6 t -69.81 -45.33 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 232' ' ' LYS . . . . . . . . . . . . . 28.3 tttt -50.25 -32.45 16.75 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 233' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -97.0 36.4 1.43 Allowed 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 234' ' ' ALA . . . . . . . . . . . . . . . -143.86 -3.68 0.87 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 235' ' ' ASN . . . . . . . . . . . . . 23.0 m-20 -136.16 116.41 13.53 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 236' ' ' GLY . . . . . . . . . . . . . . . 107.93 -8.58 36.51 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.538 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 -179.948 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 . . . . . 0 N--CA 1.449 -0.515 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.518 ' C ' HD21 ' A' ' 4' ' ' ASN . 23.9 mtmt -82.59 -40.87 20.26 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.45 HG21 ' HG3' ' B' ' 106' ' ' GLU . 96.0 m -43.51 -31.1 0.66 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.705 ' ND2' ' H ' ' A' ' 5' ' ' LEU . 0.3 OUTLIER -42.6 -50.71 5.35 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.94 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.705 ' H ' ' ND2' ' A' ' 4' ' ' ASN . 16.1 mt -43.46 -48.33 7.21 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.596 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 2.7 mp0 -64.67 -31.56 72.84 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.545 ' CG2' HD22 ' B' ' 110' ' ' LEU . 4.9 mt -65.2 -30.38 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 60.7 mt -76.48 -42.17 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.419 ' O ' ' HB ' ' A' ' 13' ' ' THR . 32.0 mt -76.54 -25.22 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.545 HD22 ' HA ' ' C' ' 207' ' ' ILE . 15.1 mt -84.6 -46.46 11.52 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.448 ' CD ' HG21 ' B' ' 113' ' ' THR . 52.1 mm-40 -58.67 -45.14 90.04 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -70.58 -57.92 6.25 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.446 HG21 ' CD ' ' C' ' 211' ' ' GLU . 44.9 m -55.69 -27.02 47.93 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.43 ' CB ' ' O ' ' A' ' 10' ' ' LEU . . . -66.45 -63.14 1.14 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.587 ' CG1' ' HG2' ' B' ' 118' ' ' MET . 2.9 t -67.49 -22.04 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.431 ' HB ' ' HA ' ' A' ' 13' ' ' THR . 34.8 mt -73.09 -64.54 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.78 -34.89 29.19 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.587 ' HG2' ' CG1' ' C' ' 215' ' ' VAL . 6.0 mtp -60.46 -60.16 4.26 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -52.28 -37.83 56.62 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.494 ' HA ' HD23 ' A' ' 23' ' ' LEU . 2.8 m-30 -62.4 -50.54 71.12 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 36.1 t-105 -70.53 -22.51 62.61 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.65 -52.05 19.95 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.558 ' HG ' ' N ' ' A' ' 24' ' ' LEU . 0.7 OUTLIER -62.24 -35.45 78.98 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.558 ' N ' ' HG ' ' A' ' 23' ' ' LEU . 13.0 mt -59.67 -51.9 67.83 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 42.8 t -65.79 -25.49 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.493 HD11 ' HA ' ' A' ' 23' ' ' LEU . 43.0 mt -70.49 -47.08 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 84.7 mt -67.2 -36.24 76.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 23.5 mt -67.17 -50.93 59.35 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 32.8 mtp180 -63.32 -48.92 76.01 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.5 m -52.55 -41.49 63.58 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 53.0 t -70.31 -43.18 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.9 ttmt -53.31 -30.63 39.96 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 33' ' ' ARG . 7.3 mtp180 -98.5 36.29 1.65 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -138.86 8.05 2.52 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 -119.98 176.63 5.33 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 139.64 55.86 0.04 OUTLIER Glycine 0 C--N 1.335 0.49 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.548 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 -179.993 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 . . . . . 0 N--CA 1.45 -0.441 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . 0.523 ' C ' HD21 ' B' ' 104' ' ' ASN . 23.9 mtmt -82.6 -40.87 20.24 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 103' ' ' THR . . . . . 0.433 HG21 ' HG3' ' C' ' 206' ' ' GLU . 96.2 m -43.52 -31.12 0.66 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . 0.702 ' ND2' ' H ' ' B' ' 105' ' ' LEU . 0.3 OUTLIER -42.66 -50.8 5.43 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.934 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . 0.702 ' H ' ' ND2' ' B' ' 104' ' ' ASN . 16.2 mt -43.57 -48.24 7.52 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 106' ' ' GLU . . . . . 0.599 ' CD ' ' N ' ' B' ' 106' ' ' GLU . 2.7 mp0 -64.58 -31.42 72.63 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 107' ' ' ILE . . . . . 0.546 ' CG2' HD22 ' C' ' 210' ' ' LEU . 4.8 mt -65.31 -30.36 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 61.0 mt -76.53 -42.07 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 109' ' ' ILE . . . . . 0.428 ' O ' ' HB ' ' B' ' 113' ' ' THR . 32.0 mt -76.64 -25.2 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . 0.545 HD22 ' CG2' ' A' ' 7' ' ' ILE . 15.1 mt -84.58 -46.53 11.46 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 111' ' ' GLU . . . . . 0.439 ' CG ' ' O ' ' B' ' 107' ' ' ILE . 52.4 mm-40 -58.72 -45.14 90.27 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 112' ' ' GLY . . . . . . . . . . . . . . . -70.56 -57.76 6.38 Favored Glycine 0 C--N 1.335 0.521 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 113' ' ' THR . . . . . 0.448 HG21 ' CD ' ' A' ' 11' ' ' GLU . 45.1 m -55.82 -26.95 48.96 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 114' ' ' ALA . . . . . 0.436 ' CB ' ' O ' ' B' ' 110' ' ' LEU . . . -66.47 -63.12 1.14 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . 0.598 ' CG1' ' HG2' ' C' ' 218' ' ' MET . 2.9 t -67.58 -22.1 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 116' ' ' ILE . . . . . 0.434 ' HB ' ' HA ' ' B' ' 113' ' ' THR . 35.3 mt -73.09 -64.53 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -50.65 -35.05 28.78 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 118' ' ' MET . . . . . 0.587 ' HG2' ' CG1' ' A' ' 15' ' ' VAL . 6.0 mtp -60.36 -60.18 4.23 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -52.68 -38.46 60.57 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . 0.502 ' HA ' HD23 ' B' ' 123' ' ' LEU . 2.8 m-30 -62.73 -49.91 73.17 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 121' ' ' TRP . . . . . . . . . . . . . 36.1 t-105 -70.5 -22.5 62.63 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -71.55 -52.08 20.07 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . 0.564 ' HG ' ' N ' ' B' ' 124' ' ' LEU . 0.8 OUTLIER -62.31 -35.21 78.35 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.959 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . 0.564 ' N ' ' HG ' ' B' ' 123' ' ' LEU . 13.0 mt -59.91 -51.54 69.26 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 42.6 t -65.19 -25.87 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . 0.5 HD11 ' HA ' ' B' ' 123' ' ' LEU . 45.2 mt -70.7 -47.28 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 84.6 mt -67.03 -35.92 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 24.2 mt -65.91 -50.8 63.18 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 32.7 mtp180 -63.84 -50.04 70.42 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 4.0 m -52.6 -42.42 64.54 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 53.3 t -70.71 -42.63 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 24.0 ttmt -52.72 -31.36 37.32 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 133' ' ' ARG . . . . . 0.432 HH11 ' HD2' ' B' ' 133' ' ' ARG . 7.3 mtp180 -97.49 36.04 1.55 Allowed 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 134' ' ' ALA . . . . . . . . . . . . . . . -139.23 8.21 2.45 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 -119.76 176.67 5.28 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . 139.75 56.1 0.04 OUTLIER Glycine 0 C--N 1.336 0.531 0 N-CA-C 110.269 -1.133 . . . . 0.0 110.269 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.537 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 -179.97 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 201' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 . . . . . 0 N--CA 1.45 -0.475 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 202' ' ' LYS . . . . . 0.523 ' C ' HD21 ' C' ' 204' ' ' ASN . 23.9 mtmt -82.62 -40.93 20.13 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 203' ' ' THR . . . . . 0.45 HG23 ' HG2' ' A' ' 6' ' ' GLU . 96.3 m -43.54 -31.12 0.67 Allowed 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 204' ' ' ASN . . . . . 0.69 ' ND2' ' H ' ' C' ' 205' ' ' LEU . 0.3 OUTLIER -42.56 -50.72 5.3 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 205' ' ' LEU . . . . . 0.69 ' H ' ' ND2' ' C' ' 204' ' ' ASN . 16.2 mt -43.6 -48.24 7.61 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 206' ' ' GLU . . . . . 0.595 ' N ' ' CD ' ' C' ' 206' ' ' GLU . 2.7 mp0 -64.66 -31.47 72.71 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 207' ' ' ILE . . . . . 0.545 ' HA ' HD22 ' A' ' 10' ' ' LEU . 4.8 mt -65.24 -30.35 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 208' ' ' ILE . . . . . . . . . . . . . 60.5 mt -76.59 -42.12 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 209' ' ' ILE . . . . . 0.415 ' O ' ' HB ' ' C' ' 213' ' ' THR . 31.8 mt -76.59 -25.21 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 210' ' ' LEU . . . . . 0.546 HD22 ' CG2' ' B' ' 107' ' ' ILE . 15.1 mt -84.62 -46.5 11.46 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 211' ' ' GLU . . . . . 0.446 ' CD ' HG21 ' A' ' 13' ' ' THR . 52.3 mm-40 -58.71 -45.04 90.45 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -70.66 -57.85 6.25 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 213' ' ' THR . . . . . 0.452 ' HA ' ' HB ' ' C' ' 216' ' ' ILE . 45.4 m -55.68 -27.11 48.4 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 214' ' ' ALA . . . . . 0.435 ' CB ' ' O ' ' C' ' 210' ' ' LEU . . . -66.51 -63.05 1.16 Allowed 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 215' ' ' VAL . . . . . 0.587 ' CG1' ' HG2' ' A' ' 18' ' ' MET . 3.0 t -67.6 -22.02 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 216' ' ' ILE . . . . . 0.452 ' HB ' ' HA ' ' C' ' 213' ' ' THR . 34.6 mt -73.19 -64.42 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -50.92 -34.78 29.97 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 218' ' ' MET . . . . . 0.598 ' HG2' ' CG1' ' B' ' 115' ' ' VAL . 6.0 mtp -60.52 -60.17 4.23 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -51.96 -38.36 56.29 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 220' ' ' PHE . . . . . 0.497 ' HA ' HD23 ' C' ' 223' ' ' LEU . 2.8 m-30 -62.8 -50.15 72.12 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 221' ' ' TRP . . . . . . . . . . . . . 36.5 t-105 -70.16 -22.48 62.97 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.54 -52.2 19.45 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 223' ' ' LEU . . . . . 0.57 ' HG ' ' N ' ' C' ' 224' ' ' LEU . 0.8 OUTLIER -62.11 -35.32 78.37 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 224' ' ' LEU . . . . . 0.57 ' N ' ' HG ' ' C' ' 223' ' ' LEU . 13.0 mt -59.9 -51.22 70.62 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 225' ' ' VAL . . . . . . . . . . . . . 42.5 t -65.8 -25.8 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 226' ' ' ILE . . . . . 0.48 HD11 ' HA ' ' C' ' 223' ' ' LEU . 43.2 mt -70.45 -47.39 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 227' ' ' ILE . . . . . . . . . . . . . 84.9 mt -66.6 -35.68 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 23.4 mt -66.66 -50.83 61.65 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 229' ' ' ARG . . . . . . . . . . . . . 32.4 mtp180 -63.63 -49.79 71.91 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 230' ' ' THR . . . . . . . . . . . . . 3.8 m -52.18 -41.48 62.66 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 53.2 t -70.75 -42.55 77.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 232' ' ' LYS . . . . . . . . . . . . . 24.2 ttmt -53.24 -31.67 44.53 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 233' ' ' ARG . . . . . 0.433 HH11 ' HD2' ' C' ' 233' ' ' ARG . 7.2 mtp180 -96.96 35.53 1.54 Allowed 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 234' ' ' ALA . . . . . . . . . . . . . . . -138.94 8.57 2.53 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 235' ' ' ASN . . . . . . . . . . . . . 45.7 m-20 -119.55 176.57 5.3 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 236' ' ' GLY . . . . . . . . . . . . . . . 139.46 55.95 0.04 OUTLIER Glycine 0 C--N 1.336 0.534 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.539 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 -179.961 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 . . . . . 0 N--CA 1.449 -0.523 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.535 ' N ' ' CD ' ' A' ' 2' ' ' LYS . 3.9 mptp? -84.67 -40.79 16.97 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.1 t -49.18 -36.23 19.06 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.502 ' HA ' HG13 ' A' ' 7' ' ' ILE . 1.6 t30 -42.84 -51.23 5.54 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 12.8 mt -42.99 -48.57 5.97 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.571 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 3.8 mp0 -64.54 -31.36 72.54 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.567 ' CG2' HD21 ' B' ' 110' ' ' LEU . 4.0 mt -65.17 -30.2 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 73.6 mt -76.75 -42.24 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.415 ' O ' ' HB ' ' A' ' 13' ' ' THR . 95.7 mt -76.75 -24.21 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.569 HD21 ' HA ' ' C' ' 207' ' ' ILE . 15.4 mt -85.6 -47.59 9.71 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.448 ' CG ' ' O ' ' A' ' 7' ' ' ILE . 57.5 mm-40 -58.95 -42.34 89.57 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.431 ' O ' ' CG1' ' A' ' 16' ' ' ILE . . . -72.65 -56.38 6.05 Favored Glycine 0 C--N 1.335 0.521 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.458 HG23 ' CD ' ' C' ' 211' ' ' GLU . 37.1 m -57.77 -25.4 60.45 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.413 ' CB ' ' O ' ' A' ' 10' ' ' LEU . . . -68.83 -63.14 1.12 Allowed 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.537 HG22 ' CG ' ' B' ' 118' ' ' MET . 2.7 t -68.56 -21.17 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.523 HG23 ' CE2' ' A' ' 20' ' ' PHE . 34.9 mt -76.84 -64.65 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.02 -32.32 21.13 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.589 ' HE3' ' CE ' ' C' ' 218' ' ' MET . 6.4 mtp -65.52 -60.23 3.15 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -54.84 -30.06 56.63 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.523 ' CE2' HG23 ' A' ' 16' ' ' ILE . 2.9 m-85 -69.25 -44.0 72.84 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 43.9 t-105 -74.12 -28.36 61.31 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 15.2 mt -71.33 -52.92 16.12 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.518 ' CD1' ' C ' ' A' ' 23' ' ' LEU . 0.9 OUTLIER -61.35 -34.25 74.97 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.488 ' N ' ' HG ' ' A' ' 23' ' ' LEU . 4.5 tt -62.73 -45.7 91.51 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 79.8 t -70.36 -23.5 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 48.1 mt -70.35 -44.3 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 36.6 mt -72.27 -37.29 58.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 24.0 mt -72.72 -37.5 67.77 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 33.8 ttm-85 -75.18 -41.52 57.82 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.6 m -62.25 -41.41 98.41 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 55.8 t -74.11 -42.47 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.516 ' HB3' ' NZ ' ' A' ' 32' ' ' LYS . 7.6 mtpm? -56.61 -29.24 61.93 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.5 mmm180 -101.95 37.62 1.81 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.87 -9.11 1.04 Allowed 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -82.47 137.95 34.5 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -110.87 -102.01 2.66 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.543 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 179.996 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 . . . . . 0 N--CA 1.449 -0.5 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . 0.536 ' N ' ' CD ' ' B' ' 102' ' ' LYS . 3.9 mptp? -84.7 -40.73 17.0 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 7.0 t -49.26 -36.19 19.77 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . 0.513 ' HA ' HG13 ' B' ' 107' ' ' ILE . 1.5 t30 -42.93 -51.24 5.65 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 12.8 mt -43.01 -48.49 6.0 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 106' ' ' GLU . . . . . 0.583 ' CD ' ' N ' ' B' ' 106' ' ' GLU . 3.8 mp0 -64.54 -31.46 72.69 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 107' ' ' ILE . . . . . 0.542 ' HA ' HD21 ' C' ' 210' ' ' LEU . 4.0 mt -65.14 -30.14 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 73.5 mt -76.77 -42.24 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 109' ' ' ILE . . . . . 0.427 ' O ' ' HB ' ' B' ' 113' ' ' THR . 95.6 mt -76.84 -24.12 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . 0.567 HD21 ' CG2' ' A' ' 7' ' ' ILE . 15.5 mt -85.62 -47.48 9.8 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 111' ' ' GLU . . . . . 0.452 ' CD ' HG23 ' C' ' 213' ' ' THR . 57.5 mm-40 -58.98 -42.45 89.98 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 112' ' ' GLY . . . . . 0.428 ' O ' ' CG1' ' B' ' 116' ' ' ILE . . . -72.67 -56.25 6.12 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.319 -1.113 . . . . 0.0 110.319 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 113' ' ' THR . . . . . 0.435 HG23 ' CD ' ' A' ' 11' ' ' GLU . 36.9 m -57.89 -25.32 60.66 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 114' ' ' ALA . . . . . 0.421 ' CB ' ' O ' ' B' ' 110' ' ' LEU . . . -68.85 -63.15 1.11 Allowed 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . 0.52 HG22 ' CG ' ' C' ' 218' ' ' MET . 2.7 t -68.54 -21.29 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 116' ' ' ILE . . . . . 0.428 ' CG1' ' O ' ' B' ' 112' ' ' GLY . 34.5 mt -76.66 -64.66 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -51.11 -32.11 21.51 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 118' ' ' MET . . . . . 0.602 ' CE ' ' HE3' ' C' ' 218' ' ' MET . 6.3 mtp -65.57 -59.72 3.67 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -53.16 -31.09 40.83 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -69.98 -42.94 72.45 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 121' ' ' TRP . . . . . . . . . . . . . 44.0 t-105 -73.98 -27.27 60.9 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 15.2 mt -71.86 -53.15 14.14 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . 0.516 ' CD1' ' C ' ' B' ' 123' ' ' LEU . 0.9 OUTLIER -61.5 -34.11 74.95 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . 0.48 ' N ' ' HG ' ' B' ' 123' ' ' LEU . 4.1 tt -63.5 -44.59 93.9 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . 0.416 ' O ' ' CB ' ' B' ' 129' ' ' ARG . 80.2 t -70.6 -23.41 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 49.4 mt -70.32 -44.39 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 37.0 mt -72.57 -38.13 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 24.9 mt -72.42 -36.71 68.67 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . 0.435 HH11 ' HD3' ' B' ' 129' ' ' ARG . 33.9 ttm-85 -75.71 -41.98 52.1 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 3.8 m -62.11 -41.58 98.37 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 54.6 t -74.54 -42.91 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 132' ' ' LYS . . . . . 0.504 ' HB3' ' NZ ' ' B' ' 132' ' ' LYS . 7.5 mtpm? -56.33 -29.0 60.74 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 8.5 mmm180 -101.54 37.31 1.83 Allowed 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 134' ' ' ALA . . . . . . . . . . . . . . . -140.66 -9.48 1.06 Allowed 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -82.97 137.89 34.0 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -110.89 -102.8 2.7 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.536 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 -179.966 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 201' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 . . . . . 0 N--CA 1.449 -0.485 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 202' ' ' LYS . . . . . 0.535 ' N ' ' CD ' ' C' ' 202' ' ' LYS . 3.8 mptp? -84.58 -40.82 17.07 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 203' ' ' THR . . . . . . . . . . . . . 7.1 t -49.23 -36.03 19.0 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.946 -0.391 . . . . 0.0 109.946 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 204' ' ' ASN . . . . . 0.526 ' HA ' HG13 ' C' ' 207' ' ' ILE . 1.5 t30 -42.88 -51.14 5.63 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 205' ' ' LEU . . . . . . . . . . . . . 12.8 mt -43.04 -48.53 6.08 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 206' ' ' GLU . . . . . 0.574 ' N ' ' CD ' ' C' ' 206' ' ' GLU . 3.8 mp0 -64.58 -31.43 72.64 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 207' ' ' ILE . . . . . 0.569 ' HA ' HD21 ' A' ' 10' ' ' LEU . 4.0 mt -65.14 -30.19 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 208' ' ' ILE . . . . . . . . . . . . . 73.3 mt -76.77 -42.26 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 209' ' ' ILE . . . . . 0.409 ' O ' ' HB ' ' C' ' 213' ' ' THR . 95.6 mt -76.74 -24.24 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 210' ' ' LEU . . . . . 0.542 HD21 ' HA ' ' B' ' 107' ' ' ILE . 15.4 mt -85.58 -47.28 10.01 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 211' ' ' GLU . . . . . 0.458 ' CD ' HG23 ' A' ' 13' ' ' THR . 57.1 mm-40 -59.03 -42.52 90.38 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 212' ' ' GLY . . . . . 0.425 ' O ' ' CG1' ' C' ' 216' ' ' ILE . . . -72.64 -56.27 6.13 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 213' ' ' THR . . . . . 0.452 HG23 ' CD ' ' B' ' 111' ' ' GLU . 38.3 m -57.82 -25.47 60.67 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 214' ' ' ALA . . . . . 0.415 ' CB ' ' O ' ' C' ' 210' ' ' LEU . . . -68.76 -63.19 1.11 Allowed 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 215' ' ' VAL . . . . . 0.536 HG22 ' CG ' ' A' ' 18' ' ' MET . 2.7 t -68.5 -21.33 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 216' ' ' ILE . . . . . 0.425 ' CG1' ' O ' ' C' ' 212' ' ' GLY . 34.3 mt -76.61 -64.62 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -51.11 -32.11 21.48 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 218' ' ' MET . . . . . 0.602 ' HE3' ' CE ' ' B' ' 118' ' ' MET . 6.3 mtp -65.49 -60.14 3.25 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -53.92 -32.06 52.27 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -70.85 -42.05 70.65 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 221' ' ' TRP . . . . . . . . . . . . . 43.9 t-105 -73.65 -26.78 60.91 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 15.1 mt -71.82 -53.4 13.41 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 223' ' ' LEU . . . . . 0.519 ' C ' ' CD1' ' C' ' 223' ' ' LEU . 0.9 OUTLIER -61.55 -33.64 74.2 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 224' ' ' LEU . . . . . 0.468 ' N ' ' HG ' ' C' ' 223' ' ' LEU . 3.9 tt -63.8 -44.41 93.4 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 225' ' ' VAL . . . . . 0.408 ' O ' ' CB ' ' C' ' 229' ' ' ARG . 82.2 t -70.29 -23.49 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 50.1 mt -70.41 -44.19 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 227' ' ' ILE . . . . . . . . . . . . . 37.3 mt -72.69 -38.02 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 24.4 mt -72.41 -36.81 68.73 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 229' ' ' ARG . . . . . 0.426 HH11 ' HD3' ' C' ' 229' ' ' ARG . 33.8 ttm-85 -75.46 -42.44 53.19 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 230' ' ' THR . . . . . . . . . . . . . 3.6 m -61.8 -41.31 97.58 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 55.6 t -74.36 -42.54 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 232' ' ' LYS . . . . . 0.512 ' NZ ' ' HB3' ' C' ' 232' ' ' LYS . 7.5 mtpm? -56.12 -29.36 60.57 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 233' ' ' ARG . . . . . . . . . . . . . 8.5 mmm180 -100.95 37.09 1.81 Allowed 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 234' ' ' ALA . . . . . . . . . . . . . . . -141.28 -9.3 0.98 Allowed 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 235' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -82.64 138.03 34.3 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 236' ' ' GLY . . . . . . . . . . . . . . . -110.89 -102.19 2.67 Favored Glycine 0 C--N 1.335 0.515 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.526 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 -179.986 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 . . . . . 0 N--CA 1.449 -0.5 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.423 ' HD3' ' HA ' ' A' ' 2' ' ' LYS . 35.6 mmtm -81.81 -50.7 8.92 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.4 t -43.67 -34.4 1.47 Allowed 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.53 ' HA ' HG13 ' A' ' 7' ' ' ILE . 1.6 t-20 -42.78 -50.85 5.57 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 11.5 mt -42.9 -48.61 5.86 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.585 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 2.1 mp0 -64.8 -31.58 72.88 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.546 ' CG2' HD21 ' B' ' 110' ' ' LEU . 4.2 mt -64.81 -30.26 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 66.1 mt -76.8 -42.74 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.416 ' O ' ' HB ' ' A' ' 13' ' ' THR . 18.9 mt -76.19 -24.0 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.546 HD21 ' HA ' ' C' ' 207' ' ' ILE . 15.8 mt -85.7 -52.78 5.56 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.445 ' CG ' ' O ' ' A' ' 7' ' ' ILE . 66.5 mm-40 -55.8 -40.96 73.45 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.434 ' O ' ' CG1' ' A' ' 16' ' ' ILE . . . -72.65 -54.99 6.93 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.458 HG22 ' CD ' ' C' ' 211' ' ' GLU . 17.2 m -57.7 -25.88 60.95 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.19 -63.38 1.08 Allowed 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.519 HG22 ' CG ' ' B' ' 118' ' ' MET . 2.6 t -67.57 -21.14 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.434 ' CG1' ' O ' ' A' ' 12' ' ' GLY . 32.6 mt -76.55 -64.6 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.42 -32.04 16.65 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.596 ' CE ' ' HE1' ' B' ' 118' ' ' MET . 6.5 mtp -71.04 -59.71 2.63 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.427 ' O ' ' CG ' ' A' ' 23' ' ' LEU . 2.4 m-85 -57.43 -23.73 51.34 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -67.85 -60.04 2.82 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 48.9 m0 -60.71 -41.43 95.21 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 11.6 tp -65.04 -41.38 95.28 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.427 ' CG ' ' O ' ' A' ' 19' ' ' PHE . 4.8 mt -55.33 -45.48 76.38 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.4 mp -64.03 -38.93 92.86 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 53.9 t -69.68 -32.19 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 37.8 mt -73.59 -36.35 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 87.2 mt -69.95 -38.66 76.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 87.0 mt -71.35 -43.77 66.34 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -66.95 -46.05 75.89 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.0 m -57.3 -43.41 83.17 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.9 t -68.25 -46.41 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -50.0 -35.92 26.46 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 10.7 mmt85 -97.25 38.25 1.27 Allowed 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -142.5 -11.1 0.82 Allowed 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -96.09 150.78 20.11 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.68 -73.82 2.61 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.517 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -179.979 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 56.5 tt0 . . . . . 0 N--CA 1.45 -0.469 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . 0.41 ' HD3' ' HA ' ' B' ' 102' ' ' LYS . 35.5 mmtm -81.86 -50.44 9.2 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 6.3 t -44.02 -34.32 1.7 Allowed 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . 0.507 ' HA ' HG13 ' B' ' 107' ' ' ILE . 1.6 t-20 -42.97 -51.16 5.73 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 11.5 mt -42.97 -48.42 5.92 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 106' ' ' GLU . . . . . 0.58 ' CD ' ' N ' ' B' ' 106' ' ' GLU . 2.2 mp0 -64.55 -31.89 73.3 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 107' ' ' ILE . . . . . 0.521 ' HA ' HD21 ' C' ' 210' ' ' LEU . 4.0 mt -64.85 -29.73 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 66.3 mt -77.01 -42.91 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 109' ' ' ILE . . . . . 0.424 ' O ' ' HB ' ' B' ' 113' ' ' THR . 18.9 mt -76.33 -23.9 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . 0.546 HD21 ' CG2' ' A' ' 7' ' ' ILE . 15.4 mt -85.67 -50.78 6.92 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 111' ' ' GLU . . . . . 0.449 ' CG ' ' O ' ' B' ' 107' ' ' ILE . 63.9 mm-40 -57.23 -40.64 77.96 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 112' ' ' GLY . . . . . 0.43 ' O ' ' CG1' ' B' ' 116' ' ' ILE . . . -73.49 -55.77 5.91 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 113' ' ' THR . . . . . 0.424 ' HB ' ' O ' ' B' ' 109' ' ' ILE . 22.2 m -57.86 -24.93 59.83 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.12 -62.69 1.29 Allowed 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . . . . . . . . . 3.1 t -68.27 -21.1 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 116' ' ' ILE . . . . . 0.43 ' CG1' ' O ' ' B' ' 112' ' ' GLY . 45.6 mt -79.61 -65.2 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -53.81 -27.98 32.62 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.786 -0.449 . . . . 0.0 109.786 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 118' ' ' MET . . . . . 0.596 ' HE1' ' CE ' ' A' ' 18' ' ' MET . 11.9 mtp -72.85 -60.01 2.44 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -57.81 -26.28 61.75 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -70.63 -58.97 3.11 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 121' ' ' TRP . . . . . . . . . . . . . 49.2 m0 -59.06 -39.89 83.47 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 11.6 tp -62.99 -42.47 99.86 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 4.9 mt -56.94 -46.77 81.83 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 4.4 mp -65.45 -36.85 85.15 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 53.7 t -67.76 -31.49 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 36.8 mt -72.64 -37.83 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 88.5 mt -70.32 -38.65 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 88.3 mt -71.05 -43.66 67.39 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -66.69 -46.29 76.06 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 6.0 m -57.46 -44.03 84.49 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 54.4 t -68.27 -45.69 82.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -49.78 -35.74 23.59 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 10.8 mmt85 -96.66 38.46 1.21 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 134' ' ' ALA . . . . . . . . . . . . . . . -143.14 -11.17 0.75 Allowed 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -96.07 150.58 20.34 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . 82.55 -74.3 2.53 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.515 0 N-CA-C 110.281 -1.127 . . . . 0.0 110.281 179.997 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 201' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 . . . . . 0 N--CA 1.45 -0.457 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 202' ' ' LYS . . . . . 0.437 ' HD3' ' HA ' ' C' ' 202' ' ' LYS . 35.5 mmtm -81.89 -50.45 9.17 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 203' ' ' THR . . . . . . . . . . . . . 6.3 t -44.09 -34.61 1.84 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 204' ' ' ASN . . . . . 0.515 ' HA ' HG13 ' C' ' 207' ' ' ILE . 1.6 t-20 -42.82 -51.12 5.56 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 205' ' ' LEU . . . . . . . . . . . . . 11.6 mt -42.95 -48.52 5.91 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 206' ' ' GLU . . . . . 0.574 ' N ' ' CD ' ' C' ' 206' ' ' GLU . 2.2 mp0 -64.66 -31.45 72.68 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 207' ' ' ILE . . . . . 0.546 ' HA ' HD21 ' A' ' 10' ' ' LEU . 4.2 mt -64.98 -30.28 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 208' ' ' ILE . . . . . . . . . . . . . 64.9 mt -76.74 -42.49 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 209' ' ' ILE . . . . . 0.424 ' O ' ' HB ' ' C' ' 213' ' ' THR . 18.7 mt -76.51 -24.09 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 210' ' ' LEU . . . . . 0.541 HD13 ' CD1' ' A' ' 10' ' ' LEU . 15.6 mt -85.71 -52.47 5.76 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 211' ' ' GLU . . . . . 0.458 ' CD ' HG22 ' A' ' 13' ' ' THR . 67.1 mm-40 -56.49 -40.69 75.38 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 212' ' ' GLY . . . . . 0.436 ' O ' ' CG1' ' C' ' 216' ' ' ILE . . . -72.7 -55.95 6.28 Favored Glycine 0 C--N 1.335 0.513 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 213' ' ' THR . . . . . 0.428 HG22 ' CD ' ' B' ' 111' ' ' GLU . 20.4 m -57.65 -25.3 60.0 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 214' ' ' ALA . . . . . . . . . . . . . . . -69.37 -63.26 1.1 Allowed 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 215' ' ' VAL . . . . . . . . . . . . . 2.8 t -68.15 -21.09 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 216' ' ' ILE . . . . . 0.436 ' CG1' ' O ' ' C' ' 212' ' ' GLY . 37.8 mt -77.53 -64.67 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -50.99 -30.93 16.42 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 218' ' ' MET . . . . . 0.594 ' HE1' ' HE1' ' B' ' 118' ' ' MET . 6.9 mtp -71.29 -60.09 2.42 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -58.8 -24.63 62.15 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -68.9 -58.51 4.05 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 221' ' ' TRP . . . . . . . . . . . . . 49.1 m0 -58.69 -40.68 84.3 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 11.6 tp -64.03 -42.11 97.19 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 223' ' ' LEU . . . . . . . . . . . . . 4.9 mt -56.58 -45.54 81.27 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 4.4 mp -64.09 -37.48 87.61 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 225' ' ' VAL . . . . . . . . . . . . . 53.8 t -67.95 -31.84 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 37.3 mt -73.44 -37.26 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 227' ' ' ILE . . . . . . . . . . . . . 88.1 mt -69.72 -38.46 76.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 228' ' ' LEU . . . . . 0.413 HD21 ' HA ' ' C' ' 228' ' ' LEU . 86.8 mt -70.67 -43.55 68.89 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 229' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -66.9 -46.54 74.56 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 230' ' ' THR . . . . . . . . . . . . . 5.8 m -57.21 -43.84 83.13 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 54.0 t -68.22 -45.98 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 232' ' ' LYS . . . . . . . . . . . . . 24.3 tptm -49.75 -35.75 23.37 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 233' ' ' ARG . . . . . . . . . . . . . 10.7 mmt85 -96.72 38.47 1.22 Allowed 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 234' ' ' ALA . . . . . . . . . . . . . . . -143.15 -11.12 0.75 Allowed 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 235' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -95.75 150.82 19.97 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 236' ' ' GLY . . . . . . . . . . . . . . . 82.63 -74.08 2.57 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.54 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 -179.991 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 . . . . . 0 N--CA 1.449 -0.493 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.452 ' HE2' ' HB2' ' A' ' 2' ' ' LYS . 10.2 tppt? -71.08 -23.43 62.12 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.505 HG22 ' CG ' ' B' ' 106' ' ' GLU . 1.6 m -69.07 -47.67 64.68 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.513 ' HA ' HG13 ' A' ' 7' ' ' ILE . 1.6 t30 -42.12 -47.22 4.54 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 12.3 mt -42.84 -50.34 5.7 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.587 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 0.1 OUTLIER -66.08 -32.17 73.48 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.912 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.526 ' CG2' HD21 ' B' ' 110' ' ' LEU . 3.6 mt -65.01 -29.76 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.404 HD12 HD22 ' A' ' 4' ' ' ASN . 44.6 mt -76.93 -42.52 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.421 ' O ' ' HB ' ' A' ' 13' ' ' THR . 29.4 mt -76.74 -24.04 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.534 HD21 ' CG2' ' C' ' 207' ' ' ILE . 15.3 mt -85.73 -48.14 9.11 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.45 ' CG ' ' O ' ' A' ' 7' ' ' ILE . 60.6 mm-40 -58.81 -41.79 87.62 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.434 ' O ' ' CG1' ' A' ' 16' ' ' ILE . . . -72.96 -56.24 5.93 Favored Glycine 0 C--N 1.336 0.555 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.436 HG23 ' CD ' ' C' ' 211' ' ' GLU . 31.8 m -57.88 -25.72 61.15 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.7 -63.09 1.13 Allowed 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.522 HG22 ' CG ' ' B' ' 118' ' ' MET . 2.7 t -68.31 -21.24 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.434 ' CG1' ' O ' ' A' ' 12' ' ' GLY . 30.5 mt -76.57 -64.68 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.93 -32.28 20.28 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.594 ' HE1' ' CE ' ' C' ' 218' ' ' MET . 6.5 mtp -65.47 -60.09 3.31 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -51.52 -34.93 38.38 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -64.52 -39.61 94.1 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 22.8 m0 -65.81 -55.36 17.57 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.411 ' HA ' HD22 ' A' ' 22' ' ' LEU . 67.0 mt -57.38 -38.07 73.65 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 15.0 mt -58.15 -51.08 71.21 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.4 tp -61.75 -29.6 70.23 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.848 -0.426 . . . . 0.0 109.848 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 75.8 t -74.3 -39.15 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 68.3 mt -73.58 -34.81 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 62.3 mt -69.25 -46.62 77.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 55.7 mt -66.04 -41.3 91.05 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -65.83 -52.08 53.55 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.1 m -52.71 -49.02 66.2 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 62.3 t -57.93 -54.08 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.444 ' HB2' ' HE3' ' A' ' 32' ' ' LYS . 23.3 ttmt -51.68 -25.41 7.18 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -97.69 31.18 2.68 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.76 3.0 1.83 Allowed 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.413 ' CG ' ' N ' ' A' ' 36' ' ' GLY . 15.6 t30 -134.68 170.25 16.1 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.413 ' N ' ' CG ' ' A' ' 35' ' ' ASN . . . -53.8 -88.51 0.01 OUTLIER Glycine 0 C--N 1.335 0.5 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.514 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 -179.975 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 . . . . . 0 N--CA 1.449 -0.496 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . 0.466 ' HE2' ' HB2' ' B' ' 102' ' ' LYS . 10.2 tppt? -71.22 -23.51 62.03 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 103' ' ' THR . . . . . 0.517 HG22 ' CG ' ' C' ' 206' ' ' GLU . 1.6 m -69.02 -47.71 64.77 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . 0.521 ' HA ' HG13 ' B' ' 107' ' ' ILE . 1.6 t30 -42.13 -47.33 4.57 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 12.3 mt -42.75 -50.32 5.59 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 106' ' ' GLU . . . . . 0.576 ' CD ' ' N ' ' B' ' 106' ' ' GLU . 0.1 OUTLIER -66.14 -32.2 73.5 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.928 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 107' ' ' ILE . . . . . 0.537 ' CG2' HD21 ' C' ' 210' ' ' LEU . 3.5 mt -65.0 -29.79 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 108' ' ' ILE . . . . . 0.414 HD12 HD22 ' B' ' 104' ' ' ASN . 44.7 mt -76.9 -42.53 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 109' ' ' ILE . . . . . 0.421 ' O ' ' HB ' ' B' ' 113' ' ' THR . 29.3 mt -76.71 -24.03 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . 0.526 HD21 ' CG2' ' A' ' 7' ' ' ILE . 15.3 mt -85.72 -47.63 9.58 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 111' ' ' GLU . . . . . 0.449 ' CG ' ' O ' ' B' ' 107' ' ' ILE . 59.7 mm-40 -59.07 -41.99 89.28 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 112' ' ' GLY . . . . . 0.425 ' O ' ' CG1' ' B' ' 116' ' ' ILE . . . -72.91 -56.15 6.01 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 113' ' ' THR . . . . . 0.427 HG23 ' CD ' ' A' ' 11' ' ' GLU . 32.8 m -57.88 -25.83 61.3 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 114' ' ' ALA . . . . . 0.41 ' CB ' ' O ' ' B' ' 110' ' ' LEU . . . -68.65 -63.07 1.13 Allowed 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . 0.498 HG22 ' CG ' ' C' ' 218' ' ' MET . 2.7 t -68.32 -21.27 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 116' ' ' ILE . . . . . 0.425 ' CG1' ' O ' ' B' ' 112' ' ' GLY . 30.1 mt -76.33 -64.62 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -51.16 -32.14 22.28 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 118' ' ' MET . . . . . 0.592 ' CE ' ' HE1' ' C' ' 218' ' ' MET . 6.3 mtp -65.2 -59.65 3.86 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -49.11 -37.42 21.67 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -67.41 -39.74 85.53 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 121' ' ' TRP . . . . . . . . . . . . . 22.8 m0 -65.93 -53.0 44.94 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 122' ' ' LEU . . . . . 0.406 ' HA ' HD22 ' B' ' 122' ' ' LEU . 65.9 mt -55.13 -38.47 68.25 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 15.1 mt -58.88 -52.03 67.5 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 15.4 tp -63.34 -28.77 70.23 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 76.2 t -72.73 -38.22 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 68.1 mt -72.3 -35.27 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 62.9 mt -70.51 -47.27 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 56.1 mt -66.42 -40.78 89.74 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . 0.416 ' HD3' HH11 ' B' ' 129' ' ' ARG . 10.7 ttt180 -65.85 -52.18 52.57 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 4.1 m -52.69 -49.64 64.91 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 67.8 t -58.31 -54.02 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 132' ' ' LYS . . . . . 0.471 ' HB2' ' HE3' ' B' ' 132' ' ' LYS . 23.7 ttmt -50.99 -25.26 4.48 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -97.09 30.8 2.61 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 134' ' ' ALA . . . . . . . . . . . . . . . -140.72 2.7 1.81 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 135' ' ' ASN . . . . . 0.422 ' CG ' ' N ' ' B' ' 136' ' ' GLY . 15.2 t30 -134.95 170.53 15.74 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 136' ' ' GLY . . . . . 0.422 ' N ' ' CG ' ' B' ' 135' ' ' ASN . . . -53.86 -88.98 0.01 OUTLIER Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.565 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 -179.955 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 201' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 . . . . . 0 N--CA 1.449 -0.496 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 202' ' ' LYS . . . . . 0.495 ' HE2' ' HB2' ' C' ' 202' ' ' LYS . 10.2 tppt? -71.07 -23.46 62.14 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 203' ' ' THR . . . . . 0.494 HG22 ' CG ' ' A' ' 6' ' ' GLU . 1.6 m -69.13 -47.64 64.54 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 204' ' ' ASN . . . . . 0.524 ' HA ' HG13 ' C' ' 207' ' ' ILE . 1.6 t30 -42.1 -47.28 4.52 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 205' ' ' LEU . . . . . . . . . . . . . 12.3 mt -42.82 -50.24 5.68 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 206' ' ' GLU . . . . . 0.588 ' N ' ' CD ' ' C' ' 206' ' ' GLU . 0.1 OUTLIER -66.17 -32.27 73.61 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.938 -0.394 . . . . 0.0 109.938 179.938 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 207' ' ' ILE . . . . . 0.534 ' CG2' HD21 ' A' ' 10' ' ' LEU . 3.5 mt -64.95 -29.81 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 208' ' ' ILE . . . . . 0.422 HD12 HD22 ' C' ' 204' ' ' ASN . 44.9 mt -76.84 -42.56 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 209' ' ' ILE . . . . . 0.408 ' O ' ' HB ' ' C' ' 213' ' ' THR . 29.4 mt -76.67 -24.01 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 210' ' ' LEU . . . . . 0.537 HD21 ' CG2' ' B' ' 107' ' ' ILE . 15.4 mt -85.73 -47.64 9.57 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 211' ' ' GLU . . . . . 0.442 ' CG ' ' O ' ' C' ' 207' ' ' ILE . 59.3 mm-40 -59.09 -41.91 89.2 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 212' ' ' GLY . . . . . 0.434 ' O ' ' CG1' ' C' ' 216' ' ' ILE . . . -73.02 -56.08 5.98 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 213' ' ' THR . . . . . 0.439 HG23 ' CD ' ' B' ' 111' ' ' GLU . 34.0 m -57.93 -25.78 61.35 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 214' ' ' ALA . . . . . 0.402 ' CB ' ' O ' ' C' ' 210' ' ' LEU . . . -68.71 -63.03 1.14 Allowed 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 215' ' ' VAL . . . . . 0.503 HG22 ' CG ' ' A' ' 18' ' ' MET . 2.7 t -68.3 -21.41 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 216' ' ' ILE . . . . . 0.434 ' CG1' ' O ' ' C' ' 212' ' ' GLY . 30.4 mt -76.2 -64.64 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -51.05 -32.26 21.27 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 218' ' ' MET . . . . . 0.594 ' CE ' ' HE1' ' A' ' 18' ' ' MET . 6.4 mtp -65.08 -60.16 3.33 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -51.83 -37.45 51.91 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -67.38 -37.84 83.79 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 221' ' ' TRP . . . . . . . . . . . . . 23.0 m0 -63.76 -53.65 47.72 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 66.7 mt -55.68 -40.1 71.85 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 223' ' ' LEU . . . . . . . . . . . . . 15.1 mt -60.42 -51.27 70.21 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 15.4 tp -62.58 -27.71 69.38 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 225' ' ' VAL . . . . . . . . . . . . . 75.5 t -71.87 -39.46 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 67.0 mt -73.37 -35.79 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 227' ' ' ILE . . . . . . . . . . . . . 63.1 mt -70.4 -46.35 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 56.9 mt -66.01 -41.59 90.82 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 229' ' ' ARG . . . . . 0.414 ' HD3' HH11 ' C' ' 229' ' ' ARG . 10.9 ttt180 -65.44 -52.36 53.72 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 230' ' ' THR . . . . . . . . . . . . . 4.2 m -53.34 -49.36 67.27 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 54.6 t -58.95 -53.68 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 232' ' ' LYS . . . . . 0.443 ' HE3' ' HB2' ' C' ' 232' ' ' LYS . 23.6 ttmt -51.36 -25.41 6.02 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 233' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -97.06 30.72 2.63 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 234' ' ' ALA . . . . . . . . . . . . . . . -141.1 3.1 1.76 Allowed 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 235' ' ' ASN . . . . . 0.409 ' CG ' ' N ' ' C' ' 236' ' ' GLY . 15.4 t30 -134.28 170.1 16.21 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 236' ' ' GLY . . . . . 0.409 ' N ' ' CG ' ' C' ' 235' ' ' ASN . . . -54.19 -88.97 0.01 OUTLIER Glycine 0 C--N 1.335 0.479 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.485 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -179.991 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 . . . . . 0 N--CA 1.449 -0.513 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.424 ' N ' ' HD3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -79.38 -59.94 2.56 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.453 ' HG1' ' HG2' ' B' ' 106' ' ' GLU . 9.7 t -48.66 -41.2 30.65 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.911 -0.404 . . . . 0.0 109.911 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.529 ' HA ' HG13 ' A' ' 7' ' ' ILE . 0.9 OUTLIER -42.77 -50.13 5.64 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 17.3 mt -42.88 -49.09 5.9 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.588 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 0.3 OUTLIER -64.57 -32.24 73.81 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.917 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.53 ' HA ' HD22 ' B' ' 110' ' ' LEU . 3.6 mt -65.19 -29.42 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 19.7 mt -76.92 -42.44 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.429 ' O ' ' HB ' ' A' ' 13' ' ' THR . 85.2 mt -77.29 -23.61 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.543 HD22 ' CG2' ' C' ' 207' ' ' ILE . 15.4 mt -85.77 -51.03 6.69 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.449 ' CG ' ' O ' ' A' ' 7' ' ' ILE . 66.7 mm-40 -58.63 -39.78 81.47 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.431 ' O ' ' CG1' ' A' ' 16' ' ' ILE . . . -73.42 -57.58 5.01 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.429 ' HB ' ' O ' ' A' ' 9' ' ' ILE . 46.2 m -57.88 -25.08 60.3 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.81 -63.03 1.14 Allowed 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.455 HG22 ' CG ' ' B' ' 118' ' ' MET . 2.5 t -69.0 -21.08 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.431 ' CG1' ' O ' ' A' ' 12' ' ' GLY . 38.0 mt -77.45 -64.85 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.429 ' O ' ' CB ' ' A' ' 21' ' ' TRP . . . -51.13 -32.03 21.52 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.601 ' CE ' ' HE1' ' B' ' 118' ' ' MET . 6.9 mtp -68.65 -60.11 2.64 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -61.53 -61.65 2.38 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -43.17 -41.83 3.92 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.429 ' CB ' ' O ' ' A' ' 17' ' ' ALA . 9.5 t-105 -64.55 -44.27 91.31 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 35.5 mt -59.01 -52.11 67.18 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 21.6 mt -54.44 -44.73 72.75 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.1 tp -59.52 -32.65 70.5 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 84.3 t -72.44 -43.13 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 60.3 mt -65.14 -37.14 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.0 mt -70.5 -44.46 77.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 75.9 mt -66.03 -38.62 88.88 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 36.3 ttm105 -70.77 -47.35 60.04 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.6 m -57.83 -40.63 80.49 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 79.3 t -74.94 -39.97 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 34.1 tttp -55.37 -30.9 61.24 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 65.2 mtp180 -95.81 34.19 1.56 Allowed 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.838 -0.431 . . . . 0.0 109.838 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -136.96 9.92 3.05 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -117.34 160.4 21.19 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -104.56 106.17 2.69 Favored Glycine 0 C--N 1.336 0.558 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.517 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -179.982 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . 0.413 ' N ' ' HD3' ' B' ' 102' ' ' LYS . 0.0 OUTLIER -71.63 -59.13 2.92 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.968 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 103' ' ' THR . . . . . 0.536 ' HG1' ' HG2' ' C' ' 206' ' ' GLU . 9.0 t -47.76 -41.85 24.24 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . 0.515 ' HA ' HG13 ' B' ' 107' ' ' ILE . 1.0 OUTLIER -42.96 -51.2 5.7 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' B' ' 105' ' ' LEU . 17.7 mt -43.05 -48.55 6.13 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 106' ' ' GLU . . . . . 0.583 ' CD ' ' N ' ' B' ' 106' ' ' GLU . 0.3 OUTLIER -64.27 -31.74 73.07 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 107' ' ' ILE . . . . . 0.534 ' CG2' HD22 ' C' ' 210' ' ' LEU . 3.8 mt -65.23 -29.86 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 20.3 mt -76.68 -42.19 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 109' ' ' ILE . . . . . 0.416 ' O ' ' HB ' ' B' ' 113' ' ' THR . 84.0 mt -77.39 -23.78 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . 0.541 ' CD1' HD12 ' C' ' 210' ' ' LEU . 15.6 mt -85.68 -50.95 6.79 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 111' ' ' GLU . . . . . 0.447 ' CG ' ' O ' ' B' ' 107' ' ' ILE . 67.3 mm-40 -58.63 -39.8 81.54 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 112' ' ' GLY . . . . . 0.433 ' O ' ' CG1' ' B' ' 116' ' ' ILE . . . -73.42 -57.59 5.0 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 113' ' ' THR . . . . . 0.446 HG21 ' CD ' ' A' ' 11' ' ' GLU . 45.0 m -57.83 -25.17 60.27 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.938 -0.394 . . . . 0.0 109.938 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.8 -63.04 1.14 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . 0.489 HG22 ' CG ' ' C' ' 218' ' ' MET . 2.5 t -68.97 -21.12 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 116' ' ' ILE . . . . . 0.433 ' CG1' ' O ' ' B' ' 112' ' ' GLY . 37.2 mt -77.24 -64.82 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . 0.409 ' O ' ' CB ' ' B' ' 121' ' ' TRP . . . -50.98 -32.26 20.56 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 118' ' ' MET . . . . . 0.601 ' HE1' ' CE ' ' A' ' 18' ' ' MET . 6.7 mtp -68.93 -60.11 2.59 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 2.4 m-30 -60.43 -61.74 2.37 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -43.16 -43.36 4.55 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 121' ' ' TRP . . . . . 0.409 ' CB ' ' O ' ' B' ' 117' ' ' ALA . 9.7 t-105 -66.11 -43.8 86.17 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 36.0 mt -58.26 -50.97 71.71 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 21.8 mt -53.39 -44.95 69.06 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 4.1 tp -59.95 -34.06 72.76 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 80.4 t -73.72 -43.21 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 59.9 mt -65.05 -36.78 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 22.8 mt -70.65 -44.54 76.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 75.0 mt -65.75 -38.62 89.61 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 36.4 ttm105 -71.05 -47.12 60.28 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 4.4 m -58.15 -40.34 81.12 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 77.3 t -75.07 -40.52 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 33.8 tttp -55.08 -31.3 61.08 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 65.3 mtp180 -95.94 34.49 1.53 Allowed 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 134' ' ' ALA . . . . . . . . . . . . . . . -137.21 9.68 2.98 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -117.43 160.56 20.97 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -104.3 106.14 2.71 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.522 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.974 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 201' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 . . . . . 0 N--CA 1.449 -0.524 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 202' ' ' LYS . . . . . 0.416 ' N ' ' HD3' ' C' ' 202' ' ' LYS . 0.0 OUTLIER -73.32 -58.89 2.99 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 203' ' ' THR . . . . . 0.531 ' HG1' ' HG2' ' A' ' 6' ' ' GLU . 8.9 t -46.74 -42.21 16.39 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 204' ' ' ASN . . . . . 0.515 ' HA ' HG13 ' C' ' 207' ' ' ILE . 1.0 OUTLIER -43.06 -51.4 5.79 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.937 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 205' ' ' LEU . . . . . . . . . . . . . 17.8 mt -43.06 -48.33 6.11 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 206' ' ' GLU . . . . . 0.581 ' N ' ' CD ' ' C' ' 206' ' ' GLU . 0.3 OUTLIER -64.24 -31.92 73.31 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 207' ' ' ILE . . . . . 0.543 ' CG2' HD22 ' A' ' 10' ' ' LEU . 3.8 mt -65.21 -29.7 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 208' ' ' ILE . . . . . . . . . . . . . 19.9 mt -76.79 -42.18 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 209' ' ' ILE . . . . . 0.42 ' O ' ' HB ' ' C' ' 213' ' ' THR . 83.8 mt -77.36 -23.86 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 210' ' ' LEU . . . . . 0.541 HD12 ' CD1' ' B' ' 110' ' ' LEU . 15.3 mt -85.58 -50.75 6.98 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 211' ' ' GLU . . . . . 0.447 ' CG ' ' O ' ' C' ' 207' ' ' ILE . 66.6 mm-40 -58.59 -40.18 82.49 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 212' ' ' GLY . . . . . 0.427 ' O ' ' CG1' ' C' ' 216' ' ' ILE . . . -73.2 -57.53 5.13 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 213' ' ' THR . . . . . 0.438 HG21 ' CD ' ' B' ' 111' ' ' GLU . 46.0 m -57.73 -25.22 60.09 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 214' ' ' ALA . . . . . . . . . . . . . . . -68.7 -63.04 1.14 Allowed 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 215' ' ' VAL . . . . . 0.492 HG22 ' CG ' ' A' ' 18' ' ' MET . 2.6 t -69.02 -21.11 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 216' ' ' ILE . . . . . 0.427 ' CG1' ' O ' ' C' ' 212' ' ' GLY . 37.1 mt -77.17 -64.72 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 217' ' ' ALA . . . . . 0.427 ' O ' ' CB ' ' C' ' 221' ' ' TRP . . . -51.22 -32.25 23.35 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 218' ' ' MET . . . . . 0.593 ' HE1' ' CE ' ' B' ' 118' ' ' MET . 6.6 mtp -68.33 -60.24 2.6 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -60.82 -61.41 2.6 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -43.48 -43.07 5.19 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 221' ' ' TRP . . . . . 0.427 ' CB ' ' O ' ' C' ' 217' ' ' ALA . 9.7 t-105 -65.94 -43.41 88.12 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 36.4 mt -56.89 -51.35 69.42 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 223' ' ' LEU . . . . . . . . . . . . . 21.9 mt -53.97 -45.83 71.48 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 4.1 tp -60.97 -33.11 72.71 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 225' ' ' VAL . . . . . . . . . . . . . 85.0 t -72.69 -42.49 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 60.0 mt -64.43 -36.67 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 227' ' ' ILE . . . . . . . . . . . . . 23.4 mt -70.5 -44.51 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 228' ' ' LEU . . . . . 0.41 ' HA ' HD23 ' C' ' 228' ' ' LEU . 75.1 mt -66.16 -38.96 89.36 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 229' ' ' ARG . . . . . . . . . . . . . 36.3 ttm105 -70.49 -47.0 62.62 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 230' ' ' THR . . . . . . . . . . . . . 3.8 m -57.76 -39.78 78.2 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 79.6 t -75.34 -40.51 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 232' ' ' LYS . . . . . . . . . . . . . 34.0 tttp -54.81 -31.27 58.95 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 233' ' ' ARG . . . . . . . . . . . . . 65.1 mtp180 -96.1 34.7 1.53 Allowed 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 234' ' ' ALA . . . . . . . . . . . . . . . -137.36 9.92 2.96 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 235' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -117.27 159.86 22.02 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 236' ' ' GLY . . . . . . . . . . . . . . . -104.88 105.89 2.61 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.524 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 -179.958 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 . . . . . 0 N--CA 1.449 -0.516 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 13.9 tptt -79.52 -45.31 19.53 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.2 t -43.53 -33.32 1.1 Allowed 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.53 ' HA ' HG13 ' A' ' 7' ' ' ILE . 1.0 OUTLIER -42.79 -51.28 5.45 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 12.1 mt -43.03 -48.43 6.03 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.587 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 1.8 mp0 -64.59 -31.3 72.45 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.548 ' HA ' HD21 ' B' ' 110' ' ' LEU . 4.1 mt -65.34 -30.07 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 73.9 mt -76.89 -42.05 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.419 ' O ' ' HB ' ' A' ' 13' ' ' THR . 15.9 mt -76.95 -24.29 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.545 HD12 ' CD1' ' C' ' 210' ' ' LEU . 15.4 mt -85.39 -49.85 7.78 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.491 ' HB3' ' HE2' ' A' ' 11' ' ' GLU . 61.7 mm-40 -57.87 -42.04 83.73 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.432 ' O ' ' CG1' ' A' ' 16' ' ' ILE . . . -72.02 -55.95 6.79 Favored Glycine 0 C--N 1.335 0.475 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.467 HG23 ' CD ' ' C' ' 211' ' ' GLU . 23.7 m -57.95 -25.38 60.88 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.52 -63.09 1.13 Allowed 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.505 HG23 ' CG ' ' B' ' 118' ' ' MET . 2.7 t -68.95 -21.13 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.432 ' CG1' ' O ' ' A' ' 12' ' ' GLY . 23.3 mt -76.54 -64.68 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.88 -33.44 24.02 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.599 ' HE3' ' CE ' ' C' ' 218' ' ' MET . 6.7 mtp -68.86 -60.03 2.66 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -55.11 -24.21 24.67 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.482 ' HA ' HD22 ' A' ' 23' ' ' LEU . 3.2 m-30 -74.5 -39.91 62.14 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 3.0 m95 -75.61 -35.42 60.53 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 13.0 mt -66.9 -54.15 25.05 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.525 ' CD1' ' C ' ' A' ' 23' ' ' LEU . 1.1 pp -59.44 -37.34 77.86 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.514 ' N ' ' HG ' ' A' ' 23' ' ' LEU . 6.1 tt -59.16 -42.48 90.86 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 96.9 t -74.09 -23.48 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.473 HD12 ' HA ' ' A' ' 23' ' ' LEU . 57.7 mt -71.45 -43.68 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 25.1 mt -71.09 -39.02 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 28' ' ' LEU . 24.4 mt -69.61 -44.22 71.15 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.511 ' HG2' ' NH1' ' A' ' 29' ' ' ARG . 6.1 ttt-85 -68.17 -48.03 66.38 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.9 m -53.36 -44.49 68.59 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 55.7 t -62.29 -46.96 95.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.446 ' HA ' ' HD3' ' A' ' 32' ' ' LYS . 15.2 tppt? -53.57 -32.55 51.33 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 6.4 mmt180 -97.56 36.05 1.56 Allowed 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.57 3.56 1.9 Allowed 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -85.18 142.63 29.32 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.29 -102.18 2.44 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.508 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 -179.984 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 . . . . . 0 N--CA 1.45 -0.456 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 13.9 tptt -79.69 -45.33 19.18 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 5.2 t -43.54 -33.33 1.11 Allowed 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . 0.521 ' HA ' HG13 ' B' ' 107' ' ' ILE . 1.0 OUTLIER -42.81 -51.23 5.5 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 12.0 mt -43.05 -48.45 6.1 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 106' ' ' GLU . . . . . 0.588 ' CD ' ' N ' ' B' ' 106' ' ' GLU . 1.8 mp0 -64.62 -31.33 72.5 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 107' ' ' ILE . . . . . 0.521 HG13 ' HA ' ' B' ' 104' ' ' ASN . 4.1 mt -65.28 -30.18 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 74.6 mt -76.84 -42.03 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 109' ' ' ILE . . . . . 0.424 ' O ' ' HB ' ' B' ' 113' ' ' THR . 16.1 mt -76.99 -24.32 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . 0.548 HD21 ' HA ' ' A' ' 7' ' ' ILE . 15.4 mt -85.44 -49.59 7.97 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 111' ' ' GLU . . . . . 0.482 ' HB3' ' HE2' ' B' ' 111' ' ' GLU . 61.5 mm-40 -57.99 -42.21 84.66 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 112' ' ' GLY . . . . . 0.434 ' O ' ' CG1' ' B' ' 116' ' ' ILE . . . -71.95 -55.94 6.84 Favored Glycine 0 C--N 1.336 0.547 0 N-CA-C 110.279 -1.129 . . . . 0.0 110.279 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 113' ' ' THR . . . . . 0.431 HG23 ' CD ' ' A' ' 11' ' ' GLU . 24.1 m -57.91 -25.58 61.05 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.34 -63.04 1.14 Allowed 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 115' ' ' VAL . . . . . 0.509 HG23 ' CG ' ' C' ' 218' ' ' MET . 2.7 t -68.98 -21.07 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 116' ' ' ILE . . . . . 0.434 ' CG1' ' O ' ' B' ' 112' ' ' GLY . 22.0 mt -76.2 -64.66 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -50.78 -34.02 25.69 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 118' ' ' MET . . . . . 0.592 ' HE3' ' CE ' ' A' ' 18' ' ' MET . 6.5 mtp -68.63 -59.57 3.03 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -54.1 -24.2 16.75 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . 0.4 ' HA ' HD22 ' B' ' 123' ' ' LEU . 3.2 m-30 -74.79 -41.05 60.72 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 121' ' ' TRP . . . . . . . . . . . . . 2.9 m95 -75.13 -34.1 61.62 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 12.9 mt -67.2 -54.68 18.86 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 123' ' ' LEU . . . . . 0.533 ' HG ' ' N ' ' B' ' 124' ' ' LEU . 1.0 OUTLIER -58.71 -38.15 77.69 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 124' ' ' LEU . . . . . 0.533 ' N ' ' HG ' ' B' ' 123' ' ' LEU . 6.1 tt -58.74 -42.61 89.19 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 97.4 t -74.61 -23.52 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . 0.467 HD12 ' HA ' ' B' ' 123' ' ' LEU . 54.3 mt -71.07 -43.56 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 24.6 mt -71.33 -38.78 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 24.5 mt -70.03 -44.02 70.12 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 129' ' ' ARG . . . . . 0.51 ' HG2' ' NH1' ' B' ' 129' ' ' ARG . 6.4 ttt-85 -68.43 -47.72 66.46 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 5.2 m -53.5 -44.4 69.04 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 53.9 t -62.24 -46.98 95.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 132' ' ' LYS . . . . . 0.409 ' HA ' ' HD3' ' B' ' 132' ' ' LYS . 15.1 tppt? -53.81 -31.66 49.92 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 133' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' B' ' 133' ' ' ARG . 6.2 mmt180 -98.23 36.17 1.64 Allowed 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 134' ' ' ALA . . . . . . . . . . . . . . . -140.24 3.65 1.97 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -84.94 143.07 29.22 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . 100.57 -101.1 2.25 Favored Glycine 0 C--N 1.335 0.496 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.513 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 179.994 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 201' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 . . . . . 0 N--CA 1.45 -0.47 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -79.64 -45.49 18.97 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 203' ' ' THR . . . . . . . . . . . . . 5.1 t -43.44 -33.51 1.09 Allowed 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 204' ' ' ASN . . . . . 0.515 ' HA ' HG13 ' C' ' 207' ' ' ILE . 1.0 OUTLIER -42.85 -51.09 5.6 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.972 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 205' ' ' LEU . . . . . . . . . . . . . 12.0 mt -43.04 -48.46 6.08 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 206' ' ' GLU . . . . . 0.582 ' N ' ' CD ' ' C' ' 206' ' ' GLU . 1.8 mp0 -64.62 -31.34 72.51 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 207' ' ' ILE . . . . . 0.536 ' HA ' HD21 ' A' ' 10' ' ' LEU . 4.1 mt -65.23 -30.16 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 208' ' ' ILE . . . . . . . . . . . . . 74.3 mt -76.83 -42.2 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 209' ' ' ILE . . . . . 0.424 ' O ' ' HB ' ' C' ' 213' ' ' THR . 16.1 mt -76.8 -24.32 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 210' ' ' LEU . . . . . 0.545 ' CD1' HD12 ' A' ' 10' ' ' LEU . 15.4 mt -85.44 -49.5 8.05 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 211' ' ' GLU . . . . . 0.467 ' CD ' HG23 ' A' ' 13' ' ' THR . 60.8 mm-40 -57.92 -42.29 84.51 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 212' ' ' GLY . . . . . 0.434 ' O ' ' CG1' ' C' ' 216' ' ' ILE . . . -72.08 -55.83 6.82 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 213' ' ' THR . . . . . 0.437 HG23 ' CD ' ' B' ' 111' ' ' GLU . 23.9 m -57.85 -25.49 60.78 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 214' ' ' ALA . . . . . . . . . . . . . . . -68.48 -63.09 1.13 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 215' ' ' VAL . . . . . 0.523 HG23 ' CG ' ' A' ' 18' ' ' MET . 2.8 t -68.89 -21.09 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 216' ' ' ILE . . . . . 0.434 ' CG1' ' O ' ' C' ' 212' ' ' GLY . 23.1 mt -76.51 -64.8 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -50.78 -33.37 23.03 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 218' ' ' MET . . . . . 0.599 ' CE ' ' HE3' ' A' ' 18' ' ' MET . 6.5 mtp -68.9 -60.19 2.55 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -54.07 -25.02 19.48 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -75.58 -38.5 59.07 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 221' ' ' TRP . . . . . . . . . . . . . 3.0 m95 -75.28 -33.69 61.27 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 13.1 mt -66.95 -54.67 19.73 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 223' ' ' LEU . . . . . 0.522 ' C ' ' CD1' ' C' ' 223' ' ' LEU . 1.1 pp -59.46 -37.62 78.65 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 224' ' ' LEU . . . . . 0.52 ' N ' ' HG ' ' C' ' 223' ' ' LEU . 6.2 tt -59.23 -41.31 88.37 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 225' ' ' VAL . . . . . . . . . . . . . 97.4 t -74.36 -24.04 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 226' ' ' ILE . . . . . 0.479 HD12 ' HA ' ' C' ' 223' ' ' LEU . 59.3 mt -71.12 -43.39 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 227' ' ' ILE . . . . . . . . . . . . . 24.2 mt -71.38 -38.88 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 23.8 mt -69.77 -44.28 70.48 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 229' ' ' ARG . . . . . 0.51 ' NH1' ' HG2' ' C' ' 229' ' ' ARG . 6.1 ttt-85 -68.1 -48.19 66.15 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 230' ' ' THR . . . . . . . . . . . . . 4.3 m -53.11 -44.62 67.79 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 53.6 t -62.44 -46.8 95.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 232' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -53.22 -31.64 44.2 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 233' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' C' ' 233' ' ' ARG . 6.2 mmt180 -97.73 35.82 1.62 Allowed 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 234' ' ' ALA . . . . . . . . . . . . . . . -140.5 3.81 1.93 Allowed 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 235' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -84.79 143.21 29.26 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 236' ' ' GLY . . . . . . . . . . . . . . . 100.8 -101.58 2.31 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.533 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.995 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.2 t . . . . . 0 N--CA 1.449 -0.507 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.5 ' HA ' HG13 ' A' ' 7' ' ' ILE . 1.5 t-20 -42.92 -51.12 5.68 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.429 ' HA ' HD23 ' A' ' 5' ' ' LEU . 14.0 mt -42.99 -48.52 5.97 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.578 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 0.8 OUTLIER -64.66 -31.36 72.55 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.916 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 1.046 HG23 ' CD2' ' B' ' 110' ' ' LEU . 4.0 mt -65.23 -30.23 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 23.7 mt -76.73 -42.11 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.421 ' O ' ' HB ' ' A' ' 13' ' ' THR . 53.7 mt -76.87 -24.29 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 1.034 ' CD2' HG23 ' C' ' 207' ' ' ILE . 15.4 mt -85.59 -46.77 10.49 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.568 ' CD ' HG22 ' B' ' 113' ' ' THR . 57.1 mm-40 -59.37 -42.71 92.25 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.74 ' C ' HD12 ' A' ' 16' ' ' ILE . . . -72.56 -56.12 6.28 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.55 HG22 ' CD ' ' C' ' 211' ' ' GLU . 39.4 m -57.83 -25.88 61.25 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.525 ' HB2' ' O ' ' A' ' 10' ' ' LEU . . . -68.38 -63.05 1.14 Allowed 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.626 HG22 ' CG ' ' B' ' 118' ' ' MET . 2.7 t -68.56 -21.36 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.74 HD12 ' C ' ' A' ' 12' ' ' GLY . 29.2 mt -76.11 -64.7 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.89 -32.95 22.16 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.61 ' CE ' ' HE1' ' B' ' 118' ' ' MET . 6.4 mtp . . . . . 0 N--CA 1.449 -0.497 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 7.0 t . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 104' ' ' ASN . . . . . 0.505 ' HA ' HG13 ' B' ' 107' ' ' ILE . 1.5 t-20 -42.92 -51.15 5.67 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 105' ' ' LEU . . . . . 0.451 ' HA ' HD23 ' B' ' 105' ' ' LEU . 14.1 mt -42.99 -48.57 5.97 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 106' ' ' GLU . . . . . 0.59 ' CD ' ' N ' ' B' ' 106' ' ' GLU . 0.8 OUTLIER -64.51 -31.41 72.61 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 107' ' ' ILE . . . . . 1.052 HG23 ' CD2' ' C' ' 210' ' ' LEU . 4.0 mt -65.2 -30.27 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 23.8 mt -76.72 -42.08 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 109' ' ' ILE . . . . . 0.417 ' O ' ' HB ' ' B' ' 113' ' ' THR . 54.1 mt -76.87 -24.29 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 110' ' ' LEU . . . . . 1.046 ' CD2' HG23 ' A' ' 7' ' ' ILE . 15.4 mt -85.53 -46.95 10.36 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 111' ' ' GLU . . . . . 0.556 ' CD ' HG22 ' C' ' 213' ' ' THR . 57.8 mm-40 -59.37 -42.65 92.12 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 112' ' ' GLY . . . . . 0.728 ' C ' HD12 ' B' ' 116' ' ' ILE . . . -72.54 -56.16 6.27 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.281 -1.127 . . . . 0.0 110.281 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 113' ' ' THR . . . . . 0.568 HG22 ' CD ' ' A' ' 11' ' ' GLU . 38.5 m -57.96 -25.72 61.35 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 114' ' ' ALA . . . . . 0.521 ' HB2' ' O ' ' B' ' 110' ' ' LEU . . . -68.42 -62.99 1.15 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 115' ' ' VAL . . . . . 0.624 HG22 ' CG ' ' C' ' 218' ' ' MET . 2.7 t -68.73 -21.22 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 116' ' ' ILE . . . . . 0.728 HD12 ' C ' ' B' ' 112' ' ' GLY . 28.7 mt -76.18 -64.58 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -51.15 -33.0 24.92 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 118' ' ' MET . . . . . 0.626 ' CG ' HG22 ' A' ' 15' ' ' VAL . 6.4 mtp . . . . . 0 N--CA 1.45 -0.474 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 203' ' ' THR . . . . . . . . . . . . . 7.0 t . . . . . 0 N--CA 1.449 -0.496 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 204' ' ' ASN . . . . . 0.487 ' HA ' HG13 ' C' ' 207' ' ' ILE . 1.5 t-20 -43.01 -51.21 5.76 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 205' ' ' LEU . . . . . . . . . . . . . 14.1 mt -43.02 -48.44 6.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 206' ' ' GLU . . . . . 0.575 ' N ' ' CD ' ' C' ' 206' ' ' GLU . 0.8 OUTLIER -64.58 -31.43 72.64 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 207' ' ' ILE . . . . . 1.034 HG23 ' CD2' ' A' ' 10' ' ' LEU . 4.0 mt -65.18 -30.24 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 208' ' ' ILE . . . . . . . . . . . . . 23.7 mt -76.72 -42.17 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 209' ' ' ILE . . . . . 0.412 ' O ' ' HB ' ' C' ' 213' ' ' THR . 54.1 mt -76.8 -24.27 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 210' ' ' LEU . . . . . 1.052 ' CD2' HG23 ' B' ' 107' ' ' ILE . 15.4 mt -85.61 -46.62 10.62 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 211' ' ' GLU . . . . . 0.55 ' CD ' HG22 ' A' ' 13' ' ' THR . 57.2 mm-40 -59.42 -42.75 92.58 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 212' ' ' GLY . . . . . 0.741 ' C ' HD12 ' C' ' 216' ' ' ILE . . . -72.58 -56.05 6.3 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 213' ' ' THR . . . . . 0.556 HG22 ' CD ' ' B' ' 111' ' ' GLU . 38.2 m -57.93 -25.94 61.56 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 214' ' ' ALA . . . . . 0.526 ' HB2' ' O ' ' C' ' 210' ' ' LEU . . . -68.28 -63.07 1.13 Allowed 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 215' ' ' VAL . . . . . 0.609 HG22 ' CG ' ' A' ' 18' ' ' MET . 2.7 t -68.52 -21.42 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 216' ' ' ILE . . . . . 0.741 HD12 ' C ' ' C' ' 212' ' ' GLY . 28.5 mt -76.03 -64.66 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -51.0 -32.77 22.3 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 218' ' ' MET . . . . . 0.624 ' CG ' HG22 ' B' ' 115' ' ' VAL . 6.2 mtp . . . . . 0 N--CA 1.449 -0.523 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.816 HG21 ' CG ' ' B' ' 106' ' ' GLU . 98.1 m . . . . . 0 N--CA 1.448 -0.545 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.477 ' HA ' HG13 ' A' ' 7' ' ' ILE . 5.9 p-10 -42.91 -50.65 5.76 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.481 ' HA ' HD23 ' A' ' 5' ' ' LEU . 13.0 mt -43.51 -47.32 7.22 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.815 ' CG ' HG21 ' C' ' 203' ' ' THR . 1.0 OUTLIER -66.04 -31.09 71.77 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 1.064 HG23 ' CD2' ' B' ' 110' ' ' LEU . 5.3 mt -64.69 -31.92 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 31.0 mt -75.75 -42.89 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.426 ' O ' ' HB ' ' A' ' 13' ' ' THR . 62.5 mt -74.34 -27.56 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 1.06 ' CD2' HG23 ' C' ' 207' ' ' ILE . 15.1 mt -83.16 -41.69 18.2 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.747 ' CD ' HG22 ' B' ' 113' ' ' THR . 34.5 mm-40 -58.54 -49.23 78.16 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.464 ' C ' HD12 ' A' ' 16' ' ' ILE . . . -69.91 -59.69 5.38 Favored Glycine 0 C--N 1.335 0.515 0 N-CA-C 110.294 -1.123 . . . . 0.0 110.294 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.764 HG22 ' CD ' ' C' ' 211' ' ' GLU . 23.6 m -49.05 -37.06 19.75 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.5 ' HB2' ' O ' ' A' ' 10' ' ' LEU . . . -60.08 -62.89 1.54 Allowed 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.649 HG22 ' HG3' ' B' ' 118' ' ' MET . 3.0 t -63.75 -21.16 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.545 HD12 ' HA ' ' A' ' 13' ' ' THR . 27.8 mt -70.73 -64.63 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.48 -35.63 30.0 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.653 ' HG2' HG13 ' C' ' 215' ' ' VAL . 4.8 mtp . . . . . 0 N--CA 1.448 -0.533 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 103' ' ' THR . . . . . 0.799 HG21 ' CG ' ' C' ' 206' ' ' GLU . 98.6 m . . . . . 0 N--CA 1.449 -0.512 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 104' ' ' ASN . . . . . 0.487 ' HA ' HG13 ' B' ' 107' ' ' ILE . 5.9 p-10 -42.93 -50.47 5.8 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 105' ' ' LEU . . . . . 0.527 ' HA ' HD23 ' B' ' 105' ' ' LEU . 13.1 mt -43.62 -47.3 7.54 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 106' ' ' GLU . . . . . 0.816 ' CG ' HG21 ' A' ' 3' ' ' THR . 1.0 OUTLIER -66.09 -30.98 71.59 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 107' ' ' ILE . . . . . 1.069 HG23 ' CD2' ' C' ' 210' ' ' LEU . 5.3 mt -64.75 -31.89 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 31.1 mt -75.72 -42.88 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 109' ' ' ILE . . . . . 0.41 ' O ' ' HB ' ' B' ' 113' ' ' THR . 62.4 mt -74.35 -27.61 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 110' ' ' LEU . . . . . 1.064 ' CD2' HG23 ' A' ' 7' ' ' ILE . 15.1 mt -83.19 -41.7 18.14 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 111' ' ' GLU . . . . . 0.747 ' CD ' HG22 ' C' ' 213' ' ' THR . 34.9 mm-40 -58.54 -49.19 78.32 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 112' ' ' GLY . . . . . 0.476 ' C ' HD12 ' B' ' 116' ' ' ILE . . . -70.01 -59.71 5.32 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 113' ' ' THR . . . . . 0.747 HG22 ' CD ' ' A' ' 11' ' ' GLU . 23.6 m -48.96 -37.07 19.04 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 114' ' ' ALA . . . . . 0.501 ' HB2' ' O ' ' B' ' 110' ' ' LEU . . . -60.11 -62.9 1.53 Allowed 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 115' ' ' VAL . . . . . 0.651 HG13 ' HG2' ' C' ' 218' ' ' MET . 3.0 t -63.72 -21.17 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 116' ' ' ILE . . . . . 0.522 HD12 ' HA ' ' B' ' 113' ' ' THR . 27.8 mt -70.67 -64.71 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -50.45 -35.53 29.25 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 118' ' ' MET . . . . . 0.649 ' HG3' HG22 ' A' ' 15' ' ' VAL . 4.7 mtp . . . . . 0 N--CA 1.449 -0.482 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 203' ' ' THR . . . . . 0.815 HG21 ' CG ' ' A' ' 6' ' ' GLU . 97.9 m . . . . . 0 N--CA 1.449 -0.482 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 204' ' ' ASN . . . . . 0.478 ' HA ' HG13 ' C' ' 207' ' ' ILE . 5.8 p-10 -42.98 -50.4 5.88 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 205' ' ' LEU . . . . . 0.479 HD23 ' HA ' ' C' ' 205' ' ' LEU . 13.1 mt -43.54 -47.35 7.31 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 206' ' ' GLU . . . . . 0.799 ' CG ' HG21 ' B' ' 103' ' ' THR . 1.0 OUTLIER -66.05 -31.14 71.85 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 207' ' ' ILE . . . . . 1.06 HG23 ' CD2' ' A' ' 10' ' ' LEU . 5.3 mt -64.67 -31.8 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 208' ' ' ILE . . . . . . . . . . . . . 30.9 mt -75.83 -42.97 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 209' ' ' ILE . . . . . 0.422 ' O ' ' HB ' ' C' ' 213' ' ' THR . 62.3 mt -74.32 -27.49 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 210' ' ' LEU . . . . . 1.069 ' CD2' HG23 ' B' ' 107' ' ' ILE . 15.1 mt -83.21 -41.64 18.18 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 211' ' ' GLU . . . . . 0.764 ' CD ' HG22 ' A' ' 13' ' ' THR . 34.5 mm-40 -58.58 -49.13 78.58 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 212' ' ' GLY . . . . . 0.461 ' C ' HD12 ' C' ' 216' ' ' ILE . . . -70.1 -59.68 5.3 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 213' ' ' THR . . . . . 0.747 HG22 ' CD ' ' B' ' 111' ' ' GLU . 23.7 m -48.92 -37.14 18.99 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 214' ' ' ALA . . . . . 0.496 ' HB2' ' O ' ' C' ' 210' ' ' LEU . . . -60.08 -62.9 1.53 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 215' ' ' VAL . . . . . 0.653 HG13 ' HG2' ' A' ' 18' ' ' MET . 3.0 t -63.73 -21.09 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 216' ' ' ILE . . . . . 0.529 HD12 ' HA ' ' C' ' 213' ' ' THR . 27.8 mt -70.73 -64.63 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -50.49 -35.47 29.34 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 218' ' ' MET . . . . . 0.651 ' HG2' HG13 ' B' ' 115' ' ' VAL . 4.7 mtp . . . . . 0 N--CA 1.449 -0.49 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.4 t . . . . . 0 N--CA 1.449 -0.523 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.496 ' HA ' HG13 ' A' ' 7' ' ' ILE . 1.4 t-20 -42.87 -50.35 5.74 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 5' ' ' LEU . 12.3 mt -43.07 -47.7 6.03 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.571 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 2.2 mp0 -66.47 -30.89 71.33 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 1.064 HG23 ' CD2' ' B' ' 110' ' ' LEU . 5.2 mt -64.19 -32.1 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 24.3 mt -75.84 -44.02 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.412 ' O ' ' HB ' ' A' ' 13' ' ' THR . 98.3 mt -73.59 -25.51 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 1.08 ' CD2' HG23 ' C' ' 207' ' ' ILE . 15.5 mt -85.44 -41.3 15.52 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.672 ' CD ' HG22 ' B' ' 113' ' ' THR . 37.4 mm-40 -58.88 -45.9 89.12 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.748 ' C ' HD12 ' A' ' 16' ' ' ILE . . . -73.42 -55.06 6.33 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.67 HG22 ' CD ' ' C' ' 211' ' ' GLU . 22.9 m -55.08 -31.05 60.88 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.502 ' HB2' ' O ' ' A' ' 10' ' ' LEU . . . -66.43 -63.2 1.13 Allowed 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.821 -0.436 . . . . 0.0 109.821 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 11' ' ' GLU . 2.8 t -64.31 -21.37 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.748 HD12 ' C ' ' A' ' 12' ' ' GLY . 22.3 mt -73.59 -64.69 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.55 -26.18 20.2 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.783 ' SD ' ' HE1' ' C' ' 218' ' ' MET . 11.6 mtp . . . . . 0 N--CA 1.449 -0.503 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 5.3 t . . . . . 0 N--CA 1.449 -0.499 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 104' ' ' ASN . . . . . 0.503 ' HA ' HG13 ' B' ' 107' ' ' ILE . 1.4 t-20 -42.91 -50.35 5.8 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 105' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' B' ' 105' ' ' LEU . 12.3 mt -43.22 -47.58 6.43 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 106' ' ' GLU . . . . . 0.582 ' CD ' ' N ' ' B' ' 106' ' ' GLU . 2.2 mp0 -66.42 -31.02 71.52 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 107' ' ' ILE . . . . . 1.082 HG23 ' CD2' ' C' ' 210' ' ' LEU . 5.2 mt -64.08 -32.02 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 24.1 mt -75.93 -44.19 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 109' ' ' ILE . . . . . 0.413 ' O ' ' HB ' ' B' ' 113' ' ' THR . 98.2 mt -73.43 -25.54 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 110' ' ' LEU . . . . . 1.064 ' CD2' HG23 ' A' ' 7' ' ' ILE . 15.5 mt -85.38 -41.45 15.45 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 111' ' ' GLU . . . . . 0.683 ' O ' HG23 ' B' ' 115' ' ' VAL . 37.2 mm-40 -58.57 -45.91 88.04 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 112' ' ' GLY . . . . . 0.735 ' C ' HD12 ' B' ' 116' ' ' ILE . . . -73.57 -55.39 6.07 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 113' ' ' THR . . . . . 0.672 HG22 ' CD ' ' A' ' 11' ' ' GLU . 23.2 m -54.69 -30.94 57.03 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 114' ' ' ALA . . . . . 0.502 ' HB2' ' O ' ' B' ' 110' ' ' LEU . . . -66.66 -63.32 1.09 Allowed 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 115' ' ' VAL . . . . . 0.683 HG23 ' O ' ' B' ' 111' ' ' GLU . 2.7 t -64.07 -21.35 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 116' ' ' ILE . . . . . 0.735 HD12 ' C ' ' B' ' 112' ' ' GLY . 23.0 mt -73.55 -64.67 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -53.59 -25.99 19.76 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 118' ' ' MET . . . . . 0.789 ' HE1' ' SD ' ' C' ' 218' ' ' MET . 11.5 mtp . . . . . 0 N--CA 1.45 -0.473 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 203' ' ' THR . . . . . . . . . . . . . 5.3 t . . . . . 0 N--CA 1.449 -0.513 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 204' ' ' ASN . . . . . 0.511 ' HA ' HG13 ' C' ' 207' ' ' ILE . 1.4 t-20 -42.86 -50.61 5.7 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 205' ' ' LEU . . . . . 0.43 HD23 ' HA ' ' C' ' 205' ' ' LEU . 12.4 mt -43.13 -47.48 6.15 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 206' ' ' GLU . . . . . 0.572 ' N ' ' CD ' ' C' ' 206' ' ' GLU . 2.2 mp0 -66.43 -30.92 71.38 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 207' ' ' ILE . . . . . 1.08 HG23 ' CD2' ' A' ' 10' ' ' LEU . 5.3 mt -64.26 -32.0 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 208' ' ' ILE . . . . . . . . . . . . . 24.1 mt -75.94 -43.92 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 209' ' ' ILE . . . . . 0.419 ' O ' ' HB ' ' C' ' 213' ' ' THR . 98.3 mt -73.6 -25.63 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.722 -0.474 . . . . 0.0 109.722 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 210' ' ' LEU . . . . . 1.082 ' CD2' HG23 ' B' ' 107' ' ' ILE . 15.5 mt -85.38 -41.26 15.62 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 211' ' ' GLU . . . . . 0.674 ' O ' HG23 ' C' ' 215' ' ' VAL . 37.3 mm-40 -58.9 -45.88 89.2 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 212' ' ' GLY . . . . . 0.739 ' C ' HD12 ' C' ' 216' ' ' ILE . . . -73.48 -55.09 6.28 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.291 -1.123 . . . . 0.0 110.291 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 213' ' ' THR . . . . . 0.678 HG22 ' CD ' ' B' ' 111' ' ' GLU . 22.8 m -55.04 -31.14 60.87 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 214' ' ' ALA . . . . . 0.503 ' HB2' ' O ' ' C' ' 210' ' ' LEU . . . -66.39 -63.36 1.09 Allowed 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 215' ' ' VAL . . . . . 0.674 HG23 ' O ' ' C' ' 211' ' ' GLU . 2.8 t -64.07 -21.55 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 216' ' ' ILE . . . . . 0.739 HD12 ' C ' ' C' ' 212' ' ' GLY . 22.2 mt -73.44 -64.67 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -53.57 -26.05 19.84 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 218' ' ' MET . . . . . 0.789 ' SD ' ' HE1' ' B' ' 118' ' ' MET . 11.6 mtp . . . . . 0 N--CA 1.45 -0.457 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.45 -0.468 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.504 ' HA ' HG13 ' A' ' 7' ' ' ILE . 1.1 t-20 -42.74 -51.05 5.48 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.463 ' HA ' HD23 ' A' ' 5' ' ' LEU . 13.1 mt -43.01 -48.9 6.07 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.587 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 2.6 mp0 -64.13 -31.63 72.9 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 1.025 HG23 ' CD2' ' B' ' 110' ' ' LEU . 3.8 mt -65.25 -29.89 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.8 mt -76.77 -42.13 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.428 ' O ' ' HB ' ' A' ' 13' ' ' THR . 83.4 mt -77.3 -23.82 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 1.045 ' CD2' HG23 ' C' ' 207' ' ' ILE . 15.5 mt -85.7 -49.75 7.72 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.579 ' O ' HG23 ' A' ' 15' ' ' VAL . 58.7 mm-40 -59.01 -40.42 84.87 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.87 ' C ' HD12 ' A' ' 16' ' ' ILE . . . -73.27 -57.52 5.11 Favored Glycine 0 C--N 1.335 0.509 0 N-CA-C 110.276 -1.129 . . . . 0.0 110.276 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.428 ' HB ' ' O ' ' A' ' 9' ' ' ILE . 49.5 m -57.78 -25.18 60.17 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.507 ' HB2' ' O ' ' A' ' 10' ' ' LEU . . . -68.79 -62.92 1.18 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 11' ' ' GLU . 2.6 t -69.04 -21.08 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.87 HD12 ' C ' ' A' ' 12' ' ' GLY . 22.4 mt -77.31 -64.85 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.15 -32.07 21.84 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.591 ' CE ' ' HE1' ' B' ' 118' ' ' MET . 6.7 mtp . . . . . 0 N--CA 1.449 -0.506 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.449 -0.51 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 104' ' ' ASN . . . . . 0.501 ' HA ' HG13 ' B' ' 107' ' ' ILE . 1.1 t-20 -42.72 -51.09 5.44 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 105' ' ' LEU . . . . . 0.464 HD23 ' HA ' ' B' ' 105' ' ' LEU . 13.1 mt -42.81 -48.92 5.79 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 106' ' ' GLU . . . . . 0.589 ' CD ' ' N ' ' B' ' 106' ' ' GLU . 2.6 mp0 -64.27 -31.65 72.94 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 107' ' ' ILE . . . . . 1.046 HG23 ' CD2' ' C' ' 210' ' ' LEU . 3.8 mt -65.34 -29.75 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 39.4 mt -76.82 -42.17 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 109' ' ' ILE . . . . . 0.418 ' O ' ' HB ' ' B' ' 113' ' ' THR . 84.1 mt -77.3 -23.81 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 110' ' ' LEU . . . . . 1.025 ' CD2' HG23 ' A' ' 7' ' ' ILE . 15.5 mt -85.67 -50.23 7.36 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 111' ' ' GLU . . . . . 0.595 ' O ' HG23 ' B' ' 115' ' ' VAL . 59.3 mm-40 -58.88 -40.19 83.67 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 112' ' ' GLY . . . . . 0.884 ' C ' HD12 ' B' ' 116' ' ' ILE . . . -73.32 -57.58 5.05 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 113' ' ' THR . . . . . 0.418 ' HB ' ' O ' ' B' ' 109' ' ' ILE . 49.5 m -57.81 -25.17 60.23 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 114' ' ' ALA . . . . . 0.498 ' HB2' ' O ' ' B' ' 110' ' ' LEU . . . -68.78 -63.11 1.12 Allowed 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 115' ' ' VAL . . . . . 0.595 HG23 ' O ' ' B' ' 111' ' ' GLU . 2.5 t -68.9 -21.09 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 116' ' ' ILE . . . . . 0.884 HD12 ' C ' ' B' ' 112' ' ' GLY . 22.6 mt -77.28 -64.81 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -51.01 -32.24 20.72 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 118' ' ' MET . . . . . 0.616 ' CE ' ' HE1' ' C' ' 218' ' ' MET . 6.6 mtp . . . . . 0 N--CA 1.449 -0.482 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 203' ' ' THR . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.448 -0.529 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 204' ' ' ASN . . . . . 0.489 ' HA ' HG13 ' C' ' 207' ' ' ILE . 1.1 t-20 -42.75 -51.23 5.43 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 205' ' ' LEU . . . . . 0.469 HD23 ' HA ' ' C' ' 205' ' ' LEU . 13.1 mt -42.89 -48.91 5.9 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 206' ' ' GLU . . . . . 0.58 ' N ' ' CD ' ' C' ' 206' ' ' GLU . 2.6 mp0 -64.03 -31.67 72.94 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 207' ' ' ILE . . . . . 1.045 HG23 ' CD2' ' A' ' 10' ' ' LEU . 3.8 mt -65.24 -29.93 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 208' ' ' ILE . . . . . . . . . . . . . 40.4 mt -76.67 -42.11 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 209' ' ' ILE . . . . . 0.414 ' O ' ' HB ' ' C' ' 213' ' ' THR . 84.0 mt -77.36 -23.87 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 210' ' ' LEU . . . . . 1.046 ' CD2' HG23 ' B' ' 107' ' ' ILE . 15.5 mt -85.66 -50.2 7.39 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 211' ' ' GLU . . . . . 0.586 ' O ' HG23 ' C' ' 215' ' ' VAL . 59.2 mm-40 -58.8 -40.39 83.93 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 212' ' ' GLY . . . . . 0.895 ' C ' HD12 ' C' ' 216' ' ' ILE . . . -73.28 -57.55 5.09 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 213' ' ' THR . . . . . 0.414 HG22 ' OE1' ' B' ' 111' ' ' GLU . 48.6 m -57.76 -25.2 60.14 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 214' ' ' ALA . . . . . 0.51 ' HB2' ' O ' ' C' ' 210' ' ' LEU . . . -68.69 -63.13 1.12 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 215' ' ' VAL . . . . . 0.586 HG23 ' O ' ' C' ' 211' ' ' GLU . 2.5 t -68.97 -21.11 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 216' ' ' ILE . . . . . 0.895 HD12 ' C ' ' C' ' 212' ' ' GLY . 22.0 mt -77.02 -64.8 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -51.07 -32.42 22.08 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 218' ' ' MET . . . . . 0.616 ' HE1' ' CE ' ' B' ' 118' ' ' MET . 6.5 mtp . . . . . 0 N--CA 1.449 -0.507 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.863 HG21 ' CG ' ' B' ' 106' ' ' GLU . 96.0 m . . . . . 0 N--CA 1.449 -0.484 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.478 ' CG ' ' N ' ' A' ' 5' ' ' LEU . 4.2 p-10 -42.6 -50.71 5.35 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.478 ' N ' ' CG ' ' A' ' 4' ' ' ASN . 16.1 mt -43.46 -48.33 7.21 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.859 ' CG ' HG21 ' C' ' 203' ' ' THR . 2.7 mp0 -64.67 -31.56 72.84 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 1.069 HG23 ' CD2' ' B' ' 110' ' ' LEU . 4.9 mt -65.2 -30.38 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 60.7 mt -76.48 -42.17 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.419 ' O ' ' HB ' ' A' ' 13' ' ' THR . 32.0 mt -76.54 -25.22 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 1.079 ' CD2' HG23 ' C' ' 207' ' ' ILE . 15.1 mt -84.6 -46.46 11.52 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.589 ' CD ' HG22 ' B' ' 113' ' ' THR . 52.1 mm-40 -58.67 -45.14 90.04 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.647 ' C ' HD12 ' A' ' 16' ' ' ILE . . . -70.58 -57.92 6.25 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.584 HG22 ' CD ' ' C' ' 211' ' ' GLU . 44.9 m -55.69 -27.02 47.93 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.553 ' HB2' ' O ' ' A' ' 10' ' ' LEU . . . -66.45 -63.14 1.14 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.687 HG22 ' HG3' ' B' ' 118' ' ' MET . 2.9 t -67.49 -22.04 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.647 HD12 ' C ' ' A' ' 12' ' ' GLY . 34.8 mt -73.09 -64.54 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.78 -34.89 29.19 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.717 ' HG3' HG22 ' C' ' 215' ' ' VAL . 6.0 mtp . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 103' ' ' THR . . . . . 0.843 HG21 ' CG ' ' C' ' 206' ' ' GLU . 96.2 m . . . . . 0 N--CA 1.449 -0.493 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 104' ' ' ASN . . . . . 0.481 ' CG ' ' N ' ' B' ' 105' ' ' LEU . 4.3 p-10 -42.66 -50.8 5.43 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 105' ' ' LEU . . . . . 0.481 ' N ' ' CG ' ' B' ' 104' ' ' ASN . 16.2 mt -43.57 -48.24 7.52 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 106' ' ' GLU . . . . . 0.863 ' CG ' HG21 ' A' ' 3' ' ' THR . 2.7 mp0 -64.58 -31.42 72.63 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 107' ' ' ILE . . . . . 1.085 HG23 ' CD2' ' C' ' 210' ' ' LEU . 4.8 mt -65.31 -30.36 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 61.0 mt -76.53 -42.07 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 109' ' ' ILE . . . . . 0.429 ' O ' ' HB ' ' B' ' 113' ' ' THR . 32.0 mt -76.64 -25.2 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 110' ' ' LEU . . . . . 1.069 ' CD2' HG23 ' A' ' 7' ' ' ILE . 15.1 mt -84.58 -46.53 11.46 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 111' ' ' GLU . . . . . 0.589 ' CD ' HG22 ' C' ' 213' ' ' THR . 52.4 mm-40 -58.72 -45.14 90.27 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 112' ' ' GLY . . . . . 0.654 ' C ' HD12 ' B' ' 116' ' ' ILE . . . -70.56 -57.76 6.38 Favored Glycine 0 C--N 1.335 0.521 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 113' ' ' THR . . . . . 0.589 HG22 ' CD ' ' A' ' 11' ' ' GLU . 45.1 m -55.82 -26.95 48.96 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 114' ' ' ALA . . . . . 0.55 ' HB2' ' O ' ' B' ' 110' ' ' LEU . . . -66.47 -63.12 1.14 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 115' ' ' VAL . . . . . 0.698 HG22 ' HG3' ' C' ' 218' ' ' MET . 2.9 t -67.58 -22.1 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 116' ' ' ILE . . . . . 0.654 HD12 ' C ' ' B' ' 112' ' ' GLY . 35.3 mt -73.09 -64.53 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -50.65 -35.05 28.78 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 118' ' ' MET . . . . . 0.687 ' HG3' HG22 ' A' ' 15' ' ' VAL . 6.0 mtp . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 203' ' ' THR . . . . . 0.859 HG21 ' CG ' ' A' ' 6' ' ' GLU . 96.3 m . . . . . 0 N--CA 1.449 -0.489 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 204' ' ' ASN . . . . . 0.485 ' CG ' ' N ' ' C' ' 205' ' ' LEU . 4.3 p-10 -42.56 -50.72 5.3 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 205' ' ' LEU . . . . . 0.485 ' N ' ' CG ' ' C' ' 204' ' ' ASN . 16.2 mt -43.6 -48.24 7.61 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 206' ' ' GLU . . . . . 0.843 ' CG ' HG21 ' B' ' 103' ' ' THR . 2.7 mp0 -64.66 -31.47 72.71 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 207' ' ' ILE . . . . . 1.079 HG23 ' CD2' ' A' ' 10' ' ' LEU . 4.8 mt -65.24 -30.35 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 208' ' ' ILE . . . . . . . . . . . . . 60.5 mt -76.59 -42.12 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 209' ' ' ILE . . . . . 0.415 ' O ' ' HB ' ' C' ' 213' ' ' THR . 31.8 mt -76.59 -25.21 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 210' ' ' LEU . . . . . 1.085 ' CD2' HG23 ' B' ' 107' ' ' ILE . 15.1 mt -84.62 -46.5 11.46 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 211' ' ' GLU . . . . . 0.584 ' CD ' HG22 ' A' ' 13' ' ' THR . 52.3 mm-40 -58.71 -45.04 90.45 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 212' ' ' GLY . . . . . 0.654 ' C ' HD12 ' C' ' 216' ' ' ILE . . . -70.66 -57.85 6.25 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 213' ' ' THR . . . . . 0.589 HG22 ' CD ' ' B' ' 111' ' ' GLU . 45.4 m -55.68 -27.11 48.4 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 214' ' ' ALA . . . . . 0.537 ' HB2' ' O ' ' C' ' 210' ' ' LEU . . . -66.51 -63.05 1.16 Allowed 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 215' ' ' VAL . . . . . 0.717 HG22 ' HG3' ' A' ' 18' ' ' MET . 3.0 t -67.6 -22.02 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 216' ' ' ILE . . . . . 0.654 HD12 ' C ' ' C' ' 212' ' ' GLY . 34.6 mt -73.19 -64.42 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -50.92 -34.78 29.97 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 218' ' ' MET . . . . . 0.698 ' HG3' HG22 ' B' ' 115' ' ' VAL . 6.0 mtp . . . . . 0 N--CA 1.449 -0.523 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.1 t . . . . . 0 N--CA 1.449 -0.481 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.484 ' HA ' HG13 ' A' ' 7' ' ' ILE . 1.6 t30 -42.84 -51.23 5.54 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.535 ' HA ' HD23 ' A' ' 5' ' ' LEU . 12.8 mt -42.99 -48.57 5.97 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.571 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 3.8 mp0 -64.54 -31.36 72.54 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 1.075 HG23 ' CD2' ' B' ' 110' ' ' LEU . 4.0 mt -65.17 -30.2 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 73.6 mt -76.75 -42.24 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.415 ' O ' ' HB ' ' A' ' 13' ' ' THR . 95.7 mt -76.75 -24.21 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 1.069 ' CD2' HG23 ' C' ' 207' ' ' ILE . 15.4 mt -85.6 -47.59 9.71 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.548 ' CD ' HG22 ' B' ' 113' ' ' THR . 57.5 mm-40 -58.95 -42.34 89.57 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.701 ' C ' HD12 ' A' ' 16' ' ' ILE . . . -72.65 -56.38 6.05 Favored Glycine 0 C--N 1.335 0.521 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.562 HG22 ' CD ' ' C' ' 211' ' ' GLU . 37.1 m -57.77 -25.4 60.45 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.517 ' HB2' ' O ' ' A' ' 10' ' ' LEU . . . -68.83 -63.14 1.12 Allowed 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.618 HG22 ' CG ' ' B' ' 118' ' ' MET . 2.7 t -68.56 -21.17 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.701 HD12 ' C ' ' A' ' 12' ' ' GLY . 34.9 mt -76.84 -64.65 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.02 -32.32 21.13 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.624 ' CG ' HG22 ' C' ' 215' ' ' VAL . 6.4 mtp . . . . . 0 N--CA 1.449 -0.482 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 7.0 t . . . . . 0 N--CA 1.449 -0.493 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 104' ' ' ASN . . . . . 0.496 ' HA ' HG13 ' B' ' 107' ' ' ILE . 1.5 t30 -42.93 -51.24 5.65 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 105' ' ' LEU . . . . . 0.481 HD23 ' HA ' ' B' ' 105' ' ' LEU . 12.8 mt -43.01 -48.49 6.0 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 106' ' ' GLU . . . . . 0.583 ' CD ' ' N ' ' B' ' 106' ' ' GLU . 3.8 mp0 -64.54 -31.46 72.69 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 107' ' ' ILE . . . . . 1.046 HG23 ' CD2' ' C' ' 210' ' ' LEU . 4.0 mt -65.14 -30.14 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 73.5 mt -76.77 -42.24 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 109' ' ' ILE . . . . . 0.426 ' O ' ' HB ' ' B' ' 113' ' ' THR . 95.6 mt -76.84 -24.12 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 110' ' ' LEU . . . . . 1.075 ' CD2' HG23 ' A' ' 7' ' ' ILE . 15.5 mt -85.62 -47.48 9.8 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 111' ' ' GLU . . . . . 0.561 ' CD ' HG22 ' C' ' 213' ' ' THR . 57.5 mm-40 -58.98 -42.45 89.98 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 112' ' ' GLY . . . . . 0.701 ' C ' HD12 ' B' ' 116' ' ' ILE . . . -72.67 -56.25 6.12 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.319 -1.113 . . . . 0.0 110.319 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 113' ' ' THR . . . . . 0.548 HG22 ' CD ' ' A' ' 11' ' ' GLU . 36.9 m -57.89 -25.32 60.66 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 114' ' ' ALA . . . . . 0.509 ' HB2' ' O ' ' B' ' 110' ' ' LEU . . . -68.85 -63.15 1.11 Allowed 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 115' ' ' VAL . . . . . 0.621 HG22 ' CG ' ' C' ' 218' ' ' MET . 2.7 t -68.54 -21.29 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 116' ' ' ILE . . . . . 0.701 HD12 ' C ' ' B' ' 112' ' ' GLY . 34.5 mt -76.66 -64.66 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -51.11 -32.11 21.51 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 118' ' ' MET . . . . . 0.618 ' CG ' HG22 ' A' ' 15' ' ' VAL . 6.3 mtp . . . . . 0 N--CA 1.449 -0.482 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 203' ' ' THR . . . . . . . . . . . . . 7.1 t . . . . . 0 N--CA 1.449 -0.476 0 N-CA-C 109.946 -0.391 . . . . 0.0 109.946 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 204' ' ' ASN . . . . . 0.503 ' HA ' HG13 ' C' ' 207' ' ' ILE . 1.5 t30 -42.88 -51.14 5.63 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 205' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' C' ' 205' ' ' LEU . 12.8 mt -43.04 -48.53 6.08 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 206' ' ' GLU . . . . . 0.574 ' N ' ' CD ' ' C' ' 206' ' ' GLU . 3.8 mp0 -64.58 -31.43 72.64 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 207' ' ' ILE . . . . . 1.069 HG23 ' CD2' ' A' ' 10' ' ' LEU . 4.0 mt -65.14 -30.19 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 208' ' ' ILE . . . . . . . . . . . . . 73.3 mt -76.77 -42.26 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 209' ' ' ILE . . . . . 0.408 ' O ' ' HB ' ' C' ' 213' ' ' THR . 95.6 mt -76.74 -24.24 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 210' ' ' LEU . . . . . 1.046 ' CD2' HG23 ' B' ' 107' ' ' ILE . 15.4 mt -85.58 -47.28 10.01 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 211' ' ' GLU . . . . . 0.562 ' CD ' HG22 ' A' ' 13' ' ' THR . 57.1 mm-40 -59.03 -42.52 90.38 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 212' ' ' GLY . . . . . 0.693 ' C ' HD12 ' C' ' 216' ' ' ILE . . . -72.64 -56.27 6.13 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 213' ' ' THR . . . . . 0.561 HG22 ' CD ' ' B' ' 111' ' ' GLU . 38.3 m -57.82 -25.47 60.67 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 214' ' ' ALA . . . . . 0.502 ' HB2' ' O ' ' C' ' 210' ' ' LEU . . . -68.76 -63.19 1.11 Allowed 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 215' ' ' VAL . . . . . 0.624 HG22 ' CG ' ' A' ' 18' ' ' MET . 2.7 t -68.5 -21.33 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 216' ' ' ILE . . . . . 0.693 HD12 ' C ' ' C' ' 212' ' ' GLY . 34.3 mt -76.61 -64.62 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -51.11 -32.11 21.48 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 218' ' ' MET . . . . . 0.621 ' CG ' HG22 ' B' ' 115' ' ' VAL . 6.3 mtp . . . . . 0 N--CA 1.448 -0.534 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.4 t . . . . . 0 N--CA 1.449 -0.523 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.508 ' HA ' HG13 ' A' ' 7' ' ' ILE . 1.6 t-20 -42.78 -50.85 5.57 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.535 ' HA ' HD23 ' A' ' 5' ' ' LEU . 11.5 mt -42.9 -48.61 5.86 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.585 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 2.1 mp0 -64.8 -31.58 72.88 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 1.066 HG23 ' CD2' ' B' ' 110' ' ' LEU . 4.2 mt -64.81 -30.26 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 66.1 mt -76.8 -42.74 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.415 ' O ' ' HB ' ' A' ' 13' ' ' THR . 18.9 mt -76.19 -24.0 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 1.046 ' CD2' HG23 ' C' ' 207' ' ' ILE . 15.8 mt -85.7 -52.78 5.56 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.54 ' CD ' HG22 ' B' ' 113' ' ' THR . 66.5 mm-40 -55.8 -40.96 73.45 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.684 ' C ' HD12 ' A' ' 16' ' ' ILE . . . -72.65 -54.99 6.93 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.589 HG22 ' CD ' ' C' ' 211' ' ' GLU . 17.2 m -57.7 -25.88 60.95 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.19 -63.38 1.08 Allowed 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.794 HG22 ' CG ' ' B' ' 118' ' ' MET . 2.6 t -67.57 -21.14 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.684 HD12 ' C ' ' A' ' 12' ' ' GLY . 32.6 mt -76.55 -64.6 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.42 -32.04 16.65 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.591 ' CE ' ' HE1' ' B' ' 118' ' ' MET . 6.5 mtp . . . . . 0 N--CA 1.449 -0.497 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 6.3 t . . . . . 0 N--CA 1.449 -0.489 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 104' ' ' ASN . . . . . 0.489 ' HA ' HG13 ' B' ' 107' ' ' ILE . 1.6 t-20 -42.97 -51.16 5.73 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 105' ' ' LEU . . . . . 0.517 ' HA ' HD23 ' B' ' 105' ' ' LEU . 11.5 mt -42.97 -48.42 5.92 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 106' ' ' GLU . . . . . 0.58 ' CD ' ' N ' ' B' ' 106' ' ' GLU . 2.2 mp0 -64.55 -31.89 73.3 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 107' ' ' ILE . . . . . 1.038 HG23 ' CD2' ' C' ' 210' ' ' LEU . 4.0 mt -64.85 -29.73 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 66.3 mt -77.01 -42.91 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 109' ' ' ILE . . . . . 0.424 ' O ' ' HB ' ' B' ' 113' ' ' THR . 18.9 mt -76.33 -23.9 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 110' ' ' LEU . . . . . 1.066 ' CD2' HG23 ' A' ' 7' ' ' ILE . 15.4 mt -85.67 -50.78 6.92 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 111' ' ' GLU . . . . . 0.537 ' O ' HG23 ' B' ' 115' ' ' VAL . 63.9 mm-40 -57.23 -40.64 77.96 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 112' ' ' GLY . . . . . 0.67 ' C ' HD12 ' B' ' 116' ' ' ILE . . . -73.49 -55.77 5.91 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 113' ' ' THR . . . . . 0.54 HG22 ' CD ' ' A' ' 11' ' ' GLU . 22.2 m -57.86 -24.93 59.83 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.12 -62.69 1.29 Allowed 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 115' ' ' VAL . . . . . 0.537 HG23 ' O ' ' B' ' 111' ' ' GLU . 3.1 t -68.27 -21.1 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 116' ' ' ILE . . . . . 0.67 HD12 ' C ' ' B' ' 112' ' ' GLY . 45.6 mt -79.61 -65.2 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -53.81 -27.98 32.62 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.786 -0.449 . . . . 0.0 109.786 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 118' ' ' MET . . . . . 0.794 ' CG ' HG22 ' A' ' 15' ' ' VAL . 11.9 mtp . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 203' ' ' THR . . . . . . . . . . . . . 6.3 t . . . . . 0 N--CA 1.449 -0.482 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 204' ' ' ASN . . . . . 0.493 ' HA ' HG13 ' C' ' 207' ' ' ILE . 1.6 t-20 -42.82 -51.12 5.56 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 205' ' ' LEU . . . . . 0.493 HD23 ' HA ' ' C' ' 205' ' ' LEU . 11.6 mt -42.95 -48.52 5.91 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 206' ' ' GLU . . . . . 0.574 ' N ' ' CD ' ' C' ' 206' ' ' GLU . 2.2 mp0 -64.66 -31.45 72.68 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 207' ' ' ILE . . . . . 1.046 HG23 ' CD2' ' A' ' 10' ' ' LEU . 4.2 mt -64.98 -30.28 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 208' ' ' ILE . . . . . . . . . . . . . 64.9 mt -76.74 -42.49 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 209' ' ' ILE . . . . . 0.423 ' O ' ' HB ' ' C' ' 213' ' ' THR . 18.7 mt -76.51 -24.09 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 210' ' ' LEU . . . . . 1.038 ' CD2' HG23 ' B' ' 107' ' ' ILE . 15.6 mt -85.71 -52.47 5.76 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 211' ' ' GLU . . . . . 0.589 ' CD ' HG22 ' A' ' 13' ' ' THR . 67.1 mm-40 -56.49 -40.69 75.38 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 212' ' ' GLY . . . . . 0.691 ' C ' HD12 ' C' ' 216' ' ' ILE . . . -72.7 -55.95 6.28 Favored Glycine 0 C--N 1.335 0.513 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 213' ' ' THR . . . . . 0.53 HG22 ' CD ' ' B' ' 111' ' ' GLU . 20.4 m -57.65 -25.3 60.0 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 214' ' ' ALA . . . . . . . . . . . . . . . -69.37 -63.26 1.1 Allowed 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 215' ' ' VAL . . . . . 0.533 HG23 ' O ' ' C' ' 211' ' ' GLU . 2.8 t -68.15 -21.09 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 216' ' ' ILE . . . . . 0.691 HD12 ' C ' ' C' ' 212' ' ' GLY . 37.8 mt -77.53 -64.67 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -50.99 -30.93 16.42 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 218' ' ' MET . . . . . 0.569 ' SD ' ' CE ' ' B' ' 118' ' ' MET . 6.9 mtp . . . . . 0 N--CA 1.449 -0.499 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.662 HG21 ' CG ' ' B' ' 106' ' ' GLU . 1.6 m . . . . . 0 N--CA 1.449 -0.499 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.49 ' HA ' HG13 ' A' ' 7' ' ' ILE . 1.6 t30 -42.12 -47.22 4.54 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.545 HD23 ' HA ' ' A' ' 5' ' ' LEU . 12.3 mt -42.84 -50.34 5.7 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.668 ' CG ' HG21 ' C' ' 203' ' ' THR . 0.1 OUTLIER -66.08 -32.17 73.48 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.912 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 1.064 HG23 ' CD2' ' B' ' 110' ' ' LEU . 3.6 mt -65.01 -29.76 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 44.6 mt -76.93 -42.52 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.42 ' O ' ' HB ' ' A' ' 13' ' ' THR . 29.4 mt -76.74 -24.04 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 1.062 ' CD2' HG23 ' C' ' 207' ' ' ILE . 15.3 mt -85.73 -48.14 9.11 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.566 ' O ' HG23 ' A' ' 15' ' ' VAL . 60.6 mm-40 -58.81 -41.79 87.62 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.718 ' C ' HD12 ' A' ' 16' ' ' ILE . . . -72.96 -56.24 5.93 Favored Glycine 0 C--N 1.336 0.555 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.54 HG22 ' CD ' ' C' ' 211' ' ' GLU . 31.8 m -57.88 -25.72 61.15 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.494 ' HB2' ' O ' ' A' ' 10' ' ' LEU . . . -68.7 -63.09 1.13 Allowed 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.589 HG22 ' CG ' ' B' ' 118' ' ' MET . 2.7 t -68.31 -21.24 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.718 HD12 ' C ' ' A' ' 12' ' ' GLY . 30.5 mt -76.57 -64.68 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.93 -32.28 20.28 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.601 ' CE ' ' HE1' ' B' ' 118' ' ' MET . 6.5 mtp . . . . . 0 N--CA 1.448 -0.526 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 103' ' ' THR . . . . . 0.671 HG21 ' CG ' ' C' ' 206' ' ' GLU . 1.6 m . . . . . 0 N--CA 1.449 -0.482 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 104' ' ' ASN . . . . . 0.495 ' HA ' HG13 ' B' ' 107' ' ' ILE . 1.6 t30 -42.13 -47.33 4.57 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 105' ' ' LEU . . . . . 0.476 ' HA ' HD23 ' B' ' 105' ' ' LEU . 12.3 mt -42.75 -50.32 5.59 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 106' ' ' GLU . . . . . 0.662 ' CG ' HG21 ' A' ' 3' ' ' THR . 0.1 OUTLIER -66.14 -32.2 73.5 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.928 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 107' ' ' ILE . . . . . 1.053 HG23 ' CD2' ' C' ' 210' ' ' LEU . 3.5 mt -65.0 -29.79 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 44.7 mt -76.9 -42.53 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 109' ' ' ILE . . . . . 0.419 ' O ' ' HB ' ' B' ' 113' ' ' THR . 29.3 mt -76.71 -24.03 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 110' ' ' LEU . . . . . 1.064 ' CD2' HG23 ' A' ' 7' ' ' ILE . 15.3 mt -85.72 -47.63 9.58 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 111' ' ' GLU . . . . . 0.555 ' O ' HG23 ' B' ' 115' ' ' VAL . 59.7 mm-40 -59.07 -41.99 89.28 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 112' ' ' GLY . . . . . 0.715 ' C ' HD12 ' B' ' 116' ' ' ILE . . . -72.91 -56.15 6.01 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 113' ' ' THR . . . . . 0.554 HG22 ' CD ' ' A' ' 11' ' ' GLU . 32.8 m -57.88 -25.83 61.3 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 114' ' ' ALA . . . . . 0.498 ' HB2' ' O ' ' B' ' 110' ' ' LEU . . . -68.65 -63.07 1.13 Allowed 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 115' ' ' VAL . . . . . 0.572 HG22 ' CG ' ' C' ' 218' ' ' MET . 2.7 t -68.32 -21.27 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 116' ' ' ILE . . . . . 0.715 HD12 ' C ' ' B' ' 112' ' ' GLY . 30.1 mt -76.33 -64.62 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -51.16 -32.14 22.28 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 118' ' ' MET . . . . . 0.605 ' CE ' ' HE1' ' C' ' 218' ' ' MET . 6.3 mtp . . . . . 0 N--CA 1.449 -0.513 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 203' ' ' THR . . . . . 0.668 HG21 ' CG ' ' A' ' 6' ' ' GLU . 1.6 m . . . . . 0 N--CA 1.449 -0.483 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 204' ' ' ASN . . . . . 0.502 ' HA ' HG13 ' C' ' 207' ' ' ILE . 1.6 t30 -42.1 -47.28 4.52 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 205' ' ' LEU . . . . . 0.527 HD23 ' HA ' ' C' ' 205' ' ' LEU . 12.3 mt -42.82 -50.24 5.68 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 206' ' ' GLU . . . . . 0.671 ' CG ' HG21 ' B' ' 103' ' ' THR . 0.1 OUTLIER -66.17 -32.27 73.61 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.938 -0.394 . . . . 0.0 109.938 179.938 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 207' ' ' ILE . . . . . 1.062 HG23 ' CD2' ' A' ' 10' ' ' LEU . 3.5 mt -64.95 -29.81 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 208' ' ' ILE . . . . . . . . . . . . . 44.9 mt -76.84 -42.56 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 209' ' ' ILE . . . . . 0.408 ' O ' ' HB ' ' C' ' 213' ' ' THR . 29.4 mt -76.67 -24.01 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 210' ' ' LEU . . . . . 1.053 ' CD2' HG23 ' B' ' 107' ' ' ILE . 15.4 mt -85.73 -47.64 9.57 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 211' ' ' GLU . . . . . 0.562 ' O ' HG23 ' C' ' 215' ' ' VAL . 59.3 mm-40 -59.09 -41.91 89.2 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 212' ' ' GLY . . . . . 0.72 ' C ' HD12 ' C' ' 216' ' ' ILE . . . -73.02 -56.08 5.98 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 213' ' ' THR . . . . . 0.55 HG22 ' CD ' ' B' ' 111' ' ' GLU . 34.0 m -57.93 -25.78 61.35 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 214' ' ' ALA . . . . . 0.494 ' HB2' ' O ' ' C' ' 210' ' ' LEU . . . -68.71 -63.03 1.14 Allowed 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 215' ' ' VAL . . . . . 0.567 HG22 ' CG ' ' A' ' 18' ' ' MET . 2.7 t -68.3 -21.41 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 216' ' ' ILE . . . . . 0.72 HD12 ' C ' ' C' ' 212' ' ' GLY . 30.4 mt -76.2 -64.64 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -51.05 -32.26 21.27 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 218' ' ' MET . . . . . 0.605 ' HE1' ' CE ' ' B' ' 118' ' ' MET . 6.4 mtp . . . . . 0 N--CA 1.449 -0.482 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.478 HG23 ' N ' ' A' ' 4' ' ' ASN . 9.7 t . . . . . 0 N--CA 1.449 -0.523 0 N-CA-C 109.911 -0.404 . . . . 0.0 109.911 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.507 ' HA ' HG13 ' A' ' 7' ' ' ILE . 2.6 t30 -42.77 -50.13 5.64 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.49 ' HA ' HD23 ' A' ' 5' ' ' LEU . 17.3 mt -42.88 -49.09 5.9 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.588 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 0.3 OUTLIER -64.57 -32.24 73.81 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.917 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 1.042 HG23 ' CD2' ' B' ' 110' ' ' LEU . 3.6 mt -65.19 -29.42 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 19.7 mt -76.92 -42.44 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.427 ' O ' ' HB ' ' A' ' 13' ' ' THR . 85.2 mt -77.29 -23.61 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 1.065 ' CD2' HG23 ' C' ' 207' ' ' ILE . 15.4 mt -85.77 -51.03 6.69 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.582 ' O ' HG23 ' A' ' 15' ' ' VAL . 66.7 mm-40 -58.63 -39.78 81.47 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.686 ' C ' HD12 ' A' ' 16' ' ' ILE . . . -73.42 -57.58 5.01 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.427 ' HB ' ' O ' ' A' ' 9' ' ' ILE . 46.2 m -57.88 -25.08 60.3 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.485 ' HB2' ' O ' ' A' ' 10' ' ' LEU . . . -68.81 -63.03 1.14 Allowed 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 11' ' ' GLU . 2.5 t -69.0 -21.08 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.686 HD12 ' C ' ' A' ' 12' ' ' GLY . 38.0 mt -77.45 -64.85 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.13 -32.03 21.52 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.622 ' CE ' ' HE1' ' B' ' 118' ' ' MET . 6.9 mtp . . . . . 0 N--CA 1.449 -0.485 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 103' ' ' THR . . . . . 0.489 HG23 ' N ' ' B' ' 104' ' ' ASN . 9.0 t . . . . . 0 N--CA 1.449 -0.506 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 104' ' ' ASN . . . . . 0.496 ' HA ' HG13 ' B' ' 107' ' ' ILE . 2.8 t30 -42.96 -51.2 5.7 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 105' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' B' ' 105' ' ' LEU . 17.7 mt -43.05 -48.55 6.13 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 106' ' ' GLU . . . . . 0.583 ' CD ' ' N ' ' B' ' 106' ' ' GLU . 0.3 OUTLIER -64.27 -31.74 73.07 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 107' ' ' ILE . . . . . 1.061 HG23 ' CD2' ' C' ' 210' ' ' LEU . 3.8 mt -65.23 -29.86 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 20.3 mt -76.68 -42.19 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 109' ' ' ILE . . . . . 0.416 ' O ' ' HB ' ' B' ' 113' ' ' THR . 84.0 mt -77.39 -23.78 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 110' ' ' LEU . . . . . 1.042 ' CD2' HG23 ' A' ' 7' ' ' ILE . 15.6 mt -85.68 -50.95 6.79 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 111' ' ' GLU . . . . . 0.602 ' O ' HG23 ' B' ' 115' ' ' VAL . 67.3 mm-40 -58.63 -39.8 81.54 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 112' ' ' GLY . . . . . 0.677 ' C ' HD12 ' B' ' 116' ' ' ILE . . . -73.42 -57.59 5.0 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 113' ' ' THR . . . . . 0.416 ' HB ' ' O ' ' B' ' 109' ' ' ILE . 45.0 m -57.83 -25.17 60.27 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.938 -0.394 . . . . 0.0 109.938 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 114' ' ' ALA . . . . . 0.479 ' HB2' ' O ' ' B' ' 110' ' ' LEU . . . -68.8 -63.04 1.14 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 115' ' ' VAL . . . . . 0.602 HG23 ' O ' ' B' ' 111' ' ' GLU . 2.5 t -68.97 -21.12 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 116' ' ' ILE . . . . . 0.677 HD12 ' C ' ' B' ' 112' ' ' GLY . 37.2 mt -77.24 -64.82 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -50.98 -32.26 20.56 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 118' ' ' MET . . . . . 0.622 ' HE1' ' CE ' ' A' ' 18' ' ' MET . 6.7 mtp . . . . . 0 N--CA 1.449 -0.481 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 203' ' ' THR . . . . . 0.483 HG23 ' N ' ' C' ' 204' ' ' ASN . 8.9 t . . . . . 0 N--CA 1.448 -0.527 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 204' ' ' ASN . . . . . 0.494 ' HA ' HG13 ' C' ' 207' ' ' ILE . 2.8 t30 -43.06 -51.4 5.79 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 205' ' ' LEU . . . . . 0.514 HD23 ' HA ' ' C' ' 205' ' ' LEU . 17.8 mt -43.06 -48.33 6.11 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 206' ' ' GLU . . . . . 0.581 ' N ' ' CD ' ' C' ' 206' ' ' GLU . 0.3 OUTLIER -64.24 -31.92 73.31 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 207' ' ' ILE . . . . . 1.065 HG23 ' CD2' ' A' ' 10' ' ' LEU . 3.8 mt -65.21 -29.7 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 208' ' ' ILE . . . . . . . . . . . . . 19.9 mt -76.79 -42.18 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 209' ' ' ILE . . . . . 0.419 ' O ' ' HB ' ' C' ' 213' ' ' THR . 83.8 mt -77.36 -23.86 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 210' ' ' LEU . . . . . 1.061 ' CD2' HG23 ' B' ' 107' ' ' ILE . 15.3 mt -85.58 -50.75 6.98 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 211' ' ' GLU . . . . . 0.579 ' O ' HG23 ' C' ' 215' ' ' VAL . 66.6 mm-40 -58.59 -40.18 82.49 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 212' ' ' GLY . . . . . 0.679 ' C ' HD12 ' C' ' 216' ' ' ILE . . . -73.2 -57.53 5.13 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 213' ' ' THR . . . . . 0.419 ' HB ' ' O ' ' C' ' 209' ' ' ILE . 46.0 m -57.73 -25.22 60.09 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 214' ' ' ALA . . . . . 0.492 ' HB2' ' O ' ' C' ' 210' ' ' LEU . . . -68.7 -63.04 1.14 Allowed 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 215' ' ' VAL . . . . . 0.579 HG23 ' O ' ' C' ' 211' ' ' GLU . 2.6 t -69.02 -21.11 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 216' ' ' ILE . . . . . 0.679 HD12 ' C ' ' C' ' 212' ' ' GLY . 37.1 mt -77.17 -64.72 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -51.22 -32.25 23.35 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 218' ' ' MET . . . . . 0.597 ' HE1' ' CE ' ' B' ' 118' ' ' MET . 6.6 mtp . . . . . 0 N--CA 1.449 -0.478 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.2 t . . . . . 0 N--CA 1.45 -0.471 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ASN . . . . . 0.508 ' HA ' HG13 ' A' ' 7' ' ' ILE . 2.1 t30 -42.79 -51.28 5.45 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.489 ' HA ' HD23 ' A' ' 5' ' ' LEU . 12.1 mt -43.03 -48.43 6.03 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.587 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 1.8 mp0 -64.59 -31.3 72.45 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 1.039 HG23 ' CD2' ' B' ' 110' ' ' LEU . 4.1 mt -65.34 -30.07 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 73.9 mt -76.89 -42.05 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.418 ' O ' ' HB ' ' A' ' 13' ' ' THR . 15.9 mt -76.95 -24.29 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 1.026 ' CD2' HG23 ' C' ' 207' ' ' ILE . 15.4 mt -85.39 -49.85 7.78 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.558 ' CD ' HG22 ' B' ' 113' ' ' THR . 61.7 mm-40 -57.87 -42.04 83.73 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.855 ' C ' HD12 ' A' ' 16' ' ' ILE . . . -72.02 -55.95 6.79 Favored Glycine 0 C--N 1.335 0.475 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.575 HG22 ' CD ' ' C' ' 211' ' ' GLU . 23.7 m -57.95 -25.38 60.88 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.429 ' HB2' ' O ' ' A' ' 10' ' ' LEU . . . -68.52 -63.09 1.13 Allowed 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.598 HG22 ' HG3' ' B' ' 118' ' ' MET . 2.7 t -68.95 -21.13 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.855 HD12 ' C ' ' A' ' 12' ' ' GLY . 23.3 mt -76.54 -64.68 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.88 -33.44 24.02 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.664 ' HE2' ' HE1' ' B' ' 118' ' ' MET . 6.7 mtp . . . . . 0 N--CA 1.449 -0.522 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 5.2 t . . . . . 0 N--CA 1.449 -0.486 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 104' ' ' ASN . . . . . 0.498 ' HA ' HG13 ' B' ' 107' ' ' ILE . 2.1 t30 -42.81 -51.23 5.5 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 105' ' ' LEU . . . . . 0.469 ' HA ' HD23 ' B' ' 105' ' ' LEU . 12.0 mt -43.05 -48.45 6.1 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 106' ' ' GLU . . . . . 0.588 ' CD ' ' N ' ' B' ' 106' ' ' GLU . 1.8 mp0 -64.62 -31.33 72.5 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 107' ' ' ILE . . . . . 1.035 HG23 ' CD2' ' C' ' 210' ' ' LEU . 4.1 mt -65.28 -30.18 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 74.6 mt -76.84 -42.03 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 109' ' ' ILE . . . . . 0.423 ' O ' ' HB ' ' B' ' 113' ' ' THR . 16.1 mt -76.99 -24.32 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 110' ' ' LEU . . . . . 1.039 ' CD2' HG23 ' A' ' 7' ' ' ILE . 15.4 mt -85.44 -49.59 7.97 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 111' ' ' GLU . . . . . 0.542 ' CD ' HG22 ' C' ' 213' ' ' THR . 61.5 mm-40 -57.99 -42.21 84.66 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 112' ' ' GLY . . . . . 0.85 ' C ' HD12 ' B' ' 116' ' ' ILE . . . -71.95 -55.94 6.84 Favored Glycine 0 C--N 1.336 0.547 0 N-CA-C 110.279 -1.129 . . . . 0.0 110.279 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 113' ' ' THR . . . . . 0.558 HG22 ' CD ' ' A' ' 11' ' ' GLU . 24.1 m -57.91 -25.58 61.05 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 114' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' B' ' 110' ' ' LEU . . . -68.34 -63.04 1.14 Allowed 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 115' ' ' VAL . . . . . 0.588 HG22 ' HG3' ' C' ' 218' ' ' MET . 2.7 t -68.98 -21.07 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 116' ' ' ILE . . . . . 0.85 HD12 ' C ' ' B' ' 112' ' ' GLY . 22.0 mt -76.2 -64.66 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -50.78 -34.02 25.69 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 118' ' ' MET . . . . . 0.664 ' HE1' ' HE2' ' A' ' 18' ' ' MET . 6.5 mtp . . . . . 0 N--CA 1.45 -0.466 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 203' ' ' THR . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.449 -0.522 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 204' ' ' ASN . . . . . 0.494 ' HA ' HG13 ' C' ' 207' ' ' ILE . 2.1 t30 -42.85 -51.09 5.6 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 205' ' ' LEU . . . . . 0.49 HD23 ' HA ' ' C' ' 205' ' ' LEU . 12.0 mt -43.04 -48.46 6.08 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 206' ' ' GLU . . . . . 0.582 ' N ' ' CD ' ' C' ' 206' ' ' GLU . 1.8 mp0 -64.62 -31.34 72.51 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 207' ' ' ILE . . . . . 1.026 HG23 ' CD2' ' A' ' 10' ' ' LEU . 4.1 mt -65.23 -30.16 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 208' ' ' ILE . . . . . . . . . . . . . 74.3 mt -76.83 -42.2 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 209' ' ' ILE . . . . . 0.424 ' O ' ' HB ' ' C' ' 213' ' ' THR . 16.1 mt -76.8 -24.32 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 210' ' ' LEU . . . . . 1.035 ' CD2' HG23 ' B' ' 107' ' ' ILE . 15.4 mt -85.44 -49.5 8.05 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 211' ' ' GLU . . . . . 0.575 ' CD ' HG22 ' A' ' 13' ' ' THR . 60.8 mm-40 -57.92 -42.29 84.51 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 212' ' ' GLY . . . . . 0.847 ' C ' HD12 ' C' ' 216' ' ' ILE . . . -72.08 -55.83 6.82 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 213' ' ' THR . . . . . 0.542 HG22 ' CD ' ' B' ' 111' ' ' GLU . 23.9 m -57.85 -25.49 60.78 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 214' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' C' ' 210' ' ' LEU . . . -68.48 -63.09 1.13 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 215' ' ' VAL . . . . . 0.612 HG22 ' CG ' ' A' ' 18' ' ' MET . 2.8 t -68.89 -21.09 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 216' ' ' ILE . . . . . 0.847 HD12 ' C ' ' C' ' 212' ' ' GLY . 23.1 mt -76.51 -64.8 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -50.78 -33.37 23.03 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 218' ' ' MET . . . . . 0.618 ' HE1' ' CE ' ' B' ' 118' ' ' MET . 6.5 mtp . . . . . 0 N--CA 1.45 -0.451 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.4 ' HE2' ' HB2' ' A' ' 2' ' ' LYS . 15.6 tppt? -78.01 -45.78 22.82 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.2 t -45.51 -36.79 4.77 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.5 ' HA ' HG13 ' A' ' 7' ' ' ILE . 1.5 t-20 -42.92 -51.12 5.68 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.429 ' HA ' HD23 ' A' ' 5' ' ' LEU . 14.0 mt -42.99 -48.52 5.97 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.578 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 0.8 OUTLIER -64.66 -31.36 72.55 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.916 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 1.046 HG23 ' CD2' ' B' ' 110' ' ' LEU . 4.0 mt -65.23 -30.23 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 23.7 mt -76.73 -42.11 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.421 ' O ' ' HB ' ' A' ' 13' ' ' THR . 53.7 mt -76.87 -24.29 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 1.034 ' CD2' HG23 ' C' ' 207' ' ' ILE . 15.4 mt -85.59 -46.77 10.49 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.568 ' CD ' HG22 ' B' ' 113' ' ' THR . 57.1 mm-40 -59.37 -42.71 92.25 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.74 ' C ' HD12 ' A' ' 16' ' ' ILE . . . -72.56 -56.12 6.28 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.55 HG22 ' CD ' ' C' ' 211' ' ' GLU . 39.4 m -57.83 -25.88 61.25 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.525 ' HB2' ' O ' ' A' ' 10' ' ' LEU . . . -68.38 -63.05 1.14 Allowed 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.626 HG22 ' CG ' ' B' ' 118' ' ' MET . 2.7 t -68.56 -21.36 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.74 HD12 ' C ' ' A' ' 12' ' ' GLY . 29.2 mt -76.11 -64.7 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.89 -32.95 22.16 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.61 ' CE ' ' HE1' ' B' ' 118' ' ' MET . 6.4 mtp -64.45 -60.25 3.37 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.495 ' CD2' HD11 ' A' ' 23' ' ' LEU . 3.9 t80 -53.14 -44.23 67.58 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 12.7 m-30 -53.93 -42.91 69.34 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.442 ' O ' HG23 ' A' ' 25' ' ' VAL . 38.3 m0 -68.58 -62.26 1.47 Allowed 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.3 tp -52.45 -20.53 2.93 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.495 HD11 ' CD2' ' A' ' 19' ' ' PHE . 11.3 mt -74.99 -61.75 1.78 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.475 HD12 HD12 ' A' ' 28' ' ' LEU . 1.2 pp -62.48 -17.72 60.21 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 21' ' ' TRP . 37.5 t -77.36 -45.14 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 97.5 mt -70.48 -33.08 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.552 ' O ' HG23 ' A' ' 31' ' ' VAL . 56.1 mt -68.99 -47.4 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.482 ' HA ' HD23 ' A' ' 28' ' ' LEU . 41.6 mt -61.76 -35.68 78.81 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.619 ' HA ' ' HE3' ' A' ' 32' ' ' LYS . 10.9 mtp-105 -76.63 -36.77 57.21 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.6 m -68.0 -32.15 72.34 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 27' ' ' ILE . 71.2 t -75.97 -57.66 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.619 ' HE3' ' HA ' ' A' ' 29' ' ' ARG . 14.3 ptpt -52.12 -29.52 22.19 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.448 ' HG2' ' HG3' ' A' ' 32' ' ' LYS . 7.5 mmm180 -93.99 30.1 1.95 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -139.31 -0.02 1.85 Allowed 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -81.27 -7.45 59.57 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.9 -174.15 49.05 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.523 0 N-CA-C 110.301 -1.119 . . . . 0.0 110.301 -179.964 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 . . . . . 0 N--CA 1.449 -0.509 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 102' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' B' ' 102' ' ' LYS . 15.7 tppt? -78.13 -45.8 22.35 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 7.0 t -45.58 -36.9 5.02 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 104' ' ' ASN . . . . . 0.505 ' HA ' HG13 ' B' ' 107' ' ' ILE . 1.5 t-20 -42.92 -51.15 5.67 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 0.451 ' HA ' HD23 ' B' ' 105' ' ' LEU . 14.1 mt -42.99 -48.57 5.97 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 106' ' ' GLU . . . . . 0.59 ' CD ' ' N ' ' B' ' 106' ' ' GLU . 0.8 OUTLIER -64.51 -31.41 72.61 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 107' ' ' ILE . . . . . 1.052 HG23 ' CD2' ' C' ' 210' ' ' LEU . 4.0 mt -65.2 -30.27 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 23.8 mt -76.72 -42.08 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 109' ' ' ILE . . . . . 0.417 ' O ' ' HB ' ' B' ' 113' ' ' THR . 54.1 mt -76.87 -24.29 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 110' ' ' LEU . . . . . 1.046 ' CD2' HG23 ' A' ' 7' ' ' ILE . 15.4 mt -85.53 -46.95 10.36 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 111' ' ' GLU . . . . . 0.556 ' CD ' HG22 ' C' ' 213' ' ' THR . 57.8 mm-40 -59.37 -42.65 92.12 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 112' ' ' GLY . . . . . 0.728 ' C ' HD12 ' B' ' 116' ' ' ILE . . . -72.54 -56.16 6.27 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.281 -1.127 . . . . 0.0 110.281 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 113' ' ' THR . . . . . 0.568 HG22 ' CD ' ' A' ' 11' ' ' GLU . 38.5 m -57.96 -25.72 61.35 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 114' ' ' ALA . . . . . 0.521 ' HB2' ' O ' ' B' ' 110' ' ' LEU . . . -68.42 -62.99 1.15 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 0.624 HG22 ' CG ' ' C' ' 218' ' ' MET . 2.7 t -68.73 -21.22 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 116' ' ' ILE . . . . . 0.728 HD12 ' C ' ' B' ' 112' ' ' GLY . 28.7 mt -76.18 -64.58 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -51.15 -33.0 24.92 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 118' ' ' MET . . . . . 0.626 ' CG ' HG22 ' A' ' 15' ' ' VAL . 6.4 mtp -64.33 -60.11 3.57 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 119' ' ' PHE . . . . . 0.494 ' CD2' HD11 ' B' ' 123' ' ' LEU . 4.0 t80 -51.93 -43.8 63.61 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 12.8 m-30 -53.27 -43.78 67.71 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 121' ' ' TRP . . . . . . . . . . . . . 38.4 m0 -69.3 -62.38 1.4 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 5.2 tp -52.1 -20.27 2.4 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 123' ' ' LEU . . . . . 0.494 HD11 ' CD2' ' B' ' 119' ' ' PHE . 10.6 mt -73.24 -61.81 1.69 Allowed 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 pp -62.04 -17.51 57.59 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 37.3 t -78.2 -45.04 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 97.9 mt -70.53 -32.53 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 127' ' ' ILE . . . . . 0.564 ' O ' HG23 ' B' ' 131' ' ' VAL . 56.4 mt -68.2 -47.54 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.442 ' HA ' HD23 ' B' ' 128' ' ' LEU . 40.4 mt -61.92 -35.71 79.2 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 129' ' ' ARG . . . . . 0.618 ' HA ' ' HE3' ' B' ' 132' ' ' LYS . 10.9 mtp-105 -76.84 -36.66 56.69 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 4.5 m -67.84 -31.87 72.02 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.564 HG23 ' O ' ' B' ' 127' ' ' ILE . 77.1 t -76.03 -57.95 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 132' ' ' LYS . . . . . 0.618 ' HE3' ' HA ' ' B' ' 129' ' ' ARG . 14.3 ptpt -51.87 -29.52 20.06 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 133' ' ' ARG . . . . . 0.484 ' HD2' ' HA ' ' B' ' 133' ' ' ARG . 7.4 mmm180 -94.24 30.24 1.98 Allowed 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 134' ' ' ALA . . . . . . . . . . . . . . . -139.03 -0.1 1.9 Allowed 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -81.26 -7.38 59.56 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -86.76 -174.7 49.3 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.51 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 -179.957 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 201' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -78.12 -45.9 22.12 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 203' ' ' THR . . . . . . . . . . . . . 7.0 t -45.59 -36.95 5.07 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 204' ' ' ASN . . . . . 0.487 ' HA ' HG13 ' C' ' 207' ' ' ILE . 1.5 t-20 -43.01 -51.21 5.76 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 205' ' ' LEU . . . . . . . . . . . . . 14.1 mt -43.02 -48.44 6.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 206' ' ' GLU . . . . . 0.575 ' N ' ' CD ' ' C' ' 206' ' ' GLU . 0.8 OUTLIER -64.58 -31.43 72.64 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 207' ' ' ILE . . . . . 1.034 HG23 ' CD2' ' A' ' 10' ' ' LEU . 4.0 mt -65.18 -30.24 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 208' ' ' ILE . . . . . . . . . . . . . 23.7 mt -76.72 -42.17 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 209' ' ' ILE . . . . . 0.412 ' O ' ' HB ' ' C' ' 213' ' ' THR . 54.1 mt -76.8 -24.27 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 210' ' ' LEU . . . . . 1.052 ' CD2' HG23 ' B' ' 107' ' ' ILE . 15.4 mt -85.61 -46.62 10.62 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 211' ' ' GLU . . . . . 0.55 ' CD ' HG22 ' A' ' 13' ' ' THR . 57.2 mm-40 -59.42 -42.75 92.58 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 212' ' ' GLY . . . . . 0.741 ' C ' HD12 ' C' ' 216' ' ' ILE . . . -72.58 -56.05 6.3 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 213' ' ' THR . . . . . 0.556 HG22 ' CD ' ' B' ' 111' ' ' GLU . 38.2 m -57.93 -25.94 61.56 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 214' ' ' ALA . . . . . 0.526 ' HB2' ' O ' ' C' ' 210' ' ' LEU . . . -68.28 -63.07 1.13 Allowed 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 215' ' ' VAL . . . . . 0.609 HG22 ' CG ' ' A' ' 18' ' ' MET . 2.7 t -68.52 -21.42 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 216' ' ' ILE . . . . . 0.741 HD12 ' C ' ' C' ' 212' ' ' GLY . 28.5 mt -76.03 -64.66 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -51.0 -32.77 22.3 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 218' ' ' MET . . . . . 0.624 ' CG ' HG22 ' B' ' 115' ' ' VAL . 6.2 mtp -64.51 -59.2 4.6 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -50.09 -44.95 52.2 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -55.39 -43.27 75.02 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 221' ' ' TRP . . . . . 0.421 ' O ' HG23 ' C' ' 225' ' ' VAL . 38.6 m0 -69.51 -61.38 1.81 Allowed 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 5.3 tp -51.02 -20.71 1.48 Allowed 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.786 -0.449 . . . . 0.0 109.786 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 223' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' C' ' 223' ' ' LEU . 11.1 mt -74.34 -61.83 1.73 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 224' ' ' LEU . . . . . 0.436 HD12 HD12 ' C' ' 228' ' ' LEU . 1.3 pp -63.48 -17.4 62.69 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 225' ' ' VAL . . . . . 0.421 HG23 ' O ' ' C' ' 221' ' ' TRP . 37.3 t -76.92 -44.46 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 92.7 mt -69.08 -33.25 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 227' ' ' ILE . . . . . 0.556 ' O ' HG23 ' C' ' 231' ' ' VAL . 56.2 mt -69.19 -48.34 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 228' ' ' LEU . . . . . 0.471 ' HA ' HD23 ' C' ' 228' ' ' LEU . 43.7 mt -62.65 -35.92 81.18 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 229' ' ' ARG . . . . . 0.623 ' HA ' ' HE3' ' C' ' 232' ' ' LYS . 11.0 mtp-105 -76.27 -36.25 58.53 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 230' ' ' THR . . . . . . . . . . . . . 4.5 m -67.89 -32.09 72.33 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 231' ' ' VAL . . . . . 0.556 HG23 ' O ' ' C' ' 227' ' ' ILE . 74.6 t -76.24 -57.49 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 232' ' ' LYS . . . . . 0.623 ' HE3' ' HA ' ' C' ' 229' ' ' ARG . 14.3 ptpt -52.29 -29.22 22.24 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 233' ' ' ARG . . . . . 0.466 ' HD2' ' HA ' ' C' ' 233' ' ' ARG . 7.5 mmm180 -94.13 30.2 1.96 Allowed 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 234' ' ' ALA . . . . . . . . . . . . . . . -139.38 -0.29 1.81 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 235' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -81.3 -7.37 59.56 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 236' ' ' GLY . . . . . . . . . . . . . . . -86.82 -174.22 49.12 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.506 0 N-CA-C 110.271 -1.131 . . . . 0.0 110.271 -179.978 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 . . . . . 0 N--CA 1.449 -0.476 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.1 tttt -70.35 -39.27 74.78 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.816 HG21 ' CG ' ' B' ' 106' ' ' GLU . 98.1 m -44.38 -30.91 0.92 Allowed 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.477 ' HA ' HG13 ' A' ' 7' ' ' ILE . 5.9 p-10 -42.91 -50.65 5.76 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.481 ' HA ' HD23 ' A' ' 5' ' ' LEU . 13.0 mt -43.51 -47.32 7.22 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.815 ' CG ' HG21 ' C' ' 203' ' ' THR . 1.0 OUTLIER -66.04 -31.09 71.77 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 1.064 HG23 ' CD2' ' B' ' 110' ' ' LEU . 5.3 mt -64.69 -31.92 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 31.0 mt -75.75 -42.89 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.426 ' O ' ' HB ' ' A' ' 13' ' ' THR . 62.5 mt -74.34 -27.56 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 1.06 ' CD2' HG23 ' C' ' 207' ' ' ILE . 15.1 mt -83.16 -41.69 18.2 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.747 ' CD ' HG22 ' B' ' 113' ' ' THR . 34.5 mm-40 -58.54 -49.23 78.16 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.464 ' C ' HD12 ' A' ' 16' ' ' ILE . . . -69.91 -59.69 5.38 Favored Glycine 0 C--N 1.335 0.515 0 N-CA-C 110.294 -1.123 . . . . 0.0 110.294 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.764 HG22 ' CD ' ' C' ' 211' ' ' GLU . 23.6 m -49.05 -37.06 19.75 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.5 ' HB2' ' O ' ' A' ' 10' ' ' LEU . . . -60.08 -62.89 1.54 Allowed 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.649 HG22 ' HG3' ' B' ' 118' ' ' MET . 3.0 t -63.75 -21.16 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.545 HD12 ' HA ' ' A' ' 13' ' ' THR . 27.8 mt -70.73 -64.63 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.48 -35.63 30.0 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.653 ' HG2' HG13 ' C' ' 215' ' ' VAL . 4.8 mtp -61.57 -60.29 3.92 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.51 ' O ' HD12 ' A' ' 23' ' ' LEU . 1.9 m-30 -63.68 -23.67 67.47 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -67.31 -47.04 71.74 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.568 ' O ' HG23 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -67.54 -37.71 83.13 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.923 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.4 mt -63.57 -46.86 83.96 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.51 HD12 ' O ' ' A' ' 19' ' ' PHE . 11.3 mt -61.46 -46.96 87.85 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 24' ' ' LEU . 12.4 tp -60.25 -35.16 74.86 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 21' ' ' TRP . 27.8 t -67.38 -38.26 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 56.6 mt -70.42 -42.35 78.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.441 ' O ' HG23 ' A' ' 31' ' ' VAL . 55.4 mt -69.49 -36.98 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.2 mt -68.93 -45.93 69.56 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 64.4 mtt180 -66.48 -48.9 68.4 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.8 m -54.87 -46.55 74.73 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 27' ' ' ILE . 54.1 t -66.54 -45.19 89.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 46.2 tttm -49.92 -33.5 17.61 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.8 mmt85 -94.01 34.67 1.22 Allowed 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.04 -5.25 1.3 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.566 ' CG ' ' N ' ' A' ' 36' ' ' GLY . 2.1 t-20 -94.92 173.25 7.68 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.566 ' N ' ' CG ' ' A' ' 35' ' ' ASN . . . 99.16 -125.43 8.57 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.573 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -179.968 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 . . . . . 0 N--CA 1.449 -0.506 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 63.9 tttt -70.37 -39.28 74.68 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 103' ' ' THR . . . . . 0.799 HG21 ' CG ' ' C' ' 206' ' ' GLU . 98.6 m -44.32 -31.04 0.92 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 104' ' ' ASN . . . . . 0.487 ' HA ' HG13 ' B' ' 107' ' ' ILE . 5.9 p-10 -42.93 -50.47 5.8 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 0.527 ' HA ' HD23 ' B' ' 105' ' ' LEU . 13.1 mt -43.62 -47.3 7.54 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 106' ' ' GLU . . . . . 0.816 ' CG ' HG21 ' A' ' 3' ' ' THR . 1.0 OUTLIER -66.09 -30.98 71.59 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 107' ' ' ILE . . . . . 1.069 HG23 ' CD2' ' C' ' 210' ' ' LEU . 5.3 mt -64.75 -31.89 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 31.1 mt -75.72 -42.88 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 109' ' ' ILE . . . . . 0.41 ' O ' ' HB ' ' B' ' 113' ' ' THR . 62.4 mt -74.35 -27.61 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 110' ' ' LEU . . . . . 1.064 ' CD2' HG23 ' A' ' 7' ' ' ILE . 15.1 mt -83.19 -41.7 18.14 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 111' ' ' GLU . . . . . 0.747 ' CD ' HG22 ' C' ' 213' ' ' THR . 34.9 mm-40 -58.54 -49.19 78.32 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 112' ' ' GLY . . . . . 0.476 ' C ' HD12 ' B' ' 116' ' ' ILE . . . -70.01 -59.71 5.32 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 113' ' ' THR . . . . . 0.747 HG22 ' CD ' ' A' ' 11' ' ' GLU . 23.6 m -48.96 -37.07 19.04 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 114' ' ' ALA . . . . . 0.501 ' HB2' ' O ' ' B' ' 110' ' ' LEU . . . -60.11 -62.9 1.53 Allowed 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 0.651 HG13 ' HG2' ' C' ' 218' ' ' MET . 3.0 t -63.72 -21.17 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 116' ' ' ILE . . . . . 0.522 HD12 ' HA ' ' B' ' 113' ' ' THR . 27.8 mt -70.67 -64.71 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -50.45 -35.53 29.25 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 118' ' ' MET . . . . . 0.649 ' HG3' HG22 ' A' ' 15' ' ' VAL . 4.7 mtp -61.85 -60.23 3.95 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 119' ' ' PHE . . . . . 0.479 ' O ' HD12 ' B' ' 123' ' ' LEU . 1.9 m-30 -63.4 -23.72 67.53 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -66.23 -47.78 72.7 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.838 -0.431 . . . . 0.0 109.838 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 121' ' ' TRP . . . . . 0.557 ' C ' ' CD1' ' B' ' 121' ' ' TRP . 0.2 OUTLIER -68.51 -37.26 79.9 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.952 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 122' ' ' LEU . . . . . 0.463 ' HA ' HD23 ' B' ' 122' ' ' LEU . 80.6 mt -63.08 -45.19 93.3 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 123' ' ' LEU . . . . . 0.479 HD12 ' O ' ' B' ' 119' ' ' PHE . 11.3 mt -59.77 -46.72 88.3 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 124' ' ' LEU . . . . . 0.424 ' HA ' HD12 ' B' ' 124' ' ' LEU . 12.4 tp -60.3 -35.61 75.98 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 28.1 t -67.36 -37.47 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 56.1 mt -69.54 -41.38 80.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 127' ' ' ILE . . . . . 0.406 ' O ' HG23 ' B' ' 131' ' ' VAL . 56.1 mt -68.86 -37.17 77.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.476 ' HA ' HD23 ' B' ' 128' ' ' LEU . 25.9 mt -69.32 -45.79 68.67 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 64.5 mtt180 -66.26 -48.6 69.96 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 4.1 m -54.26 -46.31 72.61 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.406 HG23 ' O ' ' B' ' 127' ' ' ILE . 53.3 t -66.83 -45.25 88.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 46.3 tttm -49.72 -33.48 16.15 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 133' ' ' ARG . . . . . 0.452 HH11 ' HD2' ' B' ' 133' ' ' ARG . 11.8 mmt85 -93.77 34.4 1.21 Allowed 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 134' ' ' ALA . . . . . . . . . . . . . . . -139.61 -5.22 1.38 Allowed 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 135' ' ' ASN . . . . . 0.565 ' CG ' ' N ' ' B' ' 136' ' ' GLY . 2.0 t-20 -95.12 173.2 7.69 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 136' ' ' GLY . . . . . 0.565 ' N ' ' CG ' ' B' ' 135' ' ' ASN . . . 99.11 -125.32 8.52 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.525 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.939 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 201' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 . . . . . 0 N--CA 1.449 -0.516 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 63.9 tttt -70.41 -39.37 74.49 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 203' ' ' THR . . . . . 0.815 HG21 ' CG ' ' A' ' 6' ' ' GLU . 97.9 m -44.18 -31.07 0.88 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 204' ' ' ASN . . . . . 0.478 ' HA ' HG13 ' C' ' 207' ' ' ILE . 5.8 p-10 -42.98 -50.4 5.88 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 205' ' ' LEU . . . . . 0.479 HD23 ' HA ' ' C' ' 205' ' ' LEU . 13.1 mt -43.54 -47.35 7.31 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 206' ' ' GLU . . . . . 0.799 ' CG ' HG21 ' B' ' 103' ' ' THR . 1.0 OUTLIER -66.05 -31.14 71.85 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 207' ' ' ILE . . . . . 1.06 HG23 ' CD2' ' A' ' 10' ' ' LEU . 5.3 mt -64.67 -31.8 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 208' ' ' ILE . . . . . . . . . . . . . 30.9 mt -75.83 -42.97 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 209' ' ' ILE . . . . . 0.422 ' O ' ' HB ' ' C' ' 213' ' ' THR . 62.3 mt -74.32 -27.49 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 210' ' ' LEU . . . . . 1.069 ' CD2' HG23 ' B' ' 107' ' ' ILE . 15.1 mt -83.21 -41.64 18.18 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 211' ' ' GLU . . . . . 0.764 ' CD ' HG22 ' A' ' 13' ' ' THR . 34.5 mm-40 -58.58 -49.13 78.58 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 212' ' ' GLY . . . . . 0.461 ' C ' HD12 ' C' ' 216' ' ' ILE . . . -70.1 -59.68 5.3 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 213' ' ' THR . . . . . 0.747 HG22 ' CD ' ' B' ' 111' ' ' GLU . 23.7 m -48.92 -37.14 18.99 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 214' ' ' ALA . . . . . 0.496 ' HB2' ' O ' ' C' ' 210' ' ' LEU . . . -60.08 -62.9 1.53 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 215' ' ' VAL . . . . . 0.653 HG13 ' HG2' ' A' ' 18' ' ' MET . 3.0 t -63.73 -21.09 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 216' ' ' ILE . . . . . 0.529 HD12 ' HA ' ' C' ' 213' ' ' THR . 27.8 mt -70.73 -64.63 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -50.49 -35.47 29.34 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 218' ' ' MET . . . . . 0.651 ' HG2' HG13 ' B' ' 115' ' ' VAL . 4.7 mtp -61.76 -60.31 3.86 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 219' ' ' PHE . . . . . 0.414 ' O ' HD12 ' C' ' 223' ' ' LEU . 1.9 m-30 -63.39 -23.86 67.59 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -67.71 -47.54 69.09 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 221' ' ' TRP . . . . . 0.547 ' CD1' ' C ' ' C' ' 221' ' ' TRP . 0.2 OUTLIER -68.36 -36.33 79.04 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.908 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 222' ' ' LEU . . . . . 0.448 ' HA ' HD23 ' C' ' 222' ' ' LEU . 80.0 mt -62.1 -45.35 93.86 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 223' ' ' LEU . . . . . 0.414 HD12 ' O ' ' C' ' 219' ' ' PHE . 11.5 mt -60.14 -47.3 86.5 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.83 -0.434 . . . . 0.0 109.83 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 224' ' ' LEU . . . . . 0.458 HD12 ' HA ' ' C' ' 224' ' ' LEU . 12.4 tp -60.59 -35.28 75.71 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 225' ' ' VAL . . . . . 0.459 HG23 ' O ' ' C' ' 221' ' ' TRP . 28.7 t -67.07 -37.03 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 55.8 mt -69.2 -41.49 81.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 227' ' ' ILE . . . . . 0.412 ' O ' HG23 ' C' ' 231' ' ' VAL . 55.9 mt -69.15 -37.19 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 228' ' ' LEU . . . . . 0.445 ' HA ' HD23 ' C' ' 228' ' ' LEU . 26.6 mt -69.56 -46.04 67.33 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 229' ' ' ARG . . . . . . . . . . . . . 64.8 mtt180 -66.01 -48.63 70.54 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 230' ' ' THR . . . . . . . . . . . . . 4.1 m -53.82 -46.21 71.05 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 231' ' ' VAL . . . . . 0.412 HG23 ' O ' ' C' ' 227' ' ' ILE . 52.8 t -66.94 -45.31 87.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 232' ' ' LYS . . . . . . . . . . . . . 46.3 tttm -49.58 -33.57 15.44 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 233' ' ' ARG . . . . . 0.441 HH11 ' HD2' ' C' ' 233' ' ' ARG . 11.8 mmt85 -93.65 34.36 1.2 Allowed 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 234' ' ' ALA . . . . . . . . . . . . . . . -139.6 -4.75 1.41 Allowed 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 235' ' ' ASN . . . . . 0.57 ' CG ' ' N ' ' C' ' 236' ' ' GLY . 2.0 t-20 -94.84 173.36 7.63 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 236' ' ' GLY . . . . . 0.57 ' N ' ' CG ' ' C' ' 235' ' ' ASN . . . 99.42 -125.39 8.55 Favored Glycine 0 C--N 1.336 0.562 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.537 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 -179.943 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 . . . . . 0 N--CA 1.449 -0.496 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.628 ' CE ' HD12 ' A' ' 5' ' ' LEU . 23.3 tptm -77.29 -40.49 44.29 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.4 t -47.0 -35.51 6.7 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.496 ' HA ' HG13 ' A' ' 7' ' ' ILE . 1.4 t-20 -42.87 -50.35 5.74 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.628 HD12 ' CE ' ' A' ' 2' ' ' LYS . 12.3 mt -43.07 -47.7 6.03 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.571 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 2.2 mp0 -66.47 -30.89 71.33 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 1.064 HG23 ' CD2' ' B' ' 110' ' ' LEU . 5.2 mt -64.19 -32.1 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 24.3 mt -75.84 -44.02 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.412 ' O ' ' HB ' ' A' ' 13' ' ' THR . 98.3 mt -73.59 -25.51 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 1.08 ' CD2' HG23 ' C' ' 207' ' ' ILE . 15.5 mt -85.44 -41.3 15.52 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.672 ' CD ' HG22 ' B' ' 113' ' ' THR . 37.4 mm-40 -58.88 -45.9 89.12 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.748 ' C ' HD12 ' A' ' 16' ' ' ILE . . . -73.42 -55.06 6.33 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.67 HG22 ' CD ' ' C' ' 211' ' ' GLU . 22.9 m -55.08 -31.05 60.88 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.502 ' HB2' ' O ' ' A' ' 10' ' ' LEU . . . -66.43 -63.2 1.13 Allowed 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.821 -0.436 . . . . 0.0 109.821 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 11' ' ' GLU . 2.8 t -64.31 -21.37 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.748 HD12 ' C ' ' A' ' 12' ' ' GLY . 22.3 mt -73.59 -64.69 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.55 -26.18 20.2 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.783 ' SD ' ' HE1' ' C' ' 218' ' ' MET . 11.6 mtp -66.99 -60.2 2.83 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -51.76 -35.93 45.46 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -61.14 -49.6 76.6 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -62.95 -37.65 87.92 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 88.3 mt -72.9 -27.15 61.71 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.474 ' HA ' HD23 ' A' ' 23' ' ' LEU . 14.0 mt -69.55 -61.52 1.75 Allowed 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.557 HD12 ' C ' ' A' ' 24' ' ' LEU . 2.0 pp -54.12 -39.89 66.84 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.554 ' N ' ' HG ' ' A' ' 24' ' ' LEU . 25.6 t -64.79 -38.29 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 40.3 mt -73.04 -29.58 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.485 ' O ' HG23 ' A' ' 31' ' ' VAL . 34.4 mt -70.73 -46.25 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 81.8 mt -68.95 -35.74 77.13 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 42.1 ttt85 -71.23 -46.37 61.25 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.5 m -60.01 -44.99 94.2 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 27' ' ' ILE . 53.5 t -60.9 -51.81 68.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 34.4 tttt -50.98 -34.21 28.03 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.66 ' HA ' ' HE ' ' A' ' 33' ' ' ARG . 1.5 mmp_? -95.49 35.58 1.33 Allowed 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -139.81 -1.08 1.65 Allowed 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -91.0 132.76 35.79 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.71 38.63 0.04 OUTLIER Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.492 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -179.977 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 . . . . . 0 N--CA 1.449 -0.476 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 102' ' ' LYS . . . . . 0.606 ' CE ' HD12 ' B' ' 105' ' ' LEU . 23.2 tptm -77.4 -40.54 43.28 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 5.3 t -46.98 -35.88 7.1 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 104' ' ' ASN . . . . . 0.503 ' HA ' HG13 ' B' ' 107' ' ' ILE . 1.4 t-20 -42.91 -50.35 5.8 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 0.606 HD12 ' CE ' ' B' ' 102' ' ' LYS . 12.3 mt -43.22 -47.58 6.43 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 106' ' ' GLU . . . . . 0.582 ' CD ' ' N ' ' B' ' 106' ' ' GLU . 2.2 mp0 -66.42 -31.02 71.52 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 107' ' ' ILE . . . . . 1.082 HG23 ' CD2' ' C' ' 210' ' ' LEU . 5.2 mt -64.08 -32.02 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 24.1 mt -75.93 -44.19 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 109' ' ' ILE . . . . . 0.413 ' O ' ' HB ' ' B' ' 113' ' ' THR . 98.2 mt -73.43 -25.54 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 110' ' ' LEU . . . . . 1.064 ' CD2' HG23 ' A' ' 7' ' ' ILE . 15.5 mt -85.38 -41.45 15.45 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 111' ' ' GLU . . . . . 0.683 ' O ' HG23 ' B' ' 115' ' ' VAL . 37.2 mm-40 -58.57 -45.91 88.04 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 112' ' ' GLY . . . . . 0.735 ' C ' HD12 ' B' ' 116' ' ' ILE . . . -73.57 -55.39 6.07 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 113' ' ' THR . . . . . 0.672 HG22 ' CD ' ' A' ' 11' ' ' GLU . 23.2 m -54.69 -30.94 57.03 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 114' ' ' ALA . . . . . 0.502 ' HB2' ' O ' ' B' ' 110' ' ' LEU . . . -66.66 -63.32 1.09 Allowed 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 0.683 HG23 ' O ' ' B' ' 111' ' ' GLU . 2.7 t -64.07 -21.35 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 116' ' ' ILE . . . . . 0.735 HD12 ' C ' ' B' ' 112' ' ' GLY . 23.0 mt -73.55 -64.67 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -53.59 -25.99 19.76 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 118' ' ' MET . . . . . 0.789 ' HE1' ' SD ' ' C' ' 218' ' ' MET . 11.5 mtp -67.2 -60.22 2.79 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -50.91 -37.14 42.17 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -62.59 -49.58 74.67 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 121' ' ' TRP . . . . . 0.526 ' O ' HG23 ' B' ' 125' ' ' VAL . 0.1 OUTLIER -63.74 -35.72 81.49 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.886 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 82.6 mt -71.32 -28.4 64.07 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 123' ' ' LEU . . . . . 0.496 ' HA ' HD23 ' B' ' 123' ' ' LEU . 14.3 mt -71.02 -61.65 1.69 Allowed 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 124' ' ' LEU . . . . . 0.562 HD12 ' C ' ' B' ' 124' ' ' LEU . 2.1 pp -54.92 -39.11 68.47 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 125' ' ' VAL . . . . . 0.535 ' N ' ' HG ' ' B' ' 124' ' ' LEU . 27.2 t -63.86 -37.97 81.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 41.5 mt -73.09 -29.86 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 127' ' ' ILE . . . . . 0.472 ' O ' HG23 ' B' ' 131' ' ' VAL . 35.9 mt -71.38 -46.98 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 82.4 mt -69.7 -35.27 74.93 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 42.1 ttt85 -71.17 -46.55 61.18 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 5.6 m -59.44 -44.93 92.84 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.472 HG23 ' O ' ' B' ' 127' ' ' ILE . 55.1 t -61.34 -51.54 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 34.8 tttt -51.15 -33.59 27.51 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 133' ' ' ARG . . . . . 0.654 ' HA ' ' HE ' ' B' ' 133' ' ' ARG . 1.4 mmp_? -95.39 35.04 1.36 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 134' ' ' ALA . . . . . . . . . . . . . . . -139.24 -0.89 1.78 Allowed 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -91.21 132.69 35.94 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . 174.54 38.61 0.04 OUTLIER Glycine 0 CA--C 1.523 0.531 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.526 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 -179.947 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 201' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 . . . . . 0 N--CA 1.449 -0.48 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 202' ' ' LYS . . . . . 0.59 ' CE ' HD12 ' C' ' 205' ' ' LEU . 23.3 tptm -77.4 -40.55 43.25 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 203' ' ' THR . . . . . . . . . . . . . 5.3 t -47.1 -36.06 7.81 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 204' ' ' ASN . . . . . 0.511 ' HA ' HG13 ' C' ' 207' ' ' ILE . 1.4 t-20 -42.86 -50.61 5.7 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 205' ' ' LEU . . . . . 0.59 HD12 ' CE ' ' C' ' 202' ' ' LYS . 12.4 mt -43.13 -47.48 6.15 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 206' ' ' GLU . . . . . 0.572 ' N ' ' CD ' ' C' ' 206' ' ' GLU . 2.2 mp0 -66.43 -30.92 71.38 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 207' ' ' ILE . . . . . 1.08 HG23 ' CD2' ' A' ' 10' ' ' LEU . 5.3 mt -64.26 -32.0 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 208' ' ' ILE . . . . . . . . . . . . . 24.1 mt -75.94 -43.92 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 209' ' ' ILE . . . . . 0.419 ' O ' ' HB ' ' C' ' 213' ' ' THR . 98.3 mt -73.6 -25.63 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.722 -0.474 . . . . 0.0 109.722 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 210' ' ' LEU . . . . . 1.082 ' CD2' HG23 ' B' ' 107' ' ' ILE . 15.5 mt -85.38 -41.26 15.62 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 211' ' ' GLU . . . . . 0.674 ' O ' HG23 ' C' ' 215' ' ' VAL . 37.3 mm-40 -58.9 -45.88 89.2 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 212' ' ' GLY . . . . . 0.739 ' C ' HD12 ' C' ' 216' ' ' ILE . . . -73.48 -55.09 6.28 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.291 -1.123 . . . . 0.0 110.291 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 213' ' ' THR . . . . . 0.678 HG22 ' CD ' ' B' ' 111' ' ' GLU . 22.8 m -55.04 -31.14 60.87 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 214' ' ' ALA . . . . . 0.503 ' HB2' ' O ' ' C' ' 210' ' ' LEU . . . -66.39 -63.36 1.09 Allowed 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 215' ' ' VAL . . . . . 0.674 HG23 ' O ' ' C' ' 211' ' ' GLU . 2.8 t -64.07 -21.55 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 216' ' ' ILE . . . . . 0.739 HD12 ' C ' ' C' ' 212' ' ' GLY . 22.2 mt -73.44 -64.67 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -53.57 -26.05 19.84 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 218' ' ' MET . . . . . 0.789 ' SD ' ' HE1' ' B' ' 118' ' ' MET . 11.6 mtp -67.13 -60.11 2.89 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -51.41 -36.32 43.11 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -61.68 -48.2 81.87 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 221' ' ' TRP . . . . . 0.576 ' O ' HG23 ' C' ' 225' ' ' VAL . 0.1 OUTLIER -61.9 -37.13 83.45 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.855 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 83.5 mt -72.6 -29.59 63.63 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 223' ' ' LEU . . . . . 0.478 HD23 ' HA ' ' C' ' 223' ' ' LEU . 14.4 mt -71.75 -60.87 2.01 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 224' ' ' LEU . . . . . 0.563 ' C ' HD12 ' C' ' 224' ' ' LEU . 2.1 pp -53.96 -38.88 65.46 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 225' ' ' VAL . . . . . 0.576 HG23 ' O ' ' C' ' 221' ' ' TRP . 25.7 t -63.87 -38.51 82.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 41.3 mt -73.8 -30.23 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 227' ' ' ILE . . . . . 0.459 ' O ' HG23 ' C' ' 231' ' ' VAL . 34.7 mt -71.25 -46.23 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 81.7 mt -68.93 -35.63 77.02 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 229' ' ' ARG . . . . . . . . . . . . . 42.3 ttt85 -71.31 -46.3 61.02 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 230' ' ' THR . . . . . . . . . . . . . 4.9 m -60.06 -45.21 93.63 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 231' ' ' VAL . . . . . 0.459 HG23 ' O ' ' C' ' 227' ' ' ILE . 53.3 t -61.32 -51.48 72.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 232' ' ' LYS . . . . . . . . . . . . . 34.6 tttt -50.91 -34.03 26.7 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 233' ' ' ARG . . . . . 0.666 ' HE ' ' HA ' ' C' ' 233' ' ' ARG . 1.5 mmp_? -95.46 35.44 1.34 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 234' ' ' ALA . . . . . . . . . . . . . . . -140.05 -0.72 1.64 Allowed 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 235' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -90.83 132.95 35.58 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 236' ' ' GLY . . . . . . . . . . . . . . . 174.84 38.87 0.05 OUTLIER Glycine 0 C--N 1.335 0.506 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.53 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -179.971 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 . . . . . 0 N--CA 1.45 -0.452 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -77.67 -44.75 27.01 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.1 t -43.76 -33.53 1.3 Allowed 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.504 ' HA ' HG13 ' A' ' 7' ' ' ILE . 1.1 t-20 -42.74 -51.05 5.48 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.463 ' HA ' HD23 ' A' ' 5' ' ' LEU . 13.1 mt -43.01 -48.9 6.07 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.587 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 2.6 mp0 -64.13 -31.63 72.9 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 1.025 HG23 ' CD2' ' B' ' 110' ' ' LEU . 3.8 mt -65.25 -29.89 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.8 mt -76.77 -42.13 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.428 ' O ' ' HB ' ' A' ' 13' ' ' THR . 83.4 mt -77.3 -23.82 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 1.045 ' CD2' HG23 ' C' ' 207' ' ' ILE . 15.5 mt -85.7 -49.75 7.72 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.579 ' O ' HG23 ' A' ' 15' ' ' VAL . 58.7 mm-40 -59.01 -40.42 84.87 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.87 ' C ' HD12 ' A' ' 16' ' ' ILE . . . -73.27 -57.52 5.11 Favored Glycine 0 C--N 1.335 0.509 0 N-CA-C 110.276 -1.129 . . . . 0.0 110.276 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.428 ' HB ' ' O ' ' A' ' 9' ' ' ILE . 49.5 m -57.78 -25.18 60.17 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.507 ' HB2' ' O ' ' A' ' 10' ' ' LEU . . . -68.79 -62.92 1.18 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 11' ' ' GLU . 2.6 t -69.04 -21.08 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.87 HD12 ' C ' ' A' ' 12' ' ' GLY . 22.4 mt -77.31 -64.85 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.15 -32.07 21.84 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.591 ' CE ' ' HE1' ' B' ' 118' ' ' MET . 6.7 mtp -66.1 -60.18 3.06 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.51 -25.34 67.21 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -71.29 -46.4 60.91 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -40.6 97.32 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.45 HD12 ' HA ' ' A' ' 22' ' ' LEU . 10.8 tp -61.39 -48.21 82.27 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 26.0 mt -57.22 -38.67 74.1 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.527 ' HA ' HD12 ' A' ' 24' ' ' LEU . 12.3 tp -65.66 -36.75 84.57 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.0 t -62.79 -41.22 91.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 79.6 mt -67.22 -43.1 88.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.526 ' O ' HG23 ' A' ' 31' ' ' VAL . 93.4 mt -66.23 -35.69 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.474 ' HA ' HD23 ' A' ' 28' ' ' LEU . 25.8 mt -66.15 -49.99 65.52 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 39.4 mtt180 -64.32 -47.1 80.71 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.0 m -54.35 -43.13 71.03 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 27' ' ' ILE . 53.8 t -69.18 -45.04 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.6 tttt -51.02 -32.91 22.98 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -97.19 36.8 1.4 Allowed 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.61 -3.87 0.89 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 23.5 m-20 -136.32 116.43 13.39 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.73 -8.61 37.08 Favored Glycine 0 C--N 1.335 0.505 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.525 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 -179.941 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 . . . . . 0 N--CA 1.448 -0.535 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -77.75 -44.87 26.34 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 5.1 t -43.64 -33.39 1.19 Allowed 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 104' ' ' ASN . . . . . 0.501 ' HA ' HG13 ' B' ' 107' ' ' ILE . 1.1 t-20 -42.72 -51.09 5.44 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 0.464 HD23 ' HA ' ' B' ' 105' ' ' LEU . 13.1 mt -42.81 -48.92 5.79 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 106' ' ' GLU . . . . . 0.589 ' CD ' ' N ' ' B' ' 106' ' ' GLU . 2.6 mp0 -64.27 -31.65 72.94 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 107' ' ' ILE . . . . . 1.046 HG23 ' CD2' ' C' ' 210' ' ' LEU . 3.8 mt -65.34 -29.75 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 39.4 mt -76.82 -42.17 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 109' ' ' ILE . . . . . 0.418 ' O ' ' HB ' ' B' ' 113' ' ' THR . 84.1 mt -77.3 -23.81 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 110' ' ' LEU . . . . . 1.025 ' CD2' HG23 ' A' ' 7' ' ' ILE . 15.5 mt -85.67 -50.23 7.36 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 111' ' ' GLU . . . . . 0.595 ' O ' HG23 ' B' ' 115' ' ' VAL . 59.3 mm-40 -58.88 -40.19 83.67 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 112' ' ' GLY . . . . . 0.884 ' C ' HD12 ' B' ' 116' ' ' ILE . . . -73.32 -57.58 5.05 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 113' ' ' THR . . . . . 0.418 ' HB ' ' O ' ' B' ' 109' ' ' ILE . 49.5 m -57.81 -25.17 60.23 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 114' ' ' ALA . . . . . 0.498 ' HB2' ' O ' ' B' ' 110' ' ' LEU . . . -68.78 -63.11 1.12 Allowed 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 0.595 HG23 ' O ' ' B' ' 111' ' ' GLU . 2.5 t -68.9 -21.09 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 116' ' ' ILE . . . . . 0.884 HD12 ' C ' ' B' ' 112' ' ' GLY . 22.6 mt -77.28 -64.81 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -51.01 -32.24 20.72 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 118' ' ' MET . . . . . 0.616 ' CE ' ' HE1' ' C' ' 218' ' ' MET . 6.6 mtp -66.29 -59.9 3.28 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.51 -25.58 66.2 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -71.38 -48.91 47.08 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 121' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -65.73 -40.62 92.34 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 122' ' ' LEU . . . . . 0.441 ' HA ' HD12 ' B' ' 122' ' ' LEU . 10.7 tp -61.07 -47.97 83.87 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 26.1 mt -56.58 -40.52 75.39 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 124' ' ' LEU . . . . . 0.542 ' HA ' HD12 ' B' ' 124' ' ' LEU . 12.3 tp -66.69 -36.96 83.74 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 25.0 t -63.78 -40.44 89.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 79.8 mt -66.44 -43.08 91.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 127' ' ' ILE . . . . . 0.512 ' O ' HG23 ' B' ' 131' ' ' VAL . 93.0 mt -67.03 -36.45 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.473 HD23 ' HA ' ' B' ' 128' ' ' LEU . 25.5 mt -67.06 -49.88 63.67 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 39.3 mtt180 -63.97 -46.99 82.15 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 4.0 m -54.14 -43.31 70.42 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.512 HG23 ' O ' ' B' ' 127' ' ' ILE . 54.0 t -69.18 -45.11 80.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 29.0 tttt -51.03 -33.0 23.41 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -97.11 36.6 1.41 Allowed 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 134' ' ' ALA . . . . . . . . . . . . . . . -143.53 -4.05 0.89 Allowed 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 23.7 m-20 -136.29 116.4 13.39 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . 107.44 -8.85 38.08 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.534 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 -179.983 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 201' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -77.7 -44.85 26.57 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 203' ' ' THR . . . . . . . . . . . . . 5.1 t -43.69 -33.53 1.25 Allowed 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 204' ' ' ASN . . . . . 0.489 ' HA ' HG13 ' C' ' 207' ' ' ILE . 1.1 t-20 -42.75 -51.23 5.43 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 205' ' ' LEU . . . . . 0.469 HD23 ' HA ' ' C' ' 205' ' ' LEU . 13.1 mt -42.89 -48.91 5.9 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 206' ' ' GLU . . . . . 0.58 ' N ' ' CD ' ' C' ' 206' ' ' GLU . 2.6 mp0 -64.03 -31.67 72.94 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 207' ' ' ILE . . . . . 1.045 HG23 ' CD2' ' A' ' 10' ' ' LEU . 3.8 mt -65.24 -29.93 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 208' ' ' ILE . . . . . . . . . . . . . 40.4 mt -76.67 -42.11 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 209' ' ' ILE . . . . . 0.414 ' O ' ' HB ' ' C' ' 213' ' ' THR . 84.0 mt -77.36 -23.87 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 210' ' ' LEU . . . . . 1.046 ' CD2' HG23 ' B' ' 107' ' ' ILE . 15.5 mt -85.66 -50.2 7.39 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 211' ' ' GLU . . . . . 0.586 ' O ' HG23 ' C' ' 215' ' ' VAL . 59.2 mm-40 -58.8 -40.39 83.93 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 212' ' ' GLY . . . . . 0.895 ' C ' HD12 ' C' ' 216' ' ' ILE . . . -73.28 -57.55 5.09 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 213' ' ' THR . . . . . 0.414 HG22 ' OE1' ' B' ' 111' ' ' GLU . 48.6 m -57.76 -25.2 60.14 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 214' ' ' ALA . . . . . 0.51 ' HB2' ' O ' ' C' ' 210' ' ' LEU . . . -68.69 -63.13 1.12 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 215' ' ' VAL . . . . . 0.586 HG23 ' O ' ' C' ' 211' ' ' GLU . 2.5 t -68.97 -21.11 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 216' ' ' ILE . . . . . 0.895 HD12 ' C ' ' C' ' 212' ' ' GLY . 22.0 mt -77.02 -64.8 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -51.07 -32.42 22.08 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 218' ' ' MET . . . . . 0.616 ' HE1' ' CE ' ' B' ' 118' ' ' MET . 6.5 mtp -65.99 -59.86 3.4 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.31 -26.36 66.47 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -72.9 -47.52 45.1 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 221' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.89 -39.82 94.12 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 10.8 tp -59.96 -48.74 80.48 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 223' ' ' LEU . . . . . . . . . . . . . 25.7 mt -57.63 -40.23 78.73 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 224' ' ' LEU . . . . . 0.483 HD12 ' HA ' ' C' ' 224' ' ' LEU . 12.1 tp -66.46 -36.05 81.82 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 225' ' ' VAL . . . . . . . . . . . . . 25.4 t -62.47 -39.99 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 78.1 mt -65.74 -43.73 93.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 227' ' ' ILE . . . . . 0.514 ' O ' HG23 ' C' ' 231' ' ' VAL . 92.9 mt -67.59 -36.95 77.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 228' ' ' LEU . . . . . 0.451 ' HA ' HD23 ' C' ' 228' ' ' LEU . 27.4 mt -67.17 -49.72 63.71 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 229' ' ' ARG . . . . . . . . . . . . . 39.3 mtt180 -63.91 -47.26 81.29 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 230' ' ' THR . . . . . . . . . . . . . 4.1 m -54.29 -42.8 70.47 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.911 -0.404 . . . . 0.0 109.911 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 231' ' ' VAL . . . . . 0.514 HG23 ' O ' ' C' ' 227' ' ' ILE . 53.6 t -69.81 -45.33 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 232' ' ' LYS . . . . . . . . . . . . . 28.3 tttt -50.25 -32.45 16.75 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 233' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -97.0 36.4 1.43 Allowed 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 234' ' ' ALA . . . . . . . . . . . . . . . -143.86 -3.68 0.87 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 235' ' ' ASN . . . . . . . . . . . . . 23.0 m-20 -136.16 116.41 13.53 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 236' ' ' GLY . . . . . . . . . . . . . . . 107.93 -8.58 36.51 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.538 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 -179.948 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 . . . . . 0 N--CA 1.449 -0.515 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.476 ' HB2' ' HE3' ' A' ' 2' ' ' LYS . 23.9 mtmt -82.59 -40.87 20.26 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.863 HG21 ' CG ' ' B' ' 106' ' ' GLU . 96.0 m -43.51 -31.1 0.66 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.478 ' CG ' ' N ' ' A' ' 5' ' ' LEU . 4.2 p-10 -42.6 -50.71 5.35 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.478 ' N ' ' CG ' ' A' ' 4' ' ' ASN . 16.1 mt -43.46 -48.33 7.21 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.859 ' CG ' HG21 ' C' ' 203' ' ' THR . 2.7 mp0 -64.67 -31.56 72.84 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 1.069 HG23 ' CD2' ' B' ' 110' ' ' LEU . 4.9 mt -65.2 -30.38 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 60.7 mt -76.48 -42.17 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.419 ' O ' ' HB ' ' A' ' 13' ' ' THR . 32.0 mt -76.54 -25.22 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 1.079 ' CD2' HG23 ' C' ' 207' ' ' ILE . 15.1 mt -84.6 -46.46 11.52 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.589 ' CD ' HG22 ' B' ' 113' ' ' THR . 52.1 mm-40 -58.67 -45.14 90.04 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.647 ' C ' HD12 ' A' ' 16' ' ' ILE . . . -70.58 -57.92 6.25 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.584 HG22 ' CD ' ' C' ' 211' ' ' GLU . 44.9 m -55.69 -27.02 47.93 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.553 ' HB2' ' O ' ' A' ' 10' ' ' LEU . . . -66.45 -63.14 1.14 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.687 HG22 ' HG3' ' B' ' 118' ' ' MET . 2.9 t -67.49 -22.04 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.647 HD12 ' C ' ' A' ' 12' ' ' GLY . 34.8 mt -73.09 -64.54 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.78 -34.89 29.19 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.717 ' HG3' HG22 ' C' ' 215' ' ' VAL . 6.0 mtp -60.46 -60.16 4.26 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -52.28 -37.83 56.62 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -62.4 -50.54 71.12 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.595 ' O ' HG23 ' A' ' 25' ' ' VAL . 36.1 t-105 -70.53 -22.51 62.61 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.498 HD12 HD11 ' A' ' 26' ' ' ILE . 0.1 OUTLIER -71.65 -52.05 19.95 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.992 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.662 ' HA ' HD12 ' A' ' 26' ' ' ILE . 0.7 OUTLIER -62.24 -35.45 78.98 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.557 ' N ' ' HG ' ' A' ' 23' ' ' LEU . 13.0 mt -59.67 -51.9 67.83 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 21' ' ' TRP . 42.8 t -65.79 -25.49 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.662 HD12 ' HA ' ' A' ' 23' ' ' LEU . 43.0 mt -70.49 -47.08 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.535 ' O ' HG23 ' A' ' 31' ' ' VAL . 84.7 mt -67.2 -36.24 76.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.509 ' HA ' HD23 ' A' ' 28' ' ' LEU . 23.5 mt -67.17 -50.93 59.35 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 32.8 mtp180 -63.32 -48.92 76.01 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.5 m -52.55 -41.49 63.58 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 27' ' ' ILE . 53.0 t -70.31 -43.18 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.9 ttmt -53.31 -30.63 39.96 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.428 HH11 ' HD2' ' A' ' 33' ' ' ARG . 7.3 mtp180 -98.5 36.29 1.65 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -138.86 8.05 2.52 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 -119.98 176.63 5.33 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 139.64 55.86 0.04 OUTLIER Glycine 0 C--N 1.335 0.49 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.548 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 -179.993 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 . . . . . 0 N--CA 1.45 -0.441 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 102' ' ' LYS . . . . . 0.462 ' HB2' ' HE3' ' B' ' 102' ' ' LYS . 23.9 mtmt -82.6 -40.87 20.24 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 103' ' ' THR . . . . . 0.843 HG21 ' CG ' ' C' ' 206' ' ' GLU . 96.2 m -43.52 -31.12 0.66 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 104' ' ' ASN . . . . . 0.481 ' CG ' ' N ' ' B' ' 105' ' ' LEU . 4.3 p-10 -42.66 -50.8 5.43 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 0.481 ' N ' ' CG ' ' B' ' 104' ' ' ASN . 16.2 mt -43.57 -48.24 7.52 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 106' ' ' GLU . . . . . 0.863 ' CG ' HG21 ' A' ' 3' ' ' THR . 2.7 mp0 -64.58 -31.42 72.63 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 107' ' ' ILE . . . . . 1.085 HG23 ' CD2' ' C' ' 210' ' ' LEU . 4.8 mt -65.31 -30.36 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 61.0 mt -76.53 -42.07 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 109' ' ' ILE . . . . . 0.429 ' O ' ' HB ' ' B' ' 113' ' ' THR . 32.0 mt -76.64 -25.2 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 110' ' ' LEU . . . . . 1.069 ' CD2' HG23 ' A' ' 7' ' ' ILE . 15.1 mt -84.58 -46.53 11.46 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 111' ' ' GLU . . . . . 0.589 ' CD ' HG22 ' C' ' 213' ' ' THR . 52.4 mm-40 -58.72 -45.14 90.27 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 112' ' ' GLY . . . . . 0.654 ' C ' HD12 ' B' ' 116' ' ' ILE . . . -70.56 -57.76 6.38 Favored Glycine 0 C--N 1.335 0.521 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 113' ' ' THR . . . . . 0.589 HG22 ' CD ' ' A' ' 11' ' ' GLU . 45.1 m -55.82 -26.95 48.96 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 114' ' ' ALA . . . . . 0.55 ' HB2' ' O ' ' B' ' 110' ' ' LEU . . . -66.47 -63.12 1.14 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 0.698 HG22 ' HG3' ' C' ' 218' ' ' MET . 2.9 t -67.58 -22.1 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 116' ' ' ILE . . . . . 0.654 HD12 ' C ' ' B' ' 112' ' ' GLY . 35.3 mt -73.09 -64.53 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -50.65 -35.05 28.78 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 118' ' ' MET . . . . . 0.687 ' HG3' HG22 ' A' ' 15' ' ' VAL . 6.0 mtp -60.36 -60.18 4.23 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -52.68 -38.46 60.57 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -62.73 -49.91 73.17 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 121' ' ' TRP . . . . . 0.619 ' O ' HG23 ' B' ' 125' ' ' VAL . 36.1 t-105 -70.5 -22.5 62.63 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 122' ' ' LEU . . . . . 0.406 HD12 HD11 ' B' ' 126' ' ' ILE . 0.0 OUTLIER -71.55 -52.08 20.07 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 123' ' ' LEU . . . . . 0.648 HD12 ' C ' ' B' ' 123' ' ' LEU . 0.8 OUTLIER -62.31 -35.21 78.35 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.959 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 124' ' ' LEU . . . . . 0.564 ' N ' ' HG ' ' B' ' 123' ' ' LEU . 13.0 mt -59.91 -51.54 69.26 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 125' ' ' VAL . . . . . 0.619 HG23 ' O ' ' B' ' 121' ' ' TRP . 42.6 t -65.19 -25.87 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 0.637 HD12 ' HA ' ' B' ' 123' ' ' LEU . 45.2 mt -70.7 -47.28 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 127' ' ' ILE . . . . . 0.525 ' O ' HG23 ' B' ' 131' ' ' VAL . 84.6 mt -67.03 -35.92 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.448 ' HA ' HD23 ' B' ' 128' ' ' LEU . 24.2 mt -65.91 -50.8 63.18 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 32.7 mtp180 -63.84 -50.04 70.42 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 4.0 m -52.6 -42.42 64.54 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.525 HG23 ' O ' ' B' ' 127' ' ' ILE . 53.3 t -70.71 -42.63 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 24.0 ttmt -52.72 -31.36 37.32 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 133' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' B' ' 133' ' ' ARG . 7.3 mtp180 -97.49 36.04 1.55 Allowed 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 134' ' ' ALA . . . . . . . . . . . . . . . -139.23 8.21 2.45 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 -119.76 176.67 5.28 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . 139.75 56.1 0.04 OUTLIER Glycine 0 C--N 1.336 0.531 0 N-CA-C 110.269 -1.133 . . . . 0.0 110.269 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.537 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 -179.97 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 201' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 . . . . . 0 N--CA 1.45 -0.475 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 202' ' ' LYS . . . . . 0.468 ' HB2' ' HE3' ' C' ' 202' ' ' LYS . 23.9 mtmt -82.62 -40.93 20.13 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 203' ' ' THR . . . . . 0.859 HG21 ' CG ' ' A' ' 6' ' ' GLU . 96.3 m -43.54 -31.12 0.67 Allowed 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 204' ' ' ASN . . . . . 0.485 ' CG ' ' N ' ' C' ' 205' ' ' LEU . 4.3 p-10 -42.56 -50.72 5.3 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 205' ' ' LEU . . . . . 0.485 ' N ' ' CG ' ' C' ' 204' ' ' ASN . 16.2 mt -43.6 -48.24 7.61 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 206' ' ' GLU . . . . . 0.843 ' CG ' HG21 ' B' ' 103' ' ' THR . 2.7 mp0 -64.66 -31.47 72.71 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 207' ' ' ILE . . . . . 1.079 HG23 ' CD2' ' A' ' 10' ' ' LEU . 4.8 mt -65.24 -30.35 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 208' ' ' ILE . . . . . . . . . . . . . 60.5 mt -76.59 -42.12 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 209' ' ' ILE . . . . . 0.415 ' O ' ' HB ' ' C' ' 213' ' ' THR . 31.8 mt -76.59 -25.21 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 210' ' ' LEU . . . . . 1.085 ' CD2' HG23 ' B' ' 107' ' ' ILE . 15.1 mt -84.62 -46.5 11.46 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 211' ' ' GLU . . . . . 0.584 ' CD ' HG22 ' A' ' 13' ' ' THR . 52.3 mm-40 -58.71 -45.04 90.45 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 212' ' ' GLY . . . . . 0.654 ' C ' HD12 ' C' ' 216' ' ' ILE . . . -70.66 -57.85 6.25 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 213' ' ' THR . . . . . 0.589 HG22 ' CD ' ' B' ' 111' ' ' GLU . 45.4 m -55.68 -27.11 48.4 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 214' ' ' ALA . . . . . 0.537 ' HB2' ' O ' ' C' ' 210' ' ' LEU . . . -66.51 -63.05 1.16 Allowed 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 215' ' ' VAL . . . . . 0.717 HG22 ' HG3' ' A' ' 18' ' ' MET . 3.0 t -67.6 -22.02 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 216' ' ' ILE . . . . . 0.654 HD12 ' C ' ' C' ' 212' ' ' GLY . 34.6 mt -73.19 -64.42 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -50.92 -34.78 29.97 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 218' ' ' MET . . . . . 0.698 ' HG3' HG22 ' B' ' 115' ' ' VAL . 6.0 mtp -60.52 -60.17 4.23 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -51.96 -38.36 56.29 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -62.8 -50.15 72.12 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 221' ' ' TRP . . . . . 0.607 ' O ' HG23 ' C' ' 225' ' ' VAL . 36.5 t-105 -70.16 -22.48 62.97 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.54 -52.2 19.45 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 223' ' ' LEU . . . . . 0.648 ' HA ' HD12 ' C' ' 226' ' ' ILE . 0.8 OUTLIER -62.11 -35.32 78.37 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 224' ' ' LEU . . . . . 0.57 ' N ' ' HG ' ' C' ' 223' ' ' LEU . 13.0 mt -59.9 -51.22 70.62 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 225' ' ' VAL . . . . . 0.607 HG23 ' O ' ' C' ' 221' ' ' TRP . 42.5 t -65.8 -25.8 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 226' ' ' ILE . . . . . 0.648 HD12 ' HA ' ' C' ' 223' ' ' LEU . 43.2 mt -70.45 -47.39 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 227' ' ' ILE . . . . . 0.537 ' O ' HG23 ' C' ' 231' ' ' VAL . 84.9 mt -66.6 -35.68 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 228' ' ' LEU . . . . . 0.459 ' HA ' HD23 ' C' ' 228' ' ' LEU . 23.4 mt -66.66 -50.83 61.65 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 229' ' ' ARG . . . . . . . . . . . . . 32.4 mtp180 -63.63 -49.79 71.91 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 230' ' ' THR . . . . . . . . . . . . . 3.8 m -52.18 -41.48 62.66 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 231' ' ' VAL . . . . . 0.537 HG23 ' O ' ' C' ' 227' ' ' ILE . 53.2 t -70.75 -42.55 77.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 232' ' ' LYS . . . . . . . . . . . . . 24.2 ttmt -53.24 -31.67 44.53 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 233' ' ' ARG . . . . . 0.435 HH11 ' HD2' ' C' ' 233' ' ' ARG . 7.2 mtp180 -96.96 35.53 1.54 Allowed 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 234' ' ' ALA . . . . . . . . . . . . . . . -138.94 8.57 2.53 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 235' ' ' ASN . . . . . . . . . . . . . 45.7 m-20 -119.55 176.57 5.3 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 236' ' ' GLY . . . . . . . . . . . . . . . 139.46 55.95 0.04 OUTLIER Glycine 0 C--N 1.336 0.534 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.539 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 -179.961 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 . . . . . 0 N--CA 1.449 -0.523 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.535 ' N ' ' CD ' ' A' ' 2' ' ' LYS . 3.9 mptp? -84.67 -40.79 16.97 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.1 t -49.18 -36.23 19.06 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.484 ' HA ' HG13 ' A' ' 7' ' ' ILE . 1.6 t30 -42.84 -51.23 5.54 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.535 ' HA ' HD23 ' A' ' 5' ' ' LEU . 12.8 mt -42.99 -48.57 5.97 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.571 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 3.8 mp0 -64.54 -31.36 72.54 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 1.075 HG23 ' CD2' ' B' ' 110' ' ' LEU . 4.0 mt -65.17 -30.2 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 73.6 mt -76.75 -42.24 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.415 ' O ' ' HB ' ' A' ' 13' ' ' THR . 95.7 mt -76.75 -24.21 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 1.069 ' CD2' HG23 ' C' ' 207' ' ' ILE . 15.4 mt -85.6 -47.59 9.71 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.548 ' CD ' HG22 ' B' ' 113' ' ' THR . 57.5 mm-40 -58.95 -42.34 89.57 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.701 ' C ' HD12 ' A' ' 16' ' ' ILE . . . -72.65 -56.38 6.05 Favored Glycine 0 C--N 1.335 0.521 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.562 HG22 ' CD ' ' C' ' 211' ' ' GLU . 37.1 m -57.77 -25.4 60.45 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.517 ' HB2' ' O ' ' A' ' 10' ' ' LEU . . . -68.83 -63.14 1.12 Allowed 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.618 HG22 ' CG ' ' B' ' 118' ' ' MET . 2.7 t -68.56 -21.17 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.701 HD12 ' C ' ' A' ' 12' ' ' GLY . 34.9 mt -76.84 -64.65 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.02 -32.32 21.13 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.624 ' CG ' HG22 ' C' ' 215' ' ' VAL . 6.4 mtp -65.52 -60.23 3.15 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -54.84 -30.06 56.63 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.434 ' CE2' ' CG2' ' A' ' 16' ' ' ILE . 2.9 m-85 -69.25 -44.0 72.84 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.41 ' O ' HG23 ' A' ' 25' ' ' VAL . 43.9 t-105 -74.12 -28.36 61.31 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.464 ' HA ' HD23 ' A' ' 22' ' ' LEU . 15.2 mt -71.33 -52.92 16.12 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.741 HD12 ' C ' ' A' ' 23' ' ' LEU . 0.9 OUTLIER -61.35 -34.25 74.97 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.488 ' N ' ' HG ' ' A' ' 23' ' ' LEU . 4.5 tt -62.73 -45.7 91.51 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 21' ' ' TRP . 79.8 t -70.36 -23.5 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.729 HD12 ' HA ' ' A' ' 23' ' ' LEU . 48.1 mt -70.35 -44.3 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 36.6 mt -72.27 -37.29 58.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 24.0 mt -72.72 -37.5 67.77 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 33.8 ttm-85 -75.18 -41.52 57.82 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.6 m -62.25 -41.41 98.41 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 55.8 t -74.11 -42.47 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.515 ' HB3' ' NZ ' ' A' ' 32' ' ' LYS . 7.6 mtpm? -56.61 -29.24 61.93 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.5 mmm180 -101.95 37.62 1.81 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.87 -9.11 1.04 Allowed 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -82.47 137.95 34.5 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -110.87 -102.01 2.66 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.543 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 179.996 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 . . . . . 0 N--CA 1.449 -0.5 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 102' ' ' LYS . . . . . 0.536 ' N ' ' CD ' ' B' ' 102' ' ' LYS . 3.9 mptp? -84.7 -40.73 17.0 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 7.0 t -49.26 -36.19 19.77 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 104' ' ' ASN . . . . . 0.496 ' HA ' HG13 ' B' ' 107' ' ' ILE . 1.5 t30 -42.93 -51.24 5.65 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 0.481 HD23 ' HA ' ' B' ' 105' ' ' LEU . 12.8 mt -43.01 -48.49 6.0 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 106' ' ' GLU . . . . . 0.583 ' CD ' ' N ' ' B' ' 106' ' ' GLU . 3.8 mp0 -64.54 -31.46 72.69 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 107' ' ' ILE . . . . . 1.046 HG23 ' CD2' ' C' ' 210' ' ' LEU . 4.0 mt -65.14 -30.14 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 73.5 mt -76.77 -42.24 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 109' ' ' ILE . . . . . 0.426 ' O ' ' HB ' ' B' ' 113' ' ' THR . 95.6 mt -76.84 -24.12 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 110' ' ' LEU . . . . . 1.075 ' CD2' HG23 ' A' ' 7' ' ' ILE . 15.5 mt -85.62 -47.48 9.8 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 111' ' ' GLU . . . . . 0.561 ' CD ' HG22 ' C' ' 213' ' ' THR . 57.5 mm-40 -58.98 -42.45 89.98 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 112' ' ' GLY . . . . . 0.701 ' C ' HD12 ' B' ' 116' ' ' ILE . . . -72.67 -56.25 6.12 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.319 -1.113 . . . . 0.0 110.319 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 113' ' ' THR . . . . . 0.548 HG22 ' CD ' ' A' ' 11' ' ' GLU . 36.9 m -57.89 -25.32 60.66 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 114' ' ' ALA . . . . . 0.509 ' HB2' ' O ' ' B' ' 110' ' ' LEU . . . -68.85 -63.15 1.11 Allowed 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 0.621 HG22 ' CG ' ' C' ' 218' ' ' MET . 2.7 t -68.54 -21.29 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 116' ' ' ILE . . . . . 0.701 HD12 ' C ' ' B' ' 112' ' ' GLY . 34.5 mt -76.66 -64.66 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -51.11 -32.11 21.51 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 118' ' ' MET . . . . . 0.618 ' CG ' HG22 ' A' ' 15' ' ' VAL . 6.3 mtp -65.57 -59.72 3.67 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -53.16 -31.09 40.83 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -69.98 -42.94 72.45 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 121' ' ' TRP . . . . . 0.466 ' O ' HG23 ' B' ' 125' ' ' VAL . 44.0 t-105 -73.98 -27.27 60.9 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 122' ' ' LEU . . . . . 0.477 ' HA ' HD23 ' B' ' 122' ' ' LEU . 15.2 mt -71.86 -53.15 14.14 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 123' ' ' LEU . . . . . 0.743 HD12 ' C ' ' B' ' 123' ' ' LEU . 0.9 OUTLIER -61.5 -34.11 74.95 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 124' ' ' LEU . . . . . 0.481 ' N ' ' HG ' ' B' ' 123' ' ' LEU . 4.1 tt -63.5 -44.59 93.9 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 125' ' ' VAL . . . . . 0.466 HG23 ' O ' ' B' ' 121' ' ' TRP . 80.2 t -70.6 -23.41 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 0.721 HD12 ' HA ' ' B' ' 123' ' ' LEU . 49.4 mt -70.32 -44.39 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 37.0 mt -72.57 -38.13 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.418 ' HA ' HD23 ' B' ' 128' ' ' LEU . 24.9 mt -72.42 -36.71 68.67 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 129' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' B' ' 129' ' ' ARG . 33.9 ttm-85 -75.71 -41.98 52.1 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 3.8 m -62.11 -41.58 98.37 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 54.6 t -74.54 -42.91 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 132' ' ' LYS . . . . . 0.502 ' HB3' ' NZ ' ' B' ' 132' ' ' LYS . 7.5 mtpm? -56.33 -29.0 60.74 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 8.5 mmm180 -101.54 37.31 1.83 Allowed 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 134' ' ' ALA . . . . . . . . . . . . . . . -140.66 -9.48 1.06 Allowed 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -82.97 137.89 34.0 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -110.89 -102.8 2.7 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.536 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 -179.966 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 201' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 . . . . . 0 N--CA 1.449 -0.485 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 202' ' ' LYS . . . . . 0.535 ' N ' ' CD ' ' C' ' 202' ' ' LYS . 3.8 mptp? -84.58 -40.82 17.07 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 203' ' ' THR . . . . . . . . . . . . . 7.1 t -49.23 -36.03 19.0 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.946 -0.391 . . . . 0.0 109.946 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 204' ' ' ASN . . . . . 0.503 ' HA ' HG13 ' C' ' 207' ' ' ILE . 1.5 t30 -42.88 -51.14 5.63 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 205' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' C' ' 205' ' ' LEU . 12.8 mt -43.04 -48.53 6.08 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 206' ' ' GLU . . . . . 0.574 ' N ' ' CD ' ' C' ' 206' ' ' GLU . 3.8 mp0 -64.58 -31.43 72.64 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 207' ' ' ILE . . . . . 1.069 HG23 ' CD2' ' A' ' 10' ' ' LEU . 4.0 mt -65.14 -30.19 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 208' ' ' ILE . . . . . . . . . . . . . 73.3 mt -76.77 -42.26 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 209' ' ' ILE . . . . . 0.408 ' O ' ' HB ' ' C' ' 213' ' ' THR . 95.6 mt -76.74 -24.24 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 210' ' ' LEU . . . . . 1.046 ' CD2' HG23 ' B' ' 107' ' ' ILE . 15.4 mt -85.58 -47.28 10.01 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 211' ' ' GLU . . . . . 0.562 ' CD ' HG22 ' A' ' 13' ' ' THR . 57.1 mm-40 -59.03 -42.52 90.38 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 212' ' ' GLY . . . . . 0.693 ' C ' HD12 ' C' ' 216' ' ' ILE . . . -72.64 -56.27 6.13 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 213' ' ' THR . . . . . 0.561 HG22 ' CD ' ' B' ' 111' ' ' GLU . 38.3 m -57.82 -25.47 60.67 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 214' ' ' ALA . . . . . 0.502 ' HB2' ' O ' ' C' ' 210' ' ' LEU . . . -68.76 -63.19 1.11 Allowed 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 215' ' ' VAL . . . . . 0.624 HG22 ' CG ' ' A' ' 18' ' ' MET . 2.7 t -68.5 -21.33 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 216' ' ' ILE . . . . . 0.693 HD12 ' C ' ' C' ' 212' ' ' GLY . 34.3 mt -76.61 -64.62 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -51.11 -32.11 21.48 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 218' ' ' MET . . . . . 0.621 ' CG ' HG22 ' B' ' 115' ' ' VAL . 6.3 mtp -65.49 -60.14 3.25 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -53.92 -32.06 52.27 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -70.85 -42.05 70.65 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 221' ' ' TRP . . . . . 0.495 ' O ' HG23 ' C' ' 225' ' ' VAL . 43.9 t-105 -73.65 -26.78 60.91 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 222' ' ' LEU . . . . . 0.5 ' HA ' HD23 ' C' ' 222' ' ' LEU . 15.1 mt -71.82 -53.4 13.41 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 223' ' ' LEU . . . . . 0.736 ' C ' HD12 ' C' ' 223' ' ' LEU . 0.9 OUTLIER -61.55 -33.64 74.2 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 224' ' ' LEU . . . . . 0.469 ' N ' ' HG ' ' C' ' 223' ' ' LEU . 3.9 tt -63.8 -44.41 93.4 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 225' ' ' VAL . . . . . 0.495 HG23 ' O ' ' C' ' 221' ' ' TRP . 82.2 t -70.29 -23.49 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 226' ' ' ILE . . . . . 0.719 HD12 ' HA ' ' C' ' 223' ' ' LEU . 50.1 mt -70.41 -44.19 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 227' ' ' ILE . . . . . . . . . . . . . 37.3 mt -72.69 -38.02 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 228' ' ' LEU . . . . . 0.464 ' HA ' HD23 ' C' ' 228' ' ' LEU . 24.4 mt -72.41 -36.81 68.73 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 229' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' C' ' 229' ' ' ARG . 33.8 ttm-85 -75.46 -42.44 53.19 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 230' ' ' THR . . . . . . . . . . . . . 3.6 m -61.8 -41.31 97.58 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 55.6 t -74.36 -42.54 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 232' ' ' LYS . . . . . 0.514 ' NZ ' ' HB3' ' C' ' 232' ' ' LYS . 7.5 mtpm? -56.12 -29.36 60.57 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 233' ' ' ARG . . . . . . . . . . . . . 8.5 mmm180 -100.95 37.09 1.81 Allowed 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 234' ' ' ALA . . . . . . . . . . . . . . . -141.28 -9.3 0.98 Allowed 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 235' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -82.64 138.03 34.3 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 236' ' ' GLY . . . . . . . . . . . . . . . -110.89 -102.19 2.67 Favored Glycine 0 C--N 1.335 0.515 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.526 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 -179.986 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 . . . . . 0 N--CA 1.449 -0.5 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.427 ' HD3' ' HA ' ' A' ' 2' ' ' LYS . 35.6 mmtm -81.81 -50.7 8.92 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.4 t -43.67 -34.4 1.47 Allowed 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.508 ' HA ' HG13 ' A' ' 7' ' ' ILE . 1.6 t-20 -42.78 -50.85 5.57 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.535 ' HA ' HD23 ' A' ' 5' ' ' LEU . 11.5 mt -42.9 -48.61 5.86 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.585 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 2.1 mp0 -64.8 -31.58 72.88 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 1.066 HG23 ' CD2' ' B' ' 110' ' ' LEU . 4.2 mt -64.81 -30.26 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 66.1 mt -76.8 -42.74 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.415 ' O ' ' HB ' ' A' ' 13' ' ' THR . 18.9 mt -76.19 -24.0 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 1.046 ' CD2' HG23 ' C' ' 207' ' ' ILE . 15.8 mt -85.7 -52.78 5.56 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.54 ' CD ' HG22 ' B' ' 113' ' ' THR . 66.5 mm-40 -55.8 -40.96 73.45 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.684 ' C ' HD12 ' A' ' 16' ' ' ILE . . . -72.65 -54.99 6.93 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.589 HG22 ' CD ' ' C' ' 211' ' ' GLU . 17.2 m -57.7 -25.88 60.95 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.19 -63.38 1.08 Allowed 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.794 HG22 ' CG ' ' B' ' 118' ' ' MET . 2.6 t -67.57 -21.14 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.684 HD12 ' C ' ' A' ' 12' ' ' GLY . 32.6 mt -76.55 -64.6 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.42 -32.04 16.65 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.591 ' CE ' ' HE1' ' B' ' 118' ' ' MET . 6.5 mtp -71.04 -59.71 2.63 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.629 ' O ' HD12 ' A' ' 23' ' ' LEU . 2.4 m-85 -57.43 -23.73 51.34 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -67.85 -60.04 2.82 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 48.9 m0 -60.71 -41.43 95.21 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 22' ' ' LEU . 11.6 tp -65.04 -41.38 95.28 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.629 HD12 ' O ' ' A' ' 19' ' ' PHE . 4.8 mt -55.33 -45.48 76.38 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.4 mp -64.03 -38.93 92.86 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 53.9 t -69.68 -32.19 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 26' ' ' ILE . 37.8 mt -73.59 -36.35 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.468 ' O ' HG23 ' A' ' 31' ' ' VAL . 87.2 mt -69.95 -38.66 76.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 28' ' ' LEU . 87.0 mt -71.35 -43.77 66.34 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -66.95 -46.05 75.89 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.0 m -57.3 -43.41 83.17 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 27' ' ' ILE . 54.9 t -68.25 -46.41 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -50.0 -35.92 26.46 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 10.7 mmt85 -97.25 38.25 1.27 Allowed 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -142.5 -11.1 0.82 Allowed 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -96.09 150.78 20.11 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.68 -73.82 2.61 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.517 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -179.979 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 56.5 tt0 . . . . . 0 N--CA 1.45 -0.469 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 102' ' ' LYS . . . . . 0.414 ' HD3' ' HA ' ' B' ' 102' ' ' LYS . 35.5 mmtm -81.86 -50.44 9.2 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 6.3 t -44.02 -34.32 1.7 Allowed 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 104' ' ' ASN . . . . . 0.489 ' HA ' HG13 ' B' ' 107' ' ' ILE . 1.6 t-20 -42.97 -51.16 5.73 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 0.517 ' HA ' HD23 ' B' ' 105' ' ' LEU . 11.5 mt -42.97 -48.42 5.92 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 106' ' ' GLU . . . . . 0.58 ' CD ' ' N ' ' B' ' 106' ' ' GLU . 2.2 mp0 -64.55 -31.89 73.3 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 107' ' ' ILE . . . . . 1.038 HG23 ' CD2' ' C' ' 210' ' ' LEU . 4.0 mt -64.85 -29.73 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 66.3 mt -77.01 -42.91 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 109' ' ' ILE . . . . . 0.424 ' O ' ' HB ' ' B' ' 113' ' ' THR . 18.9 mt -76.33 -23.9 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 110' ' ' LEU . . . . . 1.066 ' CD2' HG23 ' A' ' 7' ' ' ILE . 15.4 mt -85.67 -50.78 6.92 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 111' ' ' GLU . . . . . 0.537 ' O ' HG23 ' B' ' 115' ' ' VAL . 63.9 mm-40 -57.23 -40.64 77.96 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 112' ' ' GLY . . . . . 0.67 ' C ' HD12 ' B' ' 116' ' ' ILE . . . -73.49 -55.77 5.91 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 113' ' ' THR . . . . . 0.54 HG22 ' CD ' ' A' ' 11' ' ' GLU . 22.2 m -57.86 -24.93 59.83 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.12 -62.69 1.29 Allowed 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 0.537 HG23 ' O ' ' B' ' 111' ' ' GLU . 3.1 t -68.27 -21.1 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 116' ' ' ILE . . . . . 0.67 HD12 ' C ' ' B' ' 112' ' ' GLY . 45.6 mt -79.61 -65.2 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -53.81 -27.98 32.62 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.786 -0.449 . . . . 0.0 109.786 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 118' ' ' MET . . . . . 0.794 ' CG ' HG22 ' A' ' 15' ' ' VAL . 11.9 mtp -72.85 -60.01 2.44 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 119' ' ' PHE . . . . . 0.508 ' O ' HD12 ' B' ' 123' ' ' LEU . 2.4 m-85 -57.81 -26.28 61.75 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -70.63 -58.97 3.11 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 121' ' ' TRP . . . . . 0.509 ' O ' HG23 ' B' ' 125' ' ' VAL . 49.2 m0 -59.06 -39.89 83.47 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 122' ' ' LEU . . . . . 0.452 ' HA ' HD12 ' B' ' 122' ' ' LEU . 11.6 tp -62.99 -42.47 99.86 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 123' ' ' LEU . . . . . 0.508 HD12 ' O ' ' B' ' 119' ' ' PHE . 4.9 mt -56.94 -46.77 81.83 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 4.4 mp -65.45 -36.85 85.15 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 125' ' ' VAL . . . . . 0.509 HG23 ' O ' ' B' ' 121' ' ' TRP . 53.7 t -67.76 -31.49 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 36.8 mt -72.64 -37.83 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 127' ' ' ILE . . . . . 0.454 ' O ' HG23 ' B' ' 131' ' ' VAL . 88.5 mt -70.32 -38.65 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' B' ' 128' ' ' LEU . 88.3 mt -71.05 -43.66 67.39 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -66.69 -46.29 76.06 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 6.0 m -57.46 -44.03 84.49 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.454 HG23 ' O ' ' B' ' 127' ' ' ILE . 54.4 t -68.27 -45.69 82.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -49.78 -35.74 23.59 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 10.8 mmt85 -96.66 38.46 1.21 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 134' ' ' ALA . . . . . . . . . . . . . . . -143.14 -11.17 0.75 Allowed 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -96.07 150.58 20.34 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . 82.55 -74.3 2.53 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.515 0 N-CA-C 110.281 -1.127 . . . . 0.0 110.281 179.997 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 201' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 . . . . . 0 N--CA 1.45 -0.457 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 202' ' ' LYS . . . . . 0.443 ' HD3' ' HA ' ' C' ' 202' ' ' LYS . 35.5 mmtm -81.89 -50.45 9.17 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 203' ' ' THR . . . . . . . . . . . . . 6.3 t -44.09 -34.61 1.84 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 204' ' ' ASN . . . . . 0.493 ' HA ' HG13 ' C' ' 207' ' ' ILE . 1.6 t-20 -42.82 -51.12 5.56 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 205' ' ' LEU . . . . . 0.493 HD23 ' HA ' ' C' ' 205' ' ' LEU . 11.6 mt -42.95 -48.52 5.91 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 206' ' ' GLU . . . . . 0.574 ' N ' ' CD ' ' C' ' 206' ' ' GLU . 2.2 mp0 -64.66 -31.45 72.68 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 207' ' ' ILE . . . . . 1.046 HG23 ' CD2' ' A' ' 10' ' ' LEU . 4.2 mt -64.98 -30.28 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 208' ' ' ILE . . . . . . . . . . . . . 64.9 mt -76.74 -42.49 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 209' ' ' ILE . . . . . 0.423 ' O ' ' HB ' ' C' ' 213' ' ' THR . 18.7 mt -76.51 -24.09 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 210' ' ' LEU . . . . . 1.038 ' CD2' HG23 ' B' ' 107' ' ' ILE . 15.6 mt -85.71 -52.47 5.76 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 211' ' ' GLU . . . . . 0.589 ' CD ' HG22 ' A' ' 13' ' ' THR . 67.1 mm-40 -56.49 -40.69 75.38 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 212' ' ' GLY . . . . . 0.691 ' C ' HD12 ' C' ' 216' ' ' ILE . . . -72.7 -55.95 6.28 Favored Glycine 0 C--N 1.335 0.513 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 213' ' ' THR . . . . . 0.53 HG22 ' CD ' ' B' ' 111' ' ' GLU . 20.4 m -57.65 -25.3 60.0 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 214' ' ' ALA . . . . . . . . . . . . . . . -69.37 -63.26 1.1 Allowed 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 215' ' ' VAL . . . . . 0.533 HG23 ' O ' ' C' ' 211' ' ' GLU . 2.8 t -68.15 -21.09 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 216' ' ' ILE . . . . . 0.691 HD12 ' C ' ' C' ' 212' ' ' GLY . 37.8 mt -77.53 -64.67 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -50.99 -30.93 16.42 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 218' ' ' MET . . . . . 0.569 ' SD ' ' CE ' ' B' ' 118' ' ' MET . 6.9 mtp -71.29 -60.09 2.42 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 219' ' ' PHE . . . . . 0.473 ' O ' HD12 ' C' ' 223' ' ' LEU . 2.4 m-85 -58.8 -24.63 62.15 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -68.9 -58.51 4.05 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 221' ' ' TRP . . . . . . . . . . . . . 49.1 m0 -58.69 -40.68 84.3 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 222' ' ' LEU . . . . . 0.461 ' HA ' HD12 ' C' ' 222' ' ' LEU . 11.6 tp -64.03 -42.11 97.19 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 223' ' ' LEU . . . . . 0.473 HD12 ' O ' ' C' ' 219' ' ' PHE . 4.9 mt -56.58 -45.54 81.27 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 4.4 mp -64.09 -37.48 87.61 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 225' ' ' VAL . . . . . . . . . . . . . 53.8 t -67.95 -31.84 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 37.3 mt -73.44 -37.26 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 227' ' ' ILE . . . . . 0.478 ' O ' HG23 ' C' ' 231' ' ' VAL . 88.1 mt -69.72 -38.46 76.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 228' ' ' LEU . . . . . 0.434 ' HA ' HD23 ' C' ' 228' ' ' LEU . 86.8 mt -70.67 -43.55 68.89 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 229' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -66.9 -46.54 74.56 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 230' ' ' THR . . . . . . . . . . . . . 5.8 m -57.21 -43.84 83.13 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 231' ' ' VAL . . . . . 0.478 HG23 ' O ' ' C' ' 227' ' ' ILE . 54.0 t -68.22 -45.98 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 232' ' ' LYS . . . . . . . . . . . . . 24.3 tptm -49.75 -35.75 23.37 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 233' ' ' ARG . . . . . . . . . . . . . 10.7 mmt85 -96.72 38.47 1.22 Allowed 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 234' ' ' ALA . . . . . . . . . . . . . . . -143.15 -11.12 0.75 Allowed 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 235' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -95.75 150.82 19.97 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 236' ' ' GLY . . . . . . . . . . . . . . . 82.63 -74.08 2.57 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.54 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 -179.991 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 . . . . . 0 N--CA 1.449 -0.493 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.444 ' HE2' ' HB2' ' A' ' 2' ' ' LYS . 10.2 tppt? -71.08 -23.43 62.12 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.662 HG21 ' CG ' ' B' ' 106' ' ' GLU . 1.6 m -69.07 -47.67 64.68 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.49 ' HA ' HG13 ' A' ' 7' ' ' ILE . 1.6 t30 -42.12 -47.22 4.54 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.545 HD23 ' HA ' ' A' ' 5' ' ' LEU . 12.3 mt -42.84 -50.34 5.7 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.668 ' CG ' HG21 ' C' ' 203' ' ' THR . 0.1 OUTLIER -66.08 -32.17 73.48 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.912 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 1.064 HG23 ' CD2' ' B' ' 110' ' ' LEU . 3.6 mt -65.01 -29.76 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 44.6 mt -76.93 -42.52 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.42 ' O ' ' HB ' ' A' ' 13' ' ' THR . 29.4 mt -76.74 -24.04 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 1.062 ' CD2' HG23 ' C' ' 207' ' ' ILE . 15.3 mt -85.73 -48.14 9.11 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.566 ' O ' HG23 ' A' ' 15' ' ' VAL . 60.6 mm-40 -58.81 -41.79 87.62 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.718 ' C ' HD12 ' A' ' 16' ' ' ILE . . . -72.96 -56.24 5.93 Favored Glycine 0 C--N 1.336 0.555 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.54 HG22 ' CD ' ' C' ' 211' ' ' GLU . 31.8 m -57.88 -25.72 61.15 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.494 ' HB2' ' O ' ' A' ' 10' ' ' LEU . . . -68.7 -63.09 1.13 Allowed 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.589 HG22 ' CG ' ' B' ' 118' ' ' MET . 2.7 t -68.31 -21.24 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.718 HD12 ' C ' ' A' ' 12' ' ' GLY . 30.5 mt -76.57 -64.68 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.93 -32.28 20.28 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.601 ' CE ' ' HE1' ' B' ' 118' ' ' MET . 6.5 mtp -65.47 -60.09 3.31 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.462 ' CD2' HD11 ' A' ' 23' ' ' LEU . 4.8 t80 -51.52 -34.93 38.38 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -64.52 -39.61 94.1 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 22.8 m0 -65.81 -55.36 17.57 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 67.0 mt -57.38 -38.07 73.65 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.462 HD11 ' CD2' ' A' ' 19' ' ' PHE . 15.0 mt -58.15 -51.08 71.21 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.465 ' HA ' HD12 ' A' ' 24' ' ' LEU . 15.4 tp -61.75 -29.6 70.23 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.848 -0.426 . . . . 0.0 109.848 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 75.8 t -74.3 -39.15 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 68.3 mt -73.58 -34.81 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.511 ' O ' HG23 ' A' ' 31' ' ' VAL . 62.3 mt -69.25 -46.62 77.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 28' ' ' LEU . 55.7 mt -66.04 -41.3 91.05 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -65.83 -52.08 53.55 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.1 m -52.71 -49.02 66.2 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 27' ' ' ILE . 62.3 t -57.93 -54.08 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.432 ' HE3' ' HB2' ' A' ' 32' ' ' LYS . 23.3 ttmt -51.68 -25.41 7.18 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -97.69 31.18 2.68 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.76 3.0 1.83 Allowed 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.413 ' CG ' ' N ' ' A' ' 36' ' ' GLY . 15.6 t30 -134.68 170.25 16.1 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.413 ' N ' ' CG ' ' A' ' 35' ' ' ASN . . . -53.8 -88.51 0.01 OUTLIER Glycine 0 C--N 1.335 0.5 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.514 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 -179.975 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 . . . . . 0 N--CA 1.449 -0.496 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 102' ' ' LYS . . . . . 0.46 ' HE2' ' HB2' ' B' ' 102' ' ' LYS . 10.2 tppt? -71.22 -23.51 62.03 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 103' ' ' THR . . . . . 0.671 HG21 ' CG ' ' C' ' 206' ' ' GLU . 1.6 m -69.02 -47.71 64.77 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 104' ' ' ASN . . . . . 0.495 ' HA ' HG13 ' B' ' 107' ' ' ILE . 1.6 t30 -42.13 -47.33 4.57 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 0.476 ' HA ' HD23 ' B' ' 105' ' ' LEU . 12.3 mt -42.75 -50.32 5.59 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 106' ' ' GLU . . . . . 0.662 ' CG ' HG21 ' A' ' 3' ' ' THR . 0.1 OUTLIER -66.14 -32.2 73.5 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.928 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 107' ' ' ILE . . . . . 1.053 HG23 ' CD2' ' C' ' 210' ' ' LEU . 3.5 mt -65.0 -29.79 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 44.7 mt -76.9 -42.53 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 109' ' ' ILE . . . . . 0.419 ' O ' ' HB ' ' B' ' 113' ' ' THR . 29.3 mt -76.71 -24.03 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 110' ' ' LEU . . . . . 1.064 ' CD2' HG23 ' A' ' 7' ' ' ILE . 15.3 mt -85.72 -47.63 9.58 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 111' ' ' GLU . . . . . 0.555 ' O ' HG23 ' B' ' 115' ' ' VAL . 59.7 mm-40 -59.07 -41.99 89.28 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 112' ' ' GLY . . . . . 0.715 ' C ' HD12 ' B' ' 116' ' ' ILE . . . -72.91 -56.15 6.01 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 113' ' ' THR . . . . . 0.554 HG22 ' CD ' ' A' ' 11' ' ' GLU . 32.8 m -57.88 -25.83 61.3 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 114' ' ' ALA . . . . . 0.498 ' HB2' ' O ' ' B' ' 110' ' ' LEU . . . -68.65 -63.07 1.13 Allowed 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 0.572 HG22 ' CG ' ' C' ' 218' ' ' MET . 2.7 t -68.32 -21.27 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 116' ' ' ILE . . . . . 0.715 HD12 ' C ' ' B' ' 112' ' ' GLY . 30.1 mt -76.33 -64.62 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -51.16 -32.14 22.28 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 118' ' ' MET . . . . . 0.605 ' CE ' ' HE1' ' C' ' 218' ' ' MET . 6.3 mtp -65.2 -59.65 3.86 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -49.11 -37.42 21.67 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -67.41 -39.74 85.53 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 121' ' ' TRP . . . . . 0.5 ' O ' HG23 ' B' ' 125' ' ' VAL . 22.8 m0 -65.93 -53.0 44.94 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 65.9 mt -55.13 -38.47 68.25 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 123' ' ' LEU . . . . . 0.434 HD23 ' HA ' ' B' ' 123' ' ' LEU . 15.1 mt -58.88 -52.03 67.5 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 124' ' ' LEU . . . . . 0.449 ' HA ' HD12 ' B' ' 124' ' ' LEU . 15.4 tp -63.34 -28.77 70.23 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 125' ' ' VAL . . . . . 0.5 HG23 ' O ' ' B' ' 121' ' ' TRP . 76.2 t -72.73 -38.22 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 68.1 mt -72.3 -35.27 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 127' ' ' ILE . . . . . 0.47 ' O ' HG23 ' B' ' 131' ' ' VAL . 62.9 mt -70.51 -47.27 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' B' ' 128' ' ' LEU . 56.1 mt -66.42 -40.78 89.74 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 129' ' ' ARG . . . . . 0.416 ' HD3' HH11 ' B' ' 129' ' ' ARG . 10.7 ttt180 -65.85 -52.18 52.57 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 4.1 m -52.69 -49.64 64.91 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.47 HG23 ' O ' ' B' ' 127' ' ' ILE . 67.8 t -58.31 -54.02 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 132' ' ' LYS . . . . . 0.47 ' HB2' ' HE3' ' B' ' 132' ' ' LYS . 23.7 ttmt -50.99 -25.26 4.48 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -97.09 30.8 2.61 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 134' ' ' ALA . . . . . . . . . . . . . . . -140.72 2.7 1.81 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 135' ' ' ASN . . . . . 0.422 ' CG ' ' N ' ' B' ' 136' ' ' GLY . 15.2 t30 -134.95 170.53 15.74 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 136' ' ' GLY . . . . . 0.422 ' N ' ' CG ' ' B' ' 135' ' ' ASN . . . -53.86 -88.98 0.01 OUTLIER Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.565 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 -179.955 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 201' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 . . . . . 0 N--CA 1.449 -0.496 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 202' ' ' LYS . . . . . 0.489 ' HE2' ' HB2' ' C' ' 202' ' ' LYS . 10.2 tppt? -71.07 -23.46 62.14 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 203' ' ' THR . . . . . 0.668 HG21 ' CG ' ' A' ' 6' ' ' GLU . 1.6 m -69.13 -47.64 64.54 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 204' ' ' ASN . . . . . 0.502 ' HA ' HG13 ' C' ' 207' ' ' ILE . 1.6 t30 -42.1 -47.28 4.52 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 205' ' ' LEU . . . . . 0.527 HD23 ' HA ' ' C' ' 205' ' ' LEU . 12.3 mt -42.82 -50.24 5.68 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 206' ' ' GLU . . . . . 0.671 ' CG ' HG21 ' B' ' 103' ' ' THR . 0.1 OUTLIER -66.17 -32.27 73.61 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.938 -0.394 . . . . 0.0 109.938 179.938 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 207' ' ' ILE . . . . . 1.062 HG23 ' CD2' ' A' ' 10' ' ' LEU . 3.5 mt -64.95 -29.81 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 208' ' ' ILE . . . . . . . . . . . . . 44.9 mt -76.84 -42.56 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 209' ' ' ILE . . . . . 0.408 ' O ' ' HB ' ' C' ' 213' ' ' THR . 29.4 mt -76.67 -24.01 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 210' ' ' LEU . . . . . 1.053 ' CD2' HG23 ' B' ' 107' ' ' ILE . 15.4 mt -85.73 -47.64 9.57 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 211' ' ' GLU . . . . . 0.562 ' O ' HG23 ' C' ' 215' ' ' VAL . 59.3 mm-40 -59.09 -41.91 89.2 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 212' ' ' GLY . . . . . 0.72 ' C ' HD12 ' C' ' 216' ' ' ILE . . . -73.02 -56.08 5.98 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 213' ' ' THR . . . . . 0.55 HG22 ' CD ' ' B' ' 111' ' ' GLU . 34.0 m -57.93 -25.78 61.35 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 214' ' ' ALA . . . . . 0.494 ' HB2' ' O ' ' C' ' 210' ' ' LEU . . . -68.71 -63.03 1.14 Allowed 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 215' ' ' VAL . . . . . 0.567 HG22 ' CG ' ' A' ' 18' ' ' MET . 2.7 t -68.3 -21.41 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 216' ' ' ILE . . . . . 0.72 HD12 ' C ' ' C' ' 212' ' ' GLY . 30.4 mt -76.2 -64.64 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -51.05 -32.26 21.27 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 218' ' ' MET . . . . . 0.605 ' HE1' ' CE ' ' B' ' 118' ' ' MET . 6.4 mtp -65.08 -60.16 3.33 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -51.83 -37.45 51.91 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -67.38 -37.84 83.79 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 221' ' ' TRP . . . . . 0.636 ' O ' HG23 ' C' ' 225' ' ' VAL . 23.0 m0 -63.76 -53.65 47.72 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 66.7 mt -55.68 -40.1 71.85 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 223' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' C' ' 223' ' ' LEU . 15.1 mt -60.42 -51.27 70.21 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 224' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' C' ' 224' ' ' LEU . 15.4 tp -62.58 -27.71 69.38 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 225' ' ' VAL . . . . . 0.636 HG23 ' O ' ' C' ' 221' ' ' TRP . 75.5 t -71.87 -39.46 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 67.0 mt -73.37 -35.79 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 227' ' ' ILE . . . . . 0.44 ' O ' HG23 ' C' ' 231' ' ' VAL . 63.1 mt -70.4 -46.35 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 228' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' C' ' 228' ' ' LEU . 56.9 mt -66.01 -41.59 90.82 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 229' ' ' ARG . . . . . 0.415 ' HD3' HH11 ' C' ' 229' ' ' ARG . 10.9 ttt180 -65.44 -52.36 53.72 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 230' ' ' THR . . . . . . . . . . . . . 4.2 m -53.34 -49.36 67.27 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 231' ' ' VAL . . . . . 0.44 HG23 ' O ' ' C' ' 227' ' ' ILE . 54.6 t -58.95 -53.68 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 232' ' ' LYS . . . . . 0.422 ' HE3' ' HB2' ' C' ' 232' ' ' LYS . 23.6 ttmt -51.36 -25.41 6.02 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 233' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -97.06 30.72 2.63 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 234' ' ' ALA . . . . . . . . . . . . . . . -141.1 3.1 1.76 Allowed 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 235' ' ' ASN . . . . . 0.409 ' CG ' ' N ' ' C' ' 236' ' ' GLY . 15.4 t30 -134.28 170.1 16.21 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 236' ' ' GLY . . . . . 0.409 ' N ' ' CG ' ' C' ' 235' ' ' ASN . . . -54.19 -88.97 0.01 OUTLIER Glycine 0 C--N 1.335 0.479 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.485 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -179.991 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.452 ' HB3' ' H ' ' A' ' 2' ' ' LYS . 2.8 tp10 . . . . . 0 N--CA 1.449 -0.513 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.452 ' H ' ' HB3' ' A' ' 1' ' ' GLU . 0.0 OUTLIER -79.38 -59.94 2.56 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.478 HG23 ' N ' ' A' ' 4' ' ' ASN . 9.7 t -48.66 -41.2 30.65 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.911 -0.404 . . . . 0.0 109.911 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.507 ' HA ' HG13 ' A' ' 7' ' ' ILE . 2.6 t30 -42.77 -50.13 5.64 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.49 ' HA ' HD23 ' A' ' 5' ' ' LEU . 17.3 mt -42.88 -49.09 5.9 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.588 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 0.3 OUTLIER -64.57 -32.24 73.81 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.917 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 1.042 HG23 ' CD2' ' B' ' 110' ' ' LEU . 3.6 mt -65.19 -29.42 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 19.7 mt -76.92 -42.44 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.427 ' O ' ' HB ' ' A' ' 13' ' ' THR . 85.2 mt -77.29 -23.61 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 1.065 ' CD2' HG23 ' C' ' 207' ' ' ILE . 15.4 mt -85.77 -51.03 6.69 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.582 ' O ' HG23 ' A' ' 15' ' ' VAL . 66.7 mm-40 -58.63 -39.78 81.47 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.686 ' C ' HD12 ' A' ' 16' ' ' ILE . . . -73.42 -57.58 5.01 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.427 ' HB ' ' O ' ' A' ' 9' ' ' ILE . 46.2 m -57.88 -25.08 60.3 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.485 ' HB2' ' O ' ' A' ' 10' ' ' LEU . . . -68.81 -63.03 1.14 Allowed 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 11' ' ' GLU . 2.5 t -69.0 -21.08 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.686 HD12 ' C ' ' A' ' 12' ' ' GLY . 38.0 mt -77.45 -64.85 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.429 ' O ' ' CB ' ' A' ' 21' ' ' TRP . . . -51.13 -32.03 21.52 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.622 ' CE ' ' HE1' ' B' ' 118' ' ' MET . 6.9 mtp -68.65 -60.11 2.64 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -61.53 -61.65 2.38 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -43.17 -41.83 3.92 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.697 ' O ' HG23 ' A' ' 25' ' ' VAL . 9.5 t-105 -64.55 -44.27 91.31 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 22' ' ' LEU . 35.5 mt -59.01 -52.11 67.18 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 21.6 mt -54.44 -44.73 72.75 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.1 tp -59.52 -32.65 70.5 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 21' ' ' TRP . 84.3 t -72.44 -43.13 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 60.3 mt -65.14 -37.14 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.0 mt -70.5 -44.46 77.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 75.9 mt -66.03 -38.62 88.88 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 36.3 ttm105 -70.77 -47.35 60.04 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.6 m -57.83 -40.63 80.49 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 79.3 t -74.94 -39.97 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 34.1 tttp -55.37 -30.9 61.24 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 65.2 mtp180 -95.81 34.19 1.56 Allowed 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.838 -0.431 . . . . 0.0 109.838 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -136.96 9.92 3.05 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -117.34 160.4 21.19 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -104.56 106.17 2.69 Favored Glycine 0 C--N 1.336 0.558 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.517 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -179.982 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.63 -59.13 2.92 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 103' ' ' THR . . . . . 0.489 HG23 ' N ' ' B' ' 104' ' ' ASN . 9.0 t -47.76 -41.85 24.24 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 104' ' ' ASN . . . . . 0.496 ' HA ' HG13 ' B' ' 107' ' ' ILE . 2.8 t30 -42.96 -51.2 5.7 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' B' ' 105' ' ' LEU . 17.7 mt -43.05 -48.55 6.13 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 106' ' ' GLU . . . . . 0.583 ' CD ' ' N ' ' B' ' 106' ' ' GLU . 0.3 OUTLIER -64.27 -31.74 73.07 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 107' ' ' ILE . . . . . 1.061 HG23 ' CD2' ' C' ' 210' ' ' LEU . 3.8 mt -65.23 -29.86 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 20.3 mt -76.68 -42.19 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 109' ' ' ILE . . . . . 0.416 ' O ' ' HB ' ' B' ' 113' ' ' THR . 84.0 mt -77.39 -23.78 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 110' ' ' LEU . . . . . 1.042 ' CD2' HG23 ' A' ' 7' ' ' ILE . 15.6 mt -85.68 -50.95 6.79 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 111' ' ' GLU . . . . . 0.602 ' O ' HG23 ' B' ' 115' ' ' VAL . 67.3 mm-40 -58.63 -39.8 81.54 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 112' ' ' GLY . . . . . 0.677 ' C ' HD12 ' B' ' 116' ' ' ILE . . . -73.42 -57.59 5.0 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 113' ' ' THR . . . . . 0.416 ' HB ' ' O ' ' B' ' 109' ' ' ILE . 45.0 m -57.83 -25.17 60.27 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.938 -0.394 . . . . 0.0 109.938 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 114' ' ' ALA . . . . . 0.479 ' HB2' ' O ' ' B' ' 110' ' ' LEU . . . -68.8 -63.04 1.14 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 0.602 HG23 ' O ' ' B' ' 111' ' ' GLU . 2.5 t -68.97 -21.12 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 116' ' ' ILE . . . . . 0.677 HD12 ' C ' ' B' ' 112' ' ' GLY . 37.2 mt -77.24 -64.82 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 117' ' ' ALA . . . . . 0.409 ' O ' ' CB ' ' B' ' 121' ' ' TRP . . . -50.98 -32.26 20.56 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 118' ' ' MET . . . . . 0.622 ' HE1' ' CE ' ' A' ' 18' ' ' MET . 6.7 mtp -68.93 -60.11 2.59 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 2.4 m-30 -60.43 -61.74 2.37 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -43.16 -43.36 4.55 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 121' ' ' TRP . . . . . 0.591 ' O ' HG23 ' B' ' 125' ' ' VAL . 9.7 t-105 -66.11 -43.8 86.17 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 122' ' ' LEU . . . . . 0.434 ' HA ' HD23 ' B' ' 122' ' ' LEU . 36.0 mt -58.26 -50.97 71.71 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 21.8 mt -53.39 -44.95 69.06 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 4.1 tp -59.95 -34.06 72.76 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 125' ' ' VAL . . . . . 0.591 HG23 ' O ' ' B' ' 121' ' ' TRP . 80.4 t -73.72 -43.21 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 59.9 mt -65.05 -36.78 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 22.8 mt -70.65 -44.54 76.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 75.0 mt -65.75 -38.62 89.61 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 36.4 ttm105 -71.05 -47.12 60.28 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 4.4 m -58.15 -40.34 81.12 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 77.3 t -75.07 -40.52 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 33.8 tttp -55.08 -31.3 61.08 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 65.3 mtp180 -95.94 34.49 1.53 Allowed 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 134' ' ' ALA . . . . . . . . . . . . . . . -137.21 9.68 2.98 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -117.43 160.56 20.97 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -104.3 106.14 2.71 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.522 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.974 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 201' ' ' GLU . . . . . 0.407 ' HB3' ' H ' ' C' ' 202' ' ' LYS . 2.3 tp10 . . . . . 0 N--CA 1.449 -0.524 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 202' ' ' LYS . . . . . 0.407 ' H ' ' HB3' ' C' ' 201' ' ' GLU . 0.0 OUTLIER -73.32 -58.89 2.99 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 203' ' ' THR . . . . . 0.483 HG23 ' N ' ' C' ' 204' ' ' ASN . 8.9 t -46.74 -42.21 16.39 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 204' ' ' ASN . . . . . 0.494 ' HA ' HG13 ' C' ' 207' ' ' ILE . 2.8 t30 -43.06 -51.4 5.79 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 205' ' ' LEU . . . . . 0.514 HD23 ' HA ' ' C' ' 205' ' ' LEU . 17.8 mt -43.06 -48.33 6.11 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 206' ' ' GLU . . . . . 0.581 ' N ' ' CD ' ' C' ' 206' ' ' GLU . 0.3 OUTLIER -64.24 -31.92 73.31 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 207' ' ' ILE . . . . . 1.065 HG23 ' CD2' ' A' ' 10' ' ' LEU . 3.8 mt -65.21 -29.7 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 208' ' ' ILE . . . . . . . . . . . . . 19.9 mt -76.79 -42.18 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 209' ' ' ILE . . . . . 0.419 ' O ' ' HB ' ' C' ' 213' ' ' THR . 83.8 mt -77.36 -23.86 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 210' ' ' LEU . . . . . 1.061 ' CD2' HG23 ' B' ' 107' ' ' ILE . 15.3 mt -85.58 -50.75 6.98 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 211' ' ' GLU . . . . . 0.579 ' O ' HG23 ' C' ' 215' ' ' VAL . 66.6 mm-40 -58.59 -40.18 82.49 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 212' ' ' GLY . . . . . 0.679 ' C ' HD12 ' C' ' 216' ' ' ILE . . . -73.2 -57.53 5.13 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 213' ' ' THR . . . . . 0.419 ' HB ' ' O ' ' C' ' 209' ' ' ILE . 46.0 m -57.73 -25.22 60.09 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 214' ' ' ALA . . . . . 0.492 ' HB2' ' O ' ' C' ' 210' ' ' LEU . . . -68.7 -63.04 1.14 Allowed 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 215' ' ' VAL . . . . . 0.579 HG23 ' O ' ' C' ' 211' ' ' GLU . 2.6 t -69.02 -21.11 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 216' ' ' ILE . . . . . 0.679 HD12 ' C ' ' C' ' 212' ' ' GLY . 37.1 mt -77.17 -64.72 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 217' ' ' ALA . . . . . 0.427 ' O ' ' CB ' ' C' ' 221' ' ' TRP . . . -51.22 -32.25 23.35 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 218' ' ' MET . . . . . 0.597 ' HE1' ' CE ' ' B' ' 118' ' ' MET . 6.6 mtp -68.33 -60.24 2.6 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -60.82 -61.41 2.6 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -43.48 -43.07 5.19 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 221' ' ' TRP . . . . . 0.702 ' O ' HG23 ' C' ' 225' ' ' VAL . 9.7 t-105 -65.94 -43.41 88.12 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 36.4 mt -56.89 -51.35 69.42 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 223' ' ' LEU . . . . . . . . . . . . . 21.9 mt -53.97 -45.83 71.48 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 4.1 tp -60.97 -33.11 72.71 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 225' ' ' VAL . . . . . 0.702 HG23 ' O ' ' C' ' 221' ' ' TRP . 85.0 t -72.69 -42.49 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 60.0 mt -64.43 -36.67 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 227' ' ' ILE . . . . . 0.406 ' O ' HG23 ' C' ' 231' ' ' VAL . 23.4 mt -70.5 -44.51 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 75.1 mt -66.16 -38.96 89.36 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 229' ' ' ARG . . . . . . . . . . . . . 36.3 ttm105 -70.49 -47.0 62.62 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 230' ' ' THR . . . . . . . . . . . . . 3.8 m -57.76 -39.78 78.2 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 231' ' ' VAL . . . . . 0.406 HG23 ' O ' ' C' ' 227' ' ' ILE . 79.6 t -75.34 -40.51 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 232' ' ' LYS . . . . . . . . . . . . . 34.0 tttp -54.81 -31.27 58.95 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 233' ' ' ARG . . . . . . . . . . . . . 65.1 mtp180 -96.1 34.7 1.53 Allowed 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 234' ' ' ALA . . . . . . . . . . . . . . . -137.36 9.92 2.96 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 235' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -117.27 159.86 22.02 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 236' ' ' GLY . . . . . . . . . . . . . . . -104.88 105.89 2.61 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.524 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 -179.958 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 . . . . . 0 N--CA 1.449 -0.516 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 13.9 tptt -79.52 -45.31 19.53 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.2 t -43.53 -33.32 1.1 Allowed 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASN . . . . . 0.508 ' HA ' HG13 ' A' ' 7' ' ' ILE . 2.1 t30 -42.79 -51.28 5.45 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.489 ' HA ' HD23 ' A' ' 5' ' ' LEU . 12.1 mt -43.03 -48.43 6.03 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.587 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 1.8 mp0 -64.59 -31.3 72.45 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 1.039 HG23 ' CD2' ' B' ' 110' ' ' LEU . 4.1 mt -65.34 -30.07 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 73.9 mt -76.89 -42.05 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.418 ' O ' ' HB ' ' A' ' 13' ' ' THR . 15.9 mt -76.95 -24.29 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 1.026 ' CD2' HG23 ' C' ' 207' ' ' ILE . 15.4 mt -85.39 -49.85 7.78 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.558 ' CD ' HG22 ' B' ' 113' ' ' THR . 61.7 mm-40 -57.87 -42.04 83.73 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.855 ' C ' HD12 ' A' ' 16' ' ' ILE . . . -72.02 -55.95 6.79 Favored Glycine 0 C--N 1.335 0.475 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.575 HG22 ' CD ' ' C' ' 211' ' ' GLU . 23.7 m -57.95 -25.38 60.88 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.429 ' HB2' ' O ' ' A' ' 10' ' ' LEU . . . -68.52 -63.09 1.13 Allowed 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.598 HG22 ' HG3' ' B' ' 118' ' ' MET . 2.7 t -68.95 -21.13 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.855 HD12 ' C ' ' A' ' 12' ' ' GLY . 23.3 mt -76.54 -64.68 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.88 -33.44 24.02 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.664 ' HE2' ' HE1' ' B' ' 118' ' ' MET . 6.7 mtp -68.86 -60.03 2.66 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -55.11 -24.21 24.67 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -74.5 -39.91 62.14 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.419 ' O ' HG23 ' A' ' 25' ' ' VAL . 3.0 m95 -75.61 -35.42 60.53 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 13.0 mt -66.9 -54.15 25.05 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.735 HD12 ' C ' ' A' ' 23' ' ' LEU . 1.1 pp -59.44 -37.34 77.86 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.586 ' C ' HD23 ' A' ' 24' ' ' LEU . 6.1 tt -59.16 -42.48 90.86 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 21' ' ' TRP . 96.9 t -74.09 -23.48 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.662 HD12 ' HA ' ' A' ' 23' ' ' LEU . 57.7 mt -71.45 -43.68 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.59 ' O ' HG23 ' A' ' 31' ' ' VAL . 25.1 mt -71.09 -39.02 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.463 ' HA ' HD23 ' A' ' 28' ' ' LEU . 24.4 mt -69.61 -44.22 71.15 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.497 ' HG2' ' NH1' ' A' ' 29' ' ' ARG . 6.1 ttt-85 -68.17 -48.03 66.38 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.9 m -53.36 -44.49 68.59 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.59 HG23 ' O ' ' A' ' 27' ' ' ILE . 55.7 t -62.29 -46.96 95.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.445 ' HA ' ' HD3' ' A' ' 32' ' ' LYS . 15.2 tppt? -53.57 -32.55 51.33 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 6.4 mmt180 -97.56 36.05 1.56 Allowed 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.57 3.56 1.9 Allowed 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -85.18 142.63 29.32 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.29 -102.18 2.44 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.508 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 -179.984 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 . . . . . 0 N--CA 1.45 -0.456 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 13.9 tptt -79.69 -45.33 19.18 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 5.2 t -43.54 -33.33 1.11 Allowed 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 104' ' ' ASN . . . . . 0.498 ' HA ' HG13 ' B' ' 107' ' ' ILE . 2.1 t30 -42.81 -51.23 5.5 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 0.469 ' HA ' HD23 ' B' ' 105' ' ' LEU . 12.0 mt -43.05 -48.45 6.1 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 106' ' ' GLU . . . . . 0.588 ' CD ' ' N ' ' B' ' 106' ' ' GLU . 1.8 mp0 -64.62 -31.33 72.5 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 107' ' ' ILE . . . . . 1.035 HG23 ' CD2' ' C' ' 210' ' ' LEU . 4.1 mt -65.28 -30.18 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 74.6 mt -76.84 -42.03 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 109' ' ' ILE . . . . . 0.423 ' O ' ' HB ' ' B' ' 113' ' ' THR . 16.1 mt -76.99 -24.32 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 110' ' ' LEU . . . . . 1.039 ' CD2' HG23 ' A' ' 7' ' ' ILE . 15.4 mt -85.44 -49.59 7.97 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 111' ' ' GLU . . . . . 0.542 ' CD ' HG22 ' C' ' 213' ' ' THR . 61.5 mm-40 -57.99 -42.21 84.66 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 112' ' ' GLY . . . . . 0.85 ' C ' HD12 ' B' ' 116' ' ' ILE . . . -71.95 -55.94 6.84 Favored Glycine 0 C--N 1.336 0.547 0 N-CA-C 110.279 -1.129 . . . . 0.0 110.279 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 113' ' ' THR . . . . . 0.558 HG22 ' CD ' ' A' ' 11' ' ' GLU . 24.1 m -57.91 -25.58 61.05 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 114' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' B' ' 110' ' ' LEU . . . -68.34 -63.04 1.14 Allowed 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 115' ' ' VAL . . . . . 0.588 HG22 ' HG3' ' C' ' 218' ' ' MET . 2.7 t -68.98 -21.07 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 116' ' ' ILE . . . . . 0.85 HD12 ' C ' ' B' ' 112' ' ' GLY . 22.0 mt -76.2 -64.66 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -50.78 -34.02 25.69 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 118' ' ' MET . . . . . 0.664 ' HE1' ' HE2' ' A' ' 18' ' ' MET . 6.5 mtp -68.63 -59.57 3.03 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -54.1 -24.2 16.75 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -74.79 -41.05 60.72 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 121' ' ' TRP . . . . . 0.433 ' O ' HG23 ' B' ' 125' ' ' VAL . 2.9 m95 -75.13 -34.1 61.62 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 12.9 mt -67.2 -54.68 18.86 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 123' ' ' LEU . . . . . 0.729 HD12 ' C ' ' B' ' 123' ' ' LEU . 1.0 OUTLIER -58.71 -38.15 77.69 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 124' ' ' LEU . . . . . 0.586 ' C ' HD23 ' B' ' 124' ' ' LEU . 6.1 tt -58.74 -42.61 89.19 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 125' ' ' VAL . . . . . 0.433 HG23 ' O ' ' B' ' 121' ' ' TRP . 97.4 t -74.61 -23.52 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 126' ' ' ILE . . . . . 0.683 HD12 ' HA ' ' B' ' 123' ' ' LEU . 54.3 mt -71.07 -43.56 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 127' ' ' ILE . . . . . 0.576 ' O ' HG23 ' B' ' 131' ' ' VAL . 24.6 mt -71.33 -38.78 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.504 ' HA ' HD23 ' B' ' 128' ' ' LEU . 24.5 mt -70.03 -44.02 70.12 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 129' ' ' ARG . . . . . 0.493 ' HG2' ' NH1' ' B' ' 129' ' ' ARG . 6.4 ttt-85 -68.43 -47.72 66.46 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 5.2 m -53.5 -44.4 69.04 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.576 HG23 ' O ' ' B' ' 127' ' ' ILE . 53.9 t -62.24 -46.98 95.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 132' ' ' LYS . . . . . 0.412 ' HA ' ' HD3' ' B' ' 132' ' ' LYS . 15.1 tppt? -53.81 -31.66 49.92 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 133' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' B' ' 133' ' ' ARG . 6.2 mmt180 -98.23 36.17 1.64 Allowed 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 134' ' ' ALA . . . . . . . . . . . . . . . -140.24 3.65 1.97 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -84.94 143.07 29.22 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . 100.57 -101.1 2.25 Favored Glycine 0 C--N 1.335 0.496 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.513 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 179.994 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 201' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 . . . . . 0 N--CA 1.45 -0.47 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -79.64 -45.49 18.97 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 203' ' ' THR . . . . . . . . . . . . . 5.1 t -43.44 -33.51 1.09 Allowed 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 204' ' ' ASN . . . . . 0.494 ' HA ' HG13 ' C' ' 207' ' ' ILE . 2.1 t30 -42.85 -51.09 5.6 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 205' ' ' LEU . . . . . 0.49 HD23 ' HA ' ' C' ' 205' ' ' LEU . 12.0 mt -43.04 -48.46 6.08 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 206' ' ' GLU . . . . . 0.582 ' N ' ' CD ' ' C' ' 206' ' ' GLU . 1.8 mp0 -64.62 -31.34 72.51 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 207' ' ' ILE . . . . . 1.026 HG23 ' CD2' ' A' ' 10' ' ' LEU . 4.1 mt -65.23 -30.16 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 208' ' ' ILE . . . . . . . . . . . . . 74.3 mt -76.83 -42.2 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 209' ' ' ILE . . . . . 0.424 ' O ' ' HB ' ' C' ' 213' ' ' THR . 16.1 mt -76.8 -24.32 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 210' ' ' LEU . . . . . 1.035 ' CD2' HG23 ' B' ' 107' ' ' ILE . 15.4 mt -85.44 -49.5 8.05 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 211' ' ' GLU . . . . . 0.575 ' CD ' HG22 ' A' ' 13' ' ' THR . 60.8 mm-40 -57.92 -42.29 84.51 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 212' ' ' GLY . . . . . 0.847 ' C ' HD12 ' C' ' 216' ' ' ILE . . . -72.08 -55.83 6.82 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 213' ' ' THR . . . . . 0.542 HG22 ' CD ' ' B' ' 111' ' ' GLU . 23.9 m -57.85 -25.49 60.78 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 214' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' C' ' 210' ' ' LEU . . . -68.48 -63.09 1.13 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 215' ' ' VAL . . . . . 0.612 HG22 ' CG ' ' A' ' 18' ' ' MET . 2.8 t -68.89 -21.09 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 216' ' ' ILE . . . . . 0.847 HD12 ' C ' ' C' ' 212' ' ' GLY . 23.1 mt -76.51 -64.8 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -50.78 -33.37 23.03 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 218' ' ' MET . . . . . 0.618 ' HE1' ' CE ' ' B' ' 118' ' ' MET . 6.5 mtp -68.9 -60.19 2.55 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -54.07 -25.02 19.48 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -75.58 -38.5 59.07 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 221' ' ' TRP . . . . . 0.48 ' O ' HG23 ' C' ' 225' ' ' VAL . 3.0 m95 -75.28 -33.69 61.27 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 13.1 mt -66.95 -54.67 19.73 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 223' ' ' LEU . . . . . 0.739 ' C ' HD12 ' C' ' 223' ' ' LEU . 1.1 pp -59.46 -37.62 78.65 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 224' ' ' LEU . . . . . 0.578 ' C ' HD23 ' C' ' 224' ' ' LEU . 6.2 tt -59.23 -41.31 88.37 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 225' ' ' VAL . . . . . 0.48 HG23 ' O ' ' C' ' 221' ' ' TRP . 97.4 t -74.36 -24.04 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 226' ' ' ILE . . . . . 0.654 HD12 ' HA ' ' C' ' 223' ' ' LEU . 59.3 mt -71.12 -43.39 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 227' ' ' ILE . . . . . 0.565 ' O ' HG23 ' C' ' 231' ' ' VAL . 24.2 mt -71.38 -38.88 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 228' ' ' LEU . . . . . 0.489 ' HA ' HD23 ' C' ' 228' ' ' LEU . 23.8 mt -69.77 -44.28 70.48 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 229' ' ' ARG . . . . . 0.498 ' NH1' ' HG2' ' C' ' 229' ' ' ARG . 6.1 ttt-85 -68.1 -48.19 66.15 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 230' ' ' THR . . . . . . . . . . . . . 4.3 m -53.11 -44.62 67.79 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 231' ' ' VAL . . . . . 0.565 HG23 ' O ' ' C' ' 227' ' ' ILE . 53.6 t -62.44 -46.8 95.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 232' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' C' ' 232' ' ' LYS . 15.1 tppt? -53.22 -31.64 44.2 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 233' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' C' ' 233' ' ' ARG . 6.2 mmt180 -97.73 35.82 1.62 Allowed 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 234' ' ' ALA . . . . . . . . . . . . . . . -140.5 3.81 1.93 Allowed 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 235' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -84.79 143.21 29.26 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 236' ' ' GLY . . . . . . . . . . . . . . . 100.8 -101.58 2.31 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.533 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.995 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.2 t . . . . . 0 N--CA 1.449 -0.507 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.5 ' HA ' HG13 ' A' ' 7' ' ' ILE . 1.5 t-20 -42.92 -51.12 5.68 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.429 ' HA ' HD23 ' A' ' 5' ' ' LEU . 14.0 mt -42.99 -48.52 5.97 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.578 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 0.8 OUTLIER -64.66 -31.36 72.55 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.916 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 1.046 HG23 ' CD2' ' B' ' 110' ' ' LEU . 4.0 mt -65.23 -30.23 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 23.7 mt -76.73 -42.11 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.421 ' O ' ' HB ' ' A' ' 13' ' ' THR . 53.7 mt -76.87 -24.29 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 1.034 ' CD2' HG23 ' C' ' 207' ' ' ILE . 15.4 mt -85.59 -46.77 10.49 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.568 ' CD ' HG22 ' B' ' 113' ' ' THR . 57.1 mm-40 -59.37 -42.71 92.25 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.74 ' C ' HD12 ' A' ' 16' ' ' ILE . . . -72.56 -56.12 6.28 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.55 HG22 ' CD ' ' C' ' 211' ' ' GLU . 39.4 m -57.83 -25.88 61.25 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.525 ' HB2' ' O ' ' A' ' 10' ' ' LEU . . . -68.38 -63.05 1.14 Allowed 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.626 HG22 ' CG ' ' B' ' 118' ' ' MET . 2.7 t -68.56 -21.36 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.74 HD12 ' C ' ' A' ' 12' ' ' GLY . 29.2 mt -76.11 -64.7 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.89 -32.95 22.16 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.61 ' CE ' ' HE1' ' B' ' 118' ' ' MET . 6.4 mtp . . . . . 0 N--CA 1.449 -0.497 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 7.0 t . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . 0.505 ' HA ' HG13 ' B' ' 107' ' ' ILE . 1.5 t-20 -42.92 -51.15 5.67 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . 0.451 ' HA ' HD23 ' B' ' 105' ' ' LEU . 14.1 mt -42.99 -48.57 5.97 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 106' ' ' GLU . . . . . 0.59 ' CD ' ' N ' ' B' ' 106' ' ' GLU . 0.8 OUTLIER -64.51 -31.41 72.61 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 107' ' ' ILE . . . . . 1.052 HG23 ' CD2' ' C' ' 210' ' ' LEU . 4.0 mt -65.2 -30.27 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 23.8 mt -76.72 -42.08 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 109' ' ' ILE . . . . . 0.417 ' O ' ' HB ' ' B' ' 113' ' ' THR . 54.1 mt -76.87 -24.29 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . 1.046 ' CD2' HG23 ' A' ' 7' ' ' ILE . 15.4 mt -85.53 -46.95 10.36 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 111' ' ' GLU . . . . . 0.556 ' CD ' HG22 ' C' ' 213' ' ' THR . 57.8 mm-40 -59.37 -42.65 92.12 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 112' ' ' GLY . . . . . 0.728 ' C ' HD12 ' B' ' 116' ' ' ILE . . . -72.54 -56.16 6.27 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.281 -1.127 . . . . 0.0 110.281 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 113' ' ' THR . . . . . 0.568 HG22 ' CD ' ' A' ' 11' ' ' GLU . 38.5 m -57.96 -25.72 61.35 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 114' ' ' ALA . . . . . 0.521 ' HB2' ' O ' ' B' ' 110' ' ' LEU . . . -68.42 -62.99 1.15 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . 0.624 HG22 ' CG ' ' C' ' 218' ' ' MET . 2.7 t -68.73 -21.22 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 116' ' ' ILE . . . . . 0.728 HD12 ' C ' ' B' ' 112' ' ' GLY . 28.7 mt -76.18 -64.58 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -51.15 -33.0 24.92 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 118' ' ' MET . . . . . 0.626 ' CG ' HG22 ' A' ' 15' ' ' VAL . 6.4 mtp . . . . . 0 N--CA 1.45 -0.474 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 203' ' ' THR . . . . . . . . . . . . . 7.0 t . . . . . 0 N--CA 1.449 -0.496 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 204' ' ' ASN . . . . . 0.487 ' HA ' HG13 ' C' ' 207' ' ' ILE . 1.5 t-20 -43.01 -51.21 5.76 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 205' ' ' LEU . . . . . . . . . . . . . 14.1 mt -43.02 -48.44 6.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 206' ' ' GLU . . . . . 0.575 ' N ' ' CD ' ' C' ' 206' ' ' GLU . 0.8 OUTLIER -64.58 -31.43 72.64 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 207' ' ' ILE . . . . . 1.034 HG23 ' CD2' ' A' ' 10' ' ' LEU . 4.0 mt -65.18 -30.24 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 208' ' ' ILE . . . . . . . . . . . . . 23.7 mt -76.72 -42.17 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 209' ' ' ILE . . . . . 0.412 ' O ' ' HB ' ' C' ' 213' ' ' THR . 54.1 mt -76.8 -24.27 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 210' ' ' LEU . . . . . 1.052 ' CD2' HG23 ' B' ' 107' ' ' ILE . 15.4 mt -85.61 -46.62 10.62 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 211' ' ' GLU . . . . . 0.55 ' CD ' HG22 ' A' ' 13' ' ' THR . 57.2 mm-40 -59.42 -42.75 92.58 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 212' ' ' GLY . . . . . 0.741 ' C ' HD12 ' C' ' 216' ' ' ILE . . . -72.58 -56.05 6.3 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 213' ' ' THR . . . . . 0.556 HG22 ' CD ' ' B' ' 111' ' ' GLU . 38.2 m -57.93 -25.94 61.56 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 214' ' ' ALA . . . . . 0.526 ' HB2' ' O ' ' C' ' 210' ' ' LEU . . . -68.28 -63.07 1.13 Allowed 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 215' ' ' VAL . . . . . 0.609 HG22 ' CG ' ' A' ' 18' ' ' MET . 2.7 t -68.52 -21.42 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 216' ' ' ILE . . . . . 0.741 HD12 ' C ' ' C' ' 212' ' ' GLY . 28.5 mt -76.03 -64.66 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -51.0 -32.77 22.3 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 218' ' ' MET . . . . . 0.624 ' CG ' HG22 ' B' ' 115' ' ' VAL . 6.2 mtp . . . . . 0 N--CA 1.449 -0.523 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.816 HG21 ' CG ' ' B' ' 106' ' ' GLU . 98.1 m . . . . . 0 N--CA 1.448 -0.545 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.477 ' HA ' HG13 ' A' ' 7' ' ' ILE . 5.9 p-10 -42.91 -50.65 5.76 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.481 ' HA ' HD23 ' A' ' 5' ' ' LEU . 13.0 mt -43.51 -47.32 7.22 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.815 ' CG ' HG21 ' C' ' 203' ' ' THR . 1.0 OUTLIER -66.04 -31.09 71.77 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 1.064 HG23 ' CD2' ' B' ' 110' ' ' LEU . 5.3 mt -64.69 -31.92 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 31.0 mt -75.75 -42.89 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.426 ' O ' ' HB ' ' A' ' 13' ' ' THR . 62.5 mt -74.34 -27.56 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 1.06 ' CD2' HG23 ' C' ' 207' ' ' ILE . 15.1 mt -83.16 -41.69 18.2 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.747 ' CD ' HG22 ' B' ' 113' ' ' THR . 34.5 mm-40 -58.54 -49.23 78.16 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.464 ' C ' HD12 ' A' ' 16' ' ' ILE . . . -69.91 -59.69 5.38 Favored Glycine 0 C--N 1.335 0.515 0 N-CA-C 110.294 -1.123 . . . . 0.0 110.294 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.764 HG22 ' CD ' ' C' ' 211' ' ' GLU . 23.6 m -49.05 -37.06 19.75 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.5 ' HB2' ' O ' ' A' ' 10' ' ' LEU . . . -60.08 -62.89 1.54 Allowed 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.649 HG22 ' HG3' ' B' ' 118' ' ' MET . 3.0 t -63.75 -21.16 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.545 HD12 ' HA ' ' A' ' 13' ' ' THR . 27.8 mt -70.73 -64.63 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.48 -35.63 30.0 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.653 ' HG2' HG13 ' C' ' 215' ' ' VAL . 4.8 mtp . . . . . 0 N--CA 1.448 -0.533 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 103' ' ' THR . . . . . 0.799 HG21 ' CG ' ' C' ' 206' ' ' GLU . 98.6 m . . . . . 0 N--CA 1.449 -0.512 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . 0.487 ' HA ' HG13 ' B' ' 107' ' ' ILE . 5.9 p-10 -42.93 -50.47 5.8 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . 0.527 ' HA ' HD23 ' B' ' 105' ' ' LEU . 13.1 mt -43.62 -47.3 7.54 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 106' ' ' GLU . . . . . 0.816 ' CG ' HG21 ' A' ' 3' ' ' THR . 1.0 OUTLIER -66.09 -30.98 71.59 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 107' ' ' ILE . . . . . 1.069 HG23 ' CD2' ' C' ' 210' ' ' LEU . 5.3 mt -64.75 -31.89 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 31.1 mt -75.72 -42.88 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 109' ' ' ILE . . . . . 0.41 ' O ' ' HB ' ' B' ' 113' ' ' THR . 62.4 mt -74.35 -27.61 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . 1.064 ' CD2' HG23 ' A' ' 7' ' ' ILE . 15.1 mt -83.19 -41.7 18.14 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 111' ' ' GLU . . . . . 0.747 ' CD ' HG22 ' C' ' 213' ' ' THR . 34.9 mm-40 -58.54 -49.19 78.32 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 112' ' ' GLY . . . . . 0.476 ' C ' HD12 ' B' ' 116' ' ' ILE . . . -70.01 -59.71 5.32 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 113' ' ' THR . . . . . 0.747 HG22 ' CD ' ' A' ' 11' ' ' GLU . 23.6 m -48.96 -37.07 19.04 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 114' ' ' ALA . . . . . 0.501 ' HB2' ' O ' ' B' ' 110' ' ' LEU . . . -60.11 -62.9 1.53 Allowed 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . 0.651 HG13 ' HG2' ' C' ' 218' ' ' MET . 3.0 t -63.72 -21.17 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 116' ' ' ILE . . . . . 0.522 HD12 ' HA ' ' B' ' 113' ' ' THR . 27.8 mt -70.67 -64.71 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -50.45 -35.53 29.25 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 118' ' ' MET . . . . . 0.649 ' HG3' HG22 ' A' ' 15' ' ' VAL . 4.7 mtp . . . . . 0 N--CA 1.449 -0.482 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 203' ' ' THR . . . . . 0.815 HG21 ' CG ' ' A' ' 6' ' ' GLU . 97.9 m . . . . . 0 N--CA 1.449 -0.482 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 204' ' ' ASN . . . . . 0.478 ' HA ' HG13 ' C' ' 207' ' ' ILE . 5.8 p-10 -42.98 -50.4 5.88 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 205' ' ' LEU . . . . . 0.479 HD23 ' HA ' ' C' ' 205' ' ' LEU . 13.1 mt -43.54 -47.35 7.31 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 206' ' ' GLU . . . . . 0.799 ' CG ' HG21 ' B' ' 103' ' ' THR . 1.0 OUTLIER -66.05 -31.14 71.85 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 207' ' ' ILE . . . . . 1.06 HG23 ' CD2' ' A' ' 10' ' ' LEU . 5.3 mt -64.67 -31.8 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 208' ' ' ILE . . . . . . . . . . . . . 30.9 mt -75.83 -42.97 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 209' ' ' ILE . . . . . 0.422 ' O ' ' HB ' ' C' ' 213' ' ' THR . 62.3 mt -74.32 -27.49 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 210' ' ' LEU . . . . . 1.069 ' CD2' HG23 ' B' ' 107' ' ' ILE . 15.1 mt -83.21 -41.64 18.18 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 211' ' ' GLU . . . . . 0.764 ' CD ' HG22 ' A' ' 13' ' ' THR . 34.5 mm-40 -58.58 -49.13 78.58 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 212' ' ' GLY . . . . . 0.461 ' C ' HD12 ' C' ' 216' ' ' ILE . . . -70.1 -59.68 5.3 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 213' ' ' THR . . . . . 0.747 HG22 ' CD ' ' B' ' 111' ' ' GLU . 23.7 m -48.92 -37.14 18.99 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 214' ' ' ALA . . . . . 0.496 ' HB2' ' O ' ' C' ' 210' ' ' LEU . . . -60.08 -62.9 1.53 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 215' ' ' VAL . . . . . 0.653 HG13 ' HG2' ' A' ' 18' ' ' MET . 3.0 t -63.73 -21.09 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 216' ' ' ILE . . . . . 0.529 HD12 ' HA ' ' C' ' 213' ' ' THR . 27.8 mt -70.73 -64.63 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -50.49 -35.47 29.34 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 218' ' ' MET . . . . . 0.651 ' HG2' HG13 ' B' ' 115' ' ' VAL . 4.7 mtp . . . . . 0 N--CA 1.449 -0.49 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.4 t . . . . . 0 N--CA 1.449 -0.523 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.496 ' HA ' HG13 ' A' ' 7' ' ' ILE . 1.4 t-20 -42.87 -50.35 5.74 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 5' ' ' LEU . 12.3 mt -43.07 -47.7 6.03 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.571 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 2.2 mp0 -66.47 -30.89 71.33 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 1.064 HG23 ' CD2' ' B' ' 110' ' ' LEU . 5.2 mt -64.19 -32.1 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 24.3 mt -75.84 -44.02 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.412 ' O ' ' HB ' ' A' ' 13' ' ' THR . 98.3 mt -73.59 -25.51 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 1.08 ' CD2' HG23 ' C' ' 207' ' ' ILE . 15.5 mt -85.44 -41.3 15.52 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.672 ' CD ' HG22 ' B' ' 113' ' ' THR . 37.4 mm-40 -58.88 -45.9 89.12 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.748 ' C ' HD12 ' A' ' 16' ' ' ILE . . . -73.42 -55.06 6.33 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.67 HG22 ' CD ' ' C' ' 211' ' ' GLU . 22.9 m -55.08 -31.05 60.88 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.502 ' HB2' ' O ' ' A' ' 10' ' ' LEU . . . -66.43 -63.2 1.13 Allowed 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.821 -0.436 . . . . 0.0 109.821 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 11' ' ' GLU . 2.8 t -64.31 -21.37 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.748 HD12 ' C ' ' A' ' 12' ' ' GLY . 22.3 mt -73.59 -64.69 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.55 -26.18 20.2 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.783 ' SD ' ' HE1' ' C' ' 218' ' ' MET . 11.6 mtp . . . . . 0 N--CA 1.449 -0.503 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 5.3 t . . . . . 0 N--CA 1.449 -0.499 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . 0.503 ' HA ' HG13 ' B' ' 107' ' ' ILE . 1.4 t-20 -42.91 -50.35 5.8 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' B' ' 105' ' ' LEU . 12.3 mt -43.22 -47.58 6.43 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 106' ' ' GLU . . . . . 0.582 ' CD ' ' N ' ' B' ' 106' ' ' GLU . 2.2 mp0 -66.42 -31.02 71.52 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 107' ' ' ILE . . . . . 1.082 HG23 ' CD2' ' C' ' 210' ' ' LEU . 5.2 mt -64.08 -32.02 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 24.1 mt -75.93 -44.19 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 109' ' ' ILE . . . . . 0.413 ' O ' ' HB ' ' B' ' 113' ' ' THR . 98.2 mt -73.43 -25.54 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . 1.064 ' CD2' HG23 ' A' ' 7' ' ' ILE . 15.5 mt -85.38 -41.45 15.45 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 111' ' ' GLU . . . . . 0.683 ' O ' HG23 ' B' ' 115' ' ' VAL . 37.2 mm-40 -58.57 -45.91 88.04 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 112' ' ' GLY . . . . . 0.735 ' C ' HD12 ' B' ' 116' ' ' ILE . . . -73.57 -55.39 6.07 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 113' ' ' THR . . . . . 0.672 HG22 ' CD ' ' A' ' 11' ' ' GLU . 23.2 m -54.69 -30.94 57.03 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 114' ' ' ALA . . . . . 0.502 ' HB2' ' O ' ' B' ' 110' ' ' LEU . . . -66.66 -63.32 1.09 Allowed 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . 0.683 HG23 ' O ' ' B' ' 111' ' ' GLU . 2.7 t -64.07 -21.35 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 116' ' ' ILE . . . . . 0.735 HD12 ' C ' ' B' ' 112' ' ' GLY . 23.0 mt -73.55 -64.67 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -53.59 -25.99 19.76 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 118' ' ' MET . . . . . 0.789 ' HE1' ' SD ' ' C' ' 218' ' ' MET . 11.5 mtp . . . . . 0 N--CA 1.45 -0.473 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 203' ' ' THR . . . . . . . . . . . . . 5.3 t . . . . . 0 N--CA 1.449 -0.513 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 204' ' ' ASN . . . . . 0.511 ' HA ' HG13 ' C' ' 207' ' ' ILE . 1.4 t-20 -42.86 -50.61 5.7 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 205' ' ' LEU . . . . . 0.43 HD23 ' HA ' ' C' ' 205' ' ' LEU . 12.4 mt -43.13 -47.48 6.15 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 206' ' ' GLU . . . . . 0.572 ' N ' ' CD ' ' C' ' 206' ' ' GLU . 2.2 mp0 -66.43 -30.92 71.38 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 207' ' ' ILE . . . . . 1.08 HG23 ' CD2' ' A' ' 10' ' ' LEU . 5.3 mt -64.26 -32.0 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 208' ' ' ILE . . . . . . . . . . . . . 24.1 mt -75.94 -43.92 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 209' ' ' ILE . . . . . 0.419 ' O ' ' HB ' ' C' ' 213' ' ' THR . 98.3 mt -73.6 -25.63 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.722 -0.474 . . . . 0.0 109.722 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 210' ' ' LEU . . . . . 1.082 ' CD2' HG23 ' B' ' 107' ' ' ILE . 15.5 mt -85.38 -41.26 15.62 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 211' ' ' GLU . . . . . 0.674 ' O ' HG23 ' C' ' 215' ' ' VAL . 37.3 mm-40 -58.9 -45.88 89.2 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 212' ' ' GLY . . . . . 0.739 ' C ' HD12 ' C' ' 216' ' ' ILE . . . -73.48 -55.09 6.28 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.291 -1.123 . . . . 0.0 110.291 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 213' ' ' THR . . . . . 0.678 HG22 ' CD ' ' B' ' 111' ' ' GLU . 22.8 m -55.04 -31.14 60.87 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 214' ' ' ALA . . . . . 0.503 ' HB2' ' O ' ' C' ' 210' ' ' LEU . . . -66.39 -63.36 1.09 Allowed 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 215' ' ' VAL . . . . . 0.674 HG23 ' O ' ' C' ' 211' ' ' GLU . 2.8 t -64.07 -21.55 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 216' ' ' ILE . . . . . 0.739 HD12 ' C ' ' C' ' 212' ' ' GLY . 22.2 mt -73.44 -64.67 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -53.57 -26.05 19.84 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 218' ' ' MET . . . . . 0.789 ' SD ' ' HE1' ' B' ' 118' ' ' MET . 11.6 mtp . . . . . 0 N--CA 1.45 -0.457 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.45 -0.468 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.504 ' HA ' HG13 ' A' ' 7' ' ' ILE . 1.1 t-20 -42.74 -51.05 5.48 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.463 ' HA ' HD23 ' A' ' 5' ' ' LEU . 13.1 mt -43.01 -48.9 6.07 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.587 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 2.6 mp0 -64.13 -31.63 72.9 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 1.025 HG23 ' CD2' ' B' ' 110' ' ' LEU . 3.8 mt -65.25 -29.89 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.8 mt -76.77 -42.13 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.428 ' O ' ' HB ' ' A' ' 13' ' ' THR . 83.4 mt -77.3 -23.82 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 1.045 ' CD2' HG23 ' C' ' 207' ' ' ILE . 15.5 mt -85.7 -49.75 7.72 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.579 ' O ' HG23 ' A' ' 15' ' ' VAL . 58.7 mm-40 -59.01 -40.42 84.87 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.87 ' C ' HD12 ' A' ' 16' ' ' ILE . . . -73.27 -57.52 5.11 Favored Glycine 0 C--N 1.335 0.509 0 N-CA-C 110.276 -1.129 . . . . 0.0 110.276 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.428 ' HB ' ' O ' ' A' ' 9' ' ' ILE . 49.5 m -57.78 -25.18 60.17 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.507 ' HB2' ' O ' ' A' ' 10' ' ' LEU . . . -68.79 -62.92 1.18 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 11' ' ' GLU . 2.6 t -69.04 -21.08 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.87 HD12 ' C ' ' A' ' 12' ' ' GLY . 22.4 mt -77.31 -64.85 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.15 -32.07 21.84 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.591 ' CE ' ' HE1' ' B' ' 118' ' ' MET . 6.7 mtp . . . . . 0 N--CA 1.449 -0.506 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.449 -0.51 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . 0.501 ' HA ' HG13 ' B' ' 107' ' ' ILE . 1.1 t-20 -42.72 -51.09 5.44 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . 0.464 HD23 ' HA ' ' B' ' 105' ' ' LEU . 13.1 mt -42.81 -48.92 5.79 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 106' ' ' GLU . . . . . 0.589 ' CD ' ' N ' ' B' ' 106' ' ' GLU . 2.6 mp0 -64.27 -31.65 72.94 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 107' ' ' ILE . . . . . 1.046 HG23 ' CD2' ' C' ' 210' ' ' LEU . 3.8 mt -65.34 -29.75 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 39.4 mt -76.82 -42.17 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 109' ' ' ILE . . . . . 0.418 ' O ' ' HB ' ' B' ' 113' ' ' THR . 84.1 mt -77.3 -23.81 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . 1.025 ' CD2' HG23 ' A' ' 7' ' ' ILE . 15.5 mt -85.67 -50.23 7.36 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 111' ' ' GLU . . . . . 0.595 ' O ' HG23 ' B' ' 115' ' ' VAL . 59.3 mm-40 -58.88 -40.19 83.67 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 112' ' ' GLY . . . . . 0.884 ' C ' HD12 ' B' ' 116' ' ' ILE . . . -73.32 -57.58 5.05 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 113' ' ' THR . . . . . 0.418 ' HB ' ' O ' ' B' ' 109' ' ' ILE . 49.5 m -57.81 -25.17 60.23 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 114' ' ' ALA . . . . . 0.498 ' HB2' ' O ' ' B' ' 110' ' ' LEU . . . -68.78 -63.11 1.12 Allowed 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . 0.595 HG23 ' O ' ' B' ' 111' ' ' GLU . 2.5 t -68.9 -21.09 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 116' ' ' ILE . . . . . 0.884 HD12 ' C ' ' B' ' 112' ' ' GLY . 22.6 mt -77.28 -64.81 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -51.01 -32.24 20.72 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 118' ' ' MET . . . . . 0.616 ' CE ' ' HE1' ' C' ' 218' ' ' MET . 6.6 mtp . . . . . 0 N--CA 1.449 -0.482 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 203' ' ' THR . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.448 -0.529 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 204' ' ' ASN . . . . . 0.489 ' HA ' HG13 ' C' ' 207' ' ' ILE . 1.1 t-20 -42.75 -51.23 5.43 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 205' ' ' LEU . . . . . 0.469 HD23 ' HA ' ' C' ' 205' ' ' LEU . 13.1 mt -42.89 -48.91 5.9 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 206' ' ' GLU . . . . . 0.58 ' N ' ' CD ' ' C' ' 206' ' ' GLU . 2.6 mp0 -64.03 -31.67 72.94 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 207' ' ' ILE . . . . . 1.045 HG23 ' CD2' ' A' ' 10' ' ' LEU . 3.8 mt -65.24 -29.93 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 208' ' ' ILE . . . . . . . . . . . . . 40.4 mt -76.67 -42.11 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 209' ' ' ILE . . . . . 0.414 ' O ' ' HB ' ' C' ' 213' ' ' THR . 84.0 mt -77.36 -23.87 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 210' ' ' LEU . . . . . 1.046 ' CD2' HG23 ' B' ' 107' ' ' ILE . 15.5 mt -85.66 -50.2 7.39 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 211' ' ' GLU . . . . . 0.586 ' O ' HG23 ' C' ' 215' ' ' VAL . 59.2 mm-40 -58.8 -40.39 83.93 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 212' ' ' GLY . . . . . 0.895 ' C ' HD12 ' C' ' 216' ' ' ILE . . . -73.28 -57.55 5.09 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 213' ' ' THR . . . . . 0.414 HG22 ' OE1' ' B' ' 111' ' ' GLU . 48.6 m -57.76 -25.2 60.14 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 214' ' ' ALA . . . . . 0.51 ' HB2' ' O ' ' C' ' 210' ' ' LEU . . . -68.69 -63.13 1.12 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 215' ' ' VAL . . . . . 0.586 HG23 ' O ' ' C' ' 211' ' ' GLU . 2.5 t -68.97 -21.11 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 216' ' ' ILE . . . . . 0.895 HD12 ' C ' ' C' ' 212' ' ' GLY . 22.0 mt -77.02 -64.8 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -51.07 -32.42 22.08 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 218' ' ' MET . . . . . 0.616 ' HE1' ' CE ' ' B' ' 118' ' ' MET . 6.5 mtp . . . . . 0 N--CA 1.449 -0.507 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.863 HG21 ' CG ' ' B' ' 106' ' ' GLU . 96.0 m . . . . . 0 N--CA 1.449 -0.484 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.682 ' ND2' ' H ' ' A' ' 5' ' ' LEU . 0.3 OUTLIER -42.6 -50.71 5.35 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.94 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.682 ' H ' ' ND2' ' A' ' 4' ' ' ASN . 16.1 mt -43.46 -48.33 7.21 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.859 ' CG ' HG21 ' C' ' 203' ' ' THR . 2.7 mp0 -64.67 -31.56 72.84 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 1.069 HG23 ' CD2' ' B' ' 110' ' ' LEU . 4.9 mt -65.2 -30.38 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 60.7 mt -76.48 -42.17 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.419 ' O ' ' HB ' ' A' ' 13' ' ' THR . 32.0 mt -76.54 -25.22 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 1.079 ' CD2' HG23 ' C' ' 207' ' ' ILE . 15.1 mt -84.6 -46.46 11.52 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.589 ' CD ' HG22 ' B' ' 113' ' ' THR . 52.1 mm-40 -58.67 -45.14 90.04 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.647 ' C ' HD12 ' A' ' 16' ' ' ILE . . . -70.58 -57.92 6.25 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.584 HG22 ' CD ' ' C' ' 211' ' ' GLU . 44.9 m -55.69 -27.02 47.93 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.553 ' HB2' ' O ' ' A' ' 10' ' ' LEU . . . -66.45 -63.14 1.14 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.687 HG22 ' HG3' ' B' ' 118' ' ' MET . 2.9 t -67.49 -22.04 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.647 HD12 ' C ' ' A' ' 12' ' ' GLY . 34.8 mt -73.09 -64.54 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.78 -34.89 29.19 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.717 ' HG3' HG22 ' C' ' 215' ' ' VAL . 6.0 mtp . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 103' ' ' THR . . . . . 0.843 HG21 ' CG ' ' C' ' 206' ' ' GLU . 96.2 m . . . . . 0 N--CA 1.449 -0.493 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . 0.674 ' ND2' ' H ' ' B' ' 105' ' ' LEU . 0.3 OUTLIER -42.66 -50.8 5.43 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.934 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . 0.674 ' H ' ' ND2' ' B' ' 104' ' ' ASN . 16.2 mt -43.57 -48.24 7.52 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 106' ' ' GLU . . . . . 0.863 ' CG ' HG21 ' A' ' 3' ' ' THR . 2.7 mp0 -64.58 -31.42 72.63 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 107' ' ' ILE . . . . . 1.085 HG23 ' CD2' ' C' ' 210' ' ' LEU . 4.8 mt -65.31 -30.36 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 61.0 mt -76.53 -42.07 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 109' ' ' ILE . . . . . 0.429 ' O ' ' HB ' ' B' ' 113' ' ' THR . 32.0 mt -76.64 -25.2 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . 1.069 ' CD2' HG23 ' A' ' 7' ' ' ILE . 15.1 mt -84.58 -46.53 11.46 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 111' ' ' GLU . . . . . 0.589 ' CD ' HG22 ' C' ' 213' ' ' THR . 52.4 mm-40 -58.72 -45.14 90.27 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 112' ' ' GLY . . . . . 0.654 ' C ' HD12 ' B' ' 116' ' ' ILE . . . -70.56 -57.76 6.38 Favored Glycine 0 C--N 1.335 0.521 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 113' ' ' THR . . . . . 0.589 HG22 ' CD ' ' A' ' 11' ' ' GLU . 45.1 m -55.82 -26.95 48.96 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 114' ' ' ALA . . . . . 0.55 ' HB2' ' O ' ' B' ' 110' ' ' LEU . . . -66.47 -63.12 1.14 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . 0.698 HG22 ' HG3' ' C' ' 218' ' ' MET . 2.9 t -67.58 -22.1 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 116' ' ' ILE . . . . . 0.654 HD12 ' C ' ' B' ' 112' ' ' GLY . 35.3 mt -73.09 -64.53 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -50.65 -35.05 28.78 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 118' ' ' MET . . . . . 0.687 ' HG3' HG22 ' A' ' 15' ' ' VAL . 6.0 mtp . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 203' ' ' THR . . . . . 0.859 HG21 ' CG ' ' A' ' 6' ' ' GLU . 96.3 m . . . . . 0 N--CA 1.449 -0.489 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 204' ' ' ASN . . . . . 0.67 ' ND2' ' H ' ' C' ' 205' ' ' LEU . 0.3 OUTLIER -42.56 -50.72 5.3 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 205' ' ' LEU . . . . . 0.67 ' H ' ' ND2' ' C' ' 204' ' ' ASN . 16.2 mt -43.6 -48.24 7.61 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 206' ' ' GLU . . . . . 0.843 ' CG ' HG21 ' B' ' 103' ' ' THR . 2.7 mp0 -64.66 -31.47 72.71 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 207' ' ' ILE . . . . . 1.079 HG23 ' CD2' ' A' ' 10' ' ' LEU . 4.8 mt -65.24 -30.35 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 208' ' ' ILE . . . . . . . . . . . . . 60.5 mt -76.59 -42.12 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 209' ' ' ILE . . . . . 0.415 ' O ' ' HB ' ' C' ' 213' ' ' THR . 31.8 mt -76.59 -25.21 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 210' ' ' LEU . . . . . 1.085 ' CD2' HG23 ' B' ' 107' ' ' ILE . 15.1 mt -84.62 -46.5 11.46 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 211' ' ' GLU . . . . . 0.584 ' CD ' HG22 ' A' ' 13' ' ' THR . 52.3 mm-40 -58.71 -45.04 90.45 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 212' ' ' GLY . . . . . 0.654 ' C ' HD12 ' C' ' 216' ' ' ILE . . . -70.66 -57.85 6.25 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 213' ' ' THR . . . . . 0.589 HG22 ' CD ' ' B' ' 111' ' ' GLU . 45.4 m -55.68 -27.11 48.4 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 214' ' ' ALA . . . . . 0.537 ' HB2' ' O ' ' C' ' 210' ' ' LEU . . . -66.51 -63.05 1.16 Allowed 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 215' ' ' VAL . . . . . 0.717 HG22 ' HG3' ' A' ' 18' ' ' MET . 3.0 t -67.6 -22.02 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 216' ' ' ILE . . . . . 0.654 HD12 ' C ' ' C' ' 212' ' ' GLY . 34.6 mt -73.19 -64.42 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -50.92 -34.78 29.97 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 218' ' ' MET . . . . . 0.698 ' HG3' HG22 ' B' ' 115' ' ' VAL . 6.0 mtp . . . . . 0 N--CA 1.449 -0.523 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.1 t . . . . . 0 N--CA 1.449 -0.481 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.484 ' HA ' HG13 ' A' ' 7' ' ' ILE . 1.6 t30 -42.84 -51.23 5.54 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.535 ' HA ' HD23 ' A' ' 5' ' ' LEU . 12.8 mt -42.99 -48.57 5.97 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.571 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 3.8 mp0 -64.54 -31.36 72.54 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 1.075 HG23 ' CD2' ' B' ' 110' ' ' LEU . 4.0 mt -65.17 -30.2 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 73.6 mt -76.75 -42.24 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.415 ' O ' ' HB ' ' A' ' 13' ' ' THR . 95.7 mt -76.75 -24.21 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 1.069 ' CD2' HG23 ' C' ' 207' ' ' ILE . 15.4 mt -85.6 -47.59 9.71 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.548 ' CD ' HG22 ' B' ' 113' ' ' THR . 57.5 mm-40 -58.95 -42.34 89.57 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.701 ' C ' HD12 ' A' ' 16' ' ' ILE . . . -72.65 -56.38 6.05 Favored Glycine 0 C--N 1.335 0.521 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.562 HG22 ' CD ' ' C' ' 211' ' ' GLU . 37.1 m -57.77 -25.4 60.45 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.517 ' HB2' ' O ' ' A' ' 10' ' ' LEU . . . -68.83 -63.14 1.12 Allowed 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.618 HG22 ' CG ' ' B' ' 118' ' ' MET . 2.7 t -68.56 -21.17 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.701 HD12 ' C ' ' A' ' 12' ' ' GLY . 34.9 mt -76.84 -64.65 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.02 -32.32 21.13 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.624 ' CG ' HG22 ' C' ' 215' ' ' VAL . 6.4 mtp . . . . . 0 N--CA 1.449 -0.482 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 7.0 t . . . . . 0 N--CA 1.449 -0.493 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . 0.496 ' HA ' HG13 ' B' ' 107' ' ' ILE . 1.5 t30 -42.93 -51.24 5.65 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . 0.481 HD23 ' HA ' ' B' ' 105' ' ' LEU . 12.8 mt -43.01 -48.49 6.0 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 106' ' ' GLU . . . . . 0.583 ' CD ' ' N ' ' B' ' 106' ' ' GLU . 3.8 mp0 -64.54 -31.46 72.69 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 107' ' ' ILE . . . . . 1.046 HG23 ' CD2' ' C' ' 210' ' ' LEU . 4.0 mt -65.14 -30.14 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 73.5 mt -76.77 -42.24 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 109' ' ' ILE . . . . . 0.426 ' O ' ' HB ' ' B' ' 113' ' ' THR . 95.6 mt -76.84 -24.12 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . 1.075 ' CD2' HG23 ' A' ' 7' ' ' ILE . 15.5 mt -85.62 -47.48 9.8 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 111' ' ' GLU . . . . . 0.561 ' CD ' HG22 ' C' ' 213' ' ' THR . 57.5 mm-40 -58.98 -42.45 89.98 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 112' ' ' GLY . . . . . 0.701 ' C ' HD12 ' B' ' 116' ' ' ILE . . . -72.67 -56.25 6.12 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.319 -1.113 . . . . 0.0 110.319 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 113' ' ' THR . . . . . 0.548 HG22 ' CD ' ' A' ' 11' ' ' GLU . 36.9 m -57.89 -25.32 60.66 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 114' ' ' ALA . . . . . 0.509 ' HB2' ' O ' ' B' ' 110' ' ' LEU . . . -68.85 -63.15 1.11 Allowed 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . 0.621 HG22 ' CG ' ' C' ' 218' ' ' MET . 2.7 t -68.54 -21.29 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 116' ' ' ILE . . . . . 0.701 HD12 ' C ' ' B' ' 112' ' ' GLY . 34.5 mt -76.66 -64.66 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -51.11 -32.11 21.51 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 118' ' ' MET . . . . . 0.618 ' CG ' HG22 ' A' ' 15' ' ' VAL . 6.3 mtp . . . . . 0 N--CA 1.449 -0.482 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 203' ' ' THR . . . . . . . . . . . . . 7.1 t . . . . . 0 N--CA 1.449 -0.476 0 N-CA-C 109.946 -0.391 . . . . 0.0 109.946 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 204' ' ' ASN . . . . . 0.503 ' HA ' HG13 ' C' ' 207' ' ' ILE . 1.5 t30 -42.88 -51.14 5.63 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 205' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' C' ' 205' ' ' LEU . 12.8 mt -43.04 -48.53 6.08 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 206' ' ' GLU . . . . . 0.574 ' N ' ' CD ' ' C' ' 206' ' ' GLU . 3.8 mp0 -64.58 -31.43 72.64 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 207' ' ' ILE . . . . . 1.069 HG23 ' CD2' ' A' ' 10' ' ' LEU . 4.0 mt -65.14 -30.19 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 208' ' ' ILE . . . . . . . . . . . . . 73.3 mt -76.77 -42.26 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 209' ' ' ILE . . . . . 0.408 ' O ' ' HB ' ' C' ' 213' ' ' THR . 95.6 mt -76.74 -24.24 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 210' ' ' LEU . . . . . 1.046 ' CD2' HG23 ' B' ' 107' ' ' ILE . 15.4 mt -85.58 -47.28 10.01 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 211' ' ' GLU . . . . . 0.562 ' CD ' HG22 ' A' ' 13' ' ' THR . 57.1 mm-40 -59.03 -42.52 90.38 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 212' ' ' GLY . . . . . 0.693 ' C ' HD12 ' C' ' 216' ' ' ILE . . . -72.64 -56.27 6.13 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 213' ' ' THR . . . . . 0.561 HG22 ' CD ' ' B' ' 111' ' ' GLU . 38.3 m -57.82 -25.47 60.67 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 214' ' ' ALA . . . . . 0.502 ' HB2' ' O ' ' C' ' 210' ' ' LEU . . . -68.76 -63.19 1.11 Allowed 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 215' ' ' VAL . . . . . 0.624 HG22 ' CG ' ' A' ' 18' ' ' MET . 2.7 t -68.5 -21.33 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 216' ' ' ILE . . . . . 0.693 HD12 ' C ' ' C' ' 212' ' ' GLY . 34.3 mt -76.61 -64.62 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -51.11 -32.11 21.48 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 218' ' ' MET . . . . . 0.621 ' CG ' HG22 ' B' ' 115' ' ' VAL . 6.3 mtp . . . . . 0 N--CA 1.448 -0.534 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.4 t . . . . . 0 N--CA 1.449 -0.523 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.508 ' HA ' HG13 ' A' ' 7' ' ' ILE . 1.6 t-20 -42.78 -50.85 5.57 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.535 ' HA ' HD23 ' A' ' 5' ' ' LEU . 11.5 mt -42.9 -48.61 5.86 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.585 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 2.1 mp0 -64.8 -31.58 72.88 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 1.066 HG23 ' CD2' ' B' ' 110' ' ' LEU . 4.2 mt -64.81 -30.26 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 66.1 mt -76.8 -42.74 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.415 ' O ' ' HB ' ' A' ' 13' ' ' THR . 18.9 mt -76.19 -24.0 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 1.046 ' CD2' HG23 ' C' ' 207' ' ' ILE . 15.8 mt -85.7 -52.78 5.56 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.54 ' CD ' HG22 ' B' ' 113' ' ' THR . 66.5 mm-40 -55.8 -40.96 73.45 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.684 ' C ' HD12 ' A' ' 16' ' ' ILE . . . -72.65 -54.99 6.93 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.589 HG22 ' CD ' ' C' ' 211' ' ' GLU . 17.2 m -57.7 -25.88 60.95 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.19 -63.38 1.08 Allowed 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.794 HG22 ' CG ' ' B' ' 118' ' ' MET . 2.6 t -67.57 -21.14 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.684 HD12 ' C ' ' A' ' 12' ' ' GLY . 32.6 mt -76.55 -64.6 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.42 -32.04 16.65 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.591 ' CE ' ' HE1' ' B' ' 118' ' ' MET . 6.5 mtp . . . . . 0 N--CA 1.449 -0.497 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 6.3 t . . . . . 0 N--CA 1.449 -0.489 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . 0.489 ' HA ' HG13 ' B' ' 107' ' ' ILE . 1.6 t-20 -42.97 -51.16 5.73 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . 0.517 ' HA ' HD23 ' B' ' 105' ' ' LEU . 11.5 mt -42.97 -48.42 5.92 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 106' ' ' GLU . . . . . 0.58 ' CD ' ' N ' ' B' ' 106' ' ' GLU . 2.2 mp0 -64.55 -31.89 73.3 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 107' ' ' ILE . . . . . 1.038 HG23 ' CD2' ' C' ' 210' ' ' LEU . 4.0 mt -64.85 -29.73 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 66.3 mt -77.01 -42.91 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 109' ' ' ILE . . . . . 0.424 ' O ' ' HB ' ' B' ' 113' ' ' THR . 18.9 mt -76.33 -23.9 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . 1.066 ' CD2' HG23 ' A' ' 7' ' ' ILE . 15.4 mt -85.67 -50.78 6.92 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 111' ' ' GLU . . . . . 0.537 ' O ' HG23 ' B' ' 115' ' ' VAL . 63.9 mm-40 -57.23 -40.64 77.96 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 112' ' ' GLY . . . . . 0.67 ' C ' HD12 ' B' ' 116' ' ' ILE . . . -73.49 -55.77 5.91 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 113' ' ' THR . . . . . 0.54 HG22 ' CD ' ' A' ' 11' ' ' GLU . 22.2 m -57.86 -24.93 59.83 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.12 -62.69 1.29 Allowed 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . 0.537 HG23 ' O ' ' B' ' 111' ' ' GLU . 3.1 t -68.27 -21.1 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 116' ' ' ILE . . . . . 0.67 HD12 ' C ' ' B' ' 112' ' ' GLY . 45.6 mt -79.61 -65.2 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -53.81 -27.98 32.62 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.786 -0.449 . . . . 0.0 109.786 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 118' ' ' MET . . . . . 0.794 ' CG ' HG22 ' A' ' 15' ' ' VAL . 11.9 mtp . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 203' ' ' THR . . . . . . . . . . . . . 6.3 t . . . . . 0 N--CA 1.449 -0.482 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 204' ' ' ASN . . . . . 0.493 ' HA ' HG13 ' C' ' 207' ' ' ILE . 1.6 t-20 -42.82 -51.12 5.56 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 205' ' ' LEU . . . . . 0.493 HD23 ' HA ' ' C' ' 205' ' ' LEU . 11.6 mt -42.95 -48.52 5.91 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 206' ' ' GLU . . . . . 0.574 ' N ' ' CD ' ' C' ' 206' ' ' GLU . 2.2 mp0 -64.66 -31.45 72.68 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 207' ' ' ILE . . . . . 1.046 HG23 ' CD2' ' A' ' 10' ' ' LEU . 4.2 mt -64.98 -30.28 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 208' ' ' ILE . . . . . . . . . . . . . 64.9 mt -76.74 -42.49 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 209' ' ' ILE . . . . . 0.423 ' O ' ' HB ' ' C' ' 213' ' ' THR . 18.7 mt -76.51 -24.09 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 210' ' ' LEU . . . . . 1.038 ' CD2' HG23 ' B' ' 107' ' ' ILE . 15.6 mt -85.71 -52.47 5.76 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 211' ' ' GLU . . . . . 0.589 ' CD ' HG22 ' A' ' 13' ' ' THR . 67.1 mm-40 -56.49 -40.69 75.38 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 212' ' ' GLY . . . . . 0.691 ' C ' HD12 ' C' ' 216' ' ' ILE . . . -72.7 -55.95 6.28 Favored Glycine 0 C--N 1.335 0.513 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 213' ' ' THR . . . . . 0.53 HG22 ' CD ' ' B' ' 111' ' ' GLU . 20.4 m -57.65 -25.3 60.0 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 214' ' ' ALA . . . . . . . . . . . . . . . -69.37 -63.26 1.1 Allowed 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 215' ' ' VAL . . . . . 0.533 HG23 ' O ' ' C' ' 211' ' ' GLU . 2.8 t -68.15 -21.09 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 216' ' ' ILE . . . . . 0.691 HD12 ' C ' ' C' ' 212' ' ' GLY . 37.8 mt -77.53 -64.67 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -50.99 -30.93 16.42 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 218' ' ' MET . . . . . 0.569 ' SD ' ' CE ' ' B' ' 118' ' ' MET . 6.9 mtp . . . . . 0 N--CA 1.449 -0.499 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.662 HG21 ' CG ' ' B' ' 106' ' ' GLU . 1.6 m . . . . . 0 N--CA 1.449 -0.499 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.49 ' HA ' HG13 ' A' ' 7' ' ' ILE . 1.6 t30 -42.12 -47.22 4.54 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.545 HD23 ' HA ' ' A' ' 5' ' ' LEU . 12.3 mt -42.84 -50.34 5.7 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.668 ' CG ' HG21 ' C' ' 203' ' ' THR . 0.1 OUTLIER -66.08 -32.17 73.48 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 1.064 HG23 ' CD2' ' B' ' 110' ' ' LEU . 3.6 mt -65.01 -29.76 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 44.6 mt -76.93 -42.52 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.42 ' O ' ' HB ' ' A' ' 13' ' ' THR . 29.4 mt -76.74 -24.04 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 1.062 ' CD2' HG23 ' C' ' 207' ' ' ILE . 15.3 mt -85.73 -48.14 9.11 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.566 ' O ' HG23 ' A' ' 15' ' ' VAL . 60.6 mm-40 -58.81 -41.79 87.62 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.718 ' C ' HD12 ' A' ' 16' ' ' ILE . . . -72.96 -56.24 5.93 Favored Glycine 0 C--N 1.336 0.555 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.54 HG22 ' CD ' ' C' ' 211' ' ' GLU . 31.8 m -57.88 -25.72 61.15 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.494 ' HB2' ' O ' ' A' ' 10' ' ' LEU . . . -68.7 -63.09 1.13 Allowed 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.589 HG22 ' CG ' ' B' ' 118' ' ' MET . 2.7 t -68.31 -21.24 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.718 HD12 ' C ' ' A' ' 12' ' ' GLY . 30.5 mt -76.57 -64.68 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.93 -32.28 20.28 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.601 ' CE ' ' HE1' ' B' ' 118' ' ' MET . 6.5 mtp . . . . . 0 N--CA 1.448 -0.526 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 103' ' ' THR . . . . . 0.671 HG21 ' CG ' ' C' ' 206' ' ' GLU . 1.6 m . . . . . 0 N--CA 1.449 -0.482 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . 0.495 ' HA ' HG13 ' B' ' 107' ' ' ILE . 1.6 t30 -42.13 -47.33 4.57 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . 0.476 ' HA ' HD23 ' B' ' 105' ' ' LEU . 12.3 mt -42.75 -50.32 5.59 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 106' ' ' GLU . . . . . 0.662 ' CG ' HG21 ' A' ' 3' ' ' THR . 0.1 OUTLIER -66.14 -32.2 73.5 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.928 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 107' ' ' ILE . . . . . 1.053 HG23 ' CD2' ' C' ' 210' ' ' LEU . 3.5 mt -65.0 -29.79 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 44.7 mt -76.9 -42.53 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 109' ' ' ILE . . . . . 0.419 ' O ' ' HB ' ' B' ' 113' ' ' THR . 29.3 mt -76.71 -24.03 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . 1.064 ' CD2' HG23 ' A' ' 7' ' ' ILE . 15.3 mt -85.72 -47.63 9.58 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 111' ' ' GLU . . . . . 0.555 ' O ' HG23 ' B' ' 115' ' ' VAL . 59.7 mm-40 -59.07 -41.99 89.28 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 112' ' ' GLY . . . . . 0.715 ' C ' HD12 ' B' ' 116' ' ' ILE . . . -72.91 -56.15 6.01 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 113' ' ' THR . . . . . 0.554 HG22 ' CD ' ' A' ' 11' ' ' GLU . 32.8 m -57.88 -25.83 61.3 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 114' ' ' ALA . . . . . 0.498 ' HB2' ' O ' ' B' ' 110' ' ' LEU . . . -68.65 -63.07 1.13 Allowed 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . 0.572 HG22 ' CG ' ' C' ' 218' ' ' MET . 2.7 t -68.32 -21.27 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 116' ' ' ILE . . . . . 0.715 HD12 ' C ' ' B' ' 112' ' ' GLY . 30.1 mt -76.33 -64.62 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -51.16 -32.14 22.28 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 118' ' ' MET . . . . . 0.605 ' CE ' ' HE1' ' C' ' 218' ' ' MET . 6.3 mtp . . . . . 0 N--CA 1.449 -0.513 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 203' ' ' THR . . . . . 0.668 HG21 ' CG ' ' A' ' 6' ' ' GLU . 1.6 m . . . . . 0 N--CA 1.449 -0.483 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 204' ' ' ASN . . . . . 0.502 ' HA ' HG13 ' C' ' 207' ' ' ILE . 1.6 t30 -42.1 -47.28 4.52 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 205' ' ' LEU . . . . . 0.527 HD23 ' HA ' ' C' ' 205' ' ' LEU . 12.3 mt -42.82 -50.24 5.68 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 206' ' ' GLU . . . . . 0.671 ' CG ' HG21 ' B' ' 103' ' ' THR . 0.1 OUTLIER -66.17 -32.27 73.61 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.938 -0.394 . . . . 0.0 109.938 179.938 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 207' ' ' ILE . . . . . 1.062 HG23 ' CD2' ' A' ' 10' ' ' LEU . 3.5 mt -64.95 -29.81 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 208' ' ' ILE . . . . . . . . . . . . . 44.9 mt -76.84 -42.56 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 209' ' ' ILE . . . . . 0.408 ' O ' ' HB ' ' C' ' 213' ' ' THR . 29.4 mt -76.67 -24.01 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 210' ' ' LEU . . . . . 1.053 ' CD2' HG23 ' B' ' 107' ' ' ILE . 15.4 mt -85.73 -47.64 9.57 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 211' ' ' GLU . . . . . 0.562 ' O ' HG23 ' C' ' 215' ' ' VAL . 59.3 mm-40 -59.09 -41.91 89.2 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 212' ' ' GLY . . . . . 0.72 ' C ' HD12 ' C' ' 216' ' ' ILE . . . -73.02 -56.08 5.98 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 213' ' ' THR . . . . . 0.55 HG22 ' CD ' ' B' ' 111' ' ' GLU . 34.0 m -57.93 -25.78 61.35 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 214' ' ' ALA . . . . . 0.494 ' HB2' ' O ' ' C' ' 210' ' ' LEU . . . -68.71 -63.03 1.14 Allowed 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 215' ' ' VAL . . . . . 0.567 HG22 ' CG ' ' A' ' 18' ' ' MET . 2.7 t -68.3 -21.41 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 216' ' ' ILE . . . . . 0.72 HD12 ' C ' ' C' ' 212' ' ' GLY . 30.4 mt -76.2 -64.64 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -51.05 -32.26 21.27 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 218' ' ' MET . . . . . 0.605 ' HE1' ' CE ' ' B' ' 118' ' ' MET . 6.4 mtp . . . . . 0 N--CA 1.449 -0.482 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.478 HG23 ' N ' ' A' ' 4' ' ' ASN . 9.7 t . . . . . 0 N--CA 1.449 -0.523 0 N-CA-C 109.911 -0.404 . . . . 0.0 109.911 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.507 ' HA ' HG13 ' A' ' 7' ' ' ILE . 0.9 OUTLIER -42.77 -50.13 5.64 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.49 ' HA ' HD23 ' A' ' 5' ' ' LEU . 17.3 mt -42.88 -49.09 5.9 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.588 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 0.3 OUTLIER -64.57 -32.24 73.81 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.917 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 1.042 HG23 ' CD2' ' B' ' 110' ' ' LEU . 3.6 mt -65.19 -29.42 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 19.7 mt -76.92 -42.44 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.427 ' O ' ' HB ' ' A' ' 13' ' ' THR . 85.2 mt -77.29 -23.61 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 1.065 ' CD2' HG23 ' C' ' 207' ' ' ILE . 15.4 mt -85.77 -51.03 6.69 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.582 ' O ' HG23 ' A' ' 15' ' ' VAL . 66.7 mm-40 -58.63 -39.78 81.47 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.686 ' C ' HD12 ' A' ' 16' ' ' ILE . . . -73.42 -57.58 5.01 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.427 ' HB ' ' O ' ' A' ' 9' ' ' ILE . 46.2 m -57.88 -25.08 60.3 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.485 ' HB2' ' O ' ' A' ' 10' ' ' LEU . . . -68.81 -63.03 1.14 Allowed 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 11' ' ' GLU . 2.5 t -69.0 -21.08 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.686 HD12 ' C ' ' A' ' 12' ' ' GLY . 38.0 mt -77.45 -64.85 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.13 -32.03 21.52 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.622 ' CE ' ' HE1' ' B' ' 118' ' ' MET . 6.9 mtp . . . . . 0 N--CA 1.449 -0.485 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 103' ' ' THR . . . . . 0.489 HG23 ' N ' ' B' ' 104' ' ' ASN . 9.0 t . . . . . 0 N--CA 1.449 -0.506 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . 0.496 ' HA ' HG13 ' B' ' 107' ' ' ILE . 1.0 OUTLIER -42.96 -51.2 5.7 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' B' ' 105' ' ' LEU . 17.7 mt -43.05 -48.55 6.13 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 106' ' ' GLU . . . . . 0.583 ' CD ' ' N ' ' B' ' 106' ' ' GLU . 0.3 OUTLIER -64.27 -31.74 73.07 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 107' ' ' ILE . . . . . 1.061 HG23 ' CD2' ' C' ' 210' ' ' LEU . 3.8 mt -65.23 -29.86 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 20.3 mt -76.68 -42.19 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 109' ' ' ILE . . . . . 0.416 ' O ' ' HB ' ' B' ' 113' ' ' THR . 84.0 mt -77.39 -23.78 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . 1.042 ' CD2' HG23 ' A' ' 7' ' ' ILE . 15.6 mt -85.68 -50.95 6.79 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 111' ' ' GLU . . . . . 0.602 ' O ' HG23 ' B' ' 115' ' ' VAL . 67.3 mm-40 -58.63 -39.8 81.54 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 112' ' ' GLY . . . . . 0.677 ' C ' HD12 ' B' ' 116' ' ' ILE . . . -73.42 -57.59 5.0 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 113' ' ' THR . . . . . 0.416 ' HB ' ' O ' ' B' ' 109' ' ' ILE . 45.0 m -57.83 -25.17 60.27 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.938 -0.394 . . . . 0.0 109.938 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 114' ' ' ALA . . . . . 0.479 ' HB2' ' O ' ' B' ' 110' ' ' LEU . . . -68.8 -63.04 1.14 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . 0.602 HG23 ' O ' ' B' ' 111' ' ' GLU . 2.5 t -68.97 -21.12 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 116' ' ' ILE . . . . . 0.677 HD12 ' C ' ' B' ' 112' ' ' GLY . 37.2 mt -77.24 -64.82 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -50.98 -32.26 20.56 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 118' ' ' MET . . . . . 0.622 ' HE1' ' CE ' ' A' ' 18' ' ' MET . 6.7 mtp . . . . . 0 N--CA 1.449 -0.481 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 203' ' ' THR . . . . . 0.483 HG23 ' N ' ' C' ' 204' ' ' ASN . 8.9 t . . . . . 0 N--CA 1.448 -0.527 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 204' ' ' ASN . . . . . 0.494 ' HA ' HG13 ' C' ' 207' ' ' ILE . 1.0 OUTLIER -43.06 -51.4 5.79 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.937 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 205' ' ' LEU . . . . . 0.514 HD23 ' HA ' ' C' ' 205' ' ' LEU . 17.8 mt -43.06 -48.33 6.11 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 206' ' ' GLU . . . . . 0.581 ' N ' ' CD ' ' C' ' 206' ' ' GLU . 0.3 OUTLIER -64.24 -31.92 73.31 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 207' ' ' ILE . . . . . 1.065 HG23 ' CD2' ' A' ' 10' ' ' LEU . 3.8 mt -65.21 -29.7 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 208' ' ' ILE . . . . . . . . . . . . . 19.9 mt -76.79 -42.18 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 209' ' ' ILE . . . . . 0.419 ' O ' ' HB ' ' C' ' 213' ' ' THR . 83.8 mt -77.36 -23.86 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 210' ' ' LEU . . . . . 1.061 ' CD2' HG23 ' B' ' 107' ' ' ILE . 15.3 mt -85.58 -50.75 6.98 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 211' ' ' GLU . . . . . 0.579 ' O ' HG23 ' C' ' 215' ' ' VAL . 66.6 mm-40 -58.59 -40.18 82.49 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 212' ' ' GLY . . . . . 0.679 ' C ' HD12 ' C' ' 216' ' ' ILE . . . -73.2 -57.53 5.13 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 213' ' ' THR . . . . . 0.419 ' HB ' ' O ' ' C' ' 209' ' ' ILE . 46.0 m -57.73 -25.22 60.09 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 214' ' ' ALA . . . . . 0.492 ' HB2' ' O ' ' C' ' 210' ' ' LEU . . . -68.7 -63.04 1.14 Allowed 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 215' ' ' VAL . . . . . 0.579 HG23 ' O ' ' C' ' 211' ' ' GLU . 2.6 t -69.02 -21.11 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 216' ' ' ILE . . . . . 0.679 HD12 ' C ' ' C' ' 212' ' ' GLY . 37.1 mt -77.17 -64.72 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -51.22 -32.25 23.35 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 218' ' ' MET . . . . . 0.597 ' HE1' ' CE ' ' B' ' 118' ' ' MET . 6.6 mtp . . . . . 0 N--CA 1.449 -0.478 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.2 t . . . . . 0 N--CA 1.45 -0.471 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.508 ' HA ' HG13 ' A' ' 7' ' ' ILE . 1.0 OUTLIER -42.79 -51.28 5.45 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.489 ' HA ' HD23 ' A' ' 5' ' ' LEU . 12.1 mt -43.03 -48.43 6.03 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.587 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 1.8 mp0 -64.59 -31.3 72.45 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 1.039 HG23 ' CD2' ' B' ' 110' ' ' LEU . 4.1 mt -65.34 -30.07 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 73.9 mt -76.89 -42.05 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.418 ' O ' ' HB ' ' A' ' 13' ' ' THR . 15.9 mt -76.95 -24.29 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 1.026 ' CD2' HG23 ' C' ' 207' ' ' ILE . 15.4 mt -85.39 -49.85 7.78 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.558 ' CD ' HG22 ' B' ' 113' ' ' THR . 61.7 mm-40 -57.87 -42.04 83.73 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.855 ' C ' HD12 ' A' ' 16' ' ' ILE . . . -72.02 -55.95 6.79 Favored Glycine 0 C--N 1.335 0.475 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.575 HG22 ' CD ' ' C' ' 211' ' ' GLU . 23.7 m -57.95 -25.38 60.88 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.429 ' HB2' ' O ' ' A' ' 10' ' ' LEU . . . -68.52 -63.09 1.13 Allowed 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.598 HG22 ' HG3' ' B' ' 118' ' ' MET . 2.7 t -68.95 -21.13 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.855 HD12 ' C ' ' A' ' 12' ' ' GLY . 23.3 mt -76.54 -64.68 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.88 -33.44 24.02 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.664 ' HE2' ' HE1' ' B' ' 118' ' ' MET . 6.7 mtp . . . . . 0 N--CA 1.449 -0.522 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 5.2 t . . . . . 0 N--CA 1.449 -0.486 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . 0.498 ' HA ' HG13 ' B' ' 107' ' ' ILE . 1.0 OUTLIER -42.81 -51.23 5.5 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . 0.469 ' HA ' HD23 ' B' ' 105' ' ' LEU . 12.0 mt -43.05 -48.45 6.1 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 106' ' ' GLU . . . . . 0.588 ' CD ' ' N ' ' B' ' 106' ' ' GLU . 1.8 mp0 -64.62 -31.33 72.5 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 107' ' ' ILE . . . . . 1.035 HG23 ' CD2' ' C' ' 210' ' ' LEU . 4.1 mt -65.28 -30.18 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 74.6 mt -76.84 -42.03 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 109' ' ' ILE . . . . . 0.423 ' O ' ' HB ' ' B' ' 113' ' ' THR . 16.1 mt -76.99 -24.32 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . 1.039 ' CD2' HG23 ' A' ' 7' ' ' ILE . 15.4 mt -85.44 -49.59 7.97 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 111' ' ' GLU . . . . . 0.542 ' CD ' HG22 ' C' ' 213' ' ' THR . 61.5 mm-40 -57.99 -42.21 84.66 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 112' ' ' GLY . . . . . 0.85 ' C ' HD12 ' B' ' 116' ' ' ILE . . . -71.95 -55.94 6.84 Favored Glycine 0 C--N 1.336 0.547 0 N-CA-C 110.279 -1.129 . . . . 0.0 110.279 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 113' ' ' THR . . . . . 0.558 HG22 ' CD ' ' A' ' 11' ' ' GLU . 24.1 m -57.91 -25.58 61.05 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 114' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' B' ' 110' ' ' LEU . . . -68.34 -63.04 1.14 Allowed 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 115' ' ' VAL . . . . . 0.588 HG22 ' HG3' ' C' ' 218' ' ' MET . 2.7 t -68.98 -21.07 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 116' ' ' ILE . . . . . 0.85 HD12 ' C ' ' B' ' 112' ' ' GLY . 22.0 mt -76.2 -64.66 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -50.78 -34.02 25.69 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 118' ' ' MET . . . . . 0.664 ' HE1' ' HE2' ' A' ' 18' ' ' MET . 6.5 mtp . . . . . 0 N--CA 1.45 -0.466 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 203' ' ' THR . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.449 -0.522 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 204' ' ' ASN . . . . . 0.494 ' HA ' HG13 ' C' ' 207' ' ' ILE . 1.0 OUTLIER -42.85 -51.09 5.6 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 205' ' ' LEU . . . . . 0.49 HD23 ' HA ' ' C' ' 205' ' ' LEU . 12.0 mt -43.04 -48.46 6.08 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 206' ' ' GLU . . . . . 0.582 ' N ' ' CD ' ' C' ' 206' ' ' GLU . 1.8 mp0 -64.62 -31.34 72.51 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 207' ' ' ILE . . . . . 1.026 HG23 ' CD2' ' A' ' 10' ' ' LEU . 4.1 mt -65.23 -30.16 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 208' ' ' ILE . . . . . . . . . . . . . 74.3 mt -76.83 -42.2 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 209' ' ' ILE . . . . . 0.424 ' O ' ' HB ' ' C' ' 213' ' ' THR . 16.1 mt -76.8 -24.32 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 210' ' ' LEU . . . . . 1.035 ' CD2' HG23 ' B' ' 107' ' ' ILE . 15.4 mt -85.44 -49.5 8.05 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 211' ' ' GLU . . . . . 0.575 ' CD ' HG22 ' A' ' 13' ' ' THR . 60.8 mm-40 -57.92 -42.29 84.51 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 212' ' ' GLY . . . . . 0.847 ' C ' HD12 ' C' ' 216' ' ' ILE . . . -72.08 -55.83 6.82 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 213' ' ' THR . . . . . 0.542 HG22 ' CD ' ' B' ' 111' ' ' GLU . 23.9 m -57.85 -25.49 60.78 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 214' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' C' ' 210' ' ' LEU . . . -68.48 -63.09 1.13 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 215' ' ' VAL . . . . . 0.612 HG22 ' CG ' ' A' ' 18' ' ' MET . 2.8 t -68.89 -21.09 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 216' ' ' ILE . . . . . 0.847 HD12 ' C ' ' C' ' 212' ' ' GLY . 23.1 mt -76.51 -64.8 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -50.78 -33.37 23.03 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 218' ' ' MET . . . . . 0.618 ' HE1' ' CE ' ' B' ' 118' ' ' MET . 6.5 mtp . . . . . 0 N--CA 1.45 -0.451 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.4 ' HE2' ' HB2' ' A' ' 2' ' ' LYS . 15.6 tppt? -78.01 -45.78 22.82 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.2 t -45.51 -36.79 4.77 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.5 ' HA ' HG13 ' A' ' 7' ' ' ILE . 1.5 t-20 -42.92 -51.12 5.68 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.429 ' HA ' HD23 ' A' ' 5' ' ' LEU . 14.0 mt -42.99 -48.52 5.97 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.578 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 0.8 OUTLIER -64.66 -31.36 72.55 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.916 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 1.046 HG23 ' CD2' ' B' ' 110' ' ' LEU . 4.0 mt -65.23 -30.23 49.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 23.7 mt -76.73 -42.11 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.421 ' O ' ' HB ' ' A' ' 13' ' ' THR . 53.7 mt -76.87 -24.29 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 1.034 ' CD2' HG23 ' C' ' 207' ' ' ILE . 15.4 mt -85.59 -46.77 10.49 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.568 ' CD ' HG22 ' B' ' 113' ' ' THR . 57.1 mm-40 -59.37 -42.71 92.25 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.74 ' C ' HD12 ' A' ' 16' ' ' ILE . . . -72.56 -56.12 6.28 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.55 HG22 ' CD ' ' C' ' 211' ' ' GLU . 39.4 m -57.83 -25.88 61.25 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.525 ' HB2' ' O ' ' A' ' 10' ' ' LEU . . . -68.38 -63.05 1.14 Allowed 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.626 HG22 ' CG ' ' B' ' 118' ' ' MET . 2.7 t -68.56 -21.36 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.74 HD12 ' C ' ' A' ' 12' ' ' GLY . 29.2 mt -76.11 -64.7 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.89 -32.95 22.16 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.61 ' CE ' ' HE1' ' B' ' 118' ' ' MET . 6.4 mtp -64.45 -60.25 3.37 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.495 ' CD2' HD11 ' A' ' 23' ' ' LEU . 3.9 t80 -53.14 -44.23 67.58 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 12.7 m-30 -53.93 -42.91 69.34 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.442 ' O ' HG23 ' A' ' 25' ' ' VAL . 38.3 m0 -68.58 -62.26 1.47 Allowed 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.3 tp -52.45 -20.53 2.93 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.495 HD11 ' CD2' ' A' ' 19' ' ' PHE . 11.3 mt -74.99 -61.75 1.78 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.475 HD12 HD12 ' A' ' 28' ' ' LEU . 1.2 pp -62.48 -17.72 60.21 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 21' ' ' TRP . 37.5 t -77.36 -45.14 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 97.5 mt -70.48 -33.08 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.552 ' O ' HG23 ' A' ' 31' ' ' VAL . 56.1 mt -68.99 -47.4 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.482 ' HA ' HD23 ' A' ' 28' ' ' LEU . 41.6 mt -61.76 -35.68 78.81 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.619 ' HA ' ' HE3' ' A' ' 32' ' ' LYS . 10.9 mtp-105 -76.63 -36.77 57.21 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.6 m -68.0 -32.15 72.34 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 27' ' ' ILE . 71.2 t -75.97 -57.66 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.619 ' HE3' ' HA ' ' A' ' 29' ' ' ARG . 14.3 ptpt -52.12 -29.52 22.19 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.448 ' HG2' ' HG3' ' A' ' 32' ' ' LYS . 7.5 mmm180 -93.99 30.1 1.95 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -139.31 -0.02 1.85 Allowed 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -81.27 -7.45 59.57 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.9 -174.15 49.05 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.523 0 N-CA-C 110.301 -1.119 . . . . 0.0 110.301 -179.964 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 . . . . . 0 N--CA 1.449 -0.509 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' B' ' 102' ' ' LYS . 15.7 tppt? -78.13 -45.8 22.35 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 7.0 t -45.58 -36.9 5.02 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . 0.505 ' HA ' HG13 ' B' ' 107' ' ' ILE . 1.5 t-20 -42.92 -51.15 5.67 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 0.451 ' HA ' HD23 ' B' ' 105' ' ' LEU . 14.1 mt -42.99 -48.57 5.97 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' GLU . . . . . 0.59 ' CD ' ' N ' ' B' ' 106' ' ' GLU . 0.8 OUTLIER -64.51 -31.41 72.61 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' ILE . . . . . 1.052 HG23 ' CD2' ' C' ' 210' ' ' LEU . 4.0 mt -65.2 -30.27 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 23.8 mt -76.72 -42.08 33.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' ILE . . . . . 0.417 ' O ' ' HB ' ' B' ' 113' ' ' THR . 54.1 mt -76.87 -24.29 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . 1.046 ' CD2' HG23 ' A' ' 7' ' ' ILE . 15.4 mt -85.53 -46.95 10.36 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 111' ' ' GLU . . . . . 0.556 ' CD ' HG22 ' C' ' 213' ' ' THR . 57.8 mm-40 -59.37 -42.65 92.12 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 112' ' ' GLY . . . . . 0.728 ' C ' HD12 ' B' ' 116' ' ' ILE . . . -72.54 -56.16 6.27 Favored Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.281 -1.127 . . . . 0.0 110.281 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 113' ' ' THR . . . . . 0.568 HG22 ' CD ' ' A' ' 11' ' ' GLU . 38.5 m -57.96 -25.72 61.35 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 114' ' ' ALA . . . . . 0.521 ' HB2' ' O ' ' B' ' 110' ' ' LEU . . . -68.42 -62.99 1.15 Allowed 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 0.624 HG22 ' CG ' ' C' ' 218' ' ' MET . 2.7 t -68.73 -21.22 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 116' ' ' ILE . . . . . 0.728 HD12 ' C ' ' B' ' 112' ' ' GLY . 28.7 mt -76.18 -64.58 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -51.15 -33.0 24.92 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 118' ' ' MET . . . . . 0.626 ' CG ' HG22 ' A' ' 15' ' ' VAL . 6.4 mtp -64.33 -60.11 3.57 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 119' ' ' PHE . . . . . 0.494 ' CD2' HD11 ' B' ' 123' ' ' LEU . 4.0 t80 -51.93 -43.8 63.61 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 12.8 m-30 -53.27 -43.78 67.71 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 121' ' ' TRP . . . . . . . . . . . . . 38.4 m0 -69.3 -62.38 1.4 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 5.2 tp -52.1 -20.27 2.4 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . 0.494 HD11 ' CD2' ' B' ' 119' ' ' PHE . 10.6 mt -73.24 -61.81 1.69 Allowed 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 pp -62.04 -17.51 57.59 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 37.3 t -78.2 -45.04 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 97.9 mt -70.53 -32.53 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 127' ' ' ILE . . . . . 0.564 ' O ' HG23 ' B' ' 131' ' ' VAL . 56.4 mt -68.2 -47.54 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.442 ' HA ' HD23 ' B' ' 128' ' ' LEU . 40.4 mt -61.92 -35.71 79.2 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . 0.618 ' HA ' ' HE3' ' B' ' 132' ' ' LYS . 10.9 mtp-105 -76.84 -36.66 56.69 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 4.5 m -67.84 -31.87 72.02 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.564 HG23 ' O ' ' B' ' 127' ' ' ILE . 77.1 t -76.03 -57.95 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 132' ' ' LYS . . . . . 0.618 ' HE3' ' HA ' ' B' ' 129' ' ' ARG . 14.3 ptpt -51.87 -29.52 20.06 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 133' ' ' ARG . . . . . 0.484 ' HD2' ' HA ' ' B' ' 133' ' ' ARG . 7.4 mmm180 -94.24 30.24 1.98 Allowed 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 134' ' ' ALA . . . . . . . . . . . . . . . -139.03 -0.1 1.9 Allowed 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -81.26 -7.38 59.56 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -86.76 -174.7 49.3 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.51 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 -179.957 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 201' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -78.12 -45.9 22.12 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 203' ' ' THR . . . . . . . . . . . . . 7.0 t -45.59 -36.95 5.07 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 204' ' ' ASN . . . . . 0.487 ' HA ' HG13 ' C' ' 207' ' ' ILE . 1.5 t-20 -43.01 -51.21 5.76 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 205' ' ' LEU . . . . . . . . . . . . . 14.1 mt -43.02 -48.44 6.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 206' ' ' GLU . . . . . 0.575 ' N ' ' CD ' ' C' ' 206' ' ' GLU . 0.8 OUTLIER -64.58 -31.43 72.64 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 207' ' ' ILE . . . . . 1.034 HG23 ' CD2' ' A' ' 10' ' ' LEU . 4.0 mt -65.18 -30.24 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 208' ' ' ILE . . . . . . . . . . . . . 23.7 mt -76.72 -42.17 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 209' ' ' ILE . . . . . 0.412 ' O ' ' HB ' ' C' ' 213' ' ' THR . 54.1 mt -76.8 -24.27 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 210' ' ' LEU . . . . . 1.052 ' CD2' HG23 ' B' ' 107' ' ' ILE . 15.4 mt -85.61 -46.62 10.62 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 211' ' ' GLU . . . . . 0.55 ' CD ' HG22 ' A' ' 13' ' ' THR . 57.2 mm-40 -59.42 -42.75 92.58 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 212' ' ' GLY . . . . . 0.741 ' C ' HD12 ' C' ' 216' ' ' ILE . . . -72.58 -56.05 6.3 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 213' ' ' THR . . . . . 0.556 HG22 ' CD ' ' B' ' 111' ' ' GLU . 38.2 m -57.93 -25.94 61.56 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 214' ' ' ALA . . . . . 0.526 ' HB2' ' O ' ' C' ' 210' ' ' LEU . . . -68.28 -63.07 1.13 Allowed 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 215' ' ' VAL . . . . . 0.609 HG22 ' CG ' ' A' ' 18' ' ' MET . 2.7 t -68.52 -21.42 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 216' ' ' ILE . . . . . 0.741 HD12 ' C ' ' C' ' 212' ' ' GLY . 28.5 mt -76.03 -64.66 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -51.0 -32.77 22.3 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 218' ' ' MET . . . . . 0.624 ' CG ' HG22 ' B' ' 115' ' ' VAL . 6.2 mtp -64.51 -59.2 4.6 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -50.09 -44.95 52.2 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -55.39 -43.27 75.02 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 221' ' ' TRP . . . . . 0.421 ' O ' HG23 ' C' ' 225' ' ' VAL . 38.6 m0 -69.51 -61.38 1.81 Allowed 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 5.3 tp -51.02 -20.71 1.48 Allowed 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.786 -0.449 . . . . 0.0 109.786 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 223' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' C' ' 223' ' ' LEU . 11.1 mt -74.34 -61.83 1.73 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 224' ' ' LEU . . . . . 0.436 HD12 HD12 ' C' ' 228' ' ' LEU . 1.3 pp -63.48 -17.4 62.69 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 225' ' ' VAL . . . . . 0.421 HG23 ' O ' ' C' ' 221' ' ' TRP . 37.3 t -76.92 -44.46 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 92.7 mt -69.08 -33.25 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 227' ' ' ILE . . . . . 0.556 ' O ' HG23 ' C' ' 231' ' ' VAL . 56.2 mt -69.19 -48.34 69.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 228' ' ' LEU . . . . . 0.471 ' HA ' HD23 ' C' ' 228' ' ' LEU . 43.7 mt -62.65 -35.92 81.18 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 229' ' ' ARG . . . . . 0.623 ' HA ' ' HE3' ' C' ' 232' ' ' LYS . 11.0 mtp-105 -76.27 -36.25 58.53 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 230' ' ' THR . . . . . . . . . . . . . 4.5 m -67.89 -32.09 72.33 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 231' ' ' VAL . . . . . 0.556 HG23 ' O ' ' C' ' 227' ' ' ILE . 74.6 t -76.24 -57.49 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 232' ' ' LYS . . . . . 0.623 ' HE3' ' HA ' ' C' ' 229' ' ' ARG . 14.3 ptpt -52.29 -29.22 22.24 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 233' ' ' ARG . . . . . 0.466 ' HD2' ' HA ' ' C' ' 233' ' ' ARG . 7.5 mmm180 -94.13 30.2 1.96 Allowed 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 234' ' ' ALA . . . . . . . . . . . . . . . -139.38 -0.29 1.81 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 235' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -81.3 -7.37 59.56 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 236' ' ' GLY . . . . . . . . . . . . . . . -86.82 -174.22 49.12 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.506 0 N-CA-C 110.271 -1.131 . . . . 0.0 110.271 -179.978 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 . . . . . 0 N--CA 1.449 -0.476 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 64.1 tttt -70.35 -39.27 74.78 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.816 HG21 ' CG ' ' B' ' 106' ' ' GLU . 98.1 m -44.38 -30.91 0.92 Allowed 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.477 ' HA ' HG13 ' A' ' 7' ' ' ILE . 5.9 p-10 -42.91 -50.65 5.76 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.481 ' HA ' HD23 ' A' ' 5' ' ' LEU . 13.0 mt -43.51 -47.32 7.22 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.815 ' CG ' HG21 ' C' ' 203' ' ' THR . 1.0 OUTLIER -66.04 -31.09 71.77 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 1.064 HG23 ' CD2' ' B' ' 110' ' ' LEU . 5.3 mt -64.69 -31.92 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 31.0 mt -75.75 -42.89 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.426 ' O ' ' HB ' ' A' ' 13' ' ' THR . 62.5 mt -74.34 -27.56 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 1.06 ' CD2' HG23 ' C' ' 207' ' ' ILE . 15.1 mt -83.16 -41.69 18.2 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.747 ' CD ' HG22 ' B' ' 113' ' ' THR . 34.5 mm-40 -58.54 -49.23 78.16 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.464 ' C ' HD12 ' A' ' 16' ' ' ILE . . . -69.91 -59.69 5.38 Favored Glycine 0 C--N 1.335 0.515 0 N-CA-C 110.294 -1.123 . . . . 0.0 110.294 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.764 HG22 ' CD ' ' C' ' 211' ' ' GLU . 23.6 m -49.05 -37.06 19.75 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.5 ' HB2' ' O ' ' A' ' 10' ' ' LEU . . . -60.08 -62.89 1.54 Allowed 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.649 HG22 ' HG3' ' B' ' 118' ' ' MET . 3.0 t -63.75 -21.16 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.545 HD12 ' HA ' ' A' ' 13' ' ' THR . 27.8 mt -70.73 -64.63 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.48 -35.63 30.0 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.653 ' HG2' HG13 ' C' ' 215' ' ' VAL . 4.8 mtp -61.57 -60.29 3.92 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.51 ' O ' HD12 ' A' ' 23' ' ' LEU . 1.9 m-30 -63.68 -23.67 67.47 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -67.31 -47.04 71.74 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.568 ' O ' HG23 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -67.54 -37.71 83.13 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.923 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.4 mt -63.57 -46.86 83.96 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.51 HD12 ' O ' ' A' ' 19' ' ' PHE . 11.3 mt -61.46 -46.96 87.85 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 24' ' ' LEU . 12.4 tp -60.25 -35.16 74.86 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 21' ' ' TRP . 27.8 t -67.38 -38.26 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 56.6 mt -70.42 -42.35 78.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.441 ' O ' HG23 ' A' ' 31' ' ' VAL . 55.4 mt -69.49 -36.98 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 26.2 mt -68.93 -45.93 69.56 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 64.4 mtt180 -66.48 -48.9 68.4 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.8 m -54.87 -46.55 74.73 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 27' ' ' ILE . 54.1 t -66.54 -45.19 89.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 46.2 tttm -49.92 -33.5 17.61 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.8 mmt85 -94.01 34.67 1.22 Allowed 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.04 -5.25 1.3 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.566 ' CG ' ' N ' ' A' ' 36' ' ' GLY . 2.1 t-20 -94.92 173.25 7.68 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.566 ' N ' ' CG ' ' A' ' 35' ' ' ASN . . . 99.16 -125.43 8.57 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.573 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -179.968 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 . . . . . 0 N--CA 1.449 -0.506 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 63.9 tttt -70.37 -39.28 74.68 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 103' ' ' THR . . . . . 0.799 HG21 ' CG ' ' C' ' 206' ' ' GLU . 98.6 m -44.32 -31.04 0.92 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . 0.487 ' HA ' HG13 ' B' ' 107' ' ' ILE . 5.9 p-10 -42.93 -50.47 5.8 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 0.527 ' HA ' HD23 ' B' ' 105' ' ' LEU . 13.1 mt -43.62 -47.3 7.54 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 106' ' ' GLU . . . . . 0.816 ' CG ' HG21 ' A' ' 3' ' ' THR . 1.0 OUTLIER -66.09 -30.98 71.59 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 107' ' ' ILE . . . . . 1.069 HG23 ' CD2' ' C' ' 210' ' ' LEU . 5.3 mt -64.75 -31.89 55.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 31.1 mt -75.72 -42.88 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 109' ' ' ILE . . . . . 0.41 ' O ' ' HB ' ' B' ' 113' ' ' THR . 62.4 mt -74.35 -27.61 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . 1.064 ' CD2' HG23 ' A' ' 7' ' ' ILE . 15.1 mt -83.19 -41.7 18.14 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 111' ' ' GLU . . . . . 0.747 ' CD ' HG22 ' C' ' 213' ' ' THR . 34.9 mm-40 -58.54 -49.19 78.32 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 112' ' ' GLY . . . . . 0.476 ' C ' HD12 ' B' ' 116' ' ' ILE . . . -70.01 -59.71 5.32 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.262 -1.135 . . . . 0.0 110.262 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 113' ' ' THR . . . . . 0.747 HG22 ' CD ' ' A' ' 11' ' ' GLU . 23.6 m -48.96 -37.07 19.04 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 114' ' ' ALA . . . . . 0.501 ' HB2' ' O ' ' B' ' 110' ' ' LEU . . . -60.11 -62.9 1.53 Allowed 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 0.651 HG13 ' HG2' ' C' ' 218' ' ' MET . 3.0 t -63.72 -21.17 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 116' ' ' ILE . . . . . 0.522 HD12 ' HA ' ' B' ' 113' ' ' THR . 27.8 mt -70.67 -64.71 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -50.45 -35.53 29.25 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 118' ' ' MET . . . . . 0.649 ' HG3' HG22 ' A' ' 15' ' ' VAL . 4.7 mtp -61.85 -60.23 3.95 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 119' ' ' PHE . . . . . 0.479 ' O ' HD12 ' B' ' 123' ' ' LEU . 1.9 m-30 -63.4 -23.72 67.53 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -66.23 -47.78 72.7 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.838 -0.431 . . . . 0.0 109.838 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 121' ' ' TRP . . . . . 0.557 ' C ' ' CD1' ' B' ' 121' ' ' TRP . 0.2 OUTLIER -68.51 -37.26 79.9 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.952 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 122' ' ' LEU . . . . . 0.463 ' HA ' HD23 ' B' ' 122' ' ' LEU . 80.6 mt -63.08 -45.19 93.3 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . 0.479 HD12 ' O ' ' B' ' 119' ' ' PHE . 11.3 mt -59.77 -46.72 88.3 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . 0.424 ' HA ' HD12 ' B' ' 124' ' ' LEU . 12.4 tp -60.3 -35.61 75.98 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 28.1 t -67.36 -37.47 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 56.1 mt -69.54 -41.38 80.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 127' ' ' ILE . . . . . 0.406 ' O ' HG23 ' B' ' 131' ' ' VAL . 56.1 mt -68.86 -37.17 77.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.476 ' HA ' HD23 ' B' ' 128' ' ' LEU . 25.9 mt -69.32 -45.79 68.67 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 64.5 mtt180 -66.26 -48.6 69.96 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 4.1 m -54.26 -46.31 72.61 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.406 HG23 ' O ' ' B' ' 127' ' ' ILE . 53.3 t -66.83 -45.25 88.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 46.3 tttm -49.72 -33.48 16.15 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 133' ' ' ARG . . . . . 0.452 HH11 ' HD2' ' B' ' 133' ' ' ARG . 11.8 mmt85 -93.77 34.4 1.21 Allowed 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 134' ' ' ALA . . . . . . . . . . . . . . . -139.61 -5.22 1.38 Allowed 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 135' ' ' ASN . . . . . 0.565 ' CG ' ' N ' ' B' ' 136' ' ' GLY . 2.0 t-20 -95.12 173.2 7.69 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 136' ' ' GLY . . . . . 0.565 ' N ' ' CG ' ' B' ' 135' ' ' ASN . . . 99.11 -125.32 8.52 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.525 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.939 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 201' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 . . . . . 0 N--CA 1.449 -0.516 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 63.9 tttt -70.41 -39.37 74.49 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 203' ' ' THR . . . . . 0.815 HG21 ' CG ' ' A' ' 6' ' ' GLU . 97.9 m -44.18 -31.07 0.88 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 204' ' ' ASN . . . . . 0.478 ' HA ' HG13 ' C' ' 207' ' ' ILE . 5.8 p-10 -42.98 -50.4 5.88 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 205' ' ' LEU . . . . . 0.479 HD23 ' HA ' ' C' ' 205' ' ' LEU . 13.1 mt -43.54 -47.35 7.31 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 206' ' ' GLU . . . . . 0.799 ' CG ' HG21 ' B' ' 103' ' ' THR . 1.0 OUTLIER -66.05 -31.14 71.85 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 207' ' ' ILE . . . . . 1.06 HG23 ' CD2' ' A' ' 10' ' ' LEU . 5.3 mt -64.67 -31.8 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 208' ' ' ILE . . . . . . . . . . . . . 30.9 mt -75.83 -42.97 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 209' ' ' ILE . . . . . 0.422 ' O ' ' HB ' ' C' ' 213' ' ' THR . 62.3 mt -74.32 -27.49 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 210' ' ' LEU . . . . . 1.069 ' CD2' HG23 ' B' ' 107' ' ' ILE . 15.1 mt -83.21 -41.64 18.18 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 211' ' ' GLU . . . . . 0.764 ' CD ' HG22 ' A' ' 13' ' ' THR . 34.5 mm-40 -58.58 -49.13 78.58 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 212' ' ' GLY . . . . . 0.461 ' C ' HD12 ' C' ' 216' ' ' ILE . . . -70.1 -59.68 5.3 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 213' ' ' THR . . . . . 0.747 HG22 ' CD ' ' B' ' 111' ' ' GLU . 23.7 m -48.92 -37.14 18.99 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 214' ' ' ALA . . . . . 0.496 ' HB2' ' O ' ' C' ' 210' ' ' LEU . . . -60.08 -62.9 1.53 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 215' ' ' VAL . . . . . 0.653 HG13 ' HG2' ' A' ' 18' ' ' MET . 3.0 t -63.73 -21.09 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 216' ' ' ILE . . . . . 0.529 HD12 ' HA ' ' C' ' 213' ' ' THR . 27.8 mt -70.73 -64.63 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -50.49 -35.47 29.34 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 218' ' ' MET . . . . . 0.651 ' HG2' HG13 ' B' ' 115' ' ' VAL . 4.7 mtp -61.76 -60.31 3.86 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 219' ' ' PHE . . . . . 0.414 ' O ' HD12 ' C' ' 223' ' ' LEU . 1.9 m-30 -63.39 -23.86 67.59 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -67.71 -47.54 69.09 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 221' ' ' TRP . . . . . 0.547 ' CD1' ' C ' ' C' ' 221' ' ' TRP . 0.2 OUTLIER -68.36 -36.33 79.04 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.908 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 222' ' ' LEU . . . . . 0.448 ' HA ' HD23 ' C' ' 222' ' ' LEU . 80.0 mt -62.1 -45.35 93.86 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 223' ' ' LEU . . . . . 0.414 HD12 ' O ' ' C' ' 219' ' ' PHE . 11.5 mt -60.14 -47.3 86.5 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.83 -0.434 . . . . 0.0 109.83 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 224' ' ' LEU . . . . . 0.458 HD12 ' HA ' ' C' ' 224' ' ' LEU . 12.4 tp -60.59 -35.28 75.71 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 225' ' ' VAL . . . . . 0.459 HG23 ' O ' ' C' ' 221' ' ' TRP . 28.7 t -67.07 -37.03 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 55.8 mt -69.2 -41.49 81.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 227' ' ' ILE . . . . . 0.412 ' O ' HG23 ' C' ' 231' ' ' VAL . 55.9 mt -69.15 -37.19 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 228' ' ' LEU . . . . . 0.445 ' HA ' HD23 ' C' ' 228' ' ' LEU . 26.6 mt -69.56 -46.04 67.33 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 229' ' ' ARG . . . . . . . . . . . . . 64.8 mtt180 -66.01 -48.63 70.54 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 230' ' ' THR . . . . . . . . . . . . . 4.1 m -53.82 -46.21 71.05 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 231' ' ' VAL . . . . . 0.412 HG23 ' O ' ' C' ' 227' ' ' ILE . 52.8 t -66.94 -45.31 87.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 232' ' ' LYS . . . . . . . . . . . . . 46.3 tttm -49.58 -33.57 15.44 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 233' ' ' ARG . . . . . 0.441 HH11 ' HD2' ' C' ' 233' ' ' ARG . 11.8 mmt85 -93.65 34.36 1.2 Allowed 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 234' ' ' ALA . . . . . . . . . . . . . . . -139.6 -4.75 1.41 Allowed 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 235' ' ' ASN . . . . . 0.57 ' CG ' ' N ' ' C' ' 236' ' ' GLY . 2.0 t-20 -94.84 173.36 7.63 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 236' ' ' GLY . . . . . 0.57 ' N ' ' CG ' ' C' ' 235' ' ' ASN . . . 99.42 -125.39 8.55 Favored Glycine 0 C--N 1.336 0.562 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.537 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 -179.943 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 . . . . . 0 N--CA 1.449 -0.496 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.628 ' CE ' HD12 ' A' ' 5' ' ' LEU . 23.3 tptm -77.29 -40.49 44.29 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.4 t -47.0 -35.51 6.7 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.496 ' HA ' HG13 ' A' ' 7' ' ' ILE . 1.4 t-20 -42.87 -50.35 5.74 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.628 HD12 ' CE ' ' A' ' 2' ' ' LYS . 12.3 mt -43.07 -47.7 6.03 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.571 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 2.2 mp0 -66.47 -30.89 71.33 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 1.064 HG23 ' CD2' ' B' ' 110' ' ' LEU . 5.2 mt -64.19 -32.1 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 24.3 mt -75.84 -44.02 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.412 ' O ' ' HB ' ' A' ' 13' ' ' THR . 98.3 mt -73.59 -25.51 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 1.08 ' CD2' HG23 ' C' ' 207' ' ' ILE . 15.5 mt -85.44 -41.3 15.52 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.672 ' CD ' HG22 ' B' ' 113' ' ' THR . 37.4 mm-40 -58.88 -45.9 89.12 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.748 ' C ' HD12 ' A' ' 16' ' ' ILE . . . -73.42 -55.06 6.33 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.67 HG22 ' CD ' ' C' ' 211' ' ' GLU . 22.9 m -55.08 -31.05 60.88 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.502 ' HB2' ' O ' ' A' ' 10' ' ' LEU . . . -66.43 -63.2 1.13 Allowed 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.821 -0.436 . . . . 0.0 109.821 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.668 HG23 ' O ' ' A' ' 11' ' ' GLU . 2.8 t -64.31 -21.37 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.748 HD12 ' C ' ' A' ' 12' ' ' GLY . 22.3 mt -73.59 -64.69 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.55 -26.18 20.2 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.783 ' SD ' ' HE1' ' C' ' 218' ' ' MET . 11.6 mtp -66.99 -60.2 2.83 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -51.76 -35.93 45.46 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -61.14 -49.6 76.6 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -62.95 -37.65 87.92 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 88.3 mt -72.9 -27.15 61.71 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.474 ' HA ' HD23 ' A' ' 23' ' ' LEU . 14.0 mt -69.55 -61.52 1.75 Allowed 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.557 HD12 ' C ' ' A' ' 24' ' ' LEU . 2.0 pp -54.12 -39.89 66.84 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.554 ' N ' ' HG ' ' A' ' 24' ' ' LEU . 25.6 t -64.79 -38.29 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 40.3 mt -73.04 -29.58 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.485 ' O ' HG23 ' A' ' 31' ' ' VAL . 34.4 mt -70.73 -46.25 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 81.8 mt -68.95 -35.74 77.13 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 42.1 ttt85 -71.23 -46.37 61.25 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.5 m -60.01 -44.99 94.2 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 27' ' ' ILE . 53.5 t -60.9 -51.81 68.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 34.4 tttt -50.98 -34.21 28.03 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.66 ' HA ' ' HE ' ' A' ' 33' ' ' ARG . 1.5 mmp_? -95.49 35.58 1.33 Allowed 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -139.81 -1.08 1.65 Allowed 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -91.0 132.76 35.79 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 174.71 38.63 0.04 OUTLIER Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.492 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -179.977 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 . . . . . 0 N--CA 1.449 -0.476 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . 0.606 ' CE ' HD12 ' B' ' 105' ' ' LEU . 23.2 tptm -77.4 -40.54 43.28 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 5.3 t -46.98 -35.88 7.1 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . 0.503 ' HA ' HG13 ' B' ' 107' ' ' ILE . 1.4 t-20 -42.91 -50.35 5.8 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 0.606 HD12 ' CE ' ' B' ' 102' ' ' LYS . 12.3 mt -43.22 -47.58 6.43 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 106' ' ' GLU . . . . . 0.582 ' CD ' ' N ' ' B' ' 106' ' ' GLU . 2.2 mp0 -66.42 -31.02 71.52 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 107' ' ' ILE . . . . . 1.082 HG23 ' CD2' ' C' ' 210' ' ' LEU . 5.2 mt -64.08 -32.02 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 24.1 mt -75.93 -44.19 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 109' ' ' ILE . . . . . 0.413 ' O ' ' HB ' ' B' ' 113' ' ' THR . 98.2 mt -73.43 -25.54 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . 1.064 ' CD2' HG23 ' A' ' 7' ' ' ILE . 15.5 mt -85.38 -41.45 15.45 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 111' ' ' GLU . . . . . 0.683 ' O ' HG23 ' B' ' 115' ' ' VAL . 37.2 mm-40 -58.57 -45.91 88.04 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 112' ' ' GLY . . . . . 0.735 ' C ' HD12 ' B' ' 116' ' ' ILE . . . -73.57 -55.39 6.07 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 113' ' ' THR . . . . . 0.672 HG22 ' CD ' ' A' ' 11' ' ' GLU . 23.2 m -54.69 -30.94 57.03 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 114' ' ' ALA . . . . . 0.502 ' HB2' ' O ' ' B' ' 110' ' ' LEU . . . -66.66 -63.32 1.09 Allowed 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 0.683 HG23 ' O ' ' B' ' 111' ' ' GLU . 2.7 t -64.07 -21.35 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 116' ' ' ILE . . . . . 0.735 HD12 ' C ' ' B' ' 112' ' ' GLY . 23.0 mt -73.55 -64.67 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -53.59 -25.99 19.76 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 118' ' ' MET . . . . . 0.789 ' HE1' ' SD ' ' C' ' 218' ' ' MET . 11.5 mtp -67.2 -60.22 2.79 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -50.91 -37.14 42.17 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -62.59 -49.58 74.67 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 121' ' ' TRP . . . . . 0.526 ' O ' HG23 ' B' ' 125' ' ' VAL . 0.1 OUTLIER -63.74 -35.72 81.49 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.886 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 82.6 mt -71.32 -28.4 64.07 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . 0.496 ' HA ' HD23 ' B' ' 123' ' ' LEU . 14.3 mt -71.02 -61.65 1.69 Allowed 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . 0.562 HD12 ' C ' ' B' ' 124' ' ' LEU . 2.1 pp -54.92 -39.11 68.47 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . 0.535 ' N ' ' HG ' ' B' ' 124' ' ' LEU . 27.2 t -63.86 -37.97 81.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 41.5 mt -73.09 -29.86 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 127' ' ' ILE . . . . . 0.472 ' O ' HG23 ' B' ' 131' ' ' VAL . 35.9 mt -71.38 -46.98 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 82.4 mt -69.7 -35.27 74.93 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 42.1 ttt85 -71.17 -46.55 61.18 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 5.6 m -59.44 -44.93 92.84 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.472 HG23 ' O ' ' B' ' 127' ' ' ILE . 55.1 t -61.34 -51.54 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 34.8 tttt -51.15 -33.59 27.51 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 133' ' ' ARG . . . . . 0.654 ' HA ' ' HE ' ' B' ' 133' ' ' ARG . 1.4 mmp_? -95.39 35.04 1.36 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 134' ' ' ALA . . . . . . . . . . . . . . . -139.24 -0.89 1.78 Allowed 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -91.21 132.69 35.94 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . 174.54 38.61 0.04 OUTLIER Glycine 0 CA--C 1.523 0.531 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.526 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 -179.947 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 201' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 . . . . . 0 N--CA 1.449 -0.48 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 202' ' ' LYS . . . . . 0.59 ' CE ' HD12 ' C' ' 205' ' ' LEU . 23.3 tptm -77.4 -40.55 43.25 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 203' ' ' THR . . . . . . . . . . . . . 5.3 t -47.1 -36.06 7.81 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 204' ' ' ASN . . . . . 0.511 ' HA ' HG13 ' C' ' 207' ' ' ILE . 1.4 t-20 -42.86 -50.61 5.7 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 205' ' ' LEU . . . . . 0.59 HD12 ' CE ' ' C' ' 202' ' ' LYS . 12.4 mt -43.13 -47.48 6.15 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 206' ' ' GLU . . . . . 0.572 ' N ' ' CD ' ' C' ' 206' ' ' GLU . 2.2 mp0 -66.43 -30.92 71.38 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 207' ' ' ILE . . . . . 1.08 HG23 ' CD2' ' A' ' 10' ' ' LEU . 5.3 mt -64.26 -32.0 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 208' ' ' ILE . . . . . . . . . . . . . 24.1 mt -75.94 -43.92 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 209' ' ' ILE . . . . . 0.419 ' O ' ' HB ' ' C' ' 213' ' ' THR . 98.3 mt -73.6 -25.63 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.722 -0.474 . . . . 0.0 109.722 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 210' ' ' LEU . . . . . 1.082 ' CD2' HG23 ' B' ' 107' ' ' ILE . 15.5 mt -85.38 -41.26 15.62 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 211' ' ' GLU . . . . . 0.674 ' O ' HG23 ' C' ' 215' ' ' VAL . 37.3 mm-40 -58.9 -45.88 89.2 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 212' ' ' GLY . . . . . 0.739 ' C ' HD12 ' C' ' 216' ' ' ILE . . . -73.48 -55.09 6.28 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 110.291 -1.123 . . . . 0.0 110.291 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 213' ' ' THR . . . . . 0.678 HG22 ' CD ' ' B' ' 111' ' ' GLU . 22.8 m -55.04 -31.14 60.87 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 214' ' ' ALA . . . . . 0.503 ' HB2' ' O ' ' C' ' 210' ' ' LEU . . . -66.39 -63.36 1.09 Allowed 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 215' ' ' VAL . . . . . 0.674 HG23 ' O ' ' C' ' 211' ' ' GLU . 2.8 t -64.07 -21.55 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 216' ' ' ILE . . . . . 0.739 HD12 ' C ' ' C' ' 212' ' ' GLY . 22.2 mt -73.44 -64.67 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -53.57 -26.05 19.84 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 218' ' ' MET . . . . . 0.789 ' SD ' ' HE1' ' B' ' 118' ' ' MET . 11.6 mtp -67.13 -60.11 2.89 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -51.41 -36.32 43.11 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -61.68 -48.2 81.87 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 221' ' ' TRP . . . . . 0.576 ' O ' HG23 ' C' ' 225' ' ' VAL . 0.1 OUTLIER -61.9 -37.13 83.45 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.855 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 83.5 mt -72.6 -29.59 63.63 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 223' ' ' LEU . . . . . 0.478 HD23 ' HA ' ' C' ' 223' ' ' LEU . 14.4 mt -71.75 -60.87 2.01 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 224' ' ' LEU . . . . . 0.563 ' C ' HD12 ' C' ' 224' ' ' LEU . 2.1 pp -53.96 -38.88 65.46 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 225' ' ' VAL . . . . . 0.576 HG23 ' O ' ' C' ' 221' ' ' TRP . 25.7 t -63.87 -38.51 82.56 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 41.3 mt -73.8 -30.23 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 227' ' ' ILE . . . . . 0.459 ' O ' HG23 ' C' ' 231' ' ' VAL . 34.7 mt -71.25 -46.23 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 81.7 mt -68.93 -35.63 77.02 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 229' ' ' ARG . . . . . . . . . . . . . 42.3 ttt85 -71.31 -46.3 61.02 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 230' ' ' THR . . . . . . . . . . . . . 4.9 m -60.06 -45.21 93.63 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 231' ' ' VAL . . . . . 0.459 HG23 ' O ' ' C' ' 227' ' ' ILE . 53.3 t -61.32 -51.48 72.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 232' ' ' LYS . . . . . . . . . . . . . 34.6 tttt -50.91 -34.03 26.7 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 233' ' ' ARG . . . . . 0.666 ' HE ' ' HA ' ' C' ' 233' ' ' ARG . 1.5 mmp_? -95.46 35.44 1.34 Allowed 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 234' ' ' ALA . . . . . . . . . . . . . . . -140.05 -0.72 1.64 Allowed 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 235' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -90.83 132.95 35.58 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 236' ' ' GLY . . . . . . . . . . . . . . . 174.84 38.87 0.05 OUTLIER Glycine 0 C--N 1.335 0.506 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.53 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -179.971 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 . . . . . 0 N--CA 1.45 -0.452 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -77.67 -44.75 27.01 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.1 t -43.76 -33.53 1.3 Allowed 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.504 ' HA ' HG13 ' A' ' 7' ' ' ILE . 1.1 t-20 -42.74 -51.05 5.48 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.463 ' HA ' HD23 ' A' ' 5' ' ' LEU . 13.1 mt -43.01 -48.9 6.07 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.587 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 2.6 mp0 -64.13 -31.63 72.9 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 1.025 HG23 ' CD2' ' B' ' 110' ' ' LEU . 3.8 mt -65.25 -29.89 48.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.8 mt -76.77 -42.13 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.428 ' O ' ' HB ' ' A' ' 13' ' ' THR . 83.4 mt -77.3 -23.82 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 1.045 ' CD2' HG23 ' C' ' 207' ' ' ILE . 15.5 mt -85.7 -49.75 7.72 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.579 ' O ' HG23 ' A' ' 15' ' ' VAL . 58.7 mm-40 -59.01 -40.42 84.87 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.87 ' C ' HD12 ' A' ' 16' ' ' ILE . . . -73.27 -57.52 5.11 Favored Glycine 0 C--N 1.335 0.509 0 N-CA-C 110.276 -1.129 . . . . 0.0 110.276 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.428 ' HB ' ' O ' ' A' ' 9' ' ' ILE . 49.5 m -57.78 -25.18 60.17 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.507 ' HB2' ' O ' ' A' ' 10' ' ' LEU . . . -68.79 -62.92 1.18 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 11' ' ' GLU . 2.6 t -69.04 -21.08 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.87 HD12 ' C ' ' A' ' 12' ' ' GLY . 22.4 mt -77.31 -64.85 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.15 -32.07 21.84 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.591 ' CE ' ' HE1' ' B' ' 118' ' ' MET . 6.7 mtp -66.1 -60.18 3.06 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.51 -25.34 67.21 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -71.29 -46.4 60.91 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -40.6 97.32 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.45 HD12 ' HA ' ' A' ' 22' ' ' LEU . 10.8 tp -61.39 -48.21 82.27 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 26.0 mt -57.22 -38.67 74.1 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.527 ' HA ' HD12 ' A' ' 24' ' ' LEU . 12.3 tp -65.66 -36.75 84.57 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.0 t -62.79 -41.22 91.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 79.6 mt -67.22 -43.1 88.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.526 ' O ' HG23 ' A' ' 31' ' ' VAL . 93.4 mt -66.23 -35.69 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.474 ' HA ' HD23 ' A' ' 28' ' ' LEU . 25.8 mt -66.15 -49.99 65.52 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 39.4 mtt180 -64.32 -47.1 80.71 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.0 m -54.35 -43.13 71.03 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 27' ' ' ILE . 53.8 t -69.18 -45.04 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 28.6 tttt -51.02 -32.91 22.98 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -97.19 36.8 1.4 Allowed 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -143.61 -3.87 0.89 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 23.5 m-20 -136.32 116.43 13.39 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 107.73 -8.61 37.08 Favored Glycine 0 C--N 1.335 0.505 0 N-CA-C 110.288 -1.125 . . . . 0.0 110.288 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.525 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 -179.941 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 . . . . . 0 N--CA 1.448 -0.535 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 29.8 ttmt -77.75 -44.87 26.34 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 5.1 t -43.64 -33.39 1.19 Allowed 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . 0.501 ' HA ' HG13 ' B' ' 107' ' ' ILE . 1.1 t-20 -42.72 -51.09 5.44 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 0.464 HD23 ' HA ' ' B' ' 105' ' ' LEU . 13.1 mt -42.81 -48.92 5.79 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 106' ' ' GLU . . . . . 0.589 ' CD ' ' N ' ' B' ' 106' ' ' GLU . 2.6 mp0 -64.27 -31.65 72.94 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 107' ' ' ILE . . . . . 1.046 HG23 ' CD2' ' C' ' 210' ' ' LEU . 3.8 mt -65.34 -29.75 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 39.4 mt -76.82 -42.17 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 109' ' ' ILE . . . . . 0.418 ' O ' ' HB ' ' B' ' 113' ' ' THR . 84.1 mt -77.3 -23.81 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . 1.025 ' CD2' HG23 ' A' ' 7' ' ' ILE . 15.5 mt -85.67 -50.23 7.36 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 111' ' ' GLU . . . . . 0.595 ' O ' HG23 ' B' ' 115' ' ' VAL . 59.3 mm-40 -58.88 -40.19 83.67 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 112' ' ' GLY . . . . . 0.884 ' C ' HD12 ' B' ' 116' ' ' ILE . . . -73.32 -57.58 5.05 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 113' ' ' THR . . . . . 0.418 ' HB ' ' O ' ' B' ' 109' ' ' ILE . 49.5 m -57.81 -25.17 60.23 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 114' ' ' ALA . . . . . 0.498 ' HB2' ' O ' ' B' ' 110' ' ' LEU . . . -68.78 -63.11 1.12 Allowed 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 0.595 HG23 ' O ' ' B' ' 111' ' ' GLU . 2.5 t -68.9 -21.09 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 116' ' ' ILE . . . . . 0.884 HD12 ' C ' ' B' ' 112' ' ' GLY . 22.6 mt -77.28 -64.81 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -51.01 -32.24 20.72 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 118' ' ' MET . . . . . 0.616 ' CE ' ' HE1' ' C' ' 218' ' ' MET . 6.6 mtp -66.29 -59.9 3.28 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.51 -25.58 66.2 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -71.38 -48.91 47.08 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 121' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -65.73 -40.62 92.34 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 122' ' ' LEU . . . . . 0.441 ' HA ' HD12 ' B' ' 122' ' ' LEU . 10.7 tp -61.07 -47.97 83.87 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 26.1 mt -56.58 -40.52 75.39 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . 0.542 ' HA ' HD12 ' B' ' 124' ' ' LEU . 12.3 tp -66.69 -36.96 83.74 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . . . . . . . . . 25.0 t -63.78 -40.44 89.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 79.8 mt -66.44 -43.08 91.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 127' ' ' ILE . . . . . 0.512 ' O ' HG23 ' B' ' 131' ' ' VAL . 93.0 mt -67.03 -36.45 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.473 HD23 ' HA ' ' B' ' 128' ' ' LEU . 25.5 mt -67.06 -49.88 63.67 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 39.3 mtt180 -63.97 -46.99 82.15 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 4.0 m -54.14 -43.31 70.42 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.512 HG23 ' O ' ' B' ' 127' ' ' ILE . 54.0 t -69.18 -45.11 80.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 29.0 tttt -51.03 -33.0 23.41 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -97.11 36.6 1.41 Allowed 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 134' ' ' ALA . . . . . . . . . . . . . . . -143.53 -4.05 0.89 Allowed 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 23.7 m-20 -136.29 116.4 13.39 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . 107.44 -8.85 38.08 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.534 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 -179.983 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 201' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -77.7 -44.85 26.57 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 203' ' ' THR . . . . . . . . . . . . . 5.1 t -43.69 -33.53 1.25 Allowed 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 204' ' ' ASN . . . . . 0.489 ' HA ' HG13 ' C' ' 207' ' ' ILE . 1.1 t-20 -42.75 -51.23 5.43 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 205' ' ' LEU . . . . . 0.469 HD23 ' HA ' ' C' ' 205' ' ' LEU . 13.1 mt -42.89 -48.91 5.9 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 206' ' ' GLU . . . . . 0.58 ' N ' ' CD ' ' C' ' 206' ' ' GLU . 2.6 mp0 -64.03 -31.67 72.94 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 207' ' ' ILE . . . . . 1.045 HG23 ' CD2' ' A' ' 10' ' ' LEU . 3.8 mt -65.24 -29.93 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 208' ' ' ILE . . . . . . . . . . . . . 40.4 mt -76.67 -42.11 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 209' ' ' ILE . . . . . 0.414 ' O ' ' HB ' ' C' ' 213' ' ' THR . 84.0 mt -77.36 -23.87 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 210' ' ' LEU . . . . . 1.046 ' CD2' HG23 ' B' ' 107' ' ' ILE . 15.5 mt -85.66 -50.2 7.39 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 211' ' ' GLU . . . . . 0.586 ' O ' HG23 ' C' ' 215' ' ' VAL . 59.2 mm-40 -58.8 -40.39 83.93 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 212' ' ' GLY . . . . . 0.895 ' C ' HD12 ' C' ' 216' ' ' ILE . . . -73.28 -57.55 5.09 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 213' ' ' THR . . . . . 0.414 HG22 ' OE1' ' B' ' 111' ' ' GLU . 48.6 m -57.76 -25.2 60.14 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 214' ' ' ALA . . . . . 0.51 ' HB2' ' O ' ' C' ' 210' ' ' LEU . . . -68.69 -63.13 1.12 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 215' ' ' VAL . . . . . 0.586 HG23 ' O ' ' C' ' 211' ' ' GLU . 2.5 t -68.97 -21.11 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 216' ' ' ILE . . . . . 0.895 HD12 ' C ' ' C' ' 212' ' ' GLY . 22.0 mt -77.02 -64.8 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -51.07 -32.42 22.08 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 218' ' ' MET . . . . . 0.616 ' HE1' ' CE ' ' B' ' 118' ' ' MET . 6.5 mtp -65.99 -59.86 3.4 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.31 -26.36 66.47 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -72.9 -47.52 45.1 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 221' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.89 -39.82 94.12 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 10.8 tp -59.96 -48.74 80.48 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 223' ' ' LEU . . . . . . . . . . . . . 25.7 mt -57.63 -40.23 78.73 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 224' ' ' LEU . . . . . 0.483 HD12 ' HA ' ' C' ' 224' ' ' LEU . 12.1 tp -66.46 -36.05 81.82 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 225' ' ' VAL . . . . . . . . . . . . . 25.4 t -62.47 -39.99 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 78.1 mt -65.74 -43.73 93.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 227' ' ' ILE . . . . . 0.514 ' O ' HG23 ' C' ' 231' ' ' VAL . 92.9 mt -67.59 -36.95 77.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 228' ' ' LEU . . . . . 0.451 ' HA ' HD23 ' C' ' 228' ' ' LEU . 27.4 mt -67.17 -49.72 63.71 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 229' ' ' ARG . . . . . . . . . . . . . 39.3 mtt180 -63.91 -47.26 81.29 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 230' ' ' THR . . . . . . . . . . . . . 4.1 m -54.29 -42.8 70.47 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.911 -0.404 . . . . 0.0 109.911 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 231' ' ' VAL . . . . . 0.514 HG23 ' O ' ' C' ' 227' ' ' ILE . 53.6 t -69.81 -45.33 77.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 232' ' ' LYS . . . . . . . . . . . . . 28.3 tttt -50.25 -32.45 16.75 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 233' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -97.0 36.4 1.43 Allowed 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 234' ' ' ALA . . . . . . . . . . . . . . . -143.86 -3.68 0.87 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 235' ' ' ASN . . . . . . . . . . . . . 23.0 m-20 -136.16 116.41 13.53 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 236' ' ' GLY . . . . . . . . . . . . . . . 107.93 -8.58 36.51 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.538 0 N-CA-C 110.264 -1.134 . . . . 0.0 110.264 -179.948 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 . . . . . 0 N--CA 1.449 -0.515 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.527 ' C ' HD22 ' A' ' 4' ' ' ASN . 23.9 mtmt -82.59 -40.87 20.26 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.863 HG21 ' CG ' ' B' ' 106' ' ' GLU . 96.0 m -43.51 -31.1 0.66 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.682 ' ND2' ' H ' ' A' ' 5' ' ' LEU . 0.3 OUTLIER -42.6 -50.71 5.35 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.94 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.682 ' H ' ' ND2' ' A' ' 4' ' ' ASN . 16.1 mt -43.46 -48.33 7.21 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.859 ' CG ' HG21 ' C' ' 203' ' ' THR . 2.7 mp0 -64.67 -31.56 72.84 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 1.069 HG23 ' CD2' ' B' ' 110' ' ' LEU . 4.9 mt -65.2 -30.38 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 60.7 mt -76.48 -42.17 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.419 ' O ' ' HB ' ' A' ' 13' ' ' THR . 32.0 mt -76.54 -25.22 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 1.079 ' CD2' HG23 ' C' ' 207' ' ' ILE . 15.1 mt -84.6 -46.46 11.52 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.589 ' CD ' HG22 ' B' ' 113' ' ' THR . 52.1 mm-40 -58.67 -45.14 90.04 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.647 ' C ' HD12 ' A' ' 16' ' ' ILE . . . -70.58 -57.92 6.25 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.584 HG22 ' CD ' ' C' ' 211' ' ' GLU . 44.9 m -55.69 -27.02 47.93 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.553 ' HB2' ' O ' ' A' ' 10' ' ' LEU . . . -66.45 -63.14 1.14 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.687 HG22 ' HG3' ' B' ' 118' ' ' MET . 2.9 t -67.49 -22.04 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.647 HD12 ' C ' ' A' ' 12' ' ' GLY . 34.8 mt -73.09 -64.54 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.78 -34.89 29.19 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.717 ' HG3' HG22 ' C' ' 215' ' ' VAL . 6.0 mtp -60.46 -60.16 4.26 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -52.28 -37.83 56.62 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -62.4 -50.54 71.12 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.595 ' O ' HG23 ' A' ' 25' ' ' VAL . 36.1 t-105 -70.53 -22.51 62.61 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.498 HD12 HD11 ' A' ' 26' ' ' ILE . 0.1 OUTLIER -71.65 -52.05 19.95 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.992 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.662 ' HA ' HD12 ' A' ' 26' ' ' ILE . 0.7 OUTLIER -62.24 -35.45 78.98 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.557 ' N ' ' HG ' ' A' ' 23' ' ' LEU . 13.0 mt -59.67 -51.9 67.83 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 21' ' ' TRP . 42.8 t -65.79 -25.49 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.662 HD12 ' HA ' ' A' ' 23' ' ' LEU . 43.0 mt -70.49 -47.08 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.535 ' O ' HG23 ' A' ' 31' ' ' VAL . 84.7 mt -67.2 -36.24 76.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.509 ' HA ' HD23 ' A' ' 28' ' ' LEU . 23.5 mt -67.17 -50.93 59.35 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 32.8 mtp180 -63.32 -48.92 76.01 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.5 m -52.55 -41.49 63.58 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 27' ' ' ILE . 53.0 t -70.31 -43.18 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 23.9 ttmt -53.31 -30.63 39.96 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.428 HH11 ' HD2' ' A' ' 33' ' ' ARG . 7.3 mtp180 -98.5 36.29 1.65 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -138.86 8.05 2.52 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 -119.98 176.63 5.33 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 139.64 55.86 0.04 OUTLIER Glycine 0 C--N 1.335 0.49 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.548 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 -179.993 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 . . . . . 0 N--CA 1.45 -0.441 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . 0.532 ' C ' HD22 ' B' ' 104' ' ' ASN . 23.9 mtmt -82.6 -40.87 20.24 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 103' ' ' THR . . . . . 0.843 HG21 ' CG ' ' C' ' 206' ' ' GLU . 96.2 m -43.52 -31.12 0.66 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . 0.674 ' ND2' ' H ' ' B' ' 105' ' ' LEU . 0.3 OUTLIER -42.66 -50.8 5.43 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.934 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 0.674 ' H ' ' ND2' ' B' ' 104' ' ' ASN . 16.2 mt -43.57 -48.24 7.52 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 106' ' ' GLU . . . . . 0.863 ' CG ' HG21 ' A' ' 3' ' ' THR . 2.7 mp0 -64.58 -31.42 72.63 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 107' ' ' ILE . . . . . 1.085 HG23 ' CD2' ' C' ' 210' ' ' LEU . 4.8 mt -65.31 -30.36 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 61.0 mt -76.53 -42.07 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 109' ' ' ILE . . . . . 0.429 ' O ' ' HB ' ' B' ' 113' ' ' THR . 32.0 mt -76.64 -25.2 15.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . 1.069 ' CD2' HG23 ' A' ' 7' ' ' ILE . 15.1 mt -84.58 -46.53 11.46 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 111' ' ' GLU . . . . . 0.589 ' CD ' HG22 ' C' ' 213' ' ' THR . 52.4 mm-40 -58.72 -45.14 90.27 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 112' ' ' GLY . . . . . 0.654 ' C ' HD12 ' B' ' 116' ' ' ILE . . . -70.56 -57.76 6.38 Favored Glycine 0 C--N 1.335 0.521 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 113' ' ' THR . . . . . 0.589 HG22 ' CD ' ' A' ' 11' ' ' GLU . 45.1 m -55.82 -26.95 48.96 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 114' ' ' ALA . . . . . 0.55 ' HB2' ' O ' ' B' ' 110' ' ' LEU . . . -66.47 -63.12 1.14 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 0.698 HG22 ' HG3' ' C' ' 218' ' ' MET . 2.9 t -67.58 -22.1 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 116' ' ' ILE . . . . . 0.654 HD12 ' C ' ' B' ' 112' ' ' GLY . 35.3 mt -73.09 -64.53 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -50.65 -35.05 28.78 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 118' ' ' MET . . . . . 0.687 ' HG3' HG22 ' A' ' 15' ' ' VAL . 6.0 mtp -60.36 -60.18 4.23 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -52.68 -38.46 60.57 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -62.73 -49.91 73.17 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 121' ' ' TRP . . . . . 0.619 ' O ' HG23 ' B' ' 125' ' ' VAL . 36.1 t-105 -70.5 -22.5 62.63 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 122' ' ' LEU . . . . . 0.406 HD12 HD11 ' B' ' 126' ' ' ILE . 0.0 OUTLIER -71.55 -52.08 20.07 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . 0.648 HD12 ' C ' ' B' ' 123' ' ' LEU . 0.8 OUTLIER -62.31 -35.21 78.35 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.959 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . 0.564 ' N ' ' HG ' ' B' ' 123' ' ' LEU . 13.0 mt -59.91 -51.54 69.26 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . 0.619 HG23 ' O ' ' B' ' 121' ' ' TRP . 42.6 t -65.19 -25.87 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 0.637 HD12 ' HA ' ' B' ' 123' ' ' LEU . 45.2 mt -70.7 -47.28 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 127' ' ' ILE . . . . . 0.525 ' O ' HG23 ' B' ' 131' ' ' VAL . 84.6 mt -67.03 -35.92 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.448 ' HA ' HD23 ' B' ' 128' ' ' LEU . 24.2 mt -65.91 -50.8 63.18 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 32.7 mtp180 -63.84 -50.04 70.42 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 4.0 m -52.6 -42.42 64.54 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.525 HG23 ' O ' ' B' ' 127' ' ' ILE . 53.3 t -70.71 -42.63 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 24.0 ttmt -52.72 -31.36 37.32 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 133' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' B' ' 133' ' ' ARG . 7.3 mtp180 -97.49 36.04 1.55 Allowed 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 134' ' ' ALA . . . . . . . . . . . . . . . -139.23 8.21 2.45 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 -119.76 176.67 5.28 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . 139.75 56.1 0.04 OUTLIER Glycine 0 C--N 1.336 0.531 0 N-CA-C 110.269 -1.133 . . . . 0.0 110.269 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.537 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 -179.97 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 201' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 . . . . . 0 N--CA 1.45 -0.475 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 202' ' ' LYS . . . . . 0.533 ' C ' HD22 ' C' ' 204' ' ' ASN . 23.9 mtmt -82.62 -40.93 20.13 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 203' ' ' THR . . . . . 0.859 HG21 ' CG ' ' A' ' 6' ' ' GLU . 96.3 m -43.54 -31.12 0.67 Allowed 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 204' ' ' ASN . . . . . 0.67 ' ND2' ' H ' ' C' ' 205' ' ' LEU . 0.3 OUTLIER -42.56 -50.72 5.3 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 205' ' ' LEU . . . . . 0.67 ' H ' ' ND2' ' C' ' 204' ' ' ASN . 16.2 mt -43.6 -48.24 7.61 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 206' ' ' GLU . . . . . 0.843 ' CG ' HG21 ' B' ' 103' ' ' THR . 2.7 mp0 -64.66 -31.47 72.71 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 207' ' ' ILE . . . . . 1.079 HG23 ' CD2' ' A' ' 10' ' ' LEU . 4.8 mt -65.24 -30.35 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 208' ' ' ILE . . . . . . . . . . . . . 60.5 mt -76.59 -42.12 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 209' ' ' ILE . . . . . 0.415 ' O ' ' HB ' ' C' ' 213' ' ' THR . 31.8 mt -76.59 -25.21 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 210' ' ' LEU . . . . . 1.085 ' CD2' HG23 ' B' ' 107' ' ' ILE . 15.1 mt -84.62 -46.5 11.46 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 211' ' ' GLU . . . . . 0.584 ' CD ' HG22 ' A' ' 13' ' ' THR . 52.3 mm-40 -58.71 -45.04 90.45 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 212' ' ' GLY . . . . . 0.654 ' C ' HD12 ' C' ' 216' ' ' ILE . . . -70.66 -57.85 6.25 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 213' ' ' THR . . . . . 0.589 HG22 ' CD ' ' B' ' 111' ' ' GLU . 45.4 m -55.68 -27.11 48.4 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 214' ' ' ALA . . . . . 0.537 ' HB2' ' O ' ' C' ' 210' ' ' LEU . . . -66.51 -63.05 1.16 Allowed 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 215' ' ' VAL . . . . . 0.717 HG22 ' HG3' ' A' ' 18' ' ' MET . 3.0 t -67.6 -22.02 28.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 216' ' ' ILE . . . . . 0.654 HD12 ' C ' ' C' ' 212' ' ' GLY . 34.6 mt -73.19 -64.42 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -50.92 -34.78 29.97 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 218' ' ' MET . . . . . 0.698 ' HG3' HG22 ' B' ' 115' ' ' VAL . 6.0 mtp -60.52 -60.17 4.23 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -51.96 -38.36 56.29 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -62.8 -50.15 72.12 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 221' ' ' TRP . . . . . 0.607 ' O ' HG23 ' C' ' 225' ' ' VAL . 36.5 t-105 -70.16 -22.48 62.97 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.54 -52.2 19.45 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 223' ' ' LEU . . . . . 0.648 ' HA ' HD12 ' C' ' 226' ' ' ILE . 0.8 OUTLIER -62.11 -35.32 78.37 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 224' ' ' LEU . . . . . 0.57 ' N ' ' HG ' ' C' ' 223' ' ' LEU . 13.0 mt -59.9 -51.22 70.62 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 225' ' ' VAL . . . . . 0.607 HG23 ' O ' ' C' ' 221' ' ' TRP . 42.5 t -65.8 -25.8 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 226' ' ' ILE . . . . . 0.648 HD12 ' HA ' ' C' ' 223' ' ' LEU . 43.2 mt -70.45 -47.39 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 227' ' ' ILE . . . . . 0.537 ' O ' HG23 ' C' ' 231' ' ' VAL . 84.9 mt -66.6 -35.68 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 228' ' ' LEU . . . . . 0.459 ' HA ' HD23 ' C' ' 228' ' ' LEU . 23.4 mt -66.66 -50.83 61.65 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 229' ' ' ARG . . . . . . . . . . . . . 32.4 mtp180 -63.63 -49.79 71.91 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 230' ' ' THR . . . . . . . . . . . . . 3.8 m -52.18 -41.48 62.66 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 231' ' ' VAL . . . . . 0.537 HG23 ' O ' ' C' ' 227' ' ' ILE . 53.2 t -70.75 -42.55 77.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 232' ' ' LYS . . . . . . . . . . . . . 24.2 ttmt -53.24 -31.67 44.53 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 233' ' ' ARG . . . . . 0.435 HH11 ' HD2' ' C' ' 233' ' ' ARG . 7.2 mtp180 -96.96 35.53 1.54 Allowed 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 234' ' ' ALA . . . . . . . . . . . . . . . -138.94 8.57 2.53 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 235' ' ' ASN . . . . . . . . . . . . . 45.7 m-20 -119.55 176.57 5.3 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 236' ' ' GLY . . . . . . . . . . . . . . . 139.46 55.95 0.04 OUTLIER Glycine 0 C--N 1.336 0.534 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.539 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 -179.961 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 . . . . . 0 N--CA 1.449 -0.523 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.535 ' N ' ' CD ' ' A' ' 2' ' ' LYS . 3.9 mptp? -84.67 -40.79 16.97 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.1 t -49.18 -36.23 19.06 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.484 ' HA ' HG13 ' A' ' 7' ' ' ILE . 1.6 t30 -42.84 -51.23 5.54 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.535 ' HA ' HD23 ' A' ' 5' ' ' LEU . 12.8 mt -42.99 -48.57 5.97 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.571 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 3.8 mp0 -64.54 -31.36 72.54 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 1.075 HG23 ' CD2' ' B' ' 110' ' ' LEU . 4.0 mt -65.17 -30.2 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 73.6 mt -76.75 -42.24 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.415 ' O ' ' HB ' ' A' ' 13' ' ' THR . 95.7 mt -76.75 -24.21 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 1.069 ' CD2' HG23 ' C' ' 207' ' ' ILE . 15.4 mt -85.6 -47.59 9.71 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.548 ' CD ' HG22 ' B' ' 113' ' ' THR . 57.5 mm-40 -58.95 -42.34 89.57 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.701 ' C ' HD12 ' A' ' 16' ' ' ILE . . . -72.65 -56.38 6.05 Favored Glycine 0 C--N 1.335 0.521 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.562 HG22 ' CD ' ' C' ' 211' ' ' GLU . 37.1 m -57.77 -25.4 60.45 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.517 ' HB2' ' O ' ' A' ' 10' ' ' LEU . . . -68.83 -63.14 1.12 Allowed 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.618 HG22 ' CG ' ' B' ' 118' ' ' MET . 2.7 t -68.56 -21.17 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.701 HD12 ' C ' ' A' ' 12' ' ' GLY . 34.9 mt -76.84 -64.65 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.02 -32.32 21.13 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.624 ' CG ' HG22 ' C' ' 215' ' ' VAL . 6.4 mtp -65.52 -60.23 3.15 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -54.84 -30.06 56.63 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.434 ' CE2' ' CG2' ' A' ' 16' ' ' ILE . 2.9 m-85 -69.25 -44.0 72.84 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.41 ' O ' HG23 ' A' ' 25' ' ' VAL . 43.9 t-105 -74.12 -28.36 61.31 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.464 ' HA ' HD23 ' A' ' 22' ' ' LEU . 15.2 mt -71.33 -52.92 16.12 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.741 HD12 ' C ' ' A' ' 23' ' ' LEU . 0.9 OUTLIER -61.35 -34.25 74.97 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.488 ' N ' ' HG ' ' A' ' 23' ' ' LEU . 4.5 tt -62.73 -45.7 91.51 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 21' ' ' TRP . 79.8 t -70.36 -23.5 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.729 HD12 ' HA ' ' A' ' 23' ' ' LEU . 48.1 mt -70.35 -44.3 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 36.6 mt -72.27 -37.29 58.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 24.0 mt -72.72 -37.5 67.77 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 33.8 ttm-85 -75.18 -41.52 57.82 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.6 m -62.25 -41.41 98.41 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 55.8 t -74.11 -42.47 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.515 ' HB3' ' NZ ' ' A' ' 32' ' ' LYS . 7.6 mtpm? -56.61 -29.24 61.93 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.5 mmm180 -101.95 37.62 1.81 Allowed 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.87 -9.11 1.04 Allowed 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -82.47 137.95 34.5 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -110.87 -102.01 2.66 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.543 0 N-CA-C 110.305 -1.118 . . . . 0.0 110.305 179.996 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 . . . . . 0 N--CA 1.449 -0.5 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . 0.536 ' N ' ' CD ' ' B' ' 102' ' ' LYS . 3.9 mptp? -84.7 -40.73 17.0 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 7.0 t -49.26 -36.19 19.77 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . 0.496 ' HA ' HG13 ' B' ' 107' ' ' ILE . 1.5 t30 -42.93 -51.24 5.65 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 0.481 HD23 ' HA ' ' B' ' 105' ' ' LEU . 12.8 mt -43.01 -48.49 6.0 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 106' ' ' GLU . . . . . 0.583 ' CD ' ' N ' ' B' ' 106' ' ' GLU . 3.8 mp0 -64.54 -31.46 72.69 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 107' ' ' ILE . . . . . 1.046 HG23 ' CD2' ' C' ' 210' ' ' LEU . 4.0 mt -65.14 -30.14 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 73.5 mt -76.77 -42.24 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 109' ' ' ILE . . . . . 0.426 ' O ' ' HB ' ' B' ' 113' ' ' THR . 95.6 mt -76.84 -24.12 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . 1.075 ' CD2' HG23 ' A' ' 7' ' ' ILE . 15.5 mt -85.62 -47.48 9.8 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 111' ' ' GLU . . . . . 0.561 ' CD ' HG22 ' C' ' 213' ' ' THR . 57.5 mm-40 -58.98 -42.45 89.98 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 112' ' ' GLY . . . . . 0.701 ' C ' HD12 ' B' ' 116' ' ' ILE . . . -72.67 -56.25 6.12 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.319 -1.113 . . . . 0.0 110.319 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 113' ' ' THR . . . . . 0.548 HG22 ' CD ' ' A' ' 11' ' ' GLU . 36.9 m -57.89 -25.32 60.66 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 114' ' ' ALA . . . . . 0.509 ' HB2' ' O ' ' B' ' 110' ' ' LEU . . . -68.85 -63.15 1.11 Allowed 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 0.621 HG22 ' CG ' ' C' ' 218' ' ' MET . 2.7 t -68.54 -21.29 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 116' ' ' ILE . . . . . 0.701 HD12 ' C ' ' B' ' 112' ' ' GLY . 34.5 mt -76.66 -64.66 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -51.11 -32.11 21.51 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 118' ' ' MET . . . . . 0.618 ' CG ' HG22 ' A' ' 15' ' ' VAL . 6.3 mtp -65.57 -59.72 3.67 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -53.16 -31.09 40.83 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -69.98 -42.94 72.45 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 121' ' ' TRP . . . . . 0.466 ' O ' HG23 ' B' ' 125' ' ' VAL . 44.0 t-105 -73.98 -27.27 60.9 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 122' ' ' LEU . . . . . 0.477 ' HA ' HD23 ' B' ' 122' ' ' LEU . 15.2 mt -71.86 -53.15 14.14 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . 0.743 HD12 ' C ' ' B' ' 123' ' ' LEU . 0.9 OUTLIER -61.5 -34.11 74.95 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . 0.481 ' N ' ' HG ' ' B' ' 123' ' ' LEU . 4.1 tt -63.5 -44.59 93.9 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . 0.466 HG23 ' O ' ' B' ' 121' ' ' TRP . 80.2 t -70.6 -23.41 24.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 0.721 HD12 ' HA ' ' B' ' 123' ' ' LEU . 49.4 mt -70.32 -44.39 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 37.0 mt -72.57 -38.13 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.418 ' HA ' HD23 ' B' ' 128' ' ' LEU . 24.9 mt -72.42 -36.71 68.67 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' B' ' 129' ' ' ARG . 33.9 ttm-85 -75.71 -41.98 52.1 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 3.8 m -62.11 -41.58 98.37 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 54.6 t -74.54 -42.91 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 132' ' ' LYS . . . . . 0.502 ' HB3' ' NZ ' ' B' ' 132' ' ' LYS . 7.5 mtpm? -56.33 -29.0 60.74 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 8.5 mmm180 -101.54 37.31 1.83 Allowed 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 134' ' ' ALA . . . . . . . . . . . . . . . -140.66 -9.48 1.06 Allowed 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -82.97 137.89 34.0 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -110.89 -102.8 2.7 Favored Glycine 0 CA--C 1.522 0.493 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.536 0 N-CA-C 110.261 -1.136 . . . . 0.0 110.261 -179.966 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 201' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 . . . . . 0 N--CA 1.449 -0.485 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 202' ' ' LYS . . . . . 0.535 ' N ' ' CD ' ' C' ' 202' ' ' LYS . 3.8 mptp? -84.58 -40.82 17.07 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 203' ' ' THR . . . . . . . . . . . . . 7.1 t -49.23 -36.03 19.0 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.946 -0.391 . . . . 0.0 109.946 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 204' ' ' ASN . . . . . 0.503 ' HA ' HG13 ' C' ' 207' ' ' ILE . 1.5 t30 -42.88 -51.14 5.63 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 205' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' C' ' 205' ' ' LEU . 12.8 mt -43.04 -48.53 6.08 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 206' ' ' GLU . . . . . 0.574 ' N ' ' CD ' ' C' ' 206' ' ' GLU . 3.8 mp0 -64.58 -31.43 72.64 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 207' ' ' ILE . . . . . 1.069 HG23 ' CD2' ' A' ' 10' ' ' LEU . 4.0 mt -65.14 -30.19 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 208' ' ' ILE . . . . . . . . . . . . . 73.3 mt -76.77 -42.26 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 209' ' ' ILE . . . . . 0.408 ' O ' ' HB ' ' C' ' 213' ' ' THR . 95.6 mt -76.74 -24.24 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 210' ' ' LEU . . . . . 1.046 ' CD2' HG23 ' B' ' 107' ' ' ILE . 15.4 mt -85.58 -47.28 10.01 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 211' ' ' GLU . . . . . 0.562 ' CD ' HG22 ' A' ' 13' ' ' THR . 57.1 mm-40 -59.03 -42.52 90.38 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 212' ' ' GLY . . . . . 0.693 ' C ' HD12 ' C' ' 216' ' ' ILE . . . -72.64 -56.27 6.13 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 213' ' ' THR . . . . . 0.561 HG22 ' CD ' ' B' ' 111' ' ' GLU . 38.3 m -57.82 -25.47 60.67 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 214' ' ' ALA . . . . . 0.502 ' HB2' ' O ' ' C' ' 210' ' ' LEU . . . -68.76 -63.19 1.11 Allowed 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 215' ' ' VAL . . . . . 0.624 HG22 ' CG ' ' A' ' 18' ' ' MET . 2.7 t -68.5 -21.33 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 216' ' ' ILE . . . . . 0.693 HD12 ' C ' ' C' ' 212' ' ' GLY . 34.3 mt -76.61 -64.62 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -51.11 -32.11 21.48 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 218' ' ' MET . . . . . 0.621 ' CG ' HG22 ' B' ' 115' ' ' VAL . 6.3 mtp -65.49 -60.14 3.25 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -53.92 -32.06 52.27 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -70.85 -42.05 70.65 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.835 -0.432 . . . . 0.0 109.835 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 221' ' ' TRP . . . . . 0.495 ' O ' HG23 ' C' ' 225' ' ' VAL . 43.9 t-105 -73.65 -26.78 60.91 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 222' ' ' LEU . . . . . 0.5 ' HA ' HD23 ' C' ' 222' ' ' LEU . 15.1 mt -71.82 -53.4 13.41 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 223' ' ' LEU . . . . . 0.736 ' C ' HD12 ' C' ' 223' ' ' LEU . 0.9 OUTLIER -61.55 -33.64 74.2 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.934 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 224' ' ' LEU . . . . . 0.469 ' N ' ' HG ' ' C' ' 223' ' ' LEU . 3.9 tt -63.8 -44.41 93.4 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 225' ' ' VAL . . . . . 0.495 HG23 ' O ' ' C' ' 221' ' ' TRP . 82.2 t -70.29 -23.49 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 226' ' ' ILE . . . . . 0.719 HD12 ' HA ' ' C' ' 223' ' ' LEU . 50.1 mt -70.41 -44.19 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 227' ' ' ILE . . . . . . . . . . . . . 37.3 mt -72.69 -38.02 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 228' ' ' LEU . . . . . 0.464 ' HA ' HD23 ' C' ' 228' ' ' LEU . 24.4 mt -72.41 -36.81 68.73 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 229' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' C' ' 229' ' ' ARG . 33.8 ttm-85 -75.46 -42.44 53.19 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 230' ' ' THR . . . . . . . . . . . . . 3.6 m -61.8 -41.31 97.58 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 55.6 t -74.36 -42.54 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 232' ' ' LYS . . . . . 0.514 ' NZ ' ' HB3' ' C' ' 232' ' ' LYS . 7.5 mtpm? -56.12 -29.36 60.57 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 233' ' ' ARG . . . . . . . . . . . . . 8.5 mmm180 -100.95 37.09 1.81 Allowed 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 234' ' ' ALA . . . . . . . . . . . . . . . -141.28 -9.3 0.98 Allowed 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 235' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -82.64 138.03 34.3 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 236' ' ' GLY . . . . . . . . . . . . . . . -110.89 -102.19 2.67 Favored Glycine 0 C--N 1.335 0.515 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.526 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 -179.986 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 56.7 tt0 . . . . . 0 N--CA 1.449 -0.5 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.427 ' HD3' ' HA ' ' A' ' 2' ' ' LYS . 35.6 mmtm -81.81 -50.7 8.92 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.4 t -43.67 -34.4 1.47 Allowed 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.508 ' HA ' HG13 ' A' ' 7' ' ' ILE . 1.6 t-20 -42.78 -50.85 5.57 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.535 ' HA ' HD23 ' A' ' 5' ' ' LEU . 11.5 mt -42.9 -48.61 5.86 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.585 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 2.1 mp0 -64.8 -31.58 72.88 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 1.066 HG23 ' CD2' ' B' ' 110' ' ' LEU . 4.2 mt -64.81 -30.26 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 66.1 mt -76.8 -42.74 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.415 ' O ' ' HB ' ' A' ' 13' ' ' THR . 18.9 mt -76.19 -24.0 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 1.046 ' CD2' HG23 ' C' ' 207' ' ' ILE . 15.8 mt -85.7 -52.78 5.56 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.54 ' CD ' HG22 ' B' ' 113' ' ' THR . 66.5 mm-40 -55.8 -40.96 73.45 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.684 ' C ' HD12 ' A' ' 16' ' ' ILE . . . -72.65 -54.99 6.93 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.589 HG22 ' CD ' ' C' ' 211' ' ' GLU . 17.2 m -57.7 -25.88 60.95 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.19 -63.38 1.08 Allowed 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.794 HG22 ' CG ' ' B' ' 118' ' ' MET . 2.6 t -67.57 -21.14 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.684 HD12 ' C ' ' A' ' 12' ' ' GLY . 32.6 mt -76.55 -64.6 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.42 -32.04 16.65 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.591 ' CE ' ' HE1' ' B' ' 118' ' ' MET . 6.5 mtp -71.04 -59.71 2.63 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.629 ' O ' HD12 ' A' ' 23' ' ' LEU . 2.4 m-85 -57.43 -23.73 51.34 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -67.85 -60.04 2.82 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 109.865 -0.421 . . . . 0.0 109.865 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 48.9 m0 -60.71 -41.43 95.21 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 22' ' ' LEU . 11.6 tp -65.04 -41.38 95.28 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.629 HD12 ' O ' ' A' ' 19' ' ' PHE . 4.8 mt -55.33 -45.48 76.38 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.4 mp -64.03 -38.93 92.86 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 53.9 t -69.68 -32.19 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 26' ' ' ILE . 37.8 mt -73.59 -36.35 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.468 ' O ' HG23 ' A' ' 31' ' ' VAL . 87.2 mt -69.95 -38.66 76.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 28' ' ' LEU . 87.0 mt -71.35 -43.77 66.34 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -66.95 -46.05 75.89 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.0 m -57.3 -43.41 83.17 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 27' ' ' ILE . 54.9 t -68.25 -46.41 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -50.0 -35.92 26.46 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 10.7 mmt85 -97.25 38.25 1.27 Allowed 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -142.5 -11.1 0.82 Allowed 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -96.09 150.78 20.11 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.68 -73.82 2.61 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.517 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -179.979 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 56.5 tt0 . . . . . 0 N--CA 1.45 -0.469 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . 0.414 ' HD3' ' HA ' ' B' ' 102' ' ' LYS . 35.5 mmtm -81.86 -50.44 9.2 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 6.3 t -44.02 -34.32 1.7 Allowed 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . 0.489 ' HA ' HG13 ' B' ' 107' ' ' ILE . 1.6 t-20 -42.97 -51.16 5.73 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 0.517 ' HA ' HD23 ' B' ' 105' ' ' LEU . 11.5 mt -42.97 -48.42 5.92 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 106' ' ' GLU . . . . . 0.58 ' CD ' ' N ' ' B' ' 106' ' ' GLU . 2.2 mp0 -64.55 -31.89 73.3 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 107' ' ' ILE . . . . . 1.038 HG23 ' CD2' ' C' ' 210' ' ' LEU . 4.0 mt -64.85 -29.73 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 66.3 mt -77.01 -42.91 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 109' ' ' ILE . . . . . 0.424 ' O ' ' HB ' ' B' ' 113' ' ' THR . 18.9 mt -76.33 -23.9 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . 1.066 ' CD2' HG23 ' A' ' 7' ' ' ILE . 15.4 mt -85.67 -50.78 6.92 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 111' ' ' GLU . . . . . 0.537 ' O ' HG23 ' B' ' 115' ' ' VAL . 63.9 mm-40 -57.23 -40.64 77.96 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 112' ' ' GLY . . . . . 0.67 ' C ' HD12 ' B' ' 116' ' ' ILE . . . -73.49 -55.77 5.91 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 113' ' ' THR . . . . . 0.54 HG22 ' CD ' ' A' ' 11' ' ' GLU . 22.2 m -57.86 -24.93 59.83 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.12 -62.69 1.29 Allowed 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 0.537 HG23 ' O ' ' B' ' 111' ' ' GLU . 3.1 t -68.27 -21.1 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 116' ' ' ILE . . . . . 0.67 HD12 ' C ' ' B' ' 112' ' ' GLY . 45.6 mt -79.61 -65.2 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -53.81 -27.98 32.62 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.786 -0.449 . . . . 0.0 109.786 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 118' ' ' MET . . . . . 0.794 ' CG ' HG22 ' A' ' 15' ' ' VAL . 11.9 mtp -72.85 -60.01 2.44 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 119' ' ' PHE . . . . . 0.508 ' O ' HD12 ' B' ' 123' ' ' LEU . 2.4 m-85 -57.81 -26.28 61.75 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -70.63 -58.97 3.11 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 121' ' ' TRP . . . . . 0.509 ' O ' HG23 ' B' ' 125' ' ' VAL . 49.2 m0 -59.06 -39.89 83.47 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 122' ' ' LEU . . . . . 0.452 ' HA ' HD12 ' B' ' 122' ' ' LEU . 11.6 tp -62.99 -42.47 99.86 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . 0.508 HD12 ' O ' ' B' ' 119' ' ' PHE . 4.9 mt -56.94 -46.77 81.83 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 4.4 mp -65.45 -36.85 85.15 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . 0.509 HG23 ' O ' ' B' ' 121' ' ' TRP . 53.7 t -67.76 -31.49 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 36.8 mt -72.64 -37.83 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 127' ' ' ILE . . . . . 0.454 ' O ' HG23 ' B' ' 131' ' ' VAL . 88.5 mt -70.32 -38.65 74.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.418 HD23 ' HA ' ' B' ' 128' ' ' LEU . 88.3 mt -71.05 -43.66 67.39 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -66.69 -46.29 76.06 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 6.0 m -57.46 -44.03 84.49 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.454 HG23 ' O ' ' B' ' 127' ' ' ILE . 54.4 t -68.27 -45.69 82.28 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -49.78 -35.74 23.59 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 10.8 mmt85 -96.66 38.46 1.21 Allowed 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 134' ' ' ALA . . . . . . . . . . . . . . . -143.14 -11.17 0.75 Allowed 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -96.07 150.58 20.34 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . 82.55 -74.3 2.53 Favored Glycine 0 CA--C 1.523 0.544 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.515 0 N-CA-C 110.281 -1.127 . . . . 0.0 110.281 179.997 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 201' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 . . . . . 0 N--CA 1.45 -0.457 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 202' ' ' LYS . . . . . 0.443 ' HD3' ' HA ' ' C' ' 202' ' ' LYS . 35.5 mmtm -81.89 -50.45 9.17 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 203' ' ' THR . . . . . . . . . . . . . 6.3 t -44.09 -34.61 1.84 Allowed 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 204' ' ' ASN . . . . . 0.493 ' HA ' HG13 ' C' ' 207' ' ' ILE . 1.6 t-20 -42.82 -51.12 5.56 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 205' ' ' LEU . . . . . 0.493 HD23 ' HA ' ' C' ' 205' ' ' LEU . 11.6 mt -42.95 -48.52 5.91 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 206' ' ' GLU . . . . . 0.574 ' N ' ' CD ' ' C' ' 206' ' ' GLU . 2.2 mp0 -64.66 -31.45 72.68 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 207' ' ' ILE . . . . . 1.046 HG23 ' CD2' ' A' ' 10' ' ' LEU . 4.2 mt -64.98 -30.28 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 208' ' ' ILE . . . . . . . . . . . . . 64.9 mt -76.74 -42.49 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 209' ' ' ILE . . . . . 0.423 ' O ' ' HB ' ' C' ' 213' ' ' THR . 18.7 mt -76.51 -24.09 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 210' ' ' LEU . . . . . 1.038 ' CD2' HG23 ' B' ' 107' ' ' ILE . 15.6 mt -85.71 -52.47 5.76 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 211' ' ' GLU . . . . . 0.589 ' CD ' HG22 ' A' ' 13' ' ' THR . 67.1 mm-40 -56.49 -40.69 75.38 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 212' ' ' GLY . . . . . 0.691 ' C ' HD12 ' C' ' 216' ' ' ILE . . . -72.7 -55.95 6.28 Favored Glycine 0 C--N 1.335 0.513 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 213' ' ' THR . . . . . 0.53 HG22 ' CD ' ' B' ' 111' ' ' GLU . 20.4 m -57.65 -25.3 60.0 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 214' ' ' ALA . . . . . . . . . . . . . . . -69.37 -63.26 1.1 Allowed 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 215' ' ' VAL . . . . . 0.533 HG23 ' O ' ' C' ' 211' ' ' GLU . 2.8 t -68.15 -21.09 26.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 216' ' ' ILE . . . . . 0.691 HD12 ' C ' ' C' ' 212' ' ' GLY . 37.8 mt -77.53 -64.67 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -50.99 -30.93 16.42 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 218' ' ' MET . . . . . 0.569 ' SD ' ' CE ' ' B' ' 118' ' ' MET . 6.9 mtp -71.29 -60.09 2.42 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 219' ' ' PHE . . . . . 0.473 ' O ' HD12 ' C' ' 223' ' ' LEU . 2.4 m-85 -58.8 -24.63 62.15 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -68.9 -58.51 4.05 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 221' ' ' TRP . . . . . . . . . . . . . 49.1 m0 -58.69 -40.68 84.3 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 222' ' ' LEU . . . . . 0.461 ' HA ' HD12 ' C' ' 222' ' ' LEU . 11.6 tp -64.03 -42.11 97.19 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 223' ' ' LEU . . . . . 0.473 HD12 ' O ' ' C' ' 219' ' ' PHE . 4.9 mt -56.58 -45.54 81.27 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 4.4 mp -64.09 -37.48 87.61 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 225' ' ' VAL . . . . . . . . . . . . . 53.8 t -67.95 -31.84 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 37.3 mt -73.44 -37.26 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 227' ' ' ILE . . . . . 0.478 ' O ' HG23 ' C' ' 231' ' ' VAL . 88.1 mt -69.72 -38.46 76.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 228' ' ' LEU . . . . . 0.434 ' HA ' HD23 ' C' ' 228' ' ' LEU . 86.8 mt -70.67 -43.55 68.89 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 229' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -66.9 -46.54 74.56 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 230' ' ' THR . . . . . . . . . . . . . 5.8 m -57.21 -43.84 83.13 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 231' ' ' VAL . . . . . 0.478 HG23 ' O ' ' C' ' 227' ' ' ILE . 54.0 t -68.22 -45.98 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 232' ' ' LYS . . . . . . . . . . . . . 24.3 tptm -49.75 -35.75 23.37 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 233' ' ' ARG . . . . . . . . . . . . . 10.7 mmt85 -96.72 38.47 1.22 Allowed 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 234' ' ' ALA . . . . . . . . . . . . . . . -143.15 -11.12 0.75 Allowed 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 235' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -95.75 150.82 19.97 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 236' ' ' GLY . . . . . . . . . . . . . . . 82.63 -74.08 2.57 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.54 0 N-CA-C 110.225 -1.15 . . . . 0.0 110.225 -179.991 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 . . . . . 0 N--CA 1.449 -0.493 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.444 ' HE2' ' HB2' ' A' ' 2' ' ' LYS . 10.2 tppt? -71.08 -23.43 62.12 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.662 HG21 ' CG ' ' B' ' 106' ' ' GLU . 1.6 m -69.07 -47.67 64.68 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.49 ' HA ' HG13 ' A' ' 7' ' ' ILE . 1.6 t30 -42.12 -47.22 4.54 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.545 HD23 ' HA ' ' A' ' 5' ' ' LEU . 12.3 mt -42.84 -50.34 5.7 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.668 ' CG ' HG21 ' C' ' 203' ' ' THR . 0.1 OUTLIER -66.08 -32.17 73.48 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 1.064 HG23 ' CD2' ' B' ' 110' ' ' LEU . 3.6 mt -65.01 -29.76 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 44.6 mt -76.93 -42.52 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.42 ' O ' ' HB ' ' A' ' 13' ' ' THR . 29.4 mt -76.74 -24.04 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 1.062 ' CD2' HG23 ' C' ' 207' ' ' ILE . 15.3 mt -85.73 -48.14 9.11 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.566 ' O ' HG23 ' A' ' 15' ' ' VAL . 60.6 mm-40 -58.81 -41.79 87.62 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.718 ' C ' HD12 ' A' ' 16' ' ' ILE . . . -72.96 -56.24 5.93 Favored Glycine 0 C--N 1.336 0.555 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.54 HG22 ' CD ' ' C' ' 211' ' ' GLU . 31.8 m -57.88 -25.72 61.15 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.494 ' HB2' ' O ' ' A' ' 10' ' ' LEU . . . -68.7 -63.09 1.13 Allowed 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.589 HG22 ' CG ' ' B' ' 118' ' ' MET . 2.7 t -68.31 -21.24 26.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.718 HD12 ' C ' ' A' ' 12' ' ' GLY . 30.5 mt -76.57 -64.68 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.93 -32.28 20.28 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.601 ' CE ' ' HE1' ' B' ' 118' ' ' MET . 6.5 mtp -65.47 -60.09 3.31 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.462 ' CD2' HD11 ' A' ' 23' ' ' LEU . 4.8 t80 -51.52 -34.93 38.38 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -64.52 -39.61 94.1 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 22.8 m0 -65.81 -55.36 17.57 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 67.0 mt -57.38 -38.07 73.65 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.462 HD11 ' CD2' ' A' ' 19' ' ' PHE . 15.0 mt -58.15 -51.08 71.21 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.465 ' HA ' HD12 ' A' ' 24' ' ' LEU . 15.4 tp -61.75 -29.6 70.23 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.848 -0.426 . . . . 0.0 109.848 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 75.8 t -74.3 -39.15 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 68.3 mt -73.58 -34.81 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.511 ' O ' HG23 ' A' ' 31' ' ' VAL . 62.3 mt -69.25 -46.62 77.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 109.751 -0.462 . . . . 0.0 109.751 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 28' ' ' LEU . 55.7 mt -66.04 -41.3 91.05 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.9 ttt180 -65.83 -52.08 53.55 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.1 m -52.71 -49.02 66.2 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 27' ' ' ILE . 62.3 t -57.93 -54.08 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.432 ' HE3' ' HB2' ' A' ' 32' ' ' LYS . 23.3 ttmt -51.68 -25.41 7.18 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -97.69 31.18 2.68 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.76 3.0 1.83 Allowed 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.413 ' CG ' ' N ' ' A' ' 36' ' ' GLY . 15.6 t30 -134.68 170.25 16.1 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.413 ' N ' ' CG ' ' A' ' 35' ' ' ASN . . . -53.8 -88.51 0.01 OUTLIER Glycine 0 C--N 1.335 0.5 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.514 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 -179.975 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 . . . . . 0 N--CA 1.449 -0.496 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . 0.46 ' HE2' ' HB2' ' B' ' 102' ' ' LYS . 10.2 tppt? -71.22 -23.51 62.03 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 103' ' ' THR . . . . . 0.671 HG21 ' CG ' ' C' ' 206' ' ' GLU . 1.6 m -69.02 -47.71 64.77 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . 0.495 ' HA ' HG13 ' B' ' 107' ' ' ILE . 1.6 t30 -42.13 -47.33 4.57 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 0.476 ' HA ' HD23 ' B' ' 105' ' ' LEU . 12.3 mt -42.75 -50.32 5.59 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 106' ' ' GLU . . . . . 0.662 ' CG ' HG21 ' A' ' 3' ' ' THR . 0.1 OUTLIER -66.14 -32.2 73.5 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.928 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 107' ' ' ILE . . . . . 1.053 HG23 ' CD2' ' C' ' 210' ' ' LEU . 3.5 mt -65.0 -29.79 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 44.7 mt -76.9 -42.53 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 109' ' ' ILE . . . . . 0.419 ' O ' ' HB ' ' B' ' 113' ' ' THR . 29.3 mt -76.71 -24.03 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . 1.064 ' CD2' HG23 ' A' ' 7' ' ' ILE . 15.3 mt -85.72 -47.63 9.58 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 111' ' ' GLU . . . . . 0.555 ' O ' HG23 ' B' ' 115' ' ' VAL . 59.7 mm-40 -59.07 -41.99 89.28 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 112' ' ' GLY . . . . . 0.715 ' C ' HD12 ' B' ' 116' ' ' ILE . . . -72.91 -56.15 6.01 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 113' ' ' THR . . . . . 0.554 HG22 ' CD ' ' A' ' 11' ' ' GLU . 32.8 m -57.88 -25.83 61.3 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 114' ' ' ALA . . . . . 0.498 ' HB2' ' O ' ' B' ' 110' ' ' LEU . . . -68.65 -63.07 1.13 Allowed 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 0.572 HG22 ' CG ' ' C' ' 218' ' ' MET . 2.7 t -68.32 -21.27 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 116' ' ' ILE . . . . . 0.715 HD12 ' C ' ' B' ' 112' ' ' GLY . 30.1 mt -76.33 -64.62 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -51.16 -32.14 22.28 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 118' ' ' MET . . . . . 0.605 ' CE ' ' HE1' ' C' ' 218' ' ' MET . 6.3 mtp -65.2 -59.65 3.86 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -49.11 -37.42 21.67 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -67.41 -39.74 85.53 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 121' ' ' TRP . . . . . 0.5 ' O ' HG23 ' B' ' 125' ' ' VAL . 22.8 m0 -65.93 -53.0 44.94 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 65.9 mt -55.13 -38.47 68.25 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . 0.434 HD23 ' HA ' ' B' ' 123' ' ' LEU . 15.1 mt -58.88 -52.03 67.5 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . 0.449 ' HA ' HD12 ' B' ' 124' ' ' LEU . 15.4 tp -63.34 -28.77 70.23 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . 0.5 HG23 ' O ' ' B' ' 121' ' ' TRP . 76.2 t -72.73 -38.22 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 68.1 mt -72.3 -35.27 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 127' ' ' ILE . . . . . 0.47 ' O ' HG23 ' B' ' 131' ' ' VAL . 62.9 mt -70.51 -47.27 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' B' ' 128' ' ' LEU . 56.1 mt -66.42 -40.78 89.74 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . 0.416 ' HD3' HH11 ' B' ' 129' ' ' ARG . 10.7 ttt180 -65.85 -52.18 52.57 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 4.1 m -52.69 -49.64 64.91 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.47 HG23 ' O ' ' B' ' 127' ' ' ILE . 67.8 t -58.31 -54.02 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 132' ' ' LYS . . . . . 0.47 ' HB2' ' HE3' ' B' ' 132' ' ' LYS . 23.7 ttmt -50.99 -25.26 4.48 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.921 -0.399 . . . . 0.0 109.921 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -97.09 30.8 2.61 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 134' ' ' ALA . . . . . . . . . . . . . . . -140.72 2.7 1.81 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 135' ' ' ASN . . . . . 0.422 ' CG ' ' N ' ' B' ' 136' ' ' GLY . 15.2 t30 -134.95 170.53 15.74 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 136' ' ' GLY . . . . . 0.422 ' N ' ' CG ' ' B' ' 135' ' ' ASN . . . -53.86 -88.98 0.01 OUTLIER Glycine 0 CA--C 1.523 0.567 0 N-CA-C 110.284 -1.126 . . . . 0.0 110.284 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.565 0 N-CA-C 110.246 -1.142 . . . . 0.0 110.246 -179.955 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 201' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 . . . . . 0 N--CA 1.449 -0.496 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 202' ' ' LYS . . . . . 0.489 ' HE2' ' HB2' ' C' ' 202' ' ' LYS . 10.2 tppt? -71.07 -23.46 62.14 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 203' ' ' THR . . . . . 0.668 HG21 ' CG ' ' A' ' 6' ' ' GLU . 1.6 m -69.13 -47.64 64.54 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 204' ' ' ASN . . . . . 0.502 ' HA ' HG13 ' C' ' 207' ' ' ILE . 1.6 t30 -42.1 -47.28 4.52 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 205' ' ' LEU . . . . . 0.527 HD23 ' HA ' ' C' ' 205' ' ' LEU . 12.3 mt -42.82 -50.24 5.68 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 206' ' ' GLU . . . . . 0.671 ' CG ' HG21 ' B' ' 103' ' ' THR . 0.1 OUTLIER -66.17 -32.27 73.61 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.938 -0.394 . . . . 0.0 109.938 179.938 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 207' ' ' ILE . . . . . 1.062 HG23 ' CD2' ' A' ' 10' ' ' LEU . 3.5 mt -64.95 -29.81 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 208' ' ' ILE . . . . . . . . . . . . . 44.9 mt -76.84 -42.56 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 209' ' ' ILE . . . . . 0.408 ' O ' ' HB ' ' C' ' 213' ' ' THR . 29.4 mt -76.67 -24.01 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 210' ' ' LEU . . . . . 1.053 ' CD2' HG23 ' B' ' 107' ' ' ILE . 15.4 mt -85.73 -47.64 9.57 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 211' ' ' GLU . . . . . 0.562 ' O ' HG23 ' C' ' 215' ' ' VAL . 59.3 mm-40 -59.09 -41.91 89.2 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 212' ' ' GLY . . . . . 0.72 ' C ' HD12 ' C' ' 216' ' ' ILE . . . -73.02 -56.08 5.98 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 213' ' ' THR . . . . . 0.55 HG22 ' CD ' ' B' ' 111' ' ' GLU . 34.0 m -57.93 -25.78 61.35 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 214' ' ' ALA . . . . . 0.494 ' HB2' ' O ' ' C' ' 210' ' ' LEU . . . -68.71 -63.03 1.14 Allowed 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 215' ' ' VAL . . . . . 0.567 HG22 ' CG ' ' A' ' 18' ' ' MET . 2.7 t -68.3 -21.41 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 216' ' ' ILE . . . . . 0.72 HD12 ' C ' ' C' ' 212' ' ' GLY . 30.4 mt -76.2 -64.64 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -51.05 -32.26 21.27 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 218' ' ' MET . . . . . 0.605 ' HE1' ' CE ' ' B' ' 118' ' ' MET . 6.4 mtp -65.08 -60.16 3.33 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -51.83 -37.45 51.91 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -67.38 -37.84 83.79 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 221' ' ' TRP . . . . . 0.636 ' O ' HG23 ' C' ' 225' ' ' VAL . 23.0 m0 -63.76 -53.65 47.72 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 66.7 mt -55.68 -40.1 71.85 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 223' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' C' ' 223' ' ' LEU . 15.1 mt -60.42 -51.27 70.21 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 224' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' C' ' 224' ' ' LEU . 15.4 tp -62.58 -27.71 69.38 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 225' ' ' VAL . . . . . 0.636 HG23 ' O ' ' C' ' 221' ' ' TRP . 75.5 t -71.87 -39.46 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 67.0 mt -73.37 -35.79 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 227' ' ' ILE . . . . . 0.44 ' O ' HG23 ' C' ' 231' ' ' VAL . 63.1 mt -70.4 -46.35 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 228' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' C' ' 228' ' ' LEU . 56.9 mt -66.01 -41.59 90.82 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 229' ' ' ARG . . . . . 0.415 ' HD3' HH11 ' C' ' 229' ' ' ARG . 10.9 ttt180 -65.44 -52.36 53.72 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 230' ' ' THR . . . . . . . . . . . . . 4.2 m -53.34 -49.36 67.27 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 231' ' ' VAL . . . . . 0.44 HG23 ' O ' ' C' ' 227' ' ' ILE . 54.6 t -58.95 -53.68 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 232' ' ' LYS . . . . . 0.422 ' HE3' ' HB2' ' C' ' 232' ' ' LYS . 23.6 ttmt -51.36 -25.41 6.02 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 233' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -97.06 30.72 2.63 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 234' ' ' ALA . . . . . . . . . . . . . . . -141.1 3.1 1.76 Allowed 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 235' ' ' ASN . . . . . 0.409 ' CG ' ' N ' ' C' ' 236' ' ' GLY . 15.4 t30 -134.28 170.1 16.21 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 236' ' ' GLY . . . . . 0.409 ' N ' ' CG ' ' C' ' 235' ' ' ASN . . . -54.19 -88.97 0.01 OUTLIER Glycine 0 C--N 1.335 0.479 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.485 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -179.991 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.452 ' HB3' ' H ' ' A' ' 2' ' ' LYS . 2.8 tp10 . . . . . 0 N--CA 1.449 -0.513 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.452 ' H ' ' HB3' ' A' ' 1' ' ' GLU . 0.0 OUTLIER -79.38 -59.94 2.56 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.478 HG23 ' N ' ' A' ' 4' ' ' ASN . 9.7 t -48.66 -41.2 30.65 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.911 -0.404 . . . . 0.0 109.911 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.507 ' HA ' HG13 ' A' ' 7' ' ' ILE . 0.9 OUTLIER -42.77 -50.13 5.64 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.49 ' HA ' HD23 ' A' ' 5' ' ' LEU . 17.3 mt -42.88 -49.09 5.9 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.588 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 0.3 OUTLIER -64.57 -32.24 73.81 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.917 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 1.042 HG23 ' CD2' ' B' ' 110' ' ' LEU . 3.6 mt -65.19 -29.42 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 19.7 mt -76.92 -42.44 32.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.427 ' O ' ' HB ' ' A' ' 13' ' ' THR . 85.2 mt -77.29 -23.61 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 1.065 ' CD2' HG23 ' C' ' 207' ' ' ILE . 15.4 mt -85.77 -51.03 6.69 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.582 ' O ' HG23 ' A' ' 15' ' ' VAL . 66.7 mm-40 -58.63 -39.78 81.47 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.686 ' C ' HD12 ' A' ' 16' ' ' ILE . . . -73.42 -57.58 5.01 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.31 -1.116 . . . . 0.0 110.31 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.427 ' HB ' ' O ' ' A' ' 9' ' ' ILE . 46.2 m -57.88 -25.08 60.3 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.485 ' HB2' ' O ' ' A' ' 10' ' ' LEU . . . -68.81 -63.03 1.14 Allowed 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 11' ' ' GLU . 2.5 t -69.0 -21.08 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.686 HD12 ' C ' ' A' ' 12' ' ' GLY . 38.0 mt -77.45 -64.85 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.429 ' O ' ' CB ' ' A' ' 21' ' ' TRP . . . -51.13 -32.03 21.52 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.622 ' CE ' ' HE1' ' B' ' 118' ' ' MET . 6.9 mtp -68.65 -60.11 2.64 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -61.53 -61.65 2.38 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -43.17 -41.83 3.92 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.697 ' O ' HG23 ' A' ' 25' ' ' VAL . 9.5 t-105 -64.55 -44.27 91.31 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 22' ' ' LEU . 35.5 mt -59.01 -52.11 67.18 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 21.6 mt -54.44 -44.73 72.75 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.1 tp -59.52 -32.65 70.5 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 21' ' ' TRP . 84.3 t -72.44 -43.13 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 60.3 mt -65.14 -37.14 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.0 mt -70.5 -44.46 77.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 75.9 mt -66.03 -38.62 88.88 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 36.3 ttm105 -70.77 -47.35 60.04 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.6 m -57.83 -40.63 80.49 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 79.3 t -74.94 -39.97 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 34.1 tttp -55.37 -30.9 61.24 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 65.2 mtp180 -95.81 34.19 1.56 Allowed 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.838 -0.431 . . . . 0.0 109.838 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -136.96 9.92 3.05 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -117.34 160.4 21.19 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -104.56 106.17 2.69 Favored Glycine 0 C--N 1.336 0.558 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.517 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 -179.982 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 . . . . . 0 N--CA 1.449 -0.491 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.63 -59.13 2.92 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 103' ' ' THR . . . . . 0.489 HG23 ' N ' ' B' ' 104' ' ' ASN . 9.0 t -47.76 -41.85 24.24 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . 0.496 ' HA ' HG13 ' B' ' 107' ' ' ILE . 1.0 OUTLIER -42.96 -51.2 5.7 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' B' ' 105' ' ' LEU . 17.7 mt -43.05 -48.55 6.13 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 106' ' ' GLU . . . . . 0.583 ' CD ' ' N ' ' B' ' 106' ' ' GLU . 0.3 OUTLIER -64.27 -31.74 73.07 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 107' ' ' ILE . . . . . 1.061 HG23 ' CD2' ' C' ' 210' ' ' LEU . 3.8 mt -65.23 -29.86 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 20.3 mt -76.68 -42.19 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 109' ' ' ILE . . . . . 0.416 ' O ' ' HB ' ' B' ' 113' ' ' THR . 84.0 mt -77.39 -23.78 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . 1.042 ' CD2' HG23 ' A' ' 7' ' ' ILE . 15.6 mt -85.68 -50.95 6.79 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 111' ' ' GLU . . . . . 0.602 ' O ' HG23 ' B' ' 115' ' ' VAL . 67.3 mm-40 -58.63 -39.8 81.54 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 112' ' ' GLY . . . . . 0.677 ' C ' HD12 ' B' ' 116' ' ' ILE . . . -73.42 -57.59 5.0 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.233 -1.147 . . . . 0.0 110.233 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 113' ' ' THR . . . . . 0.416 ' HB ' ' O ' ' B' ' 109' ' ' ILE . 45.0 m -57.83 -25.17 60.27 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.938 -0.394 . . . . 0.0 109.938 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 114' ' ' ALA . . . . . 0.479 ' HB2' ' O ' ' B' ' 110' ' ' LEU . . . -68.8 -63.04 1.14 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 0.602 HG23 ' O ' ' B' ' 111' ' ' GLU . 2.5 t -68.97 -21.12 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 116' ' ' ILE . . . . . 0.677 HD12 ' C ' ' B' ' 112' ' ' GLY . 37.2 mt -77.24 -64.82 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . 0.409 ' O ' ' CB ' ' B' ' 121' ' ' TRP . . . -50.98 -32.26 20.56 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 118' ' ' MET . . . . . 0.622 ' HE1' ' CE ' ' A' ' 18' ' ' MET . 6.7 mtp -68.93 -60.11 2.59 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 2.4 m-30 -60.43 -61.74 2.37 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -43.16 -43.36 4.55 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 121' ' ' TRP . . . . . 0.591 ' O ' HG23 ' B' ' 125' ' ' VAL . 9.7 t-105 -66.11 -43.8 86.17 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 122' ' ' LEU . . . . . 0.434 ' HA ' HD23 ' B' ' 122' ' ' LEU . 36.0 mt -58.26 -50.97 71.71 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . . . . . . . . . 21.8 mt -53.39 -44.95 69.06 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . . . . . . . . . 4.1 tp -59.95 -34.06 72.76 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . 0.591 HG23 ' O ' ' B' ' 121' ' ' TRP . 80.4 t -73.72 -43.21 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 59.9 mt -65.05 -36.78 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 22.8 mt -70.65 -44.54 76.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.475 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 75.0 mt -65.75 -38.62 89.61 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . . . . . . . . . 36.4 ttm105 -71.05 -47.12 60.28 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 4.4 m -58.15 -40.34 81.12 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 77.3 t -75.07 -40.52 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 33.8 tttp -55.08 -31.3 61.08 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 65.3 mtp180 -95.94 34.49 1.53 Allowed 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 134' ' ' ALA . . . . . . . . . . . . . . . -137.21 9.68 2.98 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -117.43 160.56 20.97 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . -104.3 106.14 2.71 Favored Glycine 0 CA--C 1.522 0.481 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.522 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.974 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 201' ' ' GLU . . . . . 0.407 ' HB3' ' H ' ' C' ' 202' ' ' LYS . 2.3 tp10 . . . . . 0 N--CA 1.449 -0.524 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 202' ' ' LYS . . . . . 0.407 ' H ' ' HB3' ' C' ' 201' ' ' GLU . 0.0 OUTLIER -73.32 -58.89 2.99 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 203' ' ' THR . . . . . 0.483 HG23 ' N ' ' C' ' 204' ' ' ASN . 8.9 t -46.74 -42.21 16.39 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 204' ' ' ASN . . . . . 0.494 ' HA ' HG13 ' C' ' 207' ' ' ILE . 1.0 OUTLIER -43.06 -51.4 5.79 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.937 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 205' ' ' LEU . . . . . 0.514 HD23 ' HA ' ' C' ' 205' ' ' LEU . 17.8 mt -43.06 -48.33 6.11 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 206' ' ' GLU . . . . . 0.581 ' N ' ' CD ' ' C' ' 206' ' ' GLU . 0.3 OUTLIER -64.24 -31.92 73.31 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 207' ' ' ILE . . . . . 1.065 HG23 ' CD2' ' A' ' 10' ' ' LEU . 3.8 mt -65.21 -29.7 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 208' ' ' ILE . . . . . . . . . . . . . 19.9 mt -76.79 -42.18 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 209' ' ' ILE . . . . . 0.419 ' O ' ' HB ' ' C' ' 213' ' ' THR . 83.8 mt -77.36 -23.86 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 210' ' ' LEU . . . . . 1.061 ' CD2' HG23 ' B' ' 107' ' ' ILE . 15.3 mt -85.58 -50.75 6.98 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 211' ' ' GLU . . . . . 0.579 ' O ' HG23 ' C' ' 215' ' ' VAL . 66.6 mm-40 -58.59 -40.18 82.49 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 212' ' ' GLY . . . . . 0.679 ' C ' HD12 ' C' ' 216' ' ' ILE . . . -73.2 -57.53 5.13 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 213' ' ' THR . . . . . 0.419 ' HB ' ' O ' ' C' ' 209' ' ' ILE . 46.0 m -57.73 -25.22 60.09 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 214' ' ' ALA . . . . . 0.492 ' HB2' ' O ' ' C' ' 210' ' ' LEU . . . -68.7 -63.04 1.14 Allowed 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 215' ' ' VAL . . . . . 0.579 HG23 ' O ' ' C' ' 211' ' ' GLU . 2.6 t -69.02 -21.11 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 216' ' ' ILE . . . . . 0.679 HD12 ' C ' ' C' ' 212' ' ' GLY . 37.1 mt -77.17 -64.72 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 217' ' ' ALA . . . . . 0.427 ' O ' ' CB ' ' C' ' 221' ' ' TRP . . . -51.22 -32.25 23.35 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 218' ' ' MET . . . . . 0.597 ' HE1' ' CE ' ' B' ' 118' ' ' MET . 6.6 mtp -68.33 -60.24 2.6 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -60.82 -61.41 2.6 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -43.48 -43.07 5.19 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 221' ' ' TRP . . . . . 0.702 ' O ' HG23 ' C' ' 225' ' ' VAL . 9.7 t-105 -65.94 -43.41 88.12 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 36.4 mt -56.89 -51.35 69.42 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 223' ' ' LEU . . . . . . . . . . . . . 21.9 mt -53.97 -45.83 71.48 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 4.1 tp -60.97 -33.11 72.71 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 225' ' ' VAL . . . . . 0.702 HG23 ' O ' ' C' ' 221' ' ' TRP . 85.0 t -72.69 -42.49 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 60.0 mt -64.43 -36.67 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 109.784 -0.451 . . . . 0.0 109.784 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 227' ' ' ILE . . . . . 0.406 ' O ' HG23 ' C' ' 231' ' ' VAL . 23.4 mt -70.5 -44.51 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 228' ' ' LEU . . . . . . . . . . . . . 75.1 mt -66.16 -38.96 89.36 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 229' ' ' ARG . . . . . . . . . . . . . 36.3 ttm105 -70.49 -47.0 62.62 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 230' ' ' THR . . . . . . . . . . . . . 3.8 m -57.76 -39.78 78.2 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 231' ' ' VAL . . . . . 0.406 HG23 ' O ' ' C' ' 227' ' ' ILE . 79.6 t -75.34 -40.51 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 232' ' ' LYS . . . . . . . . . . . . . 34.0 tttp -54.81 -31.27 58.95 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 233' ' ' ARG . . . . . . . . . . . . . 65.1 mtp180 -96.1 34.7 1.53 Allowed 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 234' ' ' ALA . . . . . . . . . . . . . . . -137.36 9.92 2.96 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 235' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -117.27 159.86 22.02 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 236' ' ' GLY . . . . . . . . . . . . . . . -104.88 105.89 2.61 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.524 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 -179.958 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 . . . . . 0 N--CA 1.449 -0.516 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 13.9 tptt -79.52 -45.31 19.53 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.2 t -43.53 -33.32 1.1 Allowed 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.508 ' HA ' HG13 ' A' ' 7' ' ' ILE . 1.0 OUTLIER -42.79 -51.28 5.45 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.489 ' HA ' HD23 ' A' ' 5' ' ' LEU . 12.1 mt -43.03 -48.43 6.03 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.587 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 1.8 mp0 -64.59 -31.3 72.45 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 1.039 HG23 ' CD2' ' B' ' 110' ' ' LEU . 4.1 mt -65.34 -30.07 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 73.9 mt -76.89 -42.05 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.418 ' O ' ' HB ' ' A' ' 13' ' ' THR . 15.9 mt -76.95 -24.29 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 1.026 ' CD2' HG23 ' C' ' 207' ' ' ILE . 15.4 mt -85.39 -49.85 7.78 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.558 ' CD ' HG22 ' B' ' 113' ' ' THR . 61.7 mm-40 -57.87 -42.04 83.73 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.855 ' C ' HD12 ' A' ' 16' ' ' ILE . . . -72.02 -55.95 6.79 Favored Glycine 0 C--N 1.335 0.475 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.575 HG22 ' CD ' ' C' ' 211' ' ' GLU . 23.7 m -57.95 -25.38 60.88 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.429 ' HB2' ' O ' ' A' ' 10' ' ' LEU . . . -68.52 -63.09 1.13 Allowed 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.598 HG22 ' HG3' ' B' ' 118' ' ' MET . 2.7 t -68.95 -21.13 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.855 HD12 ' C ' ' A' ' 12' ' ' GLY . 23.3 mt -76.54 -64.68 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.88 -33.44 24.02 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.664 ' HE2' ' HE1' ' B' ' 118' ' ' MET . 6.7 mtp -68.86 -60.03 2.66 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -55.11 -24.21 24.67 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -74.5 -39.91 62.14 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.419 ' O ' HG23 ' A' ' 25' ' ' VAL . 3.0 m95 -75.61 -35.42 60.53 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 13.0 mt -66.9 -54.15 25.05 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.735 HD12 ' C ' ' A' ' 23' ' ' LEU . 1.1 pp -59.44 -37.34 77.86 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.586 ' C ' HD23 ' A' ' 24' ' ' LEU . 6.1 tt -59.16 -42.48 90.86 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 21' ' ' TRP . 96.9 t -74.09 -23.48 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.662 HD12 ' HA ' ' A' ' 23' ' ' LEU . 57.7 mt -71.45 -43.68 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.59 ' O ' HG23 ' A' ' 31' ' ' VAL . 25.1 mt -71.09 -39.02 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.463 ' HA ' HD23 ' A' ' 28' ' ' LEU . 24.4 mt -69.61 -44.22 71.15 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.497 ' HG2' ' NH1' ' A' ' 29' ' ' ARG . 6.1 ttt-85 -68.17 -48.03 66.38 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.9 m -53.36 -44.49 68.59 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.59 HG23 ' O ' ' A' ' 27' ' ' ILE . 55.7 t -62.29 -46.96 95.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.445 ' HA ' ' HD3' ' A' ' 32' ' ' LYS . 15.2 tppt? -53.57 -32.55 51.33 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 6.4 mmt180 -97.56 36.05 1.56 Allowed 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -140.57 3.56 1.9 Allowed 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -85.18 142.63 29.32 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.29 -102.18 2.44 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.508 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 -179.984 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 101' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 . . . . . 0 N--CA 1.45 -0.456 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 102' ' ' LYS . . . . . . . . . . . . . 13.9 tptt -79.69 -45.33 19.18 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 103' ' ' THR . . . . . . . . . . . . . 5.2 t -43.54 -33.33 1.11 Allowed 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . 0.498 ' HA ' HG13 ' B' ' 107' ' ' ILE . 1.0 OUTLIER -42.81 -51.23 5.5 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 0.469 ' HA ' HD23 ' B' ' 105' ' ' LEU . 12.0 mt -43.05 -48.45 6.1 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 106' ' ' GLU . . . . . 0.588 ' CD ' ' N ' ' B' ' 106' ' ' GLU . 1.8 mp0 -64.62 -31.33 72.5 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 107' ' ' ILE . . . . . 1.035 HG23 ' CD2' ' C' ' 210' ' ' LEU . 4.1 mt -65.28 -30.18 49.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 108' ' ' ILE . . . . . . . . . . . . . 74.6 mt -76.84 -42.03 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 109' ' ' ILE . . . . . 0.423 ' O ' ' HB ' ' B' ' 113' ' ' THR . 16.1 mt -76.99 -24.32 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . 1.039 ' CD2' HG23 ' A' ' 7' ' ' ILE . 15.4 mt -85.44 -49.59 7.97 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 111' ' ' GLU . . . . . 0.542 ' CD ' HG22 ' C' ' 213' ' ' THR . 61.5 mm-40 -57.99 -42.21 84.66 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 112' ' ' GLY . . . . . 0.85 ' C ' HD12 ' B' ' 116' ' ' ILE . . . -71.95 -55.94 6.84 Favored Glycine 0 C--N 1.336 0.547 0 N-CA-C 110.279 -1.129 . . . . 0.0 110.279 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 113' ' ' THR . . . . . 0.558 HG22 ' CD ' ' A' ' 11' ' ' GLU . 24.1 m -57.91 -25.58 61.05 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 114' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' B' ' 110' ' ' LEU . . . -68.34 -63.04 1.14 Allowed 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 115' ' ' VAL . . . . . 0.588 HG22 ' HG3' ' C' ' 218' ' ' MET . 2.7 t -68.98 -21.07 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 116' ' ' ILE . . . . . 0.85 HD12 ' C ' ' B' ' 112' ' ' GLY . 22.0 mt -76.2 -64.66 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -50.78 -34.02 25.69 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 118' ' ' MET . . . . . 0.664 ' HE1' ' HE2' ' A' ' 18' ' ' MET . 6.5 mtp -68.63 -59.57 3.03 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 119' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -54.1 -24.2 16.75 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -74.79 -41.05 60.72 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 121' ' ' TRP . . . . . 0.433 ' O ' HG23 ' B' ' 125' ' ' VAL . 2.9 m95 -75.13 -34.1 61.62 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 122' ' ' LEU . . . . . . . . . . . . . 12.9 mt -67.2 -54.68 18.86 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 123' ' ' LEU . . . . . 0.729 HD12 ' C ' ' B' ' 123' ' ' LEU . 1.0 OUTLIER -58.71 -38.15 77.69 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 124' ' ' LEU . . . . . 0.586 ' C ' HD23 ' B' ' 124' ' ' LEU . 6.1 tt -58.74 -42.61 89.19 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 125' ' ' VAL . . . . . 0.433 HG23 ' O ' ' B' ' 121' ' ' TRP . 97.4 t -74.61 -23.52 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . 0.683 HD12 ' HA ' ' B' ' 123' ' ' LEU . 54.3 mt -71.07 -43.56 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 127' ' ' ILE . . . . . 0.576 ' O ' HG23 ' B' ' 131' ' ' VAL . 24.6 mt -71.33 -38.78 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.504 ' HA ' HD23 ' B' ' 128' ' ' LEU . 24.5 mt -70.03 -44.02 70.12 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 129' ' ' ARG . . . . . 0.493 ' HG2' ' NH1' ' B' ' 129' ' ' ARG . 6.4 ttt-85 -68.43 -47.72 66.46 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 130' ' ' THR . . . . . . . . . . . . . 5.2 m -53.5 -44.4 69.04 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.576 HG23 ' O ' ' B' ' 127' ' ' ILE . 53.9 t -62.24 -46.98 95.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 132' ' ' LYS . . . . . 0.412 ' HA ' ' HD3' ' B' ' 132' ' ' LYS . 15.1 tppt? -53.81 -31.66 49.92 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 133' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' B' ' 133' ' ' ARG . 6.2 mmt180 -98.23 36.17 1.64 Allowed 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 134' ' ' ALA . . . . . . . . . . . . . . . -140.24 3.65 1.97 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 135' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -84.94 143.07 29.22 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 136' ' ' GLY . . . . . . . . . . . . . . . 100.57 -101.1 2.25 Favored Glycine 0 C--N 1.335 0.496 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 137' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.513 0 N-CA-C 110.298 -1.121 . . . . 0.0 110.298 179.994 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 201' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 . . . . . 0 N--CA 1.45 -0.47 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 202' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -79.64 -45.49 18.97 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 203' ' ' THR . . . . . . . . . . . . . 5.1 t -43.44 -33.51 1.09 Allowed 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 204' ' ' ASN . . . . . 0.494 ' HA ' HG13 ' C' ' 207' ' ' ILE . 1.0 OUTLIER -42.85 -51.09 5.6 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 205' ' ' LEU . . . . . 0.49 HD23 ' HA ' ' C' ' 205' ' ' LEU . 12.0 mt -43.04 -48.46 6.08 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 206' ' ' GLU . . . . . 0.582 ' N ' ' CD ' ' C' ' 206' ' ' GLU . 1.8 mp0 -64.62 -31.34 72.51 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 207' ' ' ILE . . . . . 1.026 HG23 ' CD2' ' A' ' 10' ' ' LEU . 4.1 mt -65.23 -30.16 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 208' ' ' ILE . . . . . . . . . . . . . 74.3 mt -76.83 -42.2 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 209' ' ' ILE . . . . . 0.424 ' O ' ' HB ' ' C' ' 213' ' ' THR . 16.1 mt -76.8 -24.32 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 210' ' ' LEU . . . . . 1.035 ' CD2' HG23 ' B' ' 107' ' ' ILE . 15.4 mt -85.44 -49.5 8.05 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 211' ' ' GLU . . . . . 0.575 ' CD ' HG22 ' A' ' 13' ' ' THR . 60.8 mm-40 -57.92 -42.29 84.51 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 212' ' ' GLY . . . . . 0.847 ' C ' HD12 ' C' ' 216' ' ' ILE . . . -72.08 -55.83 6.82 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 213' ' ' THR . . . . . 0.542 HG22 ' CD ' ' B' ' 111' ' ' GLU . 23.9 m -57.85 -25.49 60.78 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 214' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' C' ' 210' ' ' LEU . . . -68.48 -63.09 1.13 Allowed 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 215' ' ' VAL . . . . . 0.612 HG22 ' CG ' ' A' ' 18' ' ' MET . 2.8 t -68.89 -21.09 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 216' ' ' ILE . . . . . 0.847 HD12 ' C ' ' C' ' 212' ' ' GLY . 23.1 mt -76.51 -64.8 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 217' ' ' ALA . . . . . . . . . . . . . . . -50.78 -33.37 23.03 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 218' ' ' MET . . . . . 0.618 ' HE1' ' CE ' ' B' ' 118' ' ' MET . 6.5 mtp -68.9 -60.19 2.55 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 219' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -54.07 -25.02 19.48 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -75.58 -38.5 59.07 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 221' ' ' TRP . . . . . 0.48 ' O ' HG23 ' C' ' 225' ' ' VAL . 3.0 m95 -75.28 -33.69 61.27 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 222' ' ' LEU . . . . . . . . . . . . . 13.1 mt -66.95 -54.67 19.73 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 223' ' ' LEU . . . . . 0.739 ' C ' HD12 ' C' ' 223' ' ' LEU . 1.1 pp -59.46 -37.62 78.65 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 224' ' ' LEU . . . . . 0.578 ' C ' HD23 ' C' ' 224' ' ' LEU . 6.2 tt -59.23 -41.31 88.37 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 225' ' ' VAL . . . . . 0.48 HG23 ' O ' ' C' ' 221' ' ' TRP . 97.4 t -74.36 -24.04 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 226' ' ' ILE . . . . . 0.654 HD12 ' HA ' ' C' ' 223' ' ' LEU . 59.3 mt -71.12 -43.39 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 227' ' ' ILE . . . . . 0.565 ' O ' HG23 ' C' ' 231' ' ' VAL . 24.2 mt -71.38 -38.88 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 228' ' ' LEU . . . . . 0.489 ' HA ' HD23 ' C' ' 228' ' ' LEU . 23.8 mt -69.77 -44.28 70.48 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 229' ' ' ARG . . . . . 0.498 ' NH1' ' HG2' ' C' ' 229' ' ' ARG . 6.1 ttt-85 -68.1 -48.19 66.15 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 230' ' ' THR . . . . . . . . . . . . . 4.3 m -53.11 -44.62 67.79 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 231' ' ' VAL . . . . . 0.565 HG23 ' O ' ' C' ' 227' ' ' ILE . 53.6 t -62.44 -46.8 95.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 232' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' C' ' 232' ' ' LYS . 15.1 tppt? -53.22 -31.64 44.2 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 233' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' C' ' 233' ' ' ARG . 6.2 mmt180 -97.73 35.82 1.62 Allowed 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 234' ' ' ALA . . . . . . . . . . . . . . . -140.5 3.81 1.93 Allowed 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 235' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -84.79 143.21 29.26 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 236' ' ' GLY . . . . . . . . . . . . . . . 100.8 -101.58 2.31 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 237' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.533 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.995 . . . . . . . . 0 0 . 1 stop_ save_